
<html lang="en"     class="pb-page"  data-request-id="6e7ef33b-942a-41d5-b812-aae69e8a23c4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00728;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases" /></meta><meta name="dc.Creator" content="Orville&#xA;A.  Pemberton" /></meta><meta name="dc.Creator" content="Priyadarshini  Jaishankar" /></meta><meta name="dc.Creator" content="Afroza  Akhtar" /></meta><meta name="dc.Creator" content="Jessie L.  Adams" /></meta><meta name="dc.Creator" content="Lindsey N.  Shaw" /></meta><meta name="dc.Creator" content="Adam R.  Renslo" /></meta><meta name="dc.Creator" content="Yu  Chen" /></meta><meta name="dc.Description" content="Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam ant..." /></meta><meta name="Description" content="Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam ant..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00728" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00728" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00728" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00728" /></link>
        
    
    

<title>Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00728" /></meta><meta property="og:title" content="Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0007.jpeg" /></meta><meta property="og:description" content="Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam antibiotics. Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2. The most potent lead, compound 16, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2. Compound 16 potentiated imipenem efficacy against resistant clinical and laboratory bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concentrations above 100 μg/mL. Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes. These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-negative pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00728"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00728">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00728&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00728&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00728&amp;href=/doi/10.1021/acs.jmedchem.9b00728" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8480-8496</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00565" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00763" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Orville A. Pemberton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Orville A. Pemberton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Orville%0AA.++Pemberton">Orville A. Pemberton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Priyadarshini Jaishankar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Priyadarshini Jaishankar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, 600 16th Street, Genentech Hall N574, San Francisco, California 94158, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Priyadarshini++Jaishankar">Priyadarshini Jaishankar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Afroza Akhtar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Afroza Akhtar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Afroza++Akhtar">Afroza Akhtar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessie L. Adams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessie L. Adams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell Biology, Microbiology & Molecular Biology, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessie+L.++Adams">Jessie L. Adams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lindsey N. Shaw</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lindsey N. Shaw</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cell Biology, Microbiology & Molecular Biology, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lindsey+N.++Shaw">Lindsey N. Shaw</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0629-8990" title="Orcid link">http://orcid.org/0000-0002-0629-8990</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam R. Renslo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam R. Renslo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, 600 16th Street, Genentech Hall N574, San Francisco, California 94158, United States</div></div><span class="conrtib-corresp"><strong>*</strong>A.R.R.: phone, (415) 514-9698; fax, (415) 514-4507; e-mail, <a href="/cdn-cgi/l/email-protection#14757075793a66717a67787b54617767723a717061"><span class="__cf_email__" data-cfemail="78191c1915560a1d160b1417380d1b0b1e561d1c0d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam+R.++Renslo">Adam R. Renslo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link">http://orcid.org/0000-0002-1240-2846</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yu Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Y.C.: phone, (813) 974-7809; fax, (813) 974-7357; e-mail, <a href="/cdn-cgi/l/email-protection#d2abb1bab7bce392bab7b3bea6bafca7a1b4fcb7b6a7"><span class="__cf_email__" data-cfemail="d9a0bab1bcb7e899b1bcb8b5adb1f7acaabff7bcbdac">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Chen">Yu Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5115-3600" title="Orcid link">http://orcid.org/0000-0002-5115-3600</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00728&amp;href=/doi/10.1021%2Facs.jmedchem.9b00728" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8480–8496</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 4, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2019</li><li><span class="item_label"><b>Published</b> online</span>4 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00728" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00728</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8480%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DOrville%250AA.%2BPemberton%252C%2BPriyadarshini%2BJaishankar%252C%2BAfroza%2BAkhtar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b00728%26title%3DHeteroaryl%2BPhosphonates%2Bas%2BNoncovalent%2BInhibitors%2Bof%2BBoth%2BSerine-%2Band%2BMetallocarbapenemases%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8496%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00728"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2266</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00728" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Orville\nA.&quot;,&quot;last_name&quot;:&quot;Pemberton&quot;},{&quot;first_name&quot;:&quot;Priyadarshini&quot;,&quot;last_name&quot;:&quot;Jaishankar&quot;},{&quot;first_name&quot;:&quot;Afroza&quot;,&quot;last_name&quot;:&quot;Akhtar&quot;},{&quot;first_name&quot;:&quot;Jessie&quot;,&quot;last_name&quot;:&quot;L. Adams&quot;},{&quot;first_name&quot;:&quot;Lindsey&quot;,&quot;last_name&quot;:&quot;N. Shaw&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;R. Renslo&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8480-8496&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00728&quot;},&quot;abstract&quot;:&quot;Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam antibiotics. Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2. The most potent lead, compound 16, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2. Compound 16 potentiated imipenem efficacy against resistant clinical and laboratory bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concentrations above 100 μg/mL. Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes. These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-negative pathogens an&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00728&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00728" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00728&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00728" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00728&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00728" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00728&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00728&amp;href=/doi/10.1021/acs.jmedchem.9b00728" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00728" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00728" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00728%26sid%3Dliteratum%253Aachs%26pmid%3D31483651%26genre%3Darticle%26aulast%3DPemberton%26date%3D2019%26atitle%3DHeteroaryl%2BPhosphonates%2Bas%2BNoncovalent%2BInhibitors%2Bof%2BBoth%2BSerine-%2Band%2BMetallocarbapenemases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D18%26spage%3D8480%26epage%3D8496%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291157" title="Organophosphorus compounds">Organophosphorus compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/jmcmar.2019.62.issue-18/20190926/jmcmar.2019.62.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Gram-negative pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), especially those with carbapenemase activity, threaten the clinical utility of almost all β-lactam antibiotics. Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2. The most potent lead, compound <b>16</b>, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2. Compound <b>16</b> potentiated imipenem efficacy against resistant clinical and laboratory bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concentrations above 100 μg/mL. Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes. These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-negative pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The penicillins were among the first effective antibiotics, and current generation β-lactams such as the cephalosporins and carbapenems remain crucial agents in the treatment of serious, life-threatening bacterial infections.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Resistance to β-lactam antibiotics most commonly involves the production of β-lactamase enzymes that hydrolyze the β-lactam ring.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There are four classes of β-lactamase (A, B, C, and D), which differ from one another based on their amino acid sequence and mechanism of action. Classes A, C, and D are serine β-lactamases (SBLs), whereas class B are metallo-β-lactamases (MBLs) that use either one or two zinc ions to promote the hydrolysis reaction.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a></div><div class="NLM_p">Carbapenems (e.g., imipenem, meropenem, doripenem, and ertapenem) are often considered to be “last-resort” antibiotics on account of their effectiveness in treating serious, multidrug resistant infections.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Unfortunately, the recent emergence of carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) and multidrug resistant <i>Pseudomonas aeruginosa</i> threatens the utility of all currently available β-lactam antibiotics. CRE and <i>P. aeruginosa</i> infections are associated with high rates of morbidity and mortality worldwide due to limited treatment options.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> Carbapenem resistance in CRE and <i>P. aeruginosa</i> can be mediated by several factors, especially by the production of carbapenemases.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Carbapenemase activity is exhibited by some class A and D SBLs and by all class B MBLs.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Most serine carbapenemases are versatile enzymes that can hydrolyze nearly all β-lactam substrates.<a onclick="showRef(event, 'ref7 ref14'); return false;" href="javascript:void(0);" class="ref ref7 ref14">(7,14)</a> While MBLs also have a broad substrate spectrum, they are unable to catalyze the hydrolysis of monobactams.<a onclick="showRef(event, 'ref4 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref4 ref16 ref17">(4,16,17)</a> Among carbapenemases, of greatest concern currently are the class A SBL KPC-2 and the MBLs NDM-1 and VIM-2, all of which are commonly isolated from CRE, <i>P. aeruginosa</i>, and other Gram-negative pathogens.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">A number of β-lactamase inhibitors have been developed to address the growing problem of β-lactam antibiotic resistance, although currently marketed agents target only SBLs and not MBLs.<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16,18)</a> Classical β-lactamase inhibitors like clavulanic acid are active against many class A SBLs but possess limited activity against class C and D SBLs and no activity against most serine or metallocarbapenemases.<a onclick="showRef(event, 'ref16 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref19">(16,19)</a> Newer, non-β-lactam derived compounds like avibactam<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> cover an expanded spectrum of class A, C, and D SBLs, including KPC-2, but are inactive against MBLs.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Notwithstanding some recent progress with boronic acid-based inhibitors,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> finding cross-class inhibitor leads remains a significant and challenging problem.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">In this study, we used structure-based design, synthetic chemistry, and X-ray crystallography to identify and explore common features of noncovalent small molecule binding by SBLs and MBLs. We identified a heteroaryl phosphonate scaffold with low μM to low nM affinities against KPC-2, NDM-1, and VIM-2 that also exhibits promising cell-based activity and good lead-like properties. Complex crystal structures of several analogs have revealed underappreciated structural features that likely underlie the broad substrate spectrum of carbapenemases. Taken together, these data offer a new chemotype and actionable information to guide development of new agents to counter carbapenemase-mediated resistance in pathogenic Gram-negative bacteria.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Novel Inhibitor Chemotype for KPC-2 Serine Carbapenemase</h3><div class="NLM_p">To develop novel inhibitor chemotypes, we sought to identify fragment- or lead-sized compounds that bound with high ligand efficiency (LE) (defined as binding enthalpy per non-H atom)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> to the SBL KPC-2. The decision to start with KPC-2 was based on the expectation that ligand affinity for KPC-2 would derive from noncovalent interactions with active-site residues, while screening against MBLs could be dominated by chelation-driven interactions.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We thus performed molecular docking of KPC-2 using the ZINC database<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and identified several hits, including the coumarin-4-methylphosphonate <b>1</b> that is the focus of the current study (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Activities of Phosphonate Compounds against KPC-2, NDM-1, and VIM-2.</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0006.gif" alt="" id="GRAPHIC-d7e375-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">LE = ligand efficiency in units of kcal mol<sup>–1</sup> (number of heavy atoms)<sup>−1</sup> or kcal mol<sup>–1</sup> HA<sup>–1</sup>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">N/A, not tested.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Compound <b>5</b> was tested only once due to limited availability.</p></div></div><div></div></div><div class="NLM_p">Using a biochemical assay with the nitrocefin substrate, we observed <b>1</b> to be a moderately potent and ligand-efficient inhibitor of KPC-2 (<i>K</i><sub>i</sub> = 32.9 μM; LE = 0.34 kcal mol<sup>–1</sup> heavy atom<sup>–1</sup>). To probe SAR around this hit, we identified five related commercial analogs (<b>2</b>–<b>6</b>) that differed in substitution at positions C5–C7 of the coumarin ring. The potencies and ligand efficiencies of analogs <b>2</b>–<b>5</b> revealed that substitution at C7, as well as a lack of substitution at C6, was important for activity. Thus, regioisomers <b>4</b> and <b>5</b> bearing methyl groups at C7 or C6, respectively, exhibited <i>K</i><sub>i</sub> (and LE) values of 23.3 μM (0.38 kcal mol<sup>–1</sup> HA<sup>–1</sup>) and 154.4 μM (0.31 kcal mol<sup>–1</sup> HA<sup>–1</sup>) against KPC-2. Analogs <b>2</b> and <b>6</b>, both unsubstituted at C6, were the most potent and ligand efficient of the commercial analogs, with <i>K</i><sub>i</sub> values in the low-μM regime and LE values of 0.39 and 0.45, respectively.</div><div class="NLM_p">Having established an apparent preference for substitution at both C5 and C7 (as in compound <b>6</b>), we evaluated additional, similarly substituted synthetic analogs. First, the steric and electronic character of the C5 substituent was modified systematically in analogs sharing a C7-Me group (compounds <b>7</b>, <b>9</b>, <b>10</b>). Increasing the size of the C5 substituent from −F to −CH<sub>3</sub> to −Br improved potency and ligand efficiency, with the C5-Br analog <b>9</b> providing a new benchmark in potency and ligand efficiency (<i>K</i><sub>i</sub> = 0.246 μM; LE = 0.49 kcal mol<sup>–1</sup> HA<sup>–1</sup>). With respect to the electronic nature of the coumarin ring, the dimethyl substitution as in compound <b>6</b> was preferred over the more electron rich (compound <b>7</b>) or electron deficient (compound <b>8</b>) coumarin analogs.</div><div class="NLM_p">Next, we explored replacement of O1 of the coumarin ring with nitrogen to produce the 1,2-dihydroquinolin-2-one (DHQ) analogs <b>11</b>–<b>13</b>. This change was well tolerated, with 5,7-dimethyl-DHQ analog <b>13</b> (<i>K</i><sub>i</sub> = 2.2 μM; LE = 0.43 kcal mol<sup>–1</sup> HA<sup>–1</sup>) essentially equipotent to its coumarin congener <b>6</b>. Substitution on the ring N atom in the DHQ scaffold was also tolerated, with analogs <b>11</b> and <b>12</b> exhibiting comparable potencies and ligand efficiencies. The favorable effect of C5/C7 substitution noted in the coumarin series is true as well in DHQ analogs, with dimethyl analog <b>13</b> notably more potent than unsubstituted DHQ comparators <b>11</b> and <b>12</b>. Quinoline analogs <b>14</b> and <b>15</b> lacking the ring carbonyl of the DHQ scaffold exhibited very weak potencies and ligand efficiencies 2–5 times inferior to the relevant DHQ comparator <b>11</b>, suggesting that the carbonyl group is involved in recognition and binding by KPC-2. Finally, the introduction of bromine substituents at C5 and C7 of the DHQ scaffold produced compound <b>16</b>, with activity ∼7000-fold improved over the parent DHQ analog <b>11</b>, and an impressive <i>K</i><sub>i</sub> of 20 nM against KPC-2 that is to our knowledge the highest affinity noncovalent inhibitor of any SBL reported to date.</div><div class="NLM_p">To define key residues and interactions that contribute to inhibitor binding by KPC-2, we determined complex crystal structures with compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>6</b>, and <b>9</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S2</a>) at resolutions of 1.45 Å and better. All ligands were unambiguously identified in the composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps contoured at 3σ. Interestingly, for the complex with compound <b>1</b>, there appears to be additional density corresponding to a potential second copy of <b>1</b>; however, the occupancy was too low to confidently model in. In each complex structure, the phosphonate moiety establishes hydrogen bonds (HBs) with S70, S130, T235, T237 and forms a water-mediated HB with the backbone carbonyl of T216. Notably, the carbonyl oxygen atom of the inhibitor forms a water-mediated HB with R220 and H274, perhaps revealing why quinoline analogs <b>14</b> and <b>15</b> that lack such carbonyl functionality are weaker inhibitors of KPC-2.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures reveal binding mode of coumarin phosphonate analogs <b>1</b> and <b>6</b> to KPC-2. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps are colored in gray and contoured at 3σ. Water molecules are shown as red spheres. Black dashed lines represent hydrogen bonds. (a) Compound <b>1</b> bound to KPC-2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15">6D15</a>). (b) Compound <b>6</b> bound to KPC-2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18">6D18</a>). (c) Compound <b>1</b> complex (white and green) superimposed onto KPC-2 apo structure (purple, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8">5UL8</a>). (d) Compound <b>1</b> complex (white and green) superimposed onto compound <b>6</b> complex (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Also revealed in these structures were some important details concerning the KPC-2 active site. The unfavorable effect of C6-Me substitution is explained by a potential steric clash between the C6 methyl group and N132, which restricts the binding mode of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a). Moving this substituent to the C5 position as in <b>6</b> and <b>9</b> avoids the steric occlusion and allows the coumarin ring to swing toward W105 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). Concomitantly, a conformational change in W105 brings the side chain closer to the face of the coumarin ring, forming a π–π stacking interaction. At the same time, the C5-Me substituent in compounds <b>6</b> and <b>9</b> itself contributes to binding affinity by forming nonpolar interactions with W105. Regarding KPC-2 enzymology, the large hydrophobic surface of W105, coupled with a conformational flexibility revealed in our complex and apo structures (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c,d), appears to endow KPC-2 with significant versatility in interacting with small molecule substrates and inhibitors.</div><div class="NLM_p last">The SAR analysis and complex crystal structures also highlight the contribution to ligand binding of a nonpolar surface consisting of P104 and especially L167, which is in contact with the C7-Me or C7-Br substitutions in <b>6</b>, <b>9</b>, and <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">S2</a>). Replacing the C7-Me in <b>9</b> by −Br in <b>16</b> increases the activity by ∼12-fold, through increasing the interactions with this nonpolar surface.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Cross-Class Inhibition of Metallo-β-lactamases</h3><div class="NLM_p">Having established that heteroaryl phosphonates are recognized by the active site of KPC-2, we next asked whether the clinically relevant MBLs NDM-1 and VIM-2 might also recognize these compounds, as SBLs and MBLs clearly do with their shared β-lactam substrates.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We first tested a subset of the coumarin, DHQ, and quinoline analogs for biochemical activity against NDM-1 and VIM-2. Notably, inhibition of NDM-1 and VIM-2 was generally strongest for analogs with substitution at both C5 and C7, mirroring our findings with KPC-2 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Thus, compounds <b>6</b>, <b>8</b>, <b>9</b>, <b>13</b>, and <b>16</b> were better inhibitors of the MBLs than comparators lacking C5 and C7 substituents (<b>11</b>, <b>12</b>, <b>14, 15</b>). Compounds <b>9</b> and <b>16</b>, the most potent KPC-2 inhibitors, were also two of the most potent inhibitors of NDM-1 (<i>K</i><sub>i</sub> = 34.2 μM and 31.4 μM) and VIM-2 (<i>K</i><sub>i</sub> = 1.2 μM and 0.316 μM). While the compounds inhibited VIM-2 more potently than NDM-1, rank-order activity of the compound series was similar for the two enzymes. Generally and across all three enzymes, inhibitor potency improved with increasing hydrophobic surface area. There is a particularly striking correlation between the activities for KPC-2 and VIM-2 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, e.g., comparing <b>15</b>, <b>6</b>, and <b>16</b>). However, compared with KPC-2, the MBLs were less sensitive to the positioning of ring substituents (e.g., C5 vs C6, comparing <b>1</b> and <b>6</b>). Ring fluorination as in analogs <b>8</b> and <b>10</b> was unexpectedly detrimental to NDM-1 activity, an observation that will require further investigation.</div><div class="NLM_p">Complex structures were determined for NDM-1 with compounds <b>1</b>–<b>3</b>, <b>6</b>–<b>9</b>, and <b>11</b>–<b>14</b> and for VIM-2 with compounds <b>8</b> and <b>14</b>, all solved at resolutions of 1.70 Å and better (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figures S3 and S4</a>), initially using soaking conditions at acidic pH (pH 3.8) to maintain stability of NDM-1 (vide infra). The binding orientation of the inhibitors was unambiguously identified in the composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps contoured at 3σ (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figures S3 amd S4</a>). In each structure, the phosphonate group bridges the zinc ions in NDM-1 and VIM-2, displacing a hydroxide ion that is essential for catalysis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> For NDM-1, the coumarin, DHQ, and quinoline analogs all form common interactions within the active site. These interactions include HBs from the phosphonate group to N220 and D124, the latter of which forms a similar interaction with the hydroxide ion in apo structures.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> The heteroaryl rings of all three scaffolds form nonpolar interactions with M67, W93, and V73. An edge–face interaction between the heteroaryl ring and F70 is evident in many NDM-1 complex structures.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of NDM-1 and VIM-2 bound to coumarin phosphonate derivatives. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps, determined at 1.15–1.50 Å resolutions, are colored in gray and contoured at 3σ except panel d, which has been contoured at 2σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) NDM-1 with <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A">6D1A</a>). (b) NDM-1 with <b>6</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D">6D1D</a>). (c) NDM-1 with <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F">6D1F</a>). (d) VIM-2 with <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0">6DD0</a>). F70 of NDM-1 adopts two conformations (labeled F70-conf A and F70-conf B) in the complex structures of <b>6</b> and <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One interesting and unexpected aspect revealed in the NDM-1 structures is the ability of the enzyme to bind similar ligands in one of two distinct orientations: one pointing the ring carbonyl group away from V73 (pose 1, e.g., compound <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) and the other toward it (pose 2, e.g., <b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Pose 1 is observed in the complex structures of compounds lacking C5 substitution (e.g., <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <b>2</b>, <b>3</b>, <b>11</b>, <b>12</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3</a>). In contrast, pose 2 is favored for compounds with C5 substitutions as it allows additional interactions with H122 (e.g., π–σ interaction with −Me in <b>6</b> (distance 3.67 Å), <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b; π–alkyl interaction with −Br in <b>9</b> (distance 3.78 Å), <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3d</a>). This small pocket near H122 in NDM-1 is analogous to the slot adjacent to W105 in KPC-2, which similarly accommodates the C5 substituent. Also of note is that the side chain of F70 in NDM-1 exhibits significant conformational mobility, allowing the formation of favorable CH−π interactions with the C7-Me of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) and edge–face interactions with compounds <b>11</b> and <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3</a>). Overall the relative openness of the NDM-1 active site and the flexibility of the M67-F70 loop accommodate distinct binding orientations depending on ligand substitution pattern.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> To some extent this echoes the role of W105 in KPC-2 while affording more plasticity in ligand binding.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, as described earlier, KPC-2 is more sensitive than NDM-1 to the positions of the substituents on the heteroaryl ring, as demonstrated by the different activities of compounds <b>1</b> (C6/C7 substitution) and <b>6</b> (C5/C7 substitution) against KPC-2, in contrast to the similar <i>K</i><sub>i</sub> values against NDM-1.</div><div class="NLM_p">We solved structures of the 5,7-difluoro compound <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and the smaller quinoline analog <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3</a>) bound to both NDM-1 and VIM-2, also at pH 3.8, to compare how these two MBLs interacted with a common ligand. Although compound <b>8</b> did not show inhibition of NDM-1 under our standard experimental conditions, preincubation of the compound with NDM-1 demonstrated weak inhibitory activity (data not shown), suggesting the compound does interact with NDM-1. In both structures with NDM-1 and VIM-2, compound <b>8</b> adopts pose 2, with the phosphonate group forming a HB with N233 and D120 in VIM-2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d). The coumarin ring of compound <b>8</b> forms a π–π stacking interaction with Y67 of VIM-2, van der Waals interactions with W87, and an edge–face interaction with H263, analogous to the contacts made by other analogs with F70/W93/H250 in NDM-1. Unique to VIM-2 is the presence of R228 near the active site, which can establish a HB with the carbonyl oxygen of compound <b>8</b> and may enhance binding and constrain the orientation of the compound, particularly in comparison to NDM-1. In addition, the stacking interactions between the inhibitor and Y67 in VIM-2 may be more favorable than contacts with similarly positioned residues M67 or F70 in NDM-1 and can also contribute to stronger binding affinity for VIM-2.</div><div class="NLM_p">The observed displacement of the active site hydroxide by phosphonate-bearing inhibitors in the structures described above, together with the low pH of the soaks, suggested that the phosphonate group was in the protonated monoanionic state and therefore was able to form a HB with the negatively charged D124, similar to the hydroxide. The use of these conditions was required as the WT NDM-1 crystals were only stable at low pH. We hypothesized that this was due to the need for a neutral/protonated D199 at the crystal packing interface. We subsequently constructed a D199N mutant and were able to determine the complex structures of <b>7</b> and <b>16</b> at physiological pH (pH 7.5) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), where the phosphonate group may also exist in the dianionic state, especially when in close proximity to the zinc ions. As posited, the complex structures at pH 7.5 retained the active site hydroxide. The phosphonate group in this case interacts with the hydroxide and one of the zinc ions (Zn2) rather than both zinc ions as in the low pH structures. As a result, there is a shift in the position of the phosphonate group, together with the rest of the inhibitor. This movement was accompanied by different conformations of ligand-interacting residues such as M67 and F70. By comparison of <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a) and the monobromo coumarin analog <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3d</a>), a flip of the heteroarene ring was also observed, allowing <b>16</b> to adopt a binding mode similar to pose 1 as described above (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). This is possibly due to the ability of the C5/C7 bromo substituents to establish favorable interactions with H250 and F70. Overall the complex structure at pH 7.5 provides detailed and valuable information for future lead optimzation. But the lower pH structures, particularly with their well-defined electron densities, offer important insights into how active site flexibility enables NDM-1 to respond to changes in ligand/substrate structure including small changes in the ligand protonation states.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structures of NDM-1 bound to phosphonate derivatives at pH 7.5. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps, determined at 1.30–1.40 Å resolutions, are colored in gray and contoured at 3σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) NDM-1 with <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>). (b) NDM-1 with <b>7</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a>). (c) NDM-1 with <b>16</b> (light blue and green), superimposed with the NDM-1 complex with <b>9</b> determined at pH 3.8 (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G">6D1G</a>). (d) NDM-1 with <b>7</b> (light blue and green), superimposed with the same complex determined at pH 3.8 (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also determined the complex crystal structure of VIM-2 with compound <b>16</b> at pH 7.5 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S4b</a>). Unlike the complex structure with <b>8</b>, the carbonyl group is pointed away from R228 without forming a HB. One oxygen of the phosphonate group is positioned 3.7 Å from R228, suggesting favorable electrostatic interactions. The DHQ ring with the dibromo subsitutions establishes extensive interactions with H263, R228, W87, and especiallly Y67 and F61. In addition, compared with NDM-1, the binding pocket is slightly narrower in VIM-2 with the loop of G232-N233 lowered closer to the ligand and with the planar peptide bond between G232 and N233 stacked on top of the DHQ ring (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). The new contacts with R228, G232, and N233, together with the favorable stacking interactions with Y67 and F61, may explain the ∼100× higher affinity of <b>16</b> for VIM-2 than NDM-1. However, despite these differences, it is important to note that the overall binding orientation of <b>16</b> is similar between VIM-2 and NDM-1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b), echoing the observations of the complex structures of <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and desmonstrating the feasibility of lead optimization simutaneously improving activity against both enzymes.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of VIM-2 bound to phosphonate derivative <b>16</b> at pH 7.5. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit map, determined at 2.1 Å resolution, is colored in gray and contoured at 2σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) VIM-2 with <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T">6O5T</a>). (b) VIM-2 with <b>16</b> (orange and green) superimposed with the complex of NDM-1 and <b>16</b> (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cell-Based Activity of Compounds <b>9</b>, <b>11</b>, <b>13</b>, and <b>16</b></h3><div class="NLM_p">To investigate the effects of these inhibitors on bacterial cells, coumarin <b>9</b> and DHQ analogs <b>11</b> and <b>13</b> were tested (at fixed 128 μg/mL concentrations) in combination with the carbapenem antibiotic imipenem against Gram-negative clinical isolates known to produce carbapenemases (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>9</b> restored susceptibility to imipenem in a <i>K. pneumoniae</i> strain producing KPC-2 and reduced the minimum inhibitory concentration (MIC) by 64-fold. It also decreased the MIC for imipenem by 4-fold in an NDM-1 producing <i>E. coli</i> strain and more than 2-fold in an NDM-1 producing <i>K. pneumoniae</i> strain. Compound <b>9</b> did not have any activity against NDM-1 producing <i>Enterobacter cloacae</i>. Compared to KPC-2, the relatively lower cell-based activity of <b>9</b> against NDM-1 expressing strains correlates with the different in vitro activities observed in biochemical testing. The DHQ analog <b>13</b> was comparable to compound <b>9</b>, reducing the MIC of imipenem by 64-fold in KPC-2 producing <i>K. pneumoniae</i> and 4-fold in NDM-1 producing <i>E. coli</i> but unable to rescue imipenem activity in NDM-1 producing <i>K. pneumoniae</i>/<i>E. cloacae</i> or in VIM-2 producing <i>P. aeruginosa</i>. The variable susceptibility of the different bacterial strains likely reflects the influence of other resistance mechanisms such as active efflux. Consistent with its weaker biochemical activity, DHQ analog <b>11</b> was less effective than <b>9</b> or <b>13</b> in reducing the MIC of imipenem against the KPC-2 producing <i>K. pneumoniae</i> and exhibited little if any effect against NDM-1 producing <i>E. coli</i>, <i>K. pneumoniae</i>, and <i>E. cloacae</i>. In general, the microbiological studies revealed that heteroaryl phosphonate analogs can cross the outer membrane to target both serine and metallocarbapenemases in Gram-negative bacteria, at least at high concentrations.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity (MIC) of Imipenem against Bacterial Strains Expressing KPC-2, NDM-1, and VIM-2 in the Presence of <b>9</b>, <b>11</b>, <b>13</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bacterial strain</th><th class="colsep0 rowsep0" align="center">characterized β-lactamase</th><th class="colsep0 rowsep0" align="center" char=".">imipenem (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">imipenem/<b>9</b> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">imipenem/<b>11</b> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">imipenem/<b>13</b> (μg/mL)</th><th class="colsep0 rowsep0" align="center">ceftazidime/avibactam (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> 5980</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">>64/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> 4683</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">1/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> 5979</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="char" char=".">>64</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">>64/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i> 5981</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">2/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> 4698</td><td class="colsep0 rowsep0" align="left">VIM-2</td><td class="colsep0 rowsep0" align="char" char=".">>64</td><td class="colsep0 rowsep0" align="char" char=".">>64</td><td class="colsep0 rowsep0" align="char" char=".">>64</td><td class="colsep0 rowsep0" align="char" char=".">>64</td><td class="colsep0 rowsep0" align="left">32/4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Compounds <b>9</b>, <b>11</b>, and <b>13</b> were tested at a concentration of 128 μg/mL. Ceftazidime and 4 μg/mL avibactam were included as a positive control.</p></div></div></div><div class="NLM_p">Following these initial experiments, we performed a more extensive microbiological assessment of the most potent DHQ analog <b>16</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A checkerboard assay using a clinical KPC-2 expressing <i>K. pneumoniae</i> strain varied both imipenem and inhibitor concentrations and demonstrated that compound <b>16</b>, at 128 μg/mL, reduced the MIC of imipenem by 128-fold and by 32-fold when applied at 16 μg/mL concentration. In comparison, at 16 μg/mL concentration, avibactam lowered the imipenem MIC by 512-fold to 1 μg/mL. These results illustrated the dose-dependent effect of compound <b>16</b> while highlighting its activity at more therapeutically relevant concentrations. We also studied this compound (at a fixed concentration of 128 μg/mL) across a series of isogenic carbapenemase-expressing <i>P. aeruginosa</i> strains with deletion of the efflux pumps MexAB-OprM and MexXY-OprM, or overexpressing MexAB-OprM. For the strains lacking efflux pumps, the imipenem MIC was reduced by 32-, 16-, and 16-fold for KPC-2, NDM-1, and VIM-2, respectively. It should be noted that for KPC-2 (strain 4135) and VIM-2 (strain 4882), the MIC of imipenem was 2 μg/mL in these experiments in the presence of compound <b>16</b>, the same as the MIC of imipenem alone in the control strain without any carbapenemase (strain 4173, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Thus, an MIC reduction of 32- and 16-fold is the maximum that we could observe for KPC-2 and VIM-2, respectively. For the strains overexpressing efflux pumps, the imipenem MIC was reduced by 4- and 8-fold for NDM-1 and VIM-2, respectively. Overall the MIC data in the presence of compound <b>16</b> mirror the inhibition results from the biochemical assays, consistent with the different activities against KPC-2, NDM-1, and VIM-2. Although overexpressing efflux pumps did decrease its potency by up to 4-fold against NDM-1, the inhibitor retained significant cell-based activity in these bacterial strains.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Activity (MIC) of Imipenem against Bacterial Strains Expressing KPC-2, NDM-1, and VIM-2 in the Presence of <b>16</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">imipenem + <b>16</b> (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bacterial strain</th><th class="colsep0 rowsep0" align="center">characterized β-lactamase</th><th class="colsep0 rowsep0" align="center" char=".">imipenem (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">imipenem</th><th class="colsep0 rowsep0" align="center" char="."><b>16</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> C2</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="char" char=".">512</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> 4135</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> 4129</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> (eflx+) 4177</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> 4882</td><td class="colsep0 rowsep0" align="left">VIM-2</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> (eflx+) 4402</td><td class="colsep0 rowsep0" align="left">VIM-2</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> 4173</td><td class="colsep0 rowsep0" align="left">vector</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> (eflx+) 4175</td><td class="colsep0 rowsep0" align="left">vector</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The <i>P. aeruginosa</i> strains (without eflx+) lack major efflux pumps MexAB-OprM and MexXYOprM. The eflx+ strain overexpresses MexAB-OprM.</p></div></div></div><div class="NLM_p">The cytotoxicity of the phosphonate compounds was also evaluated using compound <b>16</b> and human HEK293T cells. Compound <b>16</b> showed cytotoxicity in these experiments only when used at concentrations of 100 μg/mL and above, with 88% cell recovery rate at 100 μg/mL and 70% recovery rate at 200 μg/mL (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S5</a>). In addition, without imipenem, neither <b>9</b> nor <b>16</b> showed any antibacterial effects by itself at 128 μg/mL. Although we used up to 128 μg/mL inhibitor concentrations in our MIC testing, compound <b>16</b> displayed significant cell-based activity at lower concentrations (e.g., reducing imipenem MIC by 32-fold at 16 μg/mL) that will be more relevant to clinical applications. Nevertheless the potential cytotoxicity of these inhibitors should be further characterized in future development given previous studies showing the adverse effects of the phosphonoalkylquinoline compounds.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">To assess the drug-like properties of this new scaffold, compound <b>16</b> was evaluated in a small panel of standard in vitro ADME assays (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The compound exhibited excellent stability when incubated with mouse liver microsomes and also reasonably high solubility in pH 7.4 phosphate buffered saline (PBS). Perhaps on account of its anionic nature, <b>16</b> was poorly permeable across MDCK-MDR monolayers, predicting for low oral absorption and blood–brain barrier penetrance. Given that most β-lactam antibiotics used to treat serious infections are administered parenterally, the in vitro ADME profile of <b>16</b> is quite satisfactory as a starting point for future in vivo proof-of-concept studies and lead optimization efforts.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro ADME Data for Compound <b>16</b> and Controls</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">Liver Microsome Stability (Mouse)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">CL<sub>int</sub> ((μL/min)/mg protein)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verapamil</td><td class="colsep0 rowsep0" align="left">8.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">161.9 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left"><11.6</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">Kinetic Solubility in pH 7.4 PBS</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">μM</th><th class="colsep0 rowsep0" align="center">μg/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">193</td><td class="colsep0 rowsep0" align="left">51.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">241</td><td class="colsep0 rowsep0" align="left">95.9</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">MDCK-MDR Cell Permeability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app,A–B</sub> (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app,B–A</sub> (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">recovery (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">digoxin</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">16.5</td><td class="colsep0 rowsep0" align="char" char=".">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">propranolol</td><td class="colsep0 rowsep0" align="char" char=".">57.5</td><td class="colsep0 rowsep0" align="char" char=".">34.9</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="."><0.7</td><td class="colsep0 rowsep0" align="char" char="."><0.2</td><td class="colsep0 rowsep0" align="char" char=".">91</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antibiotic resistance conferred by SBLs and MBLs in Gram-negative pathogens is a serious threat to human health. We have identified and characterized the first series of nonelectrophilic, cross-class inhibitors of SBLs and MBLs. The structures and SAR described here provide insights into inhibitor discovery against these important antibiotic targets by providing new leads and by elucidating the structural features underlying the broad substrate spectrum of carbapenemases.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Noncovalent Phosphonate Compounds as Cross-Class Inhibitors</h3><div class="NLM_p">Phosphonate-bearing fragments of modest affinity have been described previously for SBLs,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> while inhibitors bearing electrophilic phosphonate esters have been studied as traditional suicide substrate inhibitors of SBLs by Pratt and colleagues.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> Mercaptophosphonates were found to inhibit MBLs in a noncovalent fashion; however, they possess no activity against SBLs.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In contrast, the inhibitors detailed herein bind both SBLs and MBLs though a reversible, noncovalent mechanism, as evidenced by their complex crystal structures and the absence of time-dependent inhibition kinetics. The role of the phosphonate function in these new compounds resides in its ability to mimic the carboxylate group of substrates rather than as a reactive surrogate of the scissile bond in substrates, as in the case of activated phosphonate ester inhibitors. Their expanded spectrum of inhibition, novel reversible mechanism, and minimal cytotoxicity in mammalian cells suggest (2-oxo-1,2-dihydroquinolin-4-yl)methyl)phosphonates as a viable new scaffold for antibiotic development.</div><div class="NLM_p">The emergence of MBLs in recent years has led to increasing interest in novel inhibitor development against these proteins and resulted in many promising lead scaffolds including some also containing phosphonate groups.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42−46)</a> Most of these compounds are not active against SBLs. A recently identified series of MBL inhibitors contain both carboxylate and phosphonate moieties, and it is the carboxylate rather than the phosphonate group that interacts with the zinc ions in the complex crystal structures.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Bisphosphonate compounds have also been shown to inhibit both MBLs and SBLs, but the mode of action is not entirely clear for these compounds partially due to the lack of crystal structures.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In addition, preincubation appeared to significantly increase these compounds’ potency against SBLs, suggesting they may function as covalent inhibitors.</div><div class="NLM_p">Whereas most inhibitor development efforts have focused on either SBLs<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57">(47−57)</a> or MBLs,<a onclick="showRef(event, 'ref18 ref43 ref45 ref46 ref58 ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref18 ref43 ref45 ref46 ref58 ref59 ref60 ref61 ref62">(18,43,45,46,58−62)</a> there have been some early successes of cross-class inhibitors,<a onclick="showRef(event, 'ref44 ref63'); return false;" href="javascript:void(0);" class="ref ref44 ref63">(44,63)</a> most notably the cyclobutanone analogs of β-lactam antibiotics.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> The recently developed cyclic-boronate esters represent arguably the most promising broad-spectrum inhibitors targeting both SBLs and MBLs.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> One such inhibitor, named VNRX-5133, has demonstrated promising activity in clinical trials against SBL and MBL producing Gram-negative bacteria.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Essentially, these cyclic-boronates function as covalent transition state analogs in the case of SBLs and paradoxically as noncovalent inhibitors of MBLs. By contrast, the compounds described herein are to our knowledge the highest affinity cross-class inhibitors with a shared, reversible mode of noncovalent inhibition for both SBLs and MBLs. Importantly, these inhibitors capture functionally equivalent structural features of both SBLs and MBLs, with the phosphonate moiety placed in the subpocket recognizing the carboxylate of substrate in both classes of enzymes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and highlighting the potential to further improve activity simultaneously against both serine and metalloenzymes. In KPC-2, this subpocket consists of S130, T235, and T237.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In NDM-1/VIM-2, one of the two zinc ions and neighboring residues play a similar role in recognizing the same substrate C3′/4′ carboxylate group.<a onclick="showRef(event, 'ref4 ref16'); return false;" href="javascript:void(0);" class="ref ref4 ref16">(4,16)</a> The phosphonate group serves as an anchor that situates the compound similarly in KPC-2 and NDM-1/VIM-2 relative to substrate binding. Accordingly, inhibitors positioned in this way form similar interactions with other conserved active site features in both SBLs and MBLs that recognize the same substrate functional groups, such as W105 in KPC2 and W93/M67 in NDM-1 that interact with the conjugated 5/6-membered ring of the β-lactam (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Such similarities in ligand binding features are underscored by the correlation between the inhibitors’ activities for KPC-2, NDM-1, and VIM-2, as the hydrophobic surface area of the inhibitor increases (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Meanwhile, the potency of the inhibitors was consistently >10-fold weaker against NDM-1 than for KPC-2 or VIM-2, suggesting further subtleties of compound binding/inhibition that will need to be understood and exploited as these compounds are optimized toward more advanced lead compounds, which is the focus of our continuing efforts. Compared with β-lactam substrates, the current inhibitors engage only those active site surfaces that bind the core β-lactam structure (the fused bicycle and the C3′/4′ carboxylate group) leaving largely unexplored the residues interacting with distal side chains (e.g., the aminobenzyl group of ampicillin, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). Targeting these additional ligand binding hot spots is expected to further improve potencies against NDM-1 as well as against the other carbapenemases. It should also be mentioned that our current inhibitors showed no activity against OXA-48 class D carbapenemase (data not shown), possibly due to a narrower active site of class D β-lactamases that may require a smaller core heterocycle for effective inhibition. Nonetheless the heteroaryl phosphonate scaffold can be engineered to target a wide range of carbapenemases due to the need of these enzymes to recognize the same substrates.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superimposition of carbapenemase inhibitor and product complexes. (a) Superimposition of KPC-2/compound <b>9</b> (white and green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19">6D19</a>) and KPC-2/cefotaxime product (purple, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJ3">5UJ3</a>). (b) Superimposition of NDM-1/compound <b>16</b> (light blue and green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>) and NDM-1/ampicillin product (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HL2">4HL2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Structural Basis for Carbapenemase Broad-Spectrum Substrate Profile</h3><div class="NLM_p last">The novel inhibitors and complex crystal structures described here also shed light on particular aspects of carbapenemase substrate recognition that add to our understanding of these enzymes’ broad-spectrum activity and that will be useful for future antibiotic development. The new complex structures reveal the contributions of several hydrophobic residues to ligand binding, notably W105/L167 in KPC-2, Y67/W87 in VIM-2, and M67/F70/V73/W93 in NDM-1. The conformational flexibility of specific residues like W105 in KPC-2, F70 in NDM-1, and Y67/R228 in VIM-2 moreover provides important adaptability in the recognition of small molecules. Thus, in KPC-2 we uncovered multiple W105 conformations in binding of compounds <b>1</b> and <b>6</b>, a mobility rarely observed in the analogous residue Y105 of other class A SBLs.<a onclick="showRef(event, 'ref33 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref33 ref68 ref69 ref70">(33,68−70)</a> Likewise, residue F70 and the surrounding loop in NDM-1 are observed in our structures in distinct conformations depending on ligand structure. In VIM-2, R228 adopts different conformations upon binding to compounds <b>8</b> and <b>14</b>, making important HBs in both cases. The adaptability of MBLs is also revealed in the two different ligand conformations (poses 1 and 2) we observed in the complex structures of NDM-1 (e.g., <b>1</b> vs <b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a,b), resulting partially from the relative openness of the MBL active sites. Together, these features endow carbapenemases with a ligand binding versatility that may underlie their ability to hydrolyze a wide variety of β-lactam antibiotics but paradoxically may also enable and facilitate new inhibitor discovery.<a onclick="showRef(event, 'ref14 ref67'); return false;" href="javascript:void(0);" class="ref ref14 ref67">(14,67)</a> The susceptibility to small molecule inhibition is highlighted by the remarkable LE of compound <b>16</b> against KPC-2 (0.59 kcal mol<sup>–1</sup> HA<sup>–1</sup>), demonstrating the feasibility of using noncovalent inhibitors to achieve potent activity against carbapenemases. In addition, the ligand binding versatility of carbapenemases is also demonstrated by the observation of multiple copies of some inhibitors in the active site (e.g., compound <b>8</b> in VIM-2, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Figure S3</a>), even though some of them were left unmodeled due to low occupancy (e.g., compound <b>1</b> in KPC-2).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have presented herein multiple heteroaryl phosphonate scaffolds with cell-based activity, low-nM to low-μM biochemical activities against both SBLs and MBLs, and with favorably lead-like physiochemical properties (clogD, solubility) and in vitro ADME properties. As such, this new scaffold appears quite suitable for further carbapenemase inhibitor discovery efforts. To support such efforts more broadly, we have detailed new structural information that enhances current understanding of carbapenemase activity and spectrum, reveals the structural basis for ligand/substrate binding, and should help guide drug discovery efforts aimed at better addressing the most intractable of Gram-negative bacterial infections.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound Synthesis</h3><div class="NLM_p last">Compounds <b>1</b>–<b>6</b> were obtained from commercial sources while compounds <b>7</b>–<b>15</b> were synthesized as detailed below. All synthetic analogs submitted for biochemical or biological testing were judged to be ≥95% pure based on inspection of LC–MS and <sup>1</sup>H NMR spectra. Scans of representative <sup>1</sup>H NMR spectra are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Varian INOVA-400 400 MHz and Bruker 500 MHz spectrometers. Chemical shifts are reported in δ units (ppm). NMR spectra were referenced relative to residual NMR solvent peaks. Coupling constants (<i>J</i>) are reported in hertz (Hz). Air and/or moisture sensitive reactions were carried out under an argon atmosphere in oven-dried glassware using anhydrous solvents from commercial suppliers. Air and/or moisture sensitive reagents were transferred via syringe or cannula and were introduced into reaction vessels through rubber septa. Solvent removal was accomplished with a rotary evaporator at approximately 10–50 Torr. Column chromatography was carried out using a Biotage SP1 flash chromatography system and silica gel cartridges from Silicycle. Analytical TLC plates from EM Science (silica gel 60 F<sub>254</sub>) were employed for TLC analyses. Mass analyses and compound purity were determined using Waters Micromass ZQTM, equipped with Waters 2795 separation module, Waters 2996 photodiode array detector, and Waters 2424 ELS detector. Separations were carried out with an XTerra MS C18, 5 μm, 4.6 mm × 50 mm column, at ambient temperature (unregulated) using a mobile phase of water–methanol containing a constant 0.10% formic acid. Fluorescence and absorbance data were collected on a Molecular Devices Flex Station 3.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> [(5-Methoxy-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonic acid (<b>7</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of ethyl 4-bromoacetoacetate (0.66 mL, 4.8 mmol) and triethyl phosphite (0.818 mL, 4.8 mmol) was stirred at 100 °C for 25 min in a microwave reactor. Purification by flash column chromatography (50% EA/hexanes followed by 100% EA) yielded 380 mg (30%) of ethyl 4-(diethoxyphosphoryl)-3-oxobutanoate as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.18–4.06 (m, 6H), 3.61 (s, 2H), 3.24 (s, 1H), 3.19 (s, 1H), 1.35–1.20 (m, 9H).</div><div class="NLM_p"><i>Step 2.</i> To a cooled (0 °C) mixture of 5-methylresorcinol (0.12 g, 0.94 mmol) and ethyl 4-(diethoxyphosphoryl)-3-oxobutanoate (0.25 g, 0.94 mmol) was added concentrated sulfuric acid (0.25 mL). The reaction mixture was stirred at ambient temperature for 18 h. The reaction mixture was then poured into cold water. The precipitate formed was filtered and dried to obtain about 0.23 g of crude 4-diethyl [(5-hydroxy-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate as a pale pink solid that was used without further purification in the next step. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.56 (s, 1H), 6.32 (s, 1H), 6.05 (s, 1H), 4.19–4.12 (m, 4H), 3.79 (s, 1H), 3.73 (s, 1H), 2.12 (s, 3H), 1.33 (br t, <i>J</i> = 7.02 Hz, 6H). LC–MS: <i>m</i>/<i>z</i> = 327 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 3.</i> To a solution of diethyl [(5-hydroxy-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate (0.036 g, 0.1 mmol) in methanol (1 mL) was added (trimethylsilyl)diazomethane (1.1 mL, 2.2 mmol). The mixture was stirred at ambient temperature for 18 h, concentrated, and isolated by flash column chromatography (12 g, 5% methanol/dichloromethane) to obtain about 36 mg (96%) of diethyl [(5-methoxy-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.76 (s, 1H), 6.57 (s, 1H), 6.14 (s, 1H), 4.21–3.96 (m, 2H), 3.93 (s, 3H), 3.89–3.67 (m, 4H), 2.40 (s, 3H), 1.44–1.17 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.25, 157.40, 155.33, 147.66, 147.56, 143.58, 115.43, 115.35, 110.55, 107.71, 62.49, 62.42, 55.97, 52.74, 52.68, 34.38, 33.02, 22.02, 16.41, 16.35. LC–MS: <i>m</i>/<i>z</i> = 341 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 4.</i> A mixture of diethyl [(5-methoxy-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate (0.036 g, 0.1 mmol) and 4 M solution of hydrochloric acid in dioxane (1 mL) was stirred at 100 °C for 48 h. The reaction mixture was concentrated down to dryness azeotropically with toluene, washed with ethyl acetate to obtain 23 mg of compound <b>7</b> (77%) as a tan solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.78 (s, 2H), 6.18 (d, <i>J</i> = 4.7 Hz, 1H), 3.96 (s, 3H), 3.78 (s, 1H), 3.72 (s, 1H), 2.43 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 161.22, 158.01, 155.13, 150.34, 150.24, 144.02, 114.10, 114.01, 109.47, 107.98, 107.32, 55.26, 35.34, 34.04, 20.49. LC–MS: <i>m</i>/<i>z</i> = 285 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> [(5,7-Difluoro-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonic Acid (<b>8</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a cooled (0 °C) mixture of ethyl 4-bromoacetoacetate (0.26 mL, 1.9 mmol) in concentrated sulfuric acid (0.5 mL) was added 3, 5-difluorophenol (0.25 g, 1.9 mmol). The reaction mixture was stirred at ambient temperature for 18 h. Reaction mixture was then diluted with cold water and extracted with ethyl acetate. The organic extracts were washed with saturated aqueous sodium bicarbonate solution, brine, dried over magnesium sulfate, and purified by flash column chromatography (35% ethyl acetate/hexanes) to obtain 150 mg (28%) of 4-(bromomethyl)-5,7-difluoro-2<i>H</i>-chromen-2-one as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.99–6.93 (m, 1H), 6.90–6.82 (m, 1H), 6.50 (s, 1H), 4.60 (d, <i>J</i> = 2.2 Hz, 2H). LC–MS: <i>m</i>/<i>z</i> = 275 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 2.</i> A mixture of 4-(bromomethyl)-5,7-difluoro-2<i>H</i>-chromen-2-one (0.038 g, 0.1 mmol) and triethyl phosphite (0.047 mL, 0.3 mmol) was heated to 100 °C for 18 h. The reaction mixture was purified by flash column chromatography (50% ethyl acetate/hexanes followed by 5% methanol/dichloromethane) to obtain 15 mg (33%) of the title compound as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.93 (dt, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.88–6.75 (m, 1H), 6.31 (d, <i>J</i> = 4.9 Hz, 1H), 4.14 (quin, <i>J</i> = 7.4 Hz, 4H), 3.51 (s, 1H), 3.45 (s, 1H), 1.30 (t, <i>J</i> = 7.1 Hz, 6H). LC–MS: <i>m</i>/<i>z</i> = 333 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 3.</i> A mixture of diethyl [(5,7-difluoro-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate (0.014 g, 0.0 mmol) and 4 M solution of hydrochloric acid in dioxane (1 mL) was stirred at 100 °C for 48 h. The reaction mixture was concentrated down to dryness azeotropically with toluene, washed with 50% ethyl acetate /hexanes to obtain 11 mg of compound <b>8</b> (95%) as a tan solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.15–6.98 (m, 2H), 6.38 (d, <i>J</i> = 4.9 Hz, 1H), 3.57 (s, 1H), 3.51 (s, 1H), LC–MS: <i>m</i>/<i>z</i> = 277 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of [(5-Bromo-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonic Acid (<b>9</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a cooled (0 °C) mixture of 3-bromo-5-methylphenol (0.400 g, 2.1 mmol) and concentrated sulfuric acid (0.5 mL) was added ethyl 4-bromoacetoacetate (0.296 mL, 2.1 mmol) slowly. The reaction mixture was stirred at ambient temperature for 18 h. Reaction mixture was then diluted with cold water and extracted with ethyl acetate. The organic extracts were washed with brine, dried over magnesium sulfate, and purified by flash column chromatography (0–25% ethyl acetate/hexanes) to obtain 134 mg (24%) of 5-bromo-4-(bromomethyl)-7-methyl-2<i>H</i>-chromen-2-one as a cream colored solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46 (s, 1H), 7.17 (s, 1H), 6.61 (s, 1H), 5.00 (s, 2H), 2.42 (s, 3H). LC–MS: <i>m</i>/<i>z</i> = 332 [M + H, <sup>79</sup>Br]<sup>+</sup>, 334 [M + H, <sup>81</sup>Br]<sup>+</sup>.</div><div class="NLM_p"><i>Step 2.</i> A mixture of 5-bromo-4-(bromomethyl)-7-methyl-2<i>H</i>-chromen-2-one (0.130 g, 0.4 mmol) and triethyl phosphite (0.134 mL, 0.8 mmol) was stirred in at 100 °C for 24 h. The reaction mixture was diluted with ethyl acetate and washed with water and brine. The organic layer was dried over magnesium sulfate and purified by flash column chromatography (0–50% ethyl acetate/hexanes) to obtain 90 mg (59%) of diethyl [(5-bromo-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate as a yellow oil that solidifies on standing. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44 (s, 1H), 7.15 (s, 1H), 6.44 (d, <i>J</i> = 4.8 Hz, 1H), 4.24–4.08 (m, 4H), 4.06 (s, 1H), 4.00 (s, 1H), 2.41 (s, 3H), 1.28 (t, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.92, 158.89, 155.46, 147.33, 143.12, 133.20, 119.44, 119.00, 118.90, 118.08, 115.70, 62.65, 62.59, 55.97, 33.66, 32.29, 16.39, 16.33. LC–MS: <i>m</i>/<i>z</i> = 388 [M + H, <sup>79</sup>Br]<sup>+</sup>, 390 [M + H, <sup>81</sup>Br]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 3.</i> A mixture of diethyl [(5-bromo-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate (0.090 g, 0.2 mmol) and 4 M solution of hydrochloric acid in dioxane (0.6 mL) was stirred at 100 °C for 24 h. The reaction mixture was concentrated, washed with ethyl acetate, and dried to obtain 70 mg (91%) of compound <b>9</b> as a tan powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.53 (s, 1H), 7.29 (s, 1H), 6.44 (d, <i>J</i> = 4.5 Hz, 1H), 3.91 (s, 1H), 3.84 (s, 1H), 2.37 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.56, 155.31, 149.40, 149.31, 143.46, 133.13, 119.39, 118.90, 118.06, 117.97, 117.46, 115.75, 115.71, 34.17, 32.85, 19.37. LC–MS: <i>m</i>/<i>z</i> = 332 [M + H, <sup>79</sup>Br]<sup>+</sup>, 334 [M + H, <sup>81</sup>Br]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> [(5-Fluoro-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonic Acid (<b>10</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a cooled (0 °C) mixture of 3-fluoro-5-methylphenol (0.200 g, 1.6 mmol) and ethyl 4-bromoacetoacetate (0.219 mL, 1.6 mmol) was added concentrated sulfuric acid (0.8 mL). The reaction mixture was stirred at ambient temperature for 18 h. Reaction mixture was then diluted with cold water and extracted with ethyl acetate. The organic extracts were washed with brine, dried over magnesium sulfate, and concentrated in vacuo to obtain 0.23 g of the crude 4-(bromomethyl)-5-fluoro-7-methyl-2<i>H</i>-chromen-2-one as a pale yellow solid which was used without further purification.</div><div class="NLM_p"><i>Step 2.</i> A mixture of 4-(bromomethyl)-5-fluoro-7-methyl-2<i>H</i>-chromen-2-one (0.200 g, 0.7 mmol) and triethyl phosphite (0.253 mL, 1.5 mmol) was stirred at 100 °C for 18 h. The reaction mixture purified by flash column chromatography (50% ethyl acetate/hexanes followed by 100% ethyl acetate) to obtain 155 mg (64%) of diethyl [(5-fluoro-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.98 (s, 1H), 6.84 (d, <i>J</i> = 12.9 Hz, 1H), 6.44 (d, <i>J</i> = 4.8 Hz, 1H), 4.20–4.03 (m, 4H), 3.52 (s, 1H), 3.46 (s, 1H), 2.43 (s, 3H), 1.36–1.22 (m, 6H). LC–MS: <i>m</i>/<i>z</i> = 329 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 3.</i> A mixture of diethyl [(5-fluoro-7-methyl-2-oxo-2<i>H</i>-chromen-4-yl)methyl]phosphonate (0.026 g, 0.1 mmol) and 4 M solution of hydrochloric acid in dioxane (1 mL) was stirred at 100 °C for 18 h. The reaction mixture was concentrated and purified by reverse phase HPLC to obtain 16 mg (74%) of compound <b>10</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.06 (s, 1H), 6.98 (d, <i>J</i> = 13.1 Hz, 1H), 6.35 (d, <i>J</i> = 4.8 Hz, 1H), 3.56 (s, 1H), 3.51 (s, 1H), 2.45 (s, 3H). <sup>13</sup>C NMR (125 MHz, <i>d6</i>-DMSO) δ 160.33, 159.37, 158.31, 154.38, 148.39, 148.31, 144.17, 144.08, 116.21, 113.61, 113.11, 112.93, 107.37, 107.28, 35.57, 34.66, 34.57, 21.39. LC–MS: <i>m</i>/<i>z</i> = 273 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> [(2-Oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonic Acid (<b>11</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of 4-bromomethyl-2(1<i>H</i>)-quinolinone (0.500 g, 2.1 mmol) and triethyl phosphite (0.720 mL, 4.2 mmol) was heated in dioxane (2 mL) to 100 °C for 18 h. The reaction mixture was concentrated and purified by flash column chromatography (0–5% methanol/dichloromethane) to obtain 300 mg (48%) of diethyl [(2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate as cream colored solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.82 (br s, 1H), 7.82 (d, <i>J</i> = 8.2 Hz, 1H), 7.39–7.57 (m, 2H), 7.25–7.23 (m, 1H), 6.72 (d, <i>J</i> = 3.9 Hz, 1H), 4.07 (quin, <i>J</i> = 7.3 Hz, 4H), 3.46 (s, 1H), 3.40 (s, 1H), 1.25 (t, <i>J</i> = 7.0 Hz, 6H). LC–MS: <i>m</i>/<i>z</i> = 296 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> A mixture of diethyl [(2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate (0.025 g, 0.085 mmol) and 4 M solution of hydrochloric acid in dioxane (1 mL) was stirred at 100 °C for 24 h. The reaction mixture was concentrated down to dryness purified by reverse phase HPLC to obtain 11 mg (54%) of compound <b>11</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.64 (br s, 1H), 7.84 (d, <i>J</i> = 7.9 Hz, 1H), 7.46 (t, <i>J</i> = 7.4 Hz, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.15 (t, <i>J</i> = 7.4 Hz, 1H), 6.43 (d, <i>J</i> = 4.0 Hz, 1H), 3.26 (s, 1H), 3.19 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.89, 145.71, 145.63, 139.29, 130.51, 126.49, 122.17, 121.76, 119.60, 115.72, 33.21, 31.94. LC–MS: <i>m</i>/<i>z</i> = 240 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> [(1-Methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonic Acid (<b>12</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a cooled (0 °C) solution of diethyl [(2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate (0.050 g, 0.2 mmol) in DMF (0.5 mL) were added sodium hydride, 60% (0.004 g, 0.2 mmol), and iodomethane (0.032 mL, 0.5 mmol). The mixture was stirred at ambient temperature for 2 h. The reaction mixture was then quenched with aqueous saturated ammonium chloride solution, extracted with ethyl acetate, washed with water and brine. The organic layer was dried over magnesium sulfate and purified by flash column chromatography (0–10% methanol/dichloromethane) to obtain 24 mg (46%) of diethyl [(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate as a clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.87 (d, <i>J</i> = 7.6 Hz, 1H), 7.59 (t, <i>J</i> = 7.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.5 Hz, 1H), 7.33–7.26 (m, 1H), 6.72 (d, <i>J</i> = 4.4 Hz, 1H), 4.11–4.04 (m, 4H), 3.72 (s, 3H), 3.40 (s, 1H), 3.35 (s, 1H), 1.28–1.24 (m, 6H). LC–MS: <i>m</i>/<i>z</i> = 310 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> A mixture of diethyl [(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate (0.023 g, 0.1 mmol) and 4 M solution of hydrochloric acid in dioxane (2 mL) was stirred at 100 °C for 24 h. The reaction mixture was concentrated down to dryness and isolated by reverse phase HPLC to obtain 7 mg (37%) of the product as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.93 (d, <i>J</i> = 7.9 Hz, 1H), 7.63–7.59 (m, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 7.26 (t, <i>J</i> = 7.4 Hz, 1H), 6.54 (d, <i>J</i> = 3.5 Hz, 1H), 3.62 (s, 3H), 3.26 (s, 1H), 3.20 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.03, 144.42, 144.33, 140.11, 130.97, 127.17, 122.14, 121.92, 120.54, 115.07, 33.17, 31.87, 29.33. LC–MS: <i>m</i>/<i>z</i> = 254 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> [(5,7-Dimethyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonic Acid (<b>13</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of 3,5-dimethylaniline (0.514 mL, 4.1 mmol), ethyl acetoacetate (1.043 mL, 8.2 mmol), and potassium <i>tert</i>-butoxide (0.046 g, 0.4 mmol) was stirred at 120 °C for 18 h. The reaction mixture was diluted with ethyl acetate, washed with aqueous saturated ammonium chloride, water, and brine. The organic layer was dried over magnesium sulfate, concentrated, and purified by flash column chromatography (35% ethyl acetate /hexanes) to obtain 0.33 g (39%) of <i>N</i>-(3,5-dimethylphenyl)-3-oxobutanamide as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (br s, 1H), 7.18 (s, 2H), 6.77 (s, 1H), 3.55 (s, 2H), 2.30–2.20 (m, 9H). LC–MS: <i>m</i>/<i>z</i> = 206 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 2.</i> To a mixture of <i>N</i>-(3,5-dimethylphenyl)-3-oxobutanamide (0.200 g, 1.0 mmol) in EtOAc (2 mL) was added pyridinium bromide perbromide (0.156 g, 0.5 mmol). The mixture was stirred at ambient temperature for an hour. The reaction mixture was concentrated in vacuo and purified by flash column chromatography (0–25% ethyl acetate /hexanes) to obtain 88 mg (32%) of 4-bromo-<i>N</i>-(3,5-dimethylphenyl)-3-oxobutanamide. Concentrated sulfuric acid (0.2 mL) was added to a cooled (0 °C) 4-bromo-<i>N</i>-(3,5-dimethylphenyl)-3-oxobutanamide (0.088 g, 0.31 mmol). The mixture was stirred at 40 °C for 18 h. Reaction mixture was then diluted with cold water and extracted with 5% methanol in dichloromethane. The organic extracts were washed with brine, dried over magnesium sulfate, and concentrated in vacuo to obtain 68 mg of the crude 4-(bromomethyl)-5,7-dimethyl-1,2-dihydroquinolin-2-one as a cream solid which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.48 (br s, 1H), 7.17 (s, 1H), 6.92 (s, 1H), 6.74 (s, 1H), 4.77 (s, 2H), 2.91 (s, 3H), 2.43 (s, 3H). LC–MS: <i>m</i>/<i>z</i> = 265 [M + H, <sup>79</sup>Br]<sup>+</sup>, 267 [M + H, <sup>81</sup>Br]<sup>+</sup>.</div><div class="NLM_p"><i>Step 3.</i> A mixture of 4-(bromomethyl)-5,7-dimethyl-1,2-dihydroquinolin-2-one (0.033 g, 0.12 mmol) and triethyl phosphite (0.17 mL, 0.96 mmol) was stirred in dioxane (2.0 mL) at 100 °C for 22 h. The reaction mixture was concentrated and purified by flash column chromatography (0–10% methanol/dichloromethane) to obtain 23 mg (57%) of diethyl [(5,7-dimethyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.49 (br s, 1H), 7.14 (s, 1H), 6.86 (s, 1H), 6.64 (d, <i>J</i> = 4.6 Hz, 1H), 4.15–4.00 (m, 4H), 3.71 (s, 1H), 3.65 (s, 1H), 2.87 (s, 3H), 2.39 (s, 3H), 1.32–1.18 (m, 6H). LC–MS: <i>m</i>/<i>z</i> = 324 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 4.</i> A mixture of diethyl [(5,7-dimethyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate (0.023 g, 0.07 mmol) and 4 M solution of hydrochloric acid in dioxane (0.8 mL) was stirred at 100 °C for 24 h. The reaction mixture was concentrated down to dryness, purified by reverse phase HPLC to obtain 7 mg (37%) of compound <b>13</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.54 (br s, 1H), 6.92 (s, 1H), 6.76 (s, 1H), 6.28 (br s, 1H), 3.42–3.36 (m, 2H), 2.78 (s, 3H), 2.25 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.15, 141.06, 139.57, 136.60, 128.18, 123.65, 117.01, 116.98, 114.89, 36.58, 35.31, 25.02, 21.19. LC–MS: <i>m</i>/<i>z</i> = 268 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> [(Quinolin-8-yl)methyl]phosphonic Acid (<b>14</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of 8-(bromomethyl)quinoline (0.10 g, 0.5 mmol) and triethyl phosphite (0.154 mL, 0.9 mmol) was heated to 100 °C for 24 h. The crude reaction mixture was subjected to flash column chromatography (50% ethyl acetate/hexanes followed by 5% methanol/dichloromethane) to obtain 40 mg (32%) of diethyl [(quinolin-8-yl)methyl]phosphonate as a clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (d, <i>J</i> = 3.8 Hz, 1H), 8.16 (d, <i>J</i> = 8.2 Hz, 1H), 7.87 (dd, <i>J</i> = 6.5, 3.5 Hz, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.58–7.49 (m, 1H), 7.42 (dd, <i>J</i> = 8.0, 4.1 Hz, 1H), 4.13–3.91 (m, 6H), 1.21–1.07 (m, 6H). LC–MS: <i>m</i>/<i>z</i> = 280 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> A mixture of diethyl [(quinolin-8-yl)methyl]phosphonate (0.041 g, 0.1 mmol) and a 4 M solution of hydrochloric acid in dioxane (2 mL) was stirred at 100 °C for 24h. The reaction mixture was concentrated down to dryness azeotropically with toluene, washed with ethyl acetate, and dried to obtain 37 mg (97%) of the title compound as HCl salt and white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 8.67 (d, <i>J</i> = 8.3 Hz, 1H), 8.00 (d, <i>J</i> = 8.3 Hz, 1H), 7.92–7.87 (m, 1H), 7.67–7.78 (m, 2H), 3.78 (s, 1H), 3.73 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 147.51, 143.58, 140.57, 134.61, 134.54, 129.90, 129.81, 129.26, 128.61, 127.75, 122.10, 31.28, 29.98. LC–MS: <i>m</i>/<i>z</i> = 224 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> [(Quinolin-4-yl)methyl]phosphonic Acid (<b>15</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a mixture of triethyl phosphite (0.162 mL, 0.9 mmol) and zinc iodide (0.150 g, 0.5 mmol) in THF (1.5 mL) was added quinolin-4-ylmethanol (0.050 g, 0.3 mmol). The reaction mixture was stirred at 70 °C for 72 h. The mixture was then diluted with ethyl acetate, washed with aqueous saturated sodium bicarbonate solution, water, and brine. The organic layer was dried over magnesium sulfate, concentrated, and purified by reverse phase HPLC to obtain 9.5 mg (11%) of diethyl [(quinolin-4-yl)methyl]phosphonate as colorless oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.80 (d, <i>J</i> = 4.6 Hz, 1H), 8.28 (d, <i>J</i> = 8.5 Hz, 1H), 8.07 (d, <i>J</i> = 8.5 Hz, 1H), 7.82 (t, <i>J</i> = 7.7 Hz, 1H), 7.70 (t, <i>J</i> = 7.7 Hz, 1H), 7.56 (t, <i>J</i> = 4.1 Hz, 1H), 4.15–3.96 (m, 4H), 3.90 (s, 1H), 3.85 (s, 1H), 1.22(t, <i>J</i> = 7.1 Hz, 6H). LC–MS: <i>m</i>/<i>z</i> = 280 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> A mixture of diethyl [(quinolin-4-yl)methyl]phosphonate (0.009 g, 0.032 mmol) and a 4 M solution of hydrochloric acid in dioxane (0.5 mL) was stirred at 100 °C for 18 h. The reaction mixture was concentrated down to dryness to obtain 8 mg (96%) of the title compound as a hydrochloride salt, as a white hygroscopic solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.13 (d, <i>J</i> = 5.8 Hz, 1H), 8.64 (d, <i>J</i> = 8.8 Hz, 1H), 8.28–8.16 (m, 2H), 8.14–7.99 (m, 2H), 4.10 (s, 1H), 4.04 (s, 1H). LC–MS: <i>m</i>/<i>z</i> = 224 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> [(5,7-Dibromo-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonic Acid (<b>16</b>)</h3><div class="NLM_p"><i>Step 1.</i> A mixture of 3,5-dibromolaniline (0.5 g, 2.0 mmol), ethyl acetoacetate (0.5 mL, 4.0 mmol), and potassium <i>tert</i>-butoxide (0.022 g, 0.2 mmol) was stirred at 120 °C for 24 h. The reaction mixture was diluted with ethyl acetate, washed with water and brine. The organic layer was dried over magnesium sulfate, concentrated, and purified by flash column chromatography (35% ethyl acetate /hexanes) to obtain 0.1 g (15%) of <i>N</i>-(3,5-dibromophenyl)-3-oxobutanamide as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.40 (s, 1H), 7.74 (s, 2H), 7.43 (s, 1H), 3.62 (s, 2H), 2.55 (s, 3H).</div><div class="NLM_p"><i>Step 2.</i> To a mixture of <i>N</i>-(3,5-dibromophenyl)-3-oxobutanamide (0.090 g, 0.3 mmol) in acetic acid (0.2 mL), bromine (0.015 mL, 0.3 mmol) was added slowly. After stirring at room temperature for 3h, acetone (2 mL) was added to the reaction and the mixture was stirred at room temperature for 18 h. The reaction mixture was diluted with ethyl acetate and washed with water and brine. The organic layer was dried over magnesium sulfate, concentrated, and purified by flash column chromatography (25 g, 0–60% ethyl acetate/hexanes) to obtain 75 mg of 4-bromo-<i>N</i>-(3,5-dibromophenyl)-3-oxobutanamide as a pink solid. To this was added sulfuric acid (0.100 mL, 1.8 mmol), and the mixture was stirred at 45 °C for 18 h. Cold water was then added to the reaction mixture and the resulting precipitate filtered, washed with dichloromethane, and dried to obtain 65 mg (61%) of 5,7-dibromo-4-(bromomethyl)-1,2-dihydroquinolin-2-one as a beige solid that was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 1H), 7.75 (s, 1H), 7.56 (s, 1H), 6.92 (s, 1H), 5.19 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.56, 146.96, 143.17, 131.48, 127.39, 123.76, 120.11, 119.14, 115.43, 33.99.</div><div class="NLM_p"><i>Step 3.</i> A mixture of 5,7-dibromo-4-(bromomethyl)-1,2-dihydroquinolin-2-one (0.055 g, 0.14 mmol) and triethyl phosphite (0.24 mL, 1.4 mmol) was stirred in dioxane (3.0 mL) at 100 °C for 24 h. The reaction mixture was concentrated and the residue purified by flash column chromatography (0–10% methanol/dichloromethane) to obtain 62 mg (98%) of diethyl [(5,7-dibromo-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate as a beige solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.83 (br s, 1H), 7.57–7.66 (m, 2H), 6.77 (d, <i>J</i> = 4.6 Hz, 1H), 4.08–4.41 (m, 6H), 1.29 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.22, 143.96, 143.86, 141.71, 132.89, 126.12, 124.11, 120.06, 119.74, 117.11, 62.76, 62.60, 34.16, 32.80, 16.43, 16.37. LC–MS: <i>m</i>/<i>z</i> = 453 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 4.</i> A mixture of diethyl [(5,7-dibromo-2-oxo-1,2-dihydroquinolin-4-yl)methyl]phosphonate (0.035 g, 0.077 mmol) and 4 M solution of hydrochloric acid in dioxane (1.0 mL) was stirred at 100 °C for 24 h. The reaction mixture was then concentrated to dryness and purified by reverse phase HPLC to obtain 18 mg (58%) of the product (<b>16</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65 (d, J = 1.8 Hz, 1H), 7.52 (d, J = 1.8 Hz, 1H), 6.57 (d, J = 4.1 Hz, 1H), 3.73 – 3.97 (m, 2H). LC–MS: <i>m</i>/<i>z</i> = 397 [M + H]<sup>+</sup></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cloning of the KPC-2, NDM-1, and VIM-2 Genes</h3><div class="NLM_p last">For KPC-2, the gene encoding residues 25–293 were cloned into the pET-GST vector as an N-terminal 6× His-tag protein. For NDM-1, two constructs were used. NDM-1 construct 1 encoding residues 29–270 inserted into the pET-SUMO vector with an N-terminal 6× His/SUMO tag was a kind gift from Dr. Hongmin Zhang and Dr. Quan Hao. NDM-1 construct 1 was used for enzymatic assays. NDM-1 construct 2 encoding residues 42–270 was cloned using standard restriction enzyme cloning techniques into a pET28a vector with an N-terminal 6× His-tag and a thrombin cleavage site. NDM-1 construct 2 was used for crystallization. The gene encoding VIM-2 was custom synthesized (ATUM/DNA2.0) and inserted into the vector pD441-SR with an N-terminal 6× His-tag and a TEV cleavage site. NDM-1 constructs were transformed into NEB 5-α competent <i>E. coli</i> and plated on LB agar containing either 100 μg/mL ampicillin (NDM-1 construct 1) or 50 μg/mL kanamycin (NDM-1 construct 2). Single colonies of the NDM-1 constructs were grown overnight at 30 °C in LB medium containing either 100 μg/mL ampicillin or 50 μg/mL kanamycin. Cells were collected, and the plasmid DNA was isolated using a mini-prep kit. The nucleotide sequences of both NDM-1 constructs were verified. The D199N mutation was performed in NDM-1 by site-directed mutagenesis using QuikChange and its sequence verified.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Protein Expression and Purification</h3><div class="NLM_p last">KPC-2 was expressed and purified as previously described.<a onclick="showRef(event, 'ref4 ref67'); return false;" href="javascript:void(0);" class="ref ref4 ref67">(4,67)</a> Recombinant NDM-1 and VIM-2 were produced in either <i>E. coli</i> BL21(DE3) cells (NDM-1 constructs) or Rosetta 2 (DE3) cells (VIM-2) and grown at 37 °C using Terrific broth supplemented with either 100 μg/mL ampicillin (NDM-1 construct 1), 50 μg/mL kanamycin (NDM-1 construct 2), or 50 μg/mL kanamycin + 35 μg/mL chloramphenicol (VIM-2) until the OD<sub>600</sub> reached 0.8–1.0. Expression of NDM-1 and VIM-2 was initiated by the addition of 0.5 mM IPTG and 0.1 mM zinc sulfate, and the cultures were incubated at 20 °C for an additional 22 h. Cells were collected by centrifugation (6000<i>g</i>/20 min, 4 °C) and then resuspended and sonicated in either 20 mM HEPES, pH 7.4, 500 mM NaCl, 20 mM imidazole for the NDM-1 constructs or 50 mM HEPES, pH 7.5, 150 mM NaCl, 20 mM imidazole, 50 mM zinc sulfate for VIM-2. One complete EDTA-free protease inhibitor tablet was added before sonication. The lysate was centrifuged (45 000 rpm/1 h, 4 °C), filtered, and the soluble proteins were separated by nickel affinity chromatography using a HisTrap HP (GE Healthcare) column, and the proteins were eluted over a 500 mM imidazole gradient. Briefly, NDM-1 construct 1 was purified as followed. The fractions containing protein from the nickel affinity chromatography were pooled and dialyzed against 20 mM HEPES, pH 7.0, 100 mM NaCl. Cleavage of the N-terminal 6× His/SUMO was carried out using ULP1 overnight at 20 °C. The affinity tag was removed by loading the sample onto a HisTrap HP column pre-equilibrated with 20 mM HEPES, pH 7.0, 100 mM NaCl and collecting the flow through, which contained the cleaved protein. The sample was concentrated and loaded onto a HiLoad 16/600 Superdex 75 pg (GE Healthcare) pre-equilibrated with 20 mM HEPES, pH 7.0, 100 mM NaCl. The protein concentration was measured spectrophotometrically using the predicted extinction coefficient (Δε<sub>280</sub> = 27 960 cm<sup>–1</sup> M<sup>–1</sup>). NDM-1 construct 2 was purified in an identical manner as NDM-1 construct 1 except that the N-terminal 6× His-tag was removed using thrombin overnight at 4 °C overnight. Briefly, VIM-2 was purified as followed. The fractions containing protein from the nickel affinity chromatography were pooled and dialyzed into 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM DTT. Cleavage of the N-terminal 6× His-tag was carried out using the TEV protease overnight at 25 °C. The affinity tag was removed by loading the sample onto a HisTrap HP column pre-equilibrated with 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM DTT and collecting the flow through, which contained the cleaved protein. The sample was concentrated and loaded onto a HiLoad 16/600 Superdex 75 pg (GE Healthcare) pre-equilibrated with 50 mM HEPES, pH 7.5, 150 mM NaCl, 50 mM zinc sulfate. The protein concentration was measured spectrophotometrically using the predicted extinction coefficient (Δε<sub>280</sub> = 29 910 cm<sup>–1</sup> M<sup>–1</sup>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Enzyme Kinetics</h3><div class="NLM_p last">All kinetic data were determined in duplicate using a Biotek Cytation multimode reader at 37 °C. For KPC-2, assays were performed in 100 mM Tris-HCl, pH 7.0, 0.01% (v/v) Triton X-100, and 1 nM KPC-2 enzyme. For NDM-1 (construct 1) and VIM-2, the assays were performed in 50 mM HEPES, pH 7.2, 50 μM zinc sulfate, 0.01% (v/v) Triton X-100, 20 μg/mL BSA. NDM-1 enzyme concentration was 2 nM, and VIM-2 enzyme concentration was 0.5 nM. All the reactions were initiated by the addition of enzyme, and the reaction progress curves were followed spectrophotometrically. Initial steady-state velocities from nitrocefin hydrolysis were measured at a wavelength of 486 nm. Using SigmaPlot 12.5, the <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> of nitrocefin were determined by nonlinear regression using the Michaelis–Menten equation. β-Lactamase activity was measured in the presence of increasing amount of the inhibitors. The IC<sub>50</sub> was obtained from the sigmoidal concentration dependence curve calculated using SigmaPlot 12.5. The <i>K</i><sub>i</sub> of each inhibitor was calculated according to the Cheng–Prusoff equation:<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a><i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>), where [S] is the nitrocefin concentration and <i>K</i><sub>m</sub> is the Michaelis constant of the enzymes. All assays were performed in duplicate except compound <b>1</b> (tested once due to compound availability) and compound <b>16</b> (triplicate).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Computational Docking</h3><div class="NLM_p last">The program DOCK 3.5.4<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> was used to screen the fragment subset of the ZINC database<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> of small molecules, a free database containing a large number of commercially available compounds and frequently used by both academic and industry researchers. The virtual screening experiment was carried out using a deposited KPC-2 structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8">5UL8</a>) as receptor template and a previously described procedure.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Briefly, all water molecules were removed from the protein except for the catalytic water and water molecule in the oxyanion hole. Hydrogen atoms were added by the docking program, and energy potential grids were calculated. The partial charges of those polar active site residues known to interact with substrates (e.g., S70, N132) were increased to favor such interactions with the ligand. The top 1000 compounds were visually examined to select compounds to purchase.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Crystallization</h3><div class="NLM_p last">KPC-2 was crystallized and soaked as described previously.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> NDM-1 construct 2 (residues 42–270) was used to generate crystals. NDM-1 crystals were grown at 20 °C using the hanging-drop vapor diffusion method. Protein solutions (10–20 mg/mL) in 20 mM HEPES, pH 7.0, 100 mM NaCl were mixed 1:1 (v/v) with reservoir solution containing 50 mM potassium phosphate monobasic, 10 mM calcium chloride, and 25% (w/v) PEG 8000. Crystals typically formed in 2 days. To obtain the ligand bound structures, NDM-1 crystals were soaked in a solution of 50 mM sodium acetate, pH 3.85, 25% (w/v) PEG 8000, and 10 mM inhibitor for 1 h. The soaked crystals were cryoprotected in a solution containing 50 mM sodium acetate, pH 3.85, 25% (w/v) PEG 8000, and 20% (v/v) glycerol and flash-cooled in liquid nitrogen. For NDM-1 D199N mutant, a 15 mg/mL protein stock was used to grow crystals in 0.05 M potassium phosphate dibasic (pH 8.0), 0.01 M calcium chloride, 25% (w/v) PEG8000. Complex NDM-1 D199N mutant crystals were prepared via soaking in 0.05 M sodium acetate, pH 7.5, 20% (w/v) PEG 8000, and 10 mM inhibitors for about 1–2 h. The soaked crystals were cryoprotected in a solution the same as the soaking conditions but with added 20% (v/v) glycerol and flash-cooled in liquid nitrogen. Crystals of VIM-2 were grown at 20 °C using hanging-drop vapor diffusion. Protein solutions (10–20 mg/mL) in 50 mM HEPES, pH 7.0, 150 mM NaCl, and 50 μM zinc sulfate were mixed 1:1 (v/v) with reservoir solution containing 200 mM calcium acetate (pH 7.0), 20% (w/v) PEG 3350, and 1 mM TCEP. Crystals typically formed in 2 days. To obtain the ligand bound structures at low pH, VIM-2 crystals were soaked in a solution of 50 mM sodium acetate, pH 3.85, 25% (w/v) PEG 8000, and 10 mM inhibitor for 1 h. The soaked crystals were cryoprotected in a solution containing 50 mM sodium acetate, pH 3.85, 25% (w/v) PEG 8000, and 20% (v/v) glycerol and flash-cooled in liquid nitrogen. For higher pH complex structures, VIM-2 complex crystals were prepared via soaking in 0.05 M sodium acetate, pH 7.5, 20% (w/v) PEG8000, and 10 mM inhibitors for about 1 h. The soaked crystals were cryoprotected in a solution the same as the soaking conditions but with added 20% (v/v) glycerol and flash-cooled in liquid nitrogen.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Data Collection and Structure Determinations</h3><div class="NLM_p last">Data for the KPC-2, NDM-1, and VIM-2 complex structures were collected using beamlines 19-BM-D, 22-BM-D, and 22-ID-D at the Advanced Photon Source (APS), Argonne National Laboratory (ANL), and beamline 8.3.1 at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory (LBNL). Diffraction data were indexed and integrated with iMosflm<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and scaled with SCALA<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> from the CCP4 suite.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Phasing was performed using molecular replacement with the program Phaser<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> of the PHENIX suite,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> with the KPC-2 structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8">5UL8</a>), NDM-8 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF">4TZF</a>), and VIM-2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3">1KO3</a>). Structure refinement was performed using phenix.refine<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> of the PHENIX suite and model building in WinCoot.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps were generated using the composite omit map program<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> from the PHENIX suite. The program eLBOW of the PHENIX suite was used to obtain geometry restraint information.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The final model qualities were assessed using MolProbity.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Statistics for data collection and refinement are given in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">Supporting Information Table 1</a>. All protein structure figures were generated using PyMOL 2.3.2 (Schrödinger).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Susceptibility Testing</h3><div class="NLM_p last">Microbiological testing of compounds <b>9</b>, <b>11</b>, and <b>13</b> was performed under contract with Micromyx, LLC (Kalamazoo, MI). Test medium used was Mueller–Hinton II broth (MHBII; lot no. 5257869; Becton Dickinson, Sparks, MD). The medium was prepared and stored according to guidelines from the Clinical and Laboratory Standards Institute (CLSI).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The test isolates consisted of Gram-negative pathogens from the Micromyx repository. Relevant quality control organisms from the American Type Culture Collection (ATCC) were included as directed by CLSI guidelines. The MIC assay method followed the procedure described by CLSI and employed automated liquid handlers to conduct serial dilutions and liquid transfers. Automated liquid handlers included the Multidrop 384 (Labsystems, Helsinki, Finland), Biomek 2000, and Biomek FX. The Biomek 2000 was used to perform serial 2-fold dilutions of test compound. A standardized inoculum of each organism was prepared per CLSI methods. Colonies were picked from the primary plate, and a suspension was prepared to equal a 0.5 McFarland turbidity standard. Suspensions were diluted 1:20 in MHBII medium and then transferred to compartments of sterile reservoirs divided by length (Beckman Coulter). The Biomek 2000 was used to inoculate the plates. Daughter plates were placed on the Biomek 2000 in reverse orientation so that plates were inoculated from low to high drug concentration. The Biomek 2000 delivered 10 μL of standardized inoculum into each well of the appropriate daughter plate for an additional 1:20 dilution, resulting in a final concentration of approximately 5 × 10<sup>5</sup> CFU per well. Thus, the wells of the daughter plates ultimately contained 185 μL of MHBII, 5 μL of drug solution, and 10 μL of inoculum. Plates were stacked three high, covered with a lid on the top plate, placed into plastic bags, and incubated at 35 °C for 18–20 h. Plates were viewed from the bottom using a plate viewer. An uninoculated solubility control plate was observed for evidence of drug precipitation. MICs were read where visible growth of the organism was inhibited. Compounds <b>9</b>, <b>11</b>, and <b>13</b> were tested alone in the concentration range 128–0.12 μg/mL and returned MIC > 128 μg/mL against all strains. Compounds <b>9</b>, <b>11</b>, and <b>13</b> were tested at a fixed concentration of 128 μg/mL in combination with imipenem in a concentration range of 128–0.001 μg/mL. The positive control was avibactam (4 μg/mL) in combination with ceftazidime in the range 64–0.006 μg/mL.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Checkerboard Assays</h3><div class="NLM_p">The isogenic <i>P. aeruginosa</i> stains expressing various carbapenemases were a kind gift from Dr. Olga Lomovskaya of QPex Biopharma Inc. A strain lacking efflux pump was constructed using the parent strain PAM1154 and by disrupting the oprM gene to inactivate two major efflux pumps that are constitutively expressed, MexAB-OprM and MexYX-OprM. The strain overexpressing efflux pumps was constructed using the parent strain PAM1032 with a mutation in the negative regulator mexR to overexpress MexAB-OprM. Plasmids carrying various carbapenemase genes, including vector only controls, were then transformed into these two strains.</div><div class="NLM_p last">The clinical <i>K. pneumoniae</i> strain was kindly provided by Dr. Yohei Doi (University of Pittsburgh). The MIC of imipenem against all strains was determined prior to combining treatments according to CLSI guidelines. Bacterial cultures were stored in glycerol stocks at −80 °C and were streaked onto Luria broth supplemented with (15 μg/mL gentamicin for QPex strains) or without antibiotic. Stock plates were grown for 18 h at 37 °C prior to storage at 4 °C for no longer than 3 days. Prior to each assay, single colonies were resuspended in tryptic soy broth (TSB) supplemented with or without antibiotic and were incubated for approximately 20 h shaking at 37 °C. MHBII was used for all assays in a 96-well plate format. For each assay, the inhibitor was tested at a concentration of 128–2 μg/mL decreasing 2-fold across each row. Imipenem was tested starting at the MIC and decreasing 2-fold across each column. Avibactam was tested in combination with imipenem at a concentration of 16–0.25 μg/mL across each row with imipenem tested at 512–0.5 μg/mL across each column. The plates were incubated shaking at 37 °C for approximately 20 h and were then quantified by reading the optical density (OD<sub>600</sub>) using a synergy 2 plate reader (BioTek). Inhibition was defined in wells exhibiting an optical density equal to medium only wells.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cytotoxicity Testing</h3><div class="NLM_p last">To assess the toxicity of the compounds, HEK293T human embryonic kidney epithelial cells were used. Viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as a molecular probe. The assay was carried out as previously described by our group.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In brief, compounds dissolved in dimethyl sulfoxide (DMSO) were tested at a range of 200–3.125 μg/mL utilizing 2-fold dilutions. Cells were grown in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were treated for 48 h and incubated at 37 °C in 5% CO<sub>2</sub>. Following treatment, MTT was added and measured at an OD of 570 nm using a Biotek Synergy 2 plate reader. Percent recovery was then calculated compared to solvent only controls.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> ADME Analysis</h3><div class="NLM_p last">Microsome stability and MDCK-MDR permeability studies were performed at Quintara Biosciences (South San Francisco, CA). Kinetic solubility studies were performed at Analiza (Cleveland, OH).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00728" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00728" class="ext-link">10.1021/acs.jmedchem.9b00728</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional figures of IC<sub>50</sub> curves, complex structures of phosphonate compounds with KPC-2, NDM-1, and VIM-2, cytotoxicity testing, <sup>1</sup>H NMR spectra of synthetic analogs, and table of crystallographic data collection and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and the SBL/MBL <i>K</i><sub>i</sub> data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf">jm9b00728_si_001.pdf (6.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_002.csv">jm9b00728_si_002.csv (1.12 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15">6D15</a> (KPC-2 with compound <b>1</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D16">6D16</a> (KPC-2 with compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D17">6D17</a> (KPC-2 with compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18">6D18</a> (KPC-2 with compound <b>6</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19">6D19</a> (KPC-2 with compound <b>9</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A">6D1A</a> (NDM-1 with compound <b>1</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1B">6D1B</a> (NDM-1 with compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1C">6D1C</a> (NDM-1 with compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D">6D1D</a> (NDM-1 with compound <b>6</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a> (NDM-1 with compound <b>7</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F">6D1F</a> (NDM-1 with compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G">6D1G</a> (NDM-1 with compound <b>9</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1H">6D1H</a> (NDM-1 with compound <b>11</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1I">6D1I</a> (NDM-1 with compound <b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1J">6D1J</a> (NDM-1 with compound <b>13</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1K">6D1K</a> (NDM-1 with compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0">6DD0</a> (VIM-2 with compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD1">6DD1</a> (VIM-2 with compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3R">6O3R</a> (NDM-1 D199N with compound <b>7</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a> (NDM-1 D199N with compound <b>16</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T">6O5T</a> (VIM-2 with compound <b>16</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00728" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam R. Renslo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, 600 16th Street, Genentech Hall
N574, San Francisco, California 94158, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1240-2846" title="Orcid link">http://orcid.org/0000-0002-1240-2846</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#177673767a39657279647b78576274647139727362"><span class="__cf_email__" data-cfemail="cfaeabaea2e1bdaaa1bca3a08fbaacbca9e1aaabba">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, University of South
Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5115-3600" title="Orcid link">http://orcid.org/0000-0002-5115-3600</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f38a909b969dc2b39b96929f879bdd868095dd969786"><span class="__cf_email__" data-cfemail="92ebf1faf7fca3d2faf7f3fee6fabce7e1f4bcf7f6e7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Orville
A. Pemberton</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, University of South
Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priyadarshini Jaishankar</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco, 600 16th Street, Genentech Hall
N574, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Afroza Akhtar</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, University of South
Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 3522, Tampa, Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessie L. Adams</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Microbiology & Molecular Biology, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lindsey N. Shaw</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Microbiology & Molecular Biology, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0629-8990" title="Orcid link">http://orcid.org/0000-0002-0629-8990</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>O.A.P. performed the molecular docking, biochemical, and X-ray crystallographic experiments. P.J. synthesized compounds. A.A. determined NDM-1 and VIM-2 crystal structures at pH 7. J.L.A. and L.N.S. performed the cell-based assays. O.A.P., A.R.R., and Y.C. designed the experiments and wrote the manuscript. All authors discussed the results and commented on the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): O.A.P., P.J., A.R.R., and Y.C. are listed as inventors on a patent application describing compounds studied herein.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge financial support from the National Institutes of Health (NIH) Grant AI103158 (Y.C.) and Grant AI124458 (L.N.S.) and from the National Center for Advancing Translational Science UCSF-CTSI Grant UL1 TR000004 (A.R.R.). We thank Dr. Hongmin Zhang and Dr. Quan Hao (University of Hong Kong) for the NDM-1 clone, Dr. Olga Lomovskaya (QPex Biopharma Inc.) for the <i>P. aeruginosa</i> isogenic strains, and Dr. Yohei Doi (University of Pittsburgh) for the <i>K. pneumoniae</i> clinical strain. We thank the staff of beamlines 19-BM, 22-BM, and 22-ID at APS and the staff of beamline 8.3.1 at ALS.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">SBL</td><td class="NLM_def"><p class="first last">serine β-lactamase</p></td></tr><tr><td class="NLM_term">MBL</td><td class="NLM_def"><p class="first last">metallo-β-lactamase</p></td></tr><tr><td class="NLM_term">KPC-2</td><td class="NLM_def"><p class="first last"><i>Klebsiella pneumoniae</i> carbapenemase-2</p></td></tr><tr><td class="NLM_term">NDM-1</td><td class="NLM_def"><p class="first last">New Delhi metallo-β-lactamase-1</p></td></tr><tr><td class="NLM_term">VIM-2</td><td class="NLM_def"><p class="first last">Verona integron-encoded metallo-β-lactamase-2</p></td></tr><tr><td class="NLM_term">OXA-48</td><td class="NLM_def"><p class="first last">oxacillinase-48</p></td></tr><tr><td class="NLM_term">CRE</td><td class="NLM_def"><p class="first last">carbapenem-resistant <i>Enterobacteriaceae</i></p></td></tr><tr><td class="NLM_term">FBLD</td><td class="NLM_def"><p class="first last">fragment-based lead discovery</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hydrogen bond</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">DHQ</td><td class="NLM_def"><p class="first last">dihydroquinolinone</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">TEV</td><td class="NLM_def"><p class="first last">tobacco etch virus</p></td></tr><tr><td class="NLM_term">SUMO</td><td class="NLM_def"><p class="first last">small ubiquitin-like modifier</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 85 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, T. G.</span></span> <span> </span><span class="NLM_article-title">β-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1311</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.cell.2014.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=25480295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOrt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=1300-1311&author=H.+Choauthor=T.+Ueharaauthor=T.+G.+Bernhardt&title=%CE%B2-lactam+antibiotics+induce+a+lethal+malfunctioning+of+the+bacterial+cell+wall+synthesis+machinery&doi=10.1016%2Fj.cell.2014.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis Machinery</span></div><div class="casAuthors">Cho, Hongbaek; Uehara, Tsuyoshi; Bernhardt, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1300-1311</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Penicillin and related beta-lactams comprise one of our oldest and most widely used antibiotic therapies.  These drugs have long been known to target enzymes called penicillin-binding proteins (PBPs) that build the bacterial cell wall.  Investigating the downstream consequences of target inhibition and how they contribute to the lethal action of these important drugs, we demonstrate that beta-lactams do more than just inhibit the PBPs as is commonly believed.  Rather, they induce a toxic malfunctioning of their target biosynthetic machinery involving a futile cycle of cell wall synthesis and degrdn., thereby depleting cellular resources and bolstering their killing activity.  Characterization of this mode of action addnl. revealed a quality control function for enzymes that cleave bonds in the cell wall matrix.  The results thus provide insight into the mechanism of cell wall assembly and suggest how best to interfere with the process for future antibiotic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEc7F45dT_7LVg90H21EOLACvtfcHk0ljoRBZwj3O-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOrt7bO&md5=b7a3b2273f62c322bdfc78554301ffa3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DT.%2BG.%26atitle%3D%25CE%25B2-lactam%2520antibiotics%2520induce%2520a%2520lethal%2520malfunctioning%2520of%2520the%2520bacterial%2520cell%2520wall%2520synthesis%2520machinery%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D1300%26epage%3D1311%26doi%3D10.1016%2Fj.cell.2014.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span></span> <span> </span><span class="NLM_article-title">Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria</span>. <i>Annu. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1146/annurev-micro-090110-102911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1146%2Fannurev-micro-090110-102911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21740228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=455-478&author=K.+Bushauthor=J.+F.+Fisher&title=Epidemiological+expansion%2C+structural+studies%2C+and+clinical+challenges+of+new+%CE%B2-lactamases+from+gram-negative+bacteria&doi=10.1146%2Fannurev-micro-090110-102911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria</span></div><div class="casAuthors">Bush, Karen; Fisher, Jed F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455-478</span>CODEN:
                <span class="NLM_cas:coden">ARMIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4227</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  β-Lactamase evolution presents to the infectious disease community a major challenge in the treatment of infections caused by multidrug-resistant gram-neg. bacteria.  Because >1000 of these naturally occurring β-lactamases exist, attempts to correlate structure and function have become daunting.  Although new enzymes in the extended-spectrum β-lactamase (ESBL) families are frequently identified, the older CTX-M-14 and CTX-M-15 enzymes have become the most prevalent ESBLs in global surveillance.  Carbapenemases with either Ser-based or Zn-facilitated hydrolysis mechanisms are posing some of the most crit. problems.  Most geog. regions now report KPC serine carbapenemases and the metallo-β-lactamases VIM, IMP, and NDM-1, even though NDM-1 was only recently identified.  The rapid emergence of these newer enzymes, with multiple β-lactamases appearing in a single organism, makes the design of new β-lactamase inactivators or β-lactamase-stable β-lactams all the more difficult.  Combination therapy will likely be required to counteract the continuing evolution of these insidious enzymes in multidrug-resistant pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-Qqd_9pw7bVg90H21EOLACvtfcHk0lh6XD39hNS-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLbI&md5=7a836d327e02fd6a7c0c2a09ba646191</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev-micro-090110-102911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-micro-090110-102911%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26atitle%3DEpidemiological%2520expansion%252C%2520structural%2520studies%252C%2520and%2520clinical%2520challenges%2520of%2520new%2520%25CE%25B2-lactamases%2520from%2520gram-negative%2520bacteria%26jtitle%3DAnnu.%2520Rev.%2520Microbiol.%26date%3D2011%26volume%3D65%26spage%3D455%26epage%3D478%26doi%3D10.1146%2Fannurev-micro-090110-102911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, G. A.</span></span> <span> </span><span class="NLM_article-title">Updated functional classification of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1128/AAC.01009-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.01009-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19995920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=969-976&author=K.+Bushauthor=G.+A.+Jacoby&title=Updated+functional+classification+of+%CE%B2-lactamases&doi=10.1128%2FAAC.01009-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Updated functional classification of β-lactamases</span></div><div class="casAuthors">Bush, Karen; Jacoby, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">969-976</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Two classification schemes for β-lactamases are currently in use.  The mol. classification is based on the amino acid sequence and divides β-lactamases into class A, C, and D enzymes which utilize serine for β-lactam hydrolysis and class B metalloenzymes which require Zn2+ ions for substrate hydrolysis.  The functional classification scheme updated here is based on the proposal by K. Bush et al. (1995).  It takes into account substrate and inhibitor profiles in an attempt to group the enzymes in ways that can be correlated with their phenotype in clin. isolates.  Major groupings generally correlate with the more broadly based mol. classification.  The updated system includes group 1 (class C) cephalosporinases; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum β-lactamases and serine carbapenemases; and group 3 metallo-β-lactamases.  Several new subgroups of each of the major groups are described, based on specific attributes of individual enzymes.  A list of attributes is also suggested for the description of a new β-lactamase, including the requisite microbiol. properties, substrate and inhibitor profiles, and mol. sequence data that provide an adequate characterization for a new β-lactam-hydrolyzing enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofIL9Nvv4cdbVg90H21EOLACvtfcHk0lh-z4P2At_gxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsr4%253D&md5=89b376d90ff64b78f81bd43ed5925ea2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.01009-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01009-09%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DUpdated%2520functional%2520classification%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D969%26epage%3D976%26doi%3D10.1128%2FAAC.01009-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamase structure and function</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1277</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2012.06796.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1111%2Fj.1749-6632.2012.06796.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23163348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1277&publication_year=2013&pages=91-104&author=T.+Palzkill&title=Metallo-%CE%B2-lactamase+structure+and+function&doi=10.1111%2Fj.1749-6632.2012.06796.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase structure and function</span></div><div class="casAuthors">Palzkill, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1277</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">91-104</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Lactam antibiotics are the most commonly used antibacterial agents and growing resistance to these drugs is a concern.  Metallo-β-lactamases are a diverse set of enzymes that catalyze the hydrolysis of a broad range of β-lactam drugs including carbapenems.  This diversity is reflected in the observation that the enzyme mechanisms differ based on whether one or two zincs are bound in the active site that, in turn, is dependent on the subclass of β-lactamase.  The dissemination of the genes encoding these enzymes among Gram-neg. bacteria has made them an important cause of resistance.  In addn., there are currently no clin. available inhibitors to block metallo-β-lactamase action.  This review summarizes the numerous studies that have yielded insights into the structure, function, and mechanism of action of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKW_XazIQODLVg90H21EOLACvtfcHk0lh-z4P2At_gxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D&md5=ceb4276f35d73e361e2c2fe27015ab8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2012.06796.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2012.06796.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DMetallo-%25CE%25B2-lactamase%2520structure%2520and%2520function%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1277%26spage%3D91%26epage%3D104%26doi%3D10.1111%2Fj.1749-6632.2012.06796.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dortet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance in <i>Enterobacteriaceae</i>: here is the storm!</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.molmed.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22480775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=263-272&author=P.+Nordmannauthor=L.+Dortetauthor=L.+Poirel&title=Carbapenem+resistance+in+Enterobacteriaceae%3A+here+is+the+storm%21&doi=10.1016%2Fj.molmed.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance in Enterobacteriaceae: here is the storm</span></div><div class="casAuthors">Nordmann, Patrice; Dortet, Laurent; Poirel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The current worldwide emergence of resistance to the powerful antibiotic carbapenem in Enterobacteriaceae constitutes an important growing public health threat.  Sporadic outbreaks or endemic situations with enterobacterial isolates not susceptible to carbapenems are now reported not only in hospital settings but also in the community.  Acquired class A (KPC), class B (IMP, VIM, NDM), or class D (OXA-48, OXA-181) carbapenemases, are the most important determinants sustaining resistance to carbapenems.  The corresponding genes are mostly plasmid-located and assocd. with various mobile genetic structures (insertion sequences, integrons, transposons), further enhancing their spread.  This review summarizes the current knowledge on carbapenem resistance in Enterobacteriaceae, including activity, distribution, clin. impact, and possible novel antibiotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw3NvxiXmzF7Vg90H21EOLACvtfcHk0ljNGnRyTaQMOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D&md5=afb14fc82cdcf73cb9c1fdf17b3c1a2d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DNordmann%26aufirst%3DP.%26aulast%3DDortet%26aufirst%3DL.%26aulast%3DPoirel%26aufirst%3DL.%26atitle%3DCarbapenem%2520resistance%2520in%2520Enterobacteriaceae%253A%2520here%2520is%2520the%2520storm%2521%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.molmed.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trecarichi, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumbarello, M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic options for carbapenem-resistant <i>Enterobacteriaceae</i> infections</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1080/21505594.2017.1292196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1080%2F21505594.2017.1292196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28276996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=470-484&author=E.+M.+Trecarichiauthor=M.+Tumbarello&title=Therapeutic+options+for+carbapenem-resistant+Enterobacteriaceae+infections&doi=10.1080%2F21505594.2017.1292196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options for carbapenem-resistant Enterobacteriaceae infections</span></div><div class="casAuthors">Trecarichi, Enrico Maria; Tumbarello, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">470-484</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health.  The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clin. trials have been performed with this objective.  We aimed to summarize in the present review data provided by previous observational clin. studies that have investigated the impact of different treatment strategies on the outcome of CRE infections.  Most of these studies reported that combination therapy with 2 or more drugs is superior to monotherapy in providing a survival benefit.  The use of carbapenems in assocn. with other active drugs is likely ineffective for CRE isolates with carbapenem Min. Inhibitory Concns. (MICs) >8 mg/l.  The effectiveness of further therapeutic options for the treatment of extensively or pan-drug-resistant Enterobacteriaceae infections has been reported in vivo and in vitro, although few cases/case series have been reported.  Novel antimicrobials that are effective against CRE are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD0gIPYMLuGbVg90H21EOLACvtfcHk0ljNGnRyTaQMOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOlt7g%253D&md5=d65653474f068d5ed3c884c15f372444</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F21505594.2017.1292196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2017.1292196%26sid%3Dliteratum%253Aachs%26aulast%3DTrecarichi%26aufirst%3DE.%2BM.%26aulast%3DTumbarello%26aufirst%3DM.%26atitle%3DTherapeutic%2520options%2520for%2520carbapenem-resistant%2520Enterobacteriaceae%2520infections%26jtitle%3DVirulence%26date%3D2017%26volume%3D8%26spage%3D470%26epage%3D484%26doi%3D10.1080%2F21505594.2017.1292196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenems: past, present, and future</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4943</span>– <span class="NLM_lpage">4960</span>, <span class="refDoi"> DOI: 10.1128/AAC.00296-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00296-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21859938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4943-4960&author=K.+M.+Papp-Wallaceauthor=A.+Endimianiauthor=M.+A.+Taracilaauthor=R.+A.+Bonomo&title=Carbapenems%3A+past%2C+present%2C+and+future&doi=10.1128%2FAAC.00296-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems: past, present, and future</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Endimiani, Andrea; Taracila, Magdalena A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4943-4960</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In this review, we summarize the current "state of the art" of carbapenem antibiotics and their role in our antimicrobial armamentarium.  Among the β-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most β-lactamases, in some cases act as "slow substrates" or inhibitors of β-lactamases, and still target penicillin binding proteins.  This "value-added feature" of inhibiting β-lactamases serves as a major rationale for expansion of this class of β-lactams.  We describe the initial discovery and development of the carbapenem family of β-lactams.  Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compd. for all subsequent carbapenems.  To date, more than 80 compds. with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature.  We also highlight important features of the carbapenems that are presently in clin. use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem.  In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compds., as they have served us well for more than 3 decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Y-IuobRax7Vg90H21EOLACvtfcHk0ljVclLBqb-MUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ&md5=5104ffe81fe097b4ae11a5c6a8fc7fb0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.00296-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00296-11%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenems%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D4943%26epage%3D4960%26doi%3D10.1128%2FAAC.00296-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Duin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenem-resistant <i>Enterobacteriaceae</i>: a review of treatment and outcomes</span>. <i>Diagn. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.diagmicrobio.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23290507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=115-120&author=D.+van%0ADuinauthor=K.+S.+Kayeauthor=E.+A.+Neunerauthor=R.+A.+Bonomo&title=Carbapenem-resistant+Enterobacteriaceae%3A+a+review+of+treatment+and+outcomes&doi=10.1016%2Fj.diagmicrobio.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes</span></div><div class="casAuthors">van Duin, David; Kaye, Keith S.; Neuner, Elizabeth A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-120</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The emergence of carbapenem resistance in Enterobacteriaceae is an important threat to global health.  Reported outcomes of infections with carbapenem-resistant Enterobacteriaceae (CRE) are poor.  Very few options remain for the treatment of these virulent organisms.  Antibiotics which are currently in use to treat CRE infections include aminoglycosides, polymyxins, tigecycline, fosfomycin, and temocillin.  In addn., the role of combination therapy, including carbapenem contg. regimens, remains to be defined.  There are several important concerns regarding all of these treatment options such as limited efficacy, increasing reports of resistance, and specific toxicities.  Data from retrospective studies favor combination therapy over single-agent therapy for the treatment of CRE bloodstream infections.  In summary, new antibiotics are greatly needed, as is addnl. prospective research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAz43e4L1XbVg90H21EOLACvtfcHk0ljVclLBqb-MUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2huw%253D%253D&md5=b0d55d693602502f5dc2e43dfc046ecb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDuin%26aufirst%3DD.%26aulast%3DKaye%26aufirst%3DK.%2BS.%26aulast%3DNeuner%26aufirst%3DE.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenem-resistant%2520Enterobacteriaceae%253A%2520a%2520review%2520of%2520treatment%2520and%2520outcomes%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D75%26spage%3D115%26epage%3D120%26doi%3D10.1016%2Fj.diagmicrobio.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrill, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, K. L.</span></span> <span> </span><span class="NLM_article-title">Treatment options for carbapenem-resistant <i>Enterobacteriaceae</i> infections</span>. <i>Open Forum Infect Dis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">ofv050</span> <span class="refDoi"> DOI: 10.1093/ofid/ofv050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fofid%2Fofv050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26125030" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=H.+J.+Morrillauthor=J.+M.+Pogueauthor=K.+S.+Kayeauthor=K.+L.+LaPlante&title=Treatment+options+for+carbapenem-resistant+Enterobacteriaceae+infections&doi=10.1093%2Fofid%2Fofv050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofv050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofv050%26sid%3Dliteratum%253Aachs%26aulast%3DMorrill%26aufirst%3DH.%2BJ.%26aulast%3DPogue%26aufirst%3DJ.%2BM.%26aulast%3DKaye%26aufirst%3DK.%2BS.%26aulast%3DLaPlante%26aufirst%3DK.%2BL.%26atitle%3DTreatment%2520options%2520for%2520carbapenem-resistant%2520Enterobacteriaceae%2520infections%26jtitle%3DOpen%2520Forum%2520Infect%2520Dis%26date%3D2015%26volume%3D2%26doi%3D10.1093%2Fofid%2Fofv050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloush, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navon-Venezia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigman-Igra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabili, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeli, Y.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant <i>Pseudomonas aeruginosa</i>: risk factors and clinical impact</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1128/AAC.50.1.43-48.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.50.1.43-48.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=16377665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=43-48&author=V.+Aloushauthor=S.+Navon-Veneziaauthor=Y.+Seigman-Igraauthor=S.+Cabiliauthor=Y.+Carmeli&title=Multidrug-resistant+Pseudomonas+aeruginosa%3A+risk+factors+and+clinical+impact&doi=10.1128%2FAAC.50.1.43-48.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact</span></div><div class="casAuthors">Aloush, Valerie; Navon-Venezia, Shiri; Seigman-Igra, Yardena; Cabili, Shaltiel; Carmeli, Yehuda</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug resistant (MDR).  Its rate of occurrence, the individual risk factors among affected patients, and the clin. impact of infection are undetd.  We conducted an epidemiol. evaluation and mol. typing using pulsed-field gel electrophoresis (PFGE) of 36 isolates for 82 patients with MDR P. aeruginosa and 82 controls matched by ward, length of hospital stay, and calendar time.  A matched case-control study identified individual risk factors for having MDR P. aeruginosa, and a retrospective matched-cohort study examd. clin. outcomes of such infections.  The 36 isolates belonged to 12 PFGE clones.  Two clones dominated, with one originating in an intensive care unit (ICU).  Cases and controls had similar demog. characteristics and nos. of comorbid conditions.  A multivariate model identified ICU stay, being bedridden, having high invasive devices scores, and being treated with broad-spectrum cephalosporins and with aminoglycosides as significant risk factors for isolating MDR P. aeruginosa.  Having a malignant disease was a protective factor (odds ratio [OR] = 0.2; P = 0.03).  MDR P. aeruginosa was assocd. with severe outcomes compared to controls, including increased mortality (OR = 4.4; P = 0.04), hospital stay (hazard ratio, 2; P = 0.001), and requirement for procedures (OR = 5.4; P = 0.001).  The survivors functioned more poorly at discharge than the controls, and more of the survivors were discharged to rehabilitation centers or chronic care facilities.  The epidemiol. of MDR P. aeruginosa is complex.  Critically ill patients that require intensive care and are treated with multiple antibiotic agents are at high risk.  MDR P. aeruginosa infections are assocd. with severe adverse clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkTvWGwAH5T7Vg90H21EOLACvtfcHk0lj8_gadYKjwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVGmtg%253D%253D&md5=376579c57953162bf82f4b201c3fa978</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.1.43-48.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.1.43-48.2006%26sid%3Dliteratum%253Aachs%26aulast%3DAloush%26aufirst%3DV.%26aulast%3DNavon-Venezia%26aufirst%3DS.%26aulast%3DSeigman-Igra%26aufirst%3DY.%26aulast%3DCabili%26aufirst%3DS.%26aulast%3DCarmeli%26aufirst%3DY.%26atitle%3DMultidrug-resistant%2520Pseudomonas%2520aeruginosa%253A%2520risk%2520factors%2520and%2520clinical%2520impact%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D43%26epage%3D48%26doi%3D10.1128%2FAAC.50.1.43-48.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutgring, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limbago, B. M.</span></span> <span> </span><span class="NLM_article-title">The problem of carbapenemase-producing-carbapenem-resistant-<i>Enterobacteriaceae</i> detection</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1128/JCM.02771-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FJCM.02771-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26739152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1emsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=529-534&author=J.+D.+Lutgringauthor=B.+M.+Limbago&title=The+problem+of+carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae+detection&doi=10.1128%2FJCM.02771-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection</span></div><div class="casAuthors">Lutgring, Joseph D.; Limbago, Brandi M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-534</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">1098-660X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The emergence and spread of carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) are a significant clin. and public health concern.  Reliable detection of CP-CRE is the first step in combating this problem.  There are both phenotypic and mol. methods available for CP-CRE detection.  There is no single detection method that is ideal for all situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqltwoZJa5INbVg90H21EOLACvtfcHk0lj8_gadYKjwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1emsb4%253D&md5=ec87e3987d31569ebc3f357c31b82d71</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FJCM.02771-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.02771-15%26sid%3Dliteratum%253Aachs%26aulast%3DLutgring%26aufirst%3DJ.%2BD.%26aulast%3DLimbago%26aufirst%3DB.%2BM.%26atitle%3DThe%2520problem%2520of%2520carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae%2520detection%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2016%26volume%3D54%26spage%3D529%26epage%3D534%26doi%3D10.1128%2FJCM.02771-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meletis, G.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance: overview of the problem and future perspectives</span>. <i>Ther. Adv. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1177/2049936115621709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1177%2F2049936115621709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26862399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisFWhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=15-21&author=G.+Meletis&title=Carbapenem+resistance%3A+overview+of+the+problem+and+future+perspectives&doi=10.1177%2F2049936115621709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance: overview of the problem and future perspectives</span></div><div class="casAuthors">Meletis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Infectious Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">TAIDAM</span>;
        ISSN:<span class="NLM_cas:issn">2049-937X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Carbapenem resistance, mainly among Gram-neg. pathogens, is an ongoing public-health problem of global dimensions.  This type of antimicrobial resistance, esp. when mediated by transferable carbapenemase-encoding genes, is spreading rapidly causing serious outbreaks and dramatically limiting treatment options.  In this article, important key points related to carbapenem resistance are reviewed and future perspectives are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLotqN8h2BErVg90H21EOLACvtfcHk0liH3D38Hk2CVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisFWhu7g%253D&md5=fecc102d03d26f57f91dd566c36395ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1177%2F2049936115621709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2049936115621709%26sid%3Dliteratum%253Aachs%26aulast%3DMeletis%26aufirst%3DG.%26atitle%3DCarbapenem%2520resistance%253A%2520overview%2520of%2520the%2520problem%2520and%2520future%2520perspectives%26jtitle%3DTher.%2520Adv.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D15%26epage%3D21%26doi%3D10.1177%2F2049936115621709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of carbapenem-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> from a healthcare region in Hong Kong</span>. <i>Eur. J. Clin. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1007/s10096-015-2550-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2Fs10096-015-2550-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26740321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFKmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=379-385&author=P.+L.+Hoauthor=Y.+Y.+Cheungauthor=Y.+Wangauthor=W.+U.+Loauthor=E.+L.+Laiauthor=K.+H.+Chowauthor=V.+C.+Cheng&title=Characterization+of+carbapenem-resistant+Escherichia+coli+and+Klebsiella+pneumoniae+from+a+healthcare+region+in+Hong+Kong&doi=10.1007%2Fs10096-015-2550-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong</span></div><div class="casAuthors">Ho, P. L.; Cheung, Y. Y.; Wang, Y.; Lo, W. U.; Lai, E. L. Y.; Chow, K. H.; Cheng, V. C. C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Microbiology & Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">EJCDEU</span>;
        ISSN:<span class="NLM_cas:issn">0934-9723</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae represents a major public health issue.  This study investigated the clonality and resistance mechanisms of 92 carbapenem-resistant E. coli (n = 21) and K. pneumoniae (n = 71) isolates collected consecutively from clin. specimens and patients at high risk of carriage between 2010 and 2012 in a healthcare region in Hong Kong.  Combined disk tests (CDTs) and the Carba NP test were used for phenotypic detection of carbapenemases.  PCR assays were used to detect carbapenemase genes.  All isolates were intermediate or resistant to at least one carbapenem.  Nine (9.8 %) isolates were genotypic carbapenemase producers and included six K. pneumoniae (one ST1306/blaIMP-4, one ST889/blaIMP-4, two ST11/blaKPC-2, one ST258/blaKPC-2, one ST483/blaNDM-1) and three E. coli (one ST131/blaIMP-4, two ST744/ blaNDM-1) isolates.  All nine isolates carrying carbapenemase genes could be detected by the CDTs and the Carba NP test.  PCR identified blaCTX-M and blaAmpC alone or in combination in 77.8 % (7/9) and 96.4 % (80/83) of the carbapenemase-producers and non-producers, resp.  Porin loss was detected in 22.2 % (2/9) and 59.0 % (49/83) of the carbapenemase-producers and non-producers, resp.  Overall, the E. coli clones were diverse (14 different STs), but 36.6 % (26/71) of the K. pneumoniae isolates belonged to ST11.  In conclusion, the prevalence of carbapenemases among carbapenem-nonsusceptible E. coli and K. pneumoniae remained low in Hong Kong.  Porin loss combined with AmpC and/or CTX-M type ESBL was the major mechanism of carbapenem resistance in the study population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwd8PzWXxp7Vg90H21EOLACvtfcHk0liH3D38Hk2CVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvFKmsA%253D%253D&md5=6549799a45414079248f02881981eb8b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs10096-015-2550-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-015-2550-3%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DCheung%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DW.%2BU.%26aulast%3DLai%26aufirst%3DE.%2BL.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DV.%2BC.%26atitle%3DCharacterization%2520of%2520carbapenem-resistant%2520Escherichia%2520coli%2520and%2520Klebsiella%2520pneumoniae%2520from%2520a%2520healthcare%2520region%2520in%2520Hong%2520Kong%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D35%26spage%3D379%26epage%3D385%26doi%3D10.1007%2Fs10096-015-2550-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Queenan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span> <span> </span><span class="NLM_article-title">Carbapenemases: the versatile β-lactamases</span>. <i>Clin Microbiol Rev</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1128/CMR.00001-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FCMR.00001-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=17630334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFGktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=440-458&author=A.+M.+Queenanauthor=K.+Bush&title=Carbapenemases%3A+the+versatile+%CE%B2-lactamases&doi=10.1128%2FCMR.00001-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenemases: the versatile β-lactamases</span></div><div class="casAuthors">Queenan, Anne Marie; Bush, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-458</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Carbapenemases are β-lactamases with versatile hydrolytic capacities.  They have the ability to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems.  Bacteria producing these β-lactamases may cause serious infections in which the carbapenemase activity renders many β-lactams ineffective.  Carbapenemases are members of β-lactamase classes A, B, and D.  The class A and D enzymes have a serine-based hydrolytic mechanism, whereas the class B enzymes are metallo-β-lactamases that contain Zn in their active site.  The class A carbapenemase group includes members of the SME, IMI, NMC, GES, and KPC families.  Of these, the KPC carbapenemases are the most prevalent, found mostly on plasmids in Klebsiella pneumoniae.  The class D carbapenemases consist of OXA-type β-lactamases frequently detected in Acinetobacter baumannii.  The metallo-β-lactamases belong to the IMP, VIM, SPM, GIM, and SIM families and have been detected primarily in Pseudomonas aeruginosa; however, there are increasing nos. of reports worldwide of this group of β-lactamases in the Enterobacteriaceae.  This review updates the characteristics, epidemiol., and detection of the carbapenemases found in pathogenic bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHaonkCvu6ArVg90H21EOLACvtfcHk0liWsx2iQBgWtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFGktbY%253D&md5=fa85fc692f3d997feec7b2daea4f7c47</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FCMR.00001-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00001-07%26sid%3Dliteratum%253Aachs%26aulast%3DQueenan%26aufirst%3DA.%2BM.%26aulast%3DBush%26aufirst%3DK.%26atitle%3DCarbapenemases%253A%2520the%2520versatile%2520%25CE%25B2-lactamases%26jtitle%3DClin%2520Microbiol%2520Rev%26date%3D2007%26volume%3D20%26spage%3D440%26epage%3D458%26doi%3D10.1128%2FCMR.00001-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toleman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamases: the quiet before the storm?</span>. <i>Clin Microbiol Rev</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1128/CMR.18.2.306-325.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FCMR.18.2.306-325.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=15831827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVymtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=306-325&author=T.+R.+Walshauthor=M.+A.+Tolemanauthor=L.+Poirelauthor=P.+Nordmann&title=Metallo-%CE%B2-lactamases%3A+the+quiet+before+the+storm%3F&doi=10.1128%2FCMR.18.2.306-325.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamases: the quiet before the storm?</span></div><div class="casAuthors">Walsh, Timothy R.; Toleman, Mark A.; Poirel, Laurent; Nordmann, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-325</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The ascendancy of metallo-β-lactamases within the clin. sector, while not ubiquitous, has nonetheless been dramatic; some reports indicate that nearly 30% of imipenem-resistant Pseudomonas aeruginosa strains possess a metallo-β-lactamase.  Acquisition of a metallo-β-lactamase gene will invariably mediate broad-spectrum β-lactam resistance in P. aeruginosa, but the level of in vitro resistance in Acinetobacter spp. and Enterobacteriaceae is less dependable.  Their clin. significance is further embellished by their ability to hydrolyze all β-lactams and by the fact that there is currently no clin. inhibitor, nor is there likely to be for the foreseeable future.  The genes encoding metallo-β-lactamases are often procured by class 1 (sometimes class 3) integrons, which, in turn, are embedded in transposons, resulting in a highly transmissible genetic app.  Moreover, other gene cassettes within the integrons often confer resistance to aminoglycosides, precluding their use as an alternative treatment.  Thus far, the metallo-β-lactamases encoded on transferable genes include IMP, VIM, SPM, and GIM and have been reported from 28 countries.  Their rapid dissemination is worrisome and necessitates the implementation of not just surveillance studies but also metallo-β-lactamase inhibitor studies securing the longevity of important anti-infectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0boLu0SgxJbVg90H21EOLACvtfcHk0liWsx2iQBgWtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVymtb0%253D&md5=0a1581aa83ff119104c82d855da5bc86</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FCMR.18.2.306-325.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.18.2.306-325.2005%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DToleman%26aufirst%3DM.%2BA.%26aulast%3DPoirel%26aufirst%3DL.%26aulast%3DNordmann%26aufirst%3DP.%26atitle%3DMetallo-%25CE%25B2-lactamases%253A%2520the%2520quiet%2520before%2520the%2520storm%253F%26jtitle%3DClin%2520Microbiol%2520Rev%26date%3D2005%26volume%3D18%26spage%3D306%26epage%3D325%26doi%3D10.1128%2FCMR.18.2.306-325.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">New β-lactamase inhibitors in the clinic</span>. <i>Infect Dis Clin North Am</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2016.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.idc.2016.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27208767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitFGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=441-464&author=K.+M.+Papp-Wallaceauthor=R.+A.+Bonomo&title=New+%CE%B2-lactamase+inhibitors+in+the+clinic&doi=10.1016%2Fj.idc.2016.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">New β-Lactamase Inhibitors in the Clinic</span></div><div class="casAuthors">Papp-Wallace Krisztina M; Bonomo Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-464</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Given the serious medical burden of β-lactamases, many approaches are being used identify candidate agents for β-lactamase inhibition.  Here, we review two β-lactam-β-lactamase inhibitor (BL-BLI) combinations, ceftolozane-tazobactam and ceftazidime-avibactam that recently entered the clinic.  In addition, we focus on BL-BLI combinations in preclinical development that have demonstrated activity in clinical isolates via susceptibility testing and/or in in vivo models of infection.  We highlight only the BLIs that are able to reduce the Clinical Laboratory Standards Institute (CLSI) breakpoints for the BL partner into the susceptible range.  Our analysis includes the primary literature, meeting abstracts, as well as the patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpoedonpWcg3wOGIfWJ7-GfW6udTcc2eZjUUX4cn_bO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitFGitw%253D%253D&md5=45cdda811f0eeb65c7026034e399b87a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2016.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2016.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DNew%2520%25CE%25B2-lactamase%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DInfect%2520Dis%2520Clin%2520North%2520Am%26date%3D2016%26volume%3D30%26spage%3D441%26epage%3D464%26doi%3D10.1016%2Fj.idc.2016.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4524</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06839-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fs41467-018-06839-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=30375382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4524&author=Z.+Sunauthor=L.+Huauthor=B.+Sankaranauthor=B.+V.+V.+Prasadauthor=T.+Palzkill&title=Differential+active+site+requirements+for+NDM-1+%CE%B2-lactamase+hydrolysis+of+carbapenem+versus+penicillin+and+cephalosporin+antibiotics&doi=10.1038%2Fs41467-018-06839-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics</span></div><div class="casAuthors">Sun Zhizeng; Palzkill Timothy; Hu Liya; Prasad B V Venkataram; Palzkill Timothy; Sankaran Banumathi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4524</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New Delhi metallo-β-lactamase-1 exhibits a broad substrate profile for hydrolysis of the penicillin, cephalosporin and 'last resort' carbapenems, and thus confers bacterial resistance to nearly all β-lactam antibiotics.  Here we address whether the high catalytic efficiency for hydrolysis of these diverse substrates is reflected by similar sequence and structural requirements for catalysis, i.e., whether the same catalytic machinery is used to achieve hydrolysis of each class.  Deep sequencing of randomized single codon mutation libraries that were selected for resistance to representative antibiotics reveal stringent sequence requirements for carbapenem versus penicillin or cephalosporin hydrolysis.  Further, the residue positions required for hydrolysis of penicillins and cephalosporins are a subset of those required for carbapenem hydrolysis.  Thus, while a common core of residues is used for catalysis of all substrates, carbapenem hydrolysis requires an additional set of residues to achieve catalytic efficiency comparable to that for penicillins and cephalosporins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481cRAV4D_Ins_fW6udTcc2eZjUUX4cn_bO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslemtA%253D%253D&md5=3439e00b99a221418093d84743ebed31</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06839-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06839-1%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSankaran%26aufirst%3DB.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DDifferential%2520active%2520site%2520requirements%2520for%2520NDM-1%2520%25CE%25B2-lactamase%2520hydrolysis%2520of%2520carbapenem%2520versus%2520penicillin%2520and%2520cephalosporin%2520antibiotics%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4524%26doi%3D10.1038%2Fs41467-018-06839-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid-Yu, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombes, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/nature13445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnature13445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24965651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=503-506&author=A.+M.+Kingauthor=S.+A.+Reid-Yuauthor=W.+Wangauthor=D.+T.+Kingauthor=G.+De+Pascaleauthor=N.+C.+Strynadkaauthor=T.+R.+Walshauthor=B.+K.+Coombesauthor=G.+D.+Wright&title=Aspergillomarasmine+A+overcomes+metallo-%CE%B2-lactamase+antibiotic+resistance&doi=10.1038%2Fnature13445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance</span></div><div class="casAuthors">King, Andrew M.; Reid-Yu, Sarah A.; Wang, Wenliang; King, Dustin T.; De Pascale, Gianfranco; Strynadka, Natalie C.; Walsh, Timothy R.; Coombes, Brian K.; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7506</span>),
    <span class="NLM_cas:pages">503-506</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The emergence and spread of carbapenem-resistant Gram-neg. pathogens is a global public health problem.  The acquisition of metallo-β-lactamases (MBLs) such as NDM-1 is a principle contributor to the emergence of carbapenem-resistant Gram-neg. pathogens that threatens the use of penicillin, cephalosporin and carbapenem antibiotics to treat infections.  To date, a clin. inhibitor of MBLs that could reverse resistance and re-sensitize resistant Gram-neg. pathogens to carbapenems has not been found.  Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clin. relevant MBL, VIM-2.  AMA also fully restored the activity of meropenem against Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. possessing either VIM or NDM-type alleles.  In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropenem activity, demonstrating that a combination of AMA and a carbapenem antibiotic has therapeutic potential to address the clin. challenge of MBL-pos. carbapenem-resistant Gram-neg. pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSvWnWWDz9e7Vg90H21EOLACvtfcHk0lgArgmm23MSpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7fN&md5=d60cc033c506e48e3c4d7b71f003181a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature13445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13445%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BM.%26aulast%3DReid-Yu%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKing%26aufirst%3DD.%2BT.%26aulast%3DDe%2BPascale%26aufirst%3DG.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DCoombes%26aufirst%3DB.%2BK.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DAspergillomarasmine%2520A%2520overcomes%2520metallo-%25CE%25B2-lactamase%2520antibiotic%2520resistance%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D503%26epage%3D506%26doi%3D10.1038%2Fnature13445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drawz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">392</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2013.00392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.3389%2Ffmicb.2013.00392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24399995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC2czot1WltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=392&author=R.+R.+Watkinsauthor=K.+M.+Papp-Wallaceauthor=S.+M.+Drawzauthor=R.+A.+Bonomo&title=Novel+%CE%B2-lactamase+inhibitors%3A+a+therapeutic+hope+against+the+scourge+of+multidrug+resistance&doi=10.3389%2Ffmicb.2013.00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance</span></div><div class="casAuthors">Watkins Richard R; Papp-Wallace Krisztina M; Drawz Sarah M; Bonomo Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">The increasing incidence and prevalence of multi-drug resistance (MDR) among contemporary Gram-negative bacteria represents a significant threat to human health.  Since their discovery, β-lactam antibiotics have been a major component of the armamentarium against these serious pathogens.  Unfortunately, a wide range of β-lactamase enzymes have emerged that are capable of inactivating these powerful drugs.  In the past 30 years, a major advancement in the battle against microbes has been the development of β-lactamase inhibitors, which restore the efficacy of β-lactam antibiotics (e.g., ampicillin/sulbactam, amoxicillin/clavulanate, ticarcillin/clavulanate, and piperacillin/tazobactam).  Unfortunately, many newly discovered β-lactamases are not inactivated by currently available inhibitors.  Is there hope? For the first time in many years, we can anticipate the development and introduction into clinical practice of novel inhibitors.  Although these inhibitors may still not be effective for all β-lactamases, their introduction is still welcome.  This review focuses on the novel β-lactamase inhibitors that are closest to being introduced in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwYm1s3okRRH6HPRus0rAafW6udTcc2eanUhAPHUxborntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czot1WltQ%253D%253D&md5=3f3db2146597ac5cbd25bb4254a1ee40</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2013.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2013.00392%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BR.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DDrawz%26aufirst%3DS.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DNovel%2520%25CE%25B2-lactamase%2520inhibitors%253A%2520a%2520therapeutic%2520hope%2520against%2520the%2520scourge%2520of%2520multidrug%2520resistance%26jtitle%3DFront.%2520Microbiol.%26date%3D2013%26volume%3D4%26spage%3D392%26doi%3D10.3389%2Ffmicb.2013.00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. L.</span></span> <span> </span><span class="NLM_article-title">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11663</span>– <span class="NLM_lpage">11668</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205073109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.1205073109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22753474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11663-11668&author=D.+E.+Ehmannauthor=H.+Jahicauthor=P.+L.+Rossauthor=R.+F.+Guauthor=J.+Huauthor=G.+Kernauthor=G.+K.+Walkupauthor=S.+L.+Fisher&title=Avibactam+is+a+covalent%2C+reversible%2C+non-%CE%B2-lactam+%CE%B2-lactamase+inhibitor&doi=10.1073%2Fpnas.1205073109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span></div><div class="casAuthors">Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Kern, Gunther; Walkup, Grant K.; Fisher, Stewart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11663-11668, S11663/1-S11663/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Avibactam is a β-lactamase inhibitor that is in clin. development, combined with P-lactam partners, for the treatment of bacterial infections comprising Gram-neg. organisms.  Avibactam is a structural class of inhibitor that does not contain a β-lactam core but maintains the capacity to covalently acylate its β-lactamase targets.  Using the TEM-1 enzyme, we characterized avibactam inhibition by measuring the on-rate for acylation and the off-rate for deacylation.  The deacylation off-rate was 0.045 min-1, which allowed investigation of the deacylation route from TEM-1.  Using NMR and MS, we showed that deacylation proceeds through regeneration of intact avibactam and not hydrolysis.  Other than TEM-1, four addnl. clin. relevant β-lactamases were shown to release intact avibactam after being acylated.  We showed that avibactam is a covalent, slowly reversible inhibitor, which is a unique mechanism of inhibition among β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDBeJlngFA5LVg90H21EOLACvtfcHk0liQ9FmBlUoM0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K&md5=4da3c333df0a1eeb6ab84cabd65ab8ec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205073109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205073109%26sid%3Dliteratum%253Aachs%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26atitle%3DAvibactam%2520is%2520a%2520covalent%252C%2520reversible%252C%2520non-%25CE%25B2-lactam%2520%25CE%25B2-lactamase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D11663%26epage%3D11668%26doi%3D10.1073%2Fpnas.1205073109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damblon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smargiasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span> <span> </span><span class="NLM_article-title">Interaction of avibactam with class B metallo-β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5655</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1128/AAC.00897-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00897-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27401561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5655-5662&author=M.+I.+Abboudauthor=C.+Damblonauthor=J.+Bremauthor=N.+Smargiassoauthor=P.+Mercuriauthor=B.+Gilbertauthor=A.+M.+Rydzikauthor=T.+D.+Claridgeauthor=C.+J.+Schofieldauthor=J.+M.+Frere&title=Interaction+of+avibactam+with+class+B+metallo-%CE%B2-lactamases&doi=10.1128%2FAAC.00897-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Avibactam with class B metallo-β-lactamases</span></div><div class="casAuthors">Abboud, Martine I.; Damblon, Christian; Brem, Jurgen; Smargiasso, Nicolas; Mercuri, Paola; Gilbert, Bernard; Rydzik, Anna M.; Claridge, Timothy D. W.; Schofield, Christopher J.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5655-5662</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials.  There are two mechanistic classes of β-lactamases: the serine β-lactamases (SBLs) and the zinc-dependent metallo-β-lactamases (MBLs).  Avibactam, the first clin. useful non-β-lactam β-lactamase inhibitor, is a broad-spectrum SBL inhibitor, which is used in combination with a cephalosporin antibiotic (ceftazidime).  There are multiple reports on the interaction of avibactam with SBLs but few such studies with MBLs.  We report biochem. and biophys. studies on the binding and reactivity of avibactam with representatives from all 3 MBL subfamilies (B1, B2, and B3).  Avibactam has only limited or no activity vs. MBL-mediated resistance in pathogens.  Avibactam does not inhibit MBLs and binds only weakly to most of the MBLs tested; in some cases, avibactam undergoes slow hydrolysis of one of its urea N-CO bonds followed by loss of CO2, in a process different from that obsd. with the SBLs studied.  The results suggest that while the evolution of MBLs that more efficiently catalyze avibactam hydrolysis should be anticipated, pursuing the development of dual-action SBL and MBL inhibitors based on the diazabicyclooctane core of avibactam may be productive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSoutDc696brVg90H21EOLACvtfcHk0liQ9FmBlUoM0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D&md5=e789376f6e1f32c28b2b26f3ed89e926</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.00897-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00897-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DDamblon%26aufirst%3DC.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSmargiasso%26aufirst%3DN.%26aulast%3DMercuri%26aufirst%3DP.%26aulast%3DGilbert%26aufirst%3DB.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26atitle%3DInteraction%2520of%2520avibactam%2520with%2520class%2520B%2520metallo-%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5655%26epage%3D5662%26doi%3D10.1128%2FAAC.00897-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanheira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamm, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Effect of the β-lactamase inhibitor vaborbactam combined with Meropenem against serine carbapenemase-producing <i>Enterobacteriaceae</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5454</span>– <span class="NLM_lpage">5458</span>, <span class="refDoi"> DOI: 10.1128/AAC.00711-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00711-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27381386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5454-5458&author=M.+Castanheiraauthor=P.+R.+Rhombergauthor=R.+K.+Flammauthor=R.+N.+Jones&title=Effect+of+the+%CE%B2-lactamase+inhibitor+vaborbactam+combined+with+Meropenem+against+serine+carbapenemase-producing+Enterobacteriaceae&doi=10.1128%2FAAC.00711-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the β-lactamase inhibitor vaborbactam combined with meropenem against serine carbapenemase-producing Enterobacteriaceae</span></div><div class="casAuthors">Castanheira, Mariana; Rhomberg, Paul R.; Flamm, Robert K.; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5454-5458</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Klebsiella pneumoniae carbapenemase (KPC)-producing isolates have become increasingly prevalent worldwide, and these organisms are often multidrug resistant, limiting the therapeutic options available for treating infections.  We evaluated the activity of meropenem combined with the serine β-lactamase inhibitor vaborbactam (formerly RPX7009) against 315 serine carbapenemase-producing Enterobacteriaceae (CPE) isolates by use of checkerboard-designed panels to assess the optimal inhibitor concn. (range tested, 0.5-32 μg/mL).  Overall, meropenem alone (MIC50 and MIC90, 16 and >64 μg/mL, resp.) inhibited only 2.2% of the isolates at ≤1 μg/mL (the CLSI susceptibility breakpoint) and 7.3% of the isolates at ≤2 μg/mL (the EUCAST breakpoint).  Vaborbactam restored meropenem activity for 72.7-98.1% of CPE isolates at ≤2 μg/mL, and max. potentiation was achieved with fixed concns. of ≥8 μg/mL of the inhibitor (≥96.5% of isolates were inhibited at ≤2 μg/mL of meropenem-vaborbactam).  Meropenem-vaborbactam with a fixed concn. of 8 μg/mL of the inhibitor (MIC50, ≤0.06 μg/mL for all organisms) inhibited 93.7% of the CPE isolates displaying elevated meropenem MICs at ≤1 μg/mL.  Meropenem-vaborbactam MICs were elevated for isolates producing metallo-β-lactamases (MIC, 16 to >64 μg/mL) or displaying decreased expression of OmpK37 and(or) elevated expression of the AcrAB-TolC efflux system (MIC, 16 μg/mL).  Vaborbactam showed no antibacterial activity alone (all MICs, >64 μg/mL).  Meropenem-vaborbactam appears to be a good candidate for further development and it could increase the options for treatment of serious infections caused by carbapenemase-producing pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnr5l96JEPFLVg90H21EOLACvtfcHk0lg0jdCuKg20Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKlurc%253D&md5=a4de13834f14ba25527ffcd4280584e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.00711-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00711-16%26sid%3Dliteratum%253Aachs%26aulast%3DCastanheira%26aufirst%3DM.%26aulast%3DRhomberg%26aufirst%3DP.%2BR.%26aulast%3DFlamm%26aufirst%3DR.%2BK.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DEffect%2520of%2520the%2520%25CE%25B2-lactamase%2520inhibitor%2520vaborbactam%2520combined%2520with%2520Meropenem%2520against%2520serine%2520carbapenemase-producing%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5454%26epage%3D5458%26doi%3D10.1128%2FAAC.00711-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Castellanos, J.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12406</span>, <span class="refDoi"> DOI: 10.1038/ncomms12406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fncomms12406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27499424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12406&author=J.+Bremauthor=R.+Cainauthor=S.+Cahillauthor=M.+A.+McDonoughauthor=I.+J.+Cliftonauthor=J.%0AC.+Jimenez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=C.+W.+Fishwickauthor=C.+J.+Schofield&title=Structural+basis+of+metallo-%CE%B2-lactamase%2C+serine-%CE%B2-lactamase+and+penicillin-binding+protein+inhibition+by+cyclic+boronates&doi=10.1038%2Fncomms12406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span></div><div class="casAuthors">Brem, Jurgen; Cain, Ricky; Cahill, Samuel; McDonough, Michael A.; Clifton, Ian J.; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; Fishwick, Colin W. G.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12406</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lactamases enable resistance to almost all β-lactam antibiotics.  Pioneering work revealed that acyclic boronic acids can act as 'transition state analog' inhibitors of nucleophilic serine enzymes, including serine-β-lactamases.  Here we report biochem. and biophys. analyses revealing that cyclic boronates potently inhibit both nucleophilic serine and zinc-dependent β-lactamases by a mechanism involving mimicking of the common tetrahedral intermediate.  Cyclic boronates also potently inhibit the non-essential penicillin-binding protein PBP 5 by the same mechanism of action.  The results open the way for development of dual action inhibitors effective against both serine- and metallo-β-lactamases, and which could also have antimicrobial activity through inhibition of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod70NVhmwa-7Vg90H21EOLACvtfcHk0lg0jdCuKg20Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM&md5=ec35f6a2ffbfe52b9046821526658492</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms12406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12406%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DJimenez-Castellanos%26aufirst%3DJ.%2BC.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520metallo-%25CE%25B2-lactamase%252C%2520serine-%25CE%25B2-lactamase%2520and%2520penicillin-binding%2520protein%2520inhibition%2520by%2520cyclic%2520boronates%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12406%26doi%3D10.1038%2Fncomms12406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic boronates inhibit all classes of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e02260-16</span> <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28115348" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+boronates+inhibit+all+classes+of+%CE%B2-lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520boronates%2520inhibit%2520all%2520classes%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Antibacterial drug discovery in the resistance era</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>529</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/nature17042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnature17042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26791724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=529&publication_year=2016&pages=336-343&author=E.+D.+Brownauthor=G.+D.+Wright&title=Antibacterial+drug+discovery+in+the+resistance+era&doi=10.1038%2Fnature17042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial drug discovery in the resistance era</span></div><div class="casAuthors">Brown, Eric D.; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">529</span>
        (<span class="NLM_cas:issue">7586</span>),
    <span class="NLM_cas:pages">336-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The looming antibiotic resistance crisis has penetrated the consciousness of clinicians, researchers, policymakers, politicians and the public at large.  The evolution and widespread distribution of antibiotic resistance elements in bacterial pathogens has made diseases that were once easily treatable deadly again.  Unfortunately, accompanying the rise in global resistance is a failure in antibacterial drug discovery.  Lessons from the history of antibiotic discovery and fresh understanding of antibiotic action and the cell biol. of microorganisms have the potential to deliver twenty-first century medicines that are able to control infection in the resistance era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJH_K99a5abVg90H21EOLACvtfcHk0lgDyTcKw6taAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oisro%253D&md5=62e0454601a242db039e60d77be26406</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature17042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17042%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DAntibacterial%2520drug%2520discovery%2520in%2520the%2520resistance%2520era%26jtitle%3DNature%26date%3D2016%26volume%3D529%26spage%3D336%26epage%3D343%26doi%3D10.1038%2Fnature17042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency metrics: why all the fuss?</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.4155%2Ffmc.15.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26230875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1363-1365&author=C.+H.+Reynolds&title=Ligand+efficiency+metrics%3A+why+all+the+fuss%3F&doi=10.4155%2Ffmc.15.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency metrics: why all the fuss?</span></div><div class="casAuthors">Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1365</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRoxxN9bLP5rVg90H21EOLACvtfcHk0lgDyTcKw6taAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvL&md5=62d01378f043e2bda9f26248886567df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.70%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DLigand%2520efficiency%2520metrics%253A%2520why%2520all%2520the%2520fuss%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1363%26epage%3D1365%26doi%3D10.4155%2Ffmc.15.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Someya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors</span>. <i>Chem Sci</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1039/C6SC04524C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC6SC04524C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28451231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=928-937&author=G.+B.+Liauthor=M.+I.+Abboudauthor=J.+Bremauthor=H.+Someyaauthor=C.+T.+Lohansauthor=S.+Y.+Yangauthor=J.+Spencerauthor=D.+W.+Warehamauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=NMR-filtered+virtual+screening+leads+to+non-metal+chelating+metallo-%CE%B2-lactamase+inhibitors&doi=10.1039%2FC6SC04524C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors</span></div><div class="casAuthors">Li, Guo-Bo; Abboud, Martine I.; Brem, Jurgen; Someya, Hidenori; Lohans, Christopher T.; Yang, Sheng-Yong; Spencer, James; Wareham, David W.; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">928-937</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">There are no clin. useful inhibitors of metallo-β-lactamases (MBLs), which are a growing problem because they hydrolyze almost all β-lactam antibacterials.  Inhibition by most reported MBL inhibitors involves zinc ion chelation.  A structure-based virtual screening approach combined with NMR filtering led to the identification of inhibitors of the clin. relevant Verona Integron-encoded MBL (VIM)-2.  Crystallog. analyses reveal a new mode of MBL inhibition involving binding adjacent to the active site zinc ions, but which does not involve metal chelation.  The results will aid efforts to develop new types of clin. useful inhibitors targeting MBLs/MBL-fold metallo-enzymes involved in antibacterial and anticancer drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7UmnEg9kLNrVg90H21EOLACvtfcHk0lgDyTcKw6taAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOksrjI&md5=82e39be35ca8dca01edc6213a67fe9d3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC6SC04524C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC04524C%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSomeya%26aufirst%3DH.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DNMR-filtered%2520virtual%2520screening%2520leads%2520to%2520non-metal%2520chelating%2520metallo-%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DChem%2520Sci%26date%3D2017%26volume%3D8%26spage%3D928%26epage%3D937%26doi%3D10.1039%2FC6SC04524C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">ZINC--a free database of commercially available compounds for virtual screening</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1021/ci049714+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049714%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=177-182&author=J.+J.+Irwinauthor=B.+K.+Shoichet&title=ZINC%2D%2Da+free+database+of+commercially+available+compounds+for+virtual+screening&doi=10.1021%2Fci049714%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC--a free database of commercially available compounds for virtual screening</span></div><div class="casAuthors">Irwin John J; Shoichet Brian K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical information and modeling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">177-82</span>
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    </div><div class="casAbstract">A critical barrier to entry into structure-based virtual screening is the lack of a suitable, easy to access database of purchasable compounds.  We have therefore prepared a library of 727,842 molecules, each with 3D structure, using catalogs of compounds from vendors (the size of this library continues to grow).  The molecules have been assigned biologically relevant protonation states and are annotated with properties such as molecular weight, calculated LogP, and number of rotatable bonds.  Each molecule in the library contains vendor and purchasing information and is ready for docking using a number of popular docking programs.  Within certain limits, the molecules are prepared in multiple protonation states and multiple tautomeric forms.  In one format, multiple conformations are available for the molecules.  This database is available for free download (http://zinc.docking.org) in several common file formats including SMILES, mol2, 3D SDF, and DOCK flexibase format.  A Web-based query tool incorporating a molecular drawing interface enables the database to be searched and browsed and subsets to be created.  Users can process their own molecules by uploading them to a server.  Our hope is that this database will bring virtual screening libraries to a wide community of structural biologists and medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVi_-excgTX-_Q9URG6Dx8fW6udTcc2eYjRECZKBrn5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtA%253D%253D&md5=9f2e3ec06d53276884fc17b9aad47e61</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci049714%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049714%252B%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DZINC--a%2520free%2520database%2520of%2520commercially%2520available%2520compounds%2520for%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2005%26volume%3D45%26spage%3D177%26epage%3D182%26doi%3D10.1021%2Fci049714%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huggins, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidor, B.</span></span> <span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1021/jm2010332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design&doi=10.1021%2Fjm2010332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0lhgXBBvFDb0oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444%26doi%3D10.1021%2Fjm2010332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Q.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2574</span>– <span class="NLM_lpage">2582</span>, <span class="refDoi"> DOI: 10.1096/fj.11-184036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1096%2Ffj.11-184036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21507902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2574-2582&author=H.+Zhangauthor=Q.+Hao&title=Crystal+structure+of+NDM-1+reveals+a+common+%CE%B2-lactam+hydrolysis+mechanism&doi=10.1096%2Ffj.11-184036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism</span></div><div class="casAuthors">Zhang, Hong Min; Hao, Quan</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2574-2582, 10.1096/fj.11-184036</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze most β-lactam antibiotics, and bacteria contg. this kind of enzyme pose a serious threat to the public health.  The newly identified New Delhi MBL (NDM-1) is a new member of this family that shows tight binding to penicillin and cephalosporins.  The rapid dissemination of NDM-1 in clin. relevant bacteria has become a global concern.  However, no clin. useful inhibitors against MBLs exist, partly due to the lack of knowledge about the catalysis mechanism of this kind of enzyme.  Here we report the crystal structure of this novel enzyme in complex with a hydrolyzed ampicillin at its active site at 1.3-Å resoln.  Structural comparison with other MBLs revealed a new hydrolysis mechanism applicable to all three subclasses of MBLs, which might help the design of mechanism-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZmgVz8KyqbVg90H21EOLACvtfcHk0lhgXBBvFDb0oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFersrk%253D&md5=32c83d7babafe70cef7ff785b855e142</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-184036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-184036%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DQ.%26atitle%3DCrystal%2520structure%2520of%2520NDM-1%2520reveals%2520a%2520common%2520%25CE%25B2-lactam%2520hydrolysis%2520mechanism%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2574%26epage%3D2582%26doi%3D10.1096%2Ffj.11-184036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">14694</span>– <span class="NLM_lpage">14697</span>, <span class="refDoi"> DOI: 10.1021/ja508388e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja508388e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14694-14697&author=H.+Fengauthor=J.+Dingauthor=D.+Zhuauthor=X.+Liuauthor=X.+Xuauthor=Y.+Zhangauthor=S.+Zangauthor=D.+C.+Wangauthor=W.+Liu&title=Structural+and+mechanistic+insights+into+NDM-1+catalyzed+hydrolysis+of+cephalosporins&doi=10.1021%2Fja508388e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Mechanistic Insights into NDM-1 Catalyzed Hydrolysis of Cephalosporins</span></div><div class="casAuthors">Feng, Han; Ding, Jingjin; Zhu, Deyu; Liu, Xuehui; Xu, Xueyong; Zhang, Ying; Zang, Shanshan; Wang, Da-Cheng; Liu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14694-14697</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cephalosporins constitute a large class of β-lactam antibiotics clin. used as antimicrobial drugs.  New Delhi metallo-β-lactamase (NDM-1) poses a global threat to human health as it confers on bacterial pathogens resistance to almost all β-lactams, including penicillins, cephalosporins, and carbapenems.  Here we report the first crystal structures of NDM-1 in complex with cefuroxime and cephalexin, as well as NMR spectra monitoring cefuroxime and cefixime hydrolysis catalyzed by NDM-1.  Surprisingly, cephalosporoate intermediates were captured in both crystal structures detd. at 1.3 and 2.0 Å.  These results provide detailed information concerning the mechanism and pathways of cephalosporin hydrolysis.  We also present the crystal structure and enzyme assays of a D124N mutant, which reveals that D124 most likely plays a more structural than catalytic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor8vkfYEWv6LVg90H21EOLACvtfcHk0li5ssb76DVlTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrbK&md5=66868127d02c17abad6d0da6354ddcf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja508388e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508388e%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520NDM-1%2520catalyzed%2520hydrolysis%2520of%2520cephalosporins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14694%26epage%3D14697%26doi%3D10.1021%2Fja508388e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesay, D. R.</span></span> <span> </span><span class="NLM_article-title">A case study comparing quantitative stability-flexibility relationships across five metallo-β-lactamases highlighting differences within NDM-1</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1084</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-658-0_12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2F978-1-62703-658-0_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24061924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1Crt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1084&publication_year=2014&pages=227-238&author=M.+C.+Brownauthor=D.+Vermaauthor=C.+Russellauthor=D.+J.+Jacobsauthor=D.+R.+Livesay&title=A+case+study+comparing+quantitative+stability-flexibility+relationships+across+five+metallo-%CE%B2-lactamases+highlighting+differences+within+NDM-1&doi=10.1007%2F978-1-62703-658-0_12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Case Study Comparing Quantitative Stability-Flexibility Relationships Across Five Metallo-β-Lactamases Highlighting Differences Within NDM-1</span></div><div class="casAuthors">Brown, Matthew C.; Verma, Deeptak; Russell, Christian; Jacobs, Donald J.; Livesay, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1084</span>
        (<span class="NLM_cas:issue">Protein Dynamics</span>),
    <span class="NLM_cas:pages">227-238</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The Distance Constraint Model (DCM) is an ensemble-based biophys. model that integrates thermodn. and mech. viewpoints of protein structure.  The DCM outputs a large no. of structural characterizations that collectively allow for Quantified Stability-Flexibility Relationships (QSFR) to be identified and compared across protein families.  Using five metallo-β-lactamases (MBLs) as a representative set, we demonstrate how QSFR properties are both conserved and varied across protein families.  Similar to our characterizations on other protein families, the backbone flexibility of the five MBLs are overall visually conserved, yet there are interesting specific quant. differences.  For example, the plasmid-encoded NDM-1 enzyme, which leads to a fast spreading drug-resistant version of Klebsiella pneumoniae, has several regions of significantly increased rigidity relative to the other four.  In addn., the set of intramol. couplings within NDM-1 are also atypical.  While long-range couplings frequently vary significantly across protein families, NDM-1 is distinct because it has limited correlated flexibility, which is isolated within the active site S3/S4 and S11/H6 loops.  These loops are flexibly correlated in the other members, suggesting it is important to function, but the others also have significant amts. of correlated flexibility throughout the rest of their structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiyhaOaS1-7Vg90H21EOLACvtfcHk0li5ssb76DVlTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1Crt7s%253D&md5=59ce92ae09f3cc726c96a996063de0cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-658-0_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-658-0_12%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BC.%26aulast%3DVerma%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DC.%26aulast%3DJacobs%26aufirst%3DD.%2BJ.%26aulast%3DLivesay%26aufirst%3DD.%2BR.%26atitle%3DA%2520case%2520study%2520comparing%2520quantitative%2520stability-flexibility%2520relationships%2520across%2520five%2520metallo-%25CE%25B2-lactamases%2520highlighting%2520differences%2520within%2520NDM-1%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1084%26spage%3D227%26epage%3D238%26doi%3D10.1007%2F978-1-62703-658-0_12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Elucidating the role of Trp105 in the KPC-2 β-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1727</span>, <span class="refDoi"> DOI: 10.1002/pro.454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fpro.454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20662006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2gsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1714-1727&author=K.+M.+Papp-Wallaceauthor=M.+Taracilaauthor=C.+J.+Wallaceauthor=K.+M.+Hujerauthor=C.+R.+Bethelauthor=J.+M.+Hornickauthor=R.+A.+Bonomo&title=Elucidating+the+role+of+Trp105+in+the+KPC-2+%CE%B2-lactamase&doi=10.1002%2Fpro.454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating the role of Trp105 in the KPC-2 β-lactamase</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Taracila, Magdalena; Wallace, Christopher J.; Hujer, Kristine M.; Bethel, Christopher R.; Hornick, John M.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1714-1727</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mol. basis of resistance to β-lactams and β-lactam-β-lactamase inhibitor combinations in the KPC family of class A enzymes is of extreme importance to the future design of effective β-lactam therapy.  Recent crystal structures of KPC-2 and other class A β-lactamases suggest that Ambler position Trp105 may be of importance in binding β-lactam compds.  Based on this notion, we explored the role of residue Trp105 in KPC-2 by conducting site-satn. mutagenesis at this position.  Escherichia coli DH10B cells expressing the Trp105Phe, -Tyr, -Asn, and -His KPC-2 variants possessed minimal inhibitory concns. (MICs) similar to E. coli cells expressing wild type (WT) KPC-2.  Interestingly, most of the variants showed increased MICs to ampicillin-clavulanic acid but not to ampicillin-sulbactam or piperacillin-tazobactam.  To explain the biochem. basis of this behavior, four variants (Trp105Phe, -Asn, -Leu, and -Val) were studied in detail.  Consistent with the MIC data, the Trp105Phe β-lactamase displayed improved catalytic efficiencies, kcat/Km, toward piperacillin, cephalothin, and nitrocefin, but slightly decreased kcat/Km toward cefotaxime and imipenem when compared to WT β-lactamase.  The Trp105Asn variant exhibited increased Kms for all substrates.  In contrast, the Trp105Leu and -Val substituted enzymes demonstrated notably decreased catalytic efficiencies (kcat/Km) for all substrates.  With respect to clavulanic acid, the Kis and partition ratios were increased for the Trp105Phe, -Asn, and -Val variants.  We conclude that interactions between Trp105 of KPC-2 and the β-lactam are essential for hydrolysis of substrates.  Taken together, kinetic and mol. modeling studies define the role of Trp105 in β-lactam and β-lactamase inhibitor discrimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gp2YXB8MvLVg90H21EOLACvtfcHk0lgPXf-pP4CRpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2gsLrL&md5=97d5257eb1e887e6f8da804e262e6327</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fpro.454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.454%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DC.%2BJ.%26aulast%3DHujer%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DHornick%26aufirst%3DJ.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DElucidating%2520the%2520role%2520of%2520Trp105%2520in%2520the%2520KPC-2%2520%25CE%25B2-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D1714%26epage%3D1727%26doi%3D10.1002%2Fpro.454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borosky, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubrowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferkany, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbon, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and glutamate antagonist activity of 4-phosphonoalkylquinoline derivatives: a novel class of non-NMDA antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2035</span>– <span class="NLM_lpage">2040</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2FS0960-894X%2801%2980558-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2035-2040&author=G.+S.+Hamiltonauthor=D.+Bednarauthor=S.+A.+Boroskyauthor=Z.+Huangauthor=R.+Zubrowskiauthor=J.+W.+Ferkanyauthor=E.+W.+Karbon&title=Synthesis+and+glutamate+antagonist+activity+of+4-phosphonoalkylquinoline+derivatives%3A+a+novel+class+of+non-NMDA+antagonist&doi=10.1016%2FS0960-894X%2801%2980558-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980558-8%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%2BS.%26aulast%3DBednar%26aufirst%3DD.%26aulast%3DBorosky%26aufirst%3DS.%2BA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZubrowski%26aufirst%3DR.%26aulast%3DFerkany%26aufirst%3DJ.%2BW.%26aulast%3DKarbon%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520glutamate%2520antagonist%2520activity%2520of%25204-phosphonoalkylquinoline%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520non-NMDA%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2035%26epage%3D2040%26doi%3D10.1016%2FS0960-894X%2801%2980558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nchembio.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnchembio.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19305397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=358-364&author=Y.+Chenauthor=B.+K.+Shoichet&title=Molecular+docking+and+ligand+specificity+in+fragment-based+inhibitor+discovery&doi=10.1038%2Fnchembio.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span></div><div class="casAuthors">Chen, Yu; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000-10,000 compds.).  This raises two questions: would other noteworthy chemotypes be found were one to screen all com. available fragments (>300,000), and does the success rate imply low specificity of fragments.  We used mol. docking to screen large libraries of fragments against CTX-M β-lactamase.  We identified ten millimolar-range inhibitors from the 69 compds. tested.  The docking poses corresponded closely to the crystallog. structures subsequently detd.  Notably, these initial low-affinity hits showed little specificity between CTX-M and an unrelated β-lactamase, AmpC, which is unusual among β-lactamase inhibitors.  This is consistent with the idea that the high hit rates among fragments correlate to a low initial specificity.  As the inhibitors were progressed, both specificity and affinity rose together, yielding to our knowledge the first micromolar-range noncovalent inhibitors against a class A β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8zTkq9kMAbVg90H21EOLACvtfcHk0lisIX4v6Th3qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D&md5=6ee8dd19d0b99599ea74eaf735483b1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.155%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DMolecular%2520docking%2520and%2520ligand%2520specificity%2520in%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teotico, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Docking for fragment inhibitors of AmpC β-lactamase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">7455</span>– <span class="NLM_lpage">7460</span>, <span class="refDoi"> DOI: 10.1073/pnas.0813029106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.0813029106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19416920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1Khtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=7455-7460&author=D.+G.+Teoticoauthor=K.+Babaogluauthor=G.+J.+Rocklinauthor=R.+S.+Ferreiraauthor=A.+M.+Giannettiauthor=B.+K.+Shoichet&title=Docking+for+fragment+inhibitors+of+AmpC+%CE%B2-lactamase&doi=10.1073%2Fpnas.0813029106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Docking for fragment inhibitors of AmpC 83-lactamase</span></div><div class="casAuthors">Teotico, Denise G.; Babaoglu, Kerim; Rocklin, Gabriel J.; Ferreira, Rafaela S.; Giannetti, Anthony M.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7455-7460</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fragment screens for new ligands have had wide success, not withstanding their constraint to libraries of 1000-10,000 mols.  Larger libraries would be addressable were mol. docking reliable for fragment screens, but this has not been widely accepted.  To investigate docking's ability to prioritize fragments, a library of >137,000 such mols. were docked against the structure of β-lactamase.  Forty-eight fragments highly ranked by docking were acquired and tested; 23 had Ki values ranging from 0.7 to 9.2 mM.  X-ray crystal structures of the enzyme-bound complexes were detd. for 8 of the fragments.  For 4, the correspondence between the predicted and exptl. structures was high (RMSD between 1.2 and 1.4 Å), whereas for another 2, the fidelity was lower but retained most key interactions (RMSD 2.4-2.6 Å).  Two of the 8 fragments adopted very different poses in the active site owing to enzyme conformational changes.  The 48% hit rate of the fragment docking compares very favorably with "lead-like" docking and high-throughput screening against the same enzyme.  To understand this, we investigated the occurrence of the fragment scaffolds among larger, lead-like mols.  Approx. 1% of com. available fragments contain these inhibitors whereas only 10-7% of lead-like mols. do.  This suggests that many more chemotypes and combinations of chemotypes are present among fragments than are available among lead-like mols., contributing to the higher hit rates.  The ability of docking to prioritize these fragments suggests that the technique can be used to exploit the better chemotype coverage that exists at the fragment level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpafzXv4ydrVg90H21EOLACvtfcHk0lisIX4v6Th3qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1Khtrg%253D&md5=d2df01432d5381c226e8aa7e008457b5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0813029106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0813029106%26sid%3Dliteratum%253Aachs%26aulast%3DTeotico%26aufirst%3DD.%2BG.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DRocklin%26aufirst%3DG.%2BJ.%26aulast%3DFerreira%26aufirst%3DR.%2BS.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDocking%2520for%2520fragment%2520inhibitors%2520of%2520AmpC%2520%25CE%25B2-lactamase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D7455%26epage%3D7460%26doi%3D10.1073%2Fpnas.0813029106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Phosphonate monoester inhibitors of class A β-lactamases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1042/bj2750793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1042%2Fbj2750793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1903928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaK3MXksVCqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1991&pages=793-795&author=J.+Rahilauthor=R.+F.+Pratt&title=Phosphonate+monoester+inhibitors+of+class+A+%CE%B2-lactamases&doi=10.1042%2Fbj2750793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonate monoester inhibitors of class A β-lactamases</span></div><div class="casAuthors">Rahil, Jubrail; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-5</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Phosphonate monoesters with the general structure (I, R1 = H, NO2) are inhibitors of representative class A and class C β-lactamases.  This result extends the range of this type of inhibitor to the class A enzymes.  Compds. where R1 is an electron-withdrawing substituent are better inhibitors than the unsubstituted analog (R1 = H), and enzyme inhibition is concerted with stoichiometric release of the substituted phenol.  Slow turnover of the phosphonates also occurs.  These observations support the proposition that the mechanism of action of these inhibitors involves phosphorylation of the β-lactamase active site.  The inhibitory ability of these phosphonates suggests that the β-lactamase active site is very effective at stabilizing neg. charged transition states.  One of the compds. described also inactivated the Streptomyces R61 D-alanyl-D-alanine carboxypeptidase/transpeptidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4uRdqMKHvbLVg90H21EOLACvtfcHk0lgEjdg6HEMceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVCqsLk%253D&md5=cb5a248bbbbb5281bfe95a7d39149937</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1042%2Fbj2750793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2750793%26sid%3Dliteratum%253Aachs%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DPhosphonate%2520monoester%2520inhibitors%2520of%2520class%2520A%2520%25CE%25B2-lactamases%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D275%26spage%3D793%26epage%3D795%26doi%3D10.1042%2Fbj2750793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobkovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billings, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moews, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J. R.</span></span> <span> </span><span class="NLM_article-title">Crystallographic structure of a phosphonate derivative of the <i>Enterobacter cloacae</i> P99 cephalosporinase: mechanistic interpretation of a β-lactamase transition-state analog</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">6762</span>– <span class="NLM_lpage">6772</span>, <span class="refDoi"> DOI: 10.1021/bi00188a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00188a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=6762-6772&author=E.+Lobkovskyauthor=E.+M.+Billingsauthor=P.+C.+Moewsauthor=J.+Rahilauthor=R.+F.+Prattauthor=J.+R.+Knox&title=Crystallographic+structure+of+a+phosphonate+derivative+of+the+Enterobacter+cloacae+P99+cephalosporinase%3A+mechanistic+interpretation+of+a+%CE%B2-lactamase+transition-state+analog&doi=10.1021%2Fbi00188a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Structure of a Phosphonate Derivative of the Enterobacter cloacae P99 Cephalosporinase: Mechanistic Interpretation of a β-Lactamase Transition-State Analog</span></div><div class="casAuthors">Lobkovsky, Emil; Billings, Eric M.; Moews, Paul C.; Rahil, Jubrail; Pratt, R. F.; Knox, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6762-72</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The crystal structure of a complex formed on reaction of the Enterobacter cloacae P99 cephalosporinase (β-lactamase) with a phosphonate monoester inhibitor, m-carboxyphenyl [[N-[(p-iodophenyl)acetyl]amino]methyl]phosphonate, has been obtained at 2.3-Å resoln.  The structure shows that the inhibitor has phosphonylated the active site serine (Ser64) with loss of the m-carboxyphenol leaving group.  The inhibitor is positioned in the active site in a way that can be interpreted in terms of a transition-state analog.  The arylacetamido side chain is placed as anticipated from analogous β-lactamoyl complexes of penicillin-recognizing enzymes, with the amido group hydrogen-bonded to the backbone carbonyl of Ser318 (of the B3 β-strand) and to the amides of Gln120 and Asn152.  There is support in the asymmetry of the hydrogen bonding of this side chain to the protein and in the 2-fold disorder of the benzyl group for the considerable breadth in substrate specificity exhibited by class C β-lactamases.  One phosphonyl oxygen atom is in the oxyanion hole, hydrogen-bonded to main-chain NH groups of Ser318 and Ser64, while the other oxygen is solvated, not within hydrogen-bonding distance of any amino acid side chain.  The closest active site functional group to the solvated oxygen atom is the Tyr150 hydroxyl group (3.4 Å); Lys67 and Lys315 are quite distant (4.3 and 5.7 Å, resp.).  Rather, Tyr150 and Lys67 are more closely assocd. with Ser64Oγ (2.9 and 3.3 Å).  This arrangement is interpreted in terms of the transition state for breakdown of the tetrahedral intermediate in the deacylation step of catalysis, where the Tyr150 phenol seems the most likely general acid.  Thus, Tyr150, as the phenoxide anion, would be the general base catalyst in acylation, as proposed by Oefner et al. [Nature (1990) 343, 284-288].  The structure is compared with that of a similar phosphonate deriv. of a class A β-lactamase [Chen et al. (1993) J. Mol. Biol. 234, 165-178], and mechanistic comparisons are made.  The sensitivity of serine β-lactamases, as opposed to serine proteinases, toward inhibition by phosphonate monoanions is supported by electrostatic calcns. showing a net pos. potential only in the catalytic sites of the β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhBObjYH0hQ7Vg90H21EOLACvtfcHk0lgEjdg6HEMceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOisL0%253D&md5=e65cc066a080253acce6b06e42c88739</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi00188a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00188a004%26sid%3Dliteratum%253Aachs%26aulast%3DLobkovsky%26aufirst%3DE.%26aulast%3DBillings%26aufirst%3DE.%2BM.%26aulast%3DMoews%26aufirst%3DP.%2BC.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DKnox%26aufirst%3DJ.%2BR.%26atitle%3DCrystallographic%2520structure%2520of%2520a%2520phosphonate%2520derivative%2520of%2520the%2520Enterobacter%2520cloacae%2520P99%2520cephalosporinase%253A%2520mechanistic%2520interpretation%2520of%2520a%2520%25CE%25B2-lactamase%2520transition-state%2520analog%26jtitle%3DBiochemistry%26date%3D1994%26volume%3D33%26spage%3D6762%26epage%3D6772%26doi%3D10.1021%2Fbi00188a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Kinetics of turnover of cefotaxime by the <i>Enterobacter cloacae</i> P99 and GCl β-lactamases: two free enzyme forms of the P99 β-lactamase detected by a combination of pre- and post-steady state kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2664</span>– <span class="NLM_lpage">2672</span>, <span class="refDoi"> DOI: 10.1021/bi030212j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030212j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=2664-2672&author=S.+Kumarauthor=S.+A.+Adediranauthor=M.+Nukagaauthor=R.+F.+Pratt&title=Kinetics+of+turnover+of+cefotaxime+by+the+Enterobacter+cloacae+P99+and+GCl+%CE%B2-lactamases%3A+two+free+enzyme+forms+of+the+P99+%CE%B2-lactamase+detected+by+a+combination+of+pre-+and+post-steady+state+kinetics&doi=10.1021%2Fbi030212j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of Turnover of Cefotaxime by the Enterobacter cloacae P99 and GCl β-Lactamases: Two Free Enzyme Forms of the P99 β-Lactamase Detected by a Combination of Pre- and Post-Steady State Kinetics</span></div><div class="casAuthors">Kumar, Sanjai; Adediran, S. A.; Nukaga, Michiyoshi; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2664-2672</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Third-generation cephalosporins bearing oximino side chains are resistant to hydrolysis by class C β-lactamases such as that from Enterobacter cloacae P99.  For example, steady state parameters for hydrolysis of cefotaxime by this enzyme are as follows: kcat = 0.41 s-1, Km = 17.2 μM, and kcat/Km = 2.3×104 s-1 M-1.  On the other hand, however, the Ki value for cefotaxime as an inhibitor of cephalothin hydrolysis is 27 nM.  The discrepancy between Km and Ki indicated that a real steady state had not been achieved in at least one of these expts.  Anal. indicated that only two to three cefotaxime turnovers occurred during the Ki detn.  This suggested that the first few turnovers of cefotaxime by the P99 β-lactamase may be different from those in the subsequent steady state.  A direct pre-steady state expt. confirmed this hypothesis.  The simplest reaction scheme that fitted the data involved replacement of the initial enzyme form, E, which bound cefotaxime tightly, with a second more weakly binding form, E', by partitioning of the acyl-enzyme intermediate during the first few turnovers.  Steady state turnover of cefotaxime then largely involved E' as the free enzyme form. E' slowly reverted to E in the post-steady state regime.  Further evidence for this scheme included quant. anal. of the post-steady state and observation of a difference in the catalytic activity of E and E' in 2 M ammonium sulfate.  The kinetics of P99 β-lactamase-catalyzed hydrolysis of an acyclic depsipeptide substrate bearing a third-generation cephalosporin side chain showed that the side chain is necessary but not sufficient for prodn. of resistance to β-lactamase; a combination of the side chain and the dihydrothiazine ring of a cephalosporin is required.  The β-lactamase of E. cloacae GC1, an extended spectrum mutant of the P99 enzyme, rapidly hydrolyzes third-generation cephalosporins, without the structural transition described above.  The flexibility of the extended Ω loop of the GC1 enzyme probably leads to this situation.  Conformational restriction of the loop in the P99 enzyme is probably responsible for the long-lived acyl-enzyme intermediate and the transition to E' induced by cefotaxime.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOfHVlut0FrVg90H21EOLACvtfcHk0ljVw4JjgKT07w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagsLk%253D&md5=d3f5886debb44bf380cc80072d4ef5fd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi030212j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030212j%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DNukaga%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DKinetics%2520of%2520turnover%2520of%2520cefotaxime%2520by%2520the%2520Enterobacter%2520cloacae%2520P99%2520and%2520GCl%2520%25CE%25B2-lactamases%253A%2520two%2520free%2520enzyme%2520forms%2520of%2520the%2520P99%2520%25CE%25B2-lactamase%2520detected%2520by%2520a%2520combination%2520of%2520pre-%2520and%2520post-steady%2520state%2520kinetics%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D2664%26epage%3D2672%26doi%3D10.1021%2Fbi030212j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvaggi, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. A.</span></span> <span> </span><span class="NLM_article-title">Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/β-lactamase inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">7046</span>– <span class="NLM_lpage">7053</span>, <span class="refDoi"> DOI: 10.1021/bi049612c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049612c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslKqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=7046-7053&author=N.+R.+Silvaggiauthor=K.+Kaurauthor=S.+A.+Adediranauthor=R.+F.+Prattauthor=J.+A.+Kelly&title=Toward+better+antibiotics%3A+crystallographic+studies+of+a+novel+class+of+DD-peptidase%2F%CE%B2-lactamase+inhibitors&doi=10.1021%2Fbi049612c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Better Antibiotics: Crystallographic Studies of a Novel Class of DD-Peptidase/β-Lactamase Inhibitors</span></div><div class="casAuthors">Silvaggi, Nicholas R.; Kaur, Kamaljit; Adediran, S. A.; Pratt, R. F.; Kelly, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7046-7053</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are vital weapons in the treatment of bacterial infections, but their future is under increasing threat from β-lactamases.  These bacterial enzymes hydrolyze and inactivate β-lactam antibiotics, rendering the host cell resistant to the bactericidal effects of the drugs.  Nevertheless, the bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases), the killing targets of β-lactams, remain attractive targets for antibiotic compds.  Cyclic acyl phosph(on)ates have been developed and investigated as potential inhibitors of both transpeptidases and β-lactamases.  The x-ray crystal structures of the complexes of the Streptomyces strain R61 DD-peptidase inhibited by a bicyclic [1-hydroxy-4,5-benzo-2,6-dioxaphosphorinanone(3)-1-oxide] and a monocyclic [1-hydroxy-4-phenyl-2,6-dioxaphosphorinanone(3)-1-oxide] acyl phosphate were detd. to investigate the mode of action of these novel inhibitors.  The structures show, first, that these inhibitors form covalent bonds with the active site serine residue of the enzyme and that the refractory complexes thus formed are phosphoryl-enzyme species rather than acyl enzymes.  The complexes are long-lived largely because, after ring opening, the ligands adopt conformations that cannot directly recyclize, the latter a phenomenon previously obsd. with cyclic acyl phosph(on)ates.  While the two inhibitors bind in nearly identical conformations, the phosphoryl-enzyme complex formed from the monocyclic compd. is significantly less mobile than that formed from the bicyclic compd.  Despite this difference, the complex with the bicyclic compd. breaks down to regenerate free enzyme somewhat more slowly than that of the monocyclic.  This may be because of steric problems assocd. with the reorientation of the larger bicyclic ligand required for reactivation.  The structures are strikingly different in the orientation of the phosphoryl moiety from those generated using more specific phosph(on)ates.  Models of the noncovalent complexes of the monocyclic compd. with the R61 DD-peptidase and a structurally very similar class C β-lactamase suggest reasons why the former enzyme is phosphorylated by this compd., while the latter is acylated.  Finally, this paper provides information that will help in the design of addnl. DD-peptidase inhibitors with the potential to serve as leads in the development of novel antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMgbkglpwDYLVg90H21EOLACvtfcHk0ljVw4JjgKT07w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslKqtL0%253D&md5=3cb8e48467adab5ebae264668f8857d1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi049612c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049612c%26sid%3Dliteratum%253Aachs%26aulast%3DSilvaggi%26aufirst%3DN.%2BR.%26aulast%3DKaur%26aufirst%3DK.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DKelly%26aufirst%3DJ.%2BA.%26atitle%3DToward%2520better%2520antibiotics%253A%2520crystallographic%2520studies%2520of%2520a%2520novel%2520class%2520of%2520DD-peptidase%252F%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D7046%26epage%3D7053%26doi%3D10.1021%2Fbi049612c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbruck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsfall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehareng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrone, C.</span></span> <span> </span><span class="NLM_article-title">Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-β-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4862</span>– <span class="NLM_lpage">4876</span>, <span class="refDoi"> DOI: 10.1021/jm100213c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100213c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntF2ju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4862-4876&author=P.+Lassauxauthor=M.+Hamelauthor=M.+Guleaauthor=H.+Delbruckauthor=P.+S.+Mercuriauthor=L.+Horsfallauthor=D.+Deharengauthor=M.+Kupperauthor=J.+M.+Frereauthor=K.+Hoffmannauthor=M.+Galleniauthor=C.+Bebrone&title=Mercaptophosphonate+compounds+as+broad-spectrum+inhibitors+of+the+metallo-%CE%B2-lactamases&doi=10.1021%2Fjm100213c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mercaptophosphonate Compounds as Broad-Spectrum Inhibitors of the Metallo-β-lactamases</span></div><div class="casAuthors">Lassaux, Patricia; Hamel, Matthieu; Gulea, Mihaela; Delbruck, Heinrich; Mercuri, Paola Sandra; Horsfall, Louise; Dehareng, Dominique; Kupper, Michael; Frere, Jean-Marie; Hoffmann, Kurt; Galleni, Moreno; Bebrone, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4862-4876</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although commercialized inhibitors of active site serine β-lactamases are currently used in coadministration with antibiotic therapy, no clin. useful inhibitors of metallo-β-lactamases (MBLs) have yet been discovered.  In this paper, we investigated the inhibitory effect of mercaptophosphonate derivs. against the three subclasses of MBLs (B1, B2, and B3).  All 14 tested mercaptophosphonates, with the exception of 1a, behaved as competitive inhibitors for the three subclasses.  Apart from 13 and 21, all the mercaptophosphonates tested exhibit a good inhibitory effect on the subclass B2 MBL CphA with low inhibition consts. (Ki < 15 μM).  Interestingly, compd. 18 turned out to be a potent broad spectrum MBL inhibitor.  The crystallog. structures of the CphA-10a and CphA-18 complexes indicated that the sulfur atom of 10a and the phosphonato group of 18 interact with the Zn2+ ion, resp.  Mol. modeling studies of the interactions between compds. 10a and 18 and the VIM-4 (B1), CphA (B2), and FEZ-1 (B3) enzymes brought to light different binding modes depending on the enzyme and the inhibitor, consistent with the crystallog. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTg_BxmfSurVg90H21EOLACvtfcHk0lhkGkEYCguYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntF2ju74%253D&md5=c0161b56023beeefe300d50ae2fc43d9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm100213c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100213c%26sid%3Dliteratum%253Aachs%26aulast%3DLassaux%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DM.%26aulast%3DGulea%26aufirst%3DM.%26aulast%3DDelbruck%26aufirst%3DH.%26aulast%3DMercuri%26aufirst%3DP.%2BS.%26aulast%3DHorsfall%26aufirst%3DL.%26aulast%3DDehareng%26aufirst%3DD.%26aulast%3DKupper%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26aulast%3DHoffmann%26aufirst%3DK.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DBebrone%26aufirst%3DC.%26atitle%3DMercaptophosphonate%2520compounds%2520as%2520broad-spectrum%2520inhibitors%2520of%2520the%2520metallo-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4862%26epage%3D4876%26doi%3D10.1021%2Fjm100213c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagseth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauksund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiros, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, A.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.ejmech.2017.04.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28445786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslOitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=159-173&author=S.+Skagsethauthor=S.+Akhterauthor=M.+H.+Paulsenauthor=Z.+Muhammadauthor=S.+Lauksundauthor=O.+Samuelsenauthor=H.+S.+Leirosauthor=A.+Bayer&title=Metallo-%CE%B2-lactamase+inhibitors+by+bioisosteric+replacement%3A+preparation%2C+activity+and+binding&doi=10.1016%2Fj.ejmech.2017.04.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding</span></div><div class="casAuthors">Skagseth, Susann; Akhter, Sundus; Paulsen, Marianne H.; Muhammad, Zeeshan; Lauksund, Silje; Samuelsen, Oerjan; Leiros, Hanna-Kirsti S.; Bayer, Annette</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Bacterial resistance is compromising the use of β-lactam antibiotics including carbapenems.  The main resistance mechanism against β-lactams is hydrolysis of the β-lactam ring mediated by serine- or metallo-β-lactamases (MBLs).  Although several inhibitors of MBLs have been reported, none has been developed into a clin. useful inhibitor.  Mercaptocarboxylic acids are among the most prominent scaffolds reported as MBL inhibitors.  In this study, the carboxylate group of mercaptocarboxylic acids was replaced with bioisosteric groups like phosphonate esters, phosphonic acids and NH-tetrazoles.  The influence of the replacement on the bioactivity and inhibitor binding was evaluated.  A series of bioisosteres of previously reported inhibitors was synthesized and evaluated against the MBLs VIM-2, NDM-1 and GIM-1.  The most active inhibitors combined a mercapto group and a phosphonate ester or acid, with two/three carbon chains connecting a Ph group.  Surprisingly, also compds. contg. thioacetate groups instead of thiols showed low IC50 values.  High-resoln. crystal structures of three inhibitors in complex with VIM-2 revealed hydrophobic interactions for the di-Et groups in the phosphonate ester (inhibitor 2b), the mercapto bridging the two active site zinc ions, and tight stacking of the benzene ring to the inhibitor between Phe62, Tyr67, Arg228 and His263.  The inhibitors show reduced enzyme activity in Escherichia coli cells harboring MBL.  The obtained results will be useful for further structural guided design of MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETOxPVcXLKbVg90H21EOLACvtfcHk0lhkGkEYCguYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslOitb4%253D&md5=fdcbe36f5777a32eaed8c3059c2d4e6d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.035%26sid%3Dliteratum%253Aachs%26aulast%3DSkagseth%26aufirst%3DS.%26aulast%3DAkhter%26aufirst%3DS.%26aulast%3DPaulsen%26aufirst%3DM.%2BH.%26aulast%3DMuhammad%26aufirst%3DZ.%26aulast%3DLauksund%26aufirst%3DS.%26aulast%3DSamuelsen%26aufirst%3DO.%26aulast%3DLeiros%26aufirst%3DH.%2BS.%26aulast%3DBayer%26aufirst%3DA.%26atitle%3DMetallo-%25CE%25B2-lactamase%2520inhibitors%2520by%2520bioisosteric%2520replacement%253A%2520preparation%252C%2520activity%2520and%2520binding%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D159%26epage%3D173%26doi%3D10.1016%2Fj.ejmech.2017.04.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krismanich, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desoky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bols, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrienko, G. I.</span></span> <span> </span><span class="NLM_article-title">Structural and kinetic studies of the potent inhibition of metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlGrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1880-1892&author=P.+Hinchliffeauthor=C.+A.+Tannerauthor=A.+P.+Krismanichauthor=G.+Labbeauthor=V.+J.+Goodfellowauthor=L.+Marroneauthor=A.+Y.+Desokyauthor=K.+Calvopinaauthor=E.+E.+Whittleauthor=F.+Zengauthor=M.+B.+Avisonauthor=N.+C.+Bolsauthor=S.+Siemannauthor=J.+Spencerauthor=G.+I.+Dmitrienko&title=Structural+and+kinetic+studies+of+the+potent+inhibition+of+metallo-%CE%B2-lactamases+by+6-Phosphonomethylpyridine-2-carboxylates&doi=10.1021%2Facs.biochem.7b01299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates</span></div><div class="casAuthors">Hinchliffe, Philip; Tanner, Carol A.; Krismanich, Anthony P.; Labbe, Genevieve; Goodfellow, Valerie J.; Marrone, Laura; Desoky, Ahmed Y.; Calvopina, Karina; Whittle, Emily E.; Zeng, Fanxing; Avison, Matthew B.; Bols, Niels C.; Siemann, Stefan; Spencer, James; Dmitrienko, Gary I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1880-1892</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no clin. available inhibitors of metallo-β-lactamases (MBLs), enzymes which hydrolyze β-lactam antibiotics and confer resistance on Gram-neg. bacteria.  Here we present 6-phosphonomethylpyridine-2-carboxylates (PMPCs) as potent inhibitors of subclass B1 (IMP-1, VIM-2, NDM-1) and B3 (L1) MBLs.  Inhibition followed a competitive, slow-binding model without an isomerization step (IC50 values 0.3 - 7.2 μM; Ki 0.03 - 1.5 μM).  Min. inhibitory concn. assays demonstrated potentiation of β-lactam (meropenem) activity against MBL-producing bacteria, including clin. isolates, at concns. where eukaryotic cells remain viable.  Crystal structures revealed unprecedented modes of inhibitor binding to B1 (IMP-1) and B3 (L1) MBLs.  In IMP-1, binding does not replace the nucleophilic hydroxide and the PMPC carboxylate and pyridine nitrogen interact closely (2.3 and 2.7 Å, resp.) with the Zn2 ion of the binuclear metal site.  The phosphonate group makes limited interactions, but is 2.6 Å from the nucleophilic hydroxide.  Furthermore, the presence of a water mol. interacting with the PMPC phosphonate and pyridine N-C2 π-bond, as well as the nucleophilic hydroxide, suggests that the PMPC binds to the MBL active site as its hydrate.  Binding is markedly different in L1, with the phosphonate displacing both Zn2, forming a monozinc enzyme, and the nucleophilic hydroxide, while also making multiple interactions with the protein main chain and Zn1.  The carboxylate and pyridine nitrogen interact with Ser221/223, resp. (3 Å distance).  The potency, low toxicity, cellular activity and amenability to further modification of PMPCs indicate these and similar phosphonate compds. can be further considered for future MBL inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Msvht-yg4bVg90H21EOLACvtfcHk0lgBCbluew4YkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlGrtrs%253D&md5=f4fbb072f4bed72adf8d7e643cd684bb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01299%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DTanner%26aufirst%3DC.%2BA.%26aulast%3DKrismanich%26aufirst%3DA.%2BP.%26aulast%3DLabbe%26aufirst%3DG.%26aulast%3DGoodfellow%26aufirst%3DV.%2BJ.%26aulast%3DMarrone%26aufirst%3DL.%26aulast%3DDesoky%26aufirst%3DA.%2BY.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DWhittle%26aufirst%3DE.%2BE.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DBols%26aufirst%3DN.%2BC.%26aulast%3DSiemann%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DDmitrienko%26aufirst%3DG.%2BI.%26atitle%3DStructural%2520and%2520kinetic%2520studies%2520of%2520the%2520potent%2520inhibition%2520of%2520metallo-%25CE%25B2-lactamases%2520by%25206-Phosphonomethylpyridine-2-carboxylates%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D1880%26epage%3D1892%26doi%3D10.1021%2Facs.biochem.7b01299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Y.-c.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Rh(iii)-catalyzed directed C–H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and serine-β-lactamases</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1039/C8QO00009C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC8QO00009C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=1288-1292&author=C.+Zhangauthor=Y.-c.+Puauthor=Z.-J.+Yuauthor=C.-y.+Wuauthor=J.+Bremauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=G.-B.+Liauthor=Y.+Wu&title=Rh%28iii%29-catalyzed+directed+C%E2%80%93H+carbenoid+coupling+reveals+aromatic+bisphosphonates+inhibiting+metallo-+and+serine-%CE%B2-lactamases&doi=10.1039%2FC8QO00009C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rh(III)-Catalyzed directed C-H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and Serine-β-lactamases</span></div><div class="casAuthors">Zhang, Chen; Pu, Yan-chi; Yu, Zhu-Jun; Wu, Cheng-yong; Brem, Jurgen; McDonough, Michael A.; Schofield, Christopher J.; Li, Guo-Bo; Wu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1288-1292</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the highly efficient and scalable Rh(III)-catalyzed C-H coupling of arenes with diazo-methylene-diphosphonates to give structurally diverse arom. bisphosphonates in good to excellent yields.  These bisphosphonates are one of the very few classes of inhibitors acting against the mechanistically distinct metallo-β-lactamases and serine-β-lactamases and thus represent good starting points for the development of broad spectrum β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouKaH5Ab53CbVg90H21EOLACvtfcHk0lht7KlWfz9Qeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yqt7g%253D&md5=512e68684f75728af5f627492cd5ed82</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC8QO00009C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QO00009C%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPu%26aufirst%3DY.-c.%26aulast%3DYu%26aufirst%3DZ.-J.%26aulast%3DWu%26aufirst%3DC.-y.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DLi%26aufirst%3DG.-B.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DRh%2528iii%2529-catalyzed%2520directed%2520C%25E2%2580%2593H%2520carbenoid%2520coupling%2520reveals%2520aromatic%2520bisphosphonates%2520inhibiting%2520metallo-%2520and%2520serine-%25CE%25B2-lactamases%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2018%26volume%3D5%26spage%3D1288%26epage%3D1292%26doi%3D10.1039%2FC8QO00009C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E3745</span>– <span class="NLM_lpage">E3754</span>, <span class="refDoi"> DOI: 10.1073/pnas.1601368113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.1601368113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27303030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E3745-E3754&author=P.+Hinchliffeauthor=M.+M.+Gonzalezauthor=M.+F.+Mojicaauthor=J.+M.+Gonzalezauthor=V.+Castilloauthor=C.+Saizauthor=M.+Kosmopoulouauthor=C.+L.+Tookeauthor=L.+I.+Llarrullauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=A.+J.+Vilaauthor=J.+Spencer&title=Cross-class+metallo-%CE%B2-lactamase+inhibition+by+bisthiazolidines+reveals+multiple+binding+modes&doi=10.1073%2Fpnas.1601368113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span></div><div class="casAuthors">Hinchliffe, Philip; Gonzalez, Mariano M.; Mojica, Maria F.; Gonzalez, Javier M.; Castillo, Valerie; Saiz, Cecilia; Kosmopoulou, Magda; Tooke, Catherine L.; Llarrull, Leticia I.; Mahler, Graciela; Bonomo, Robert A.; Vila, Alejandro J.; Spencer, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E3745-E3754</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze almost all β-lactam antibiotics and are unaffected by clin. available β-lactamase inhibitors (βLIs).  Active site architecture divides MBLs into 3 classes (B1, B2, and B3), complicating the development of βLIs effective against all enzymes.  Bisthiazolidines (BTZs) are carboxylate-contg., bicyclic compds., considered as penicillin analogs with an addnl. free thiol.  Here, the authors show both L- and D-BTZ enantiomers are micromolar competitive βLIs of all MBL classes in vitro, with Ki values of 6-15 or 36-84 μM for subclass B1 MBLs (IMP-1 and BcII, resp.), and 10-12 μM for B3 enzyme L1.  Against B2 MBL Sfh-I, the L-BTZ enantiomers exhibited 100-fold lower Ki values (0.26-0.36 μM) than D-BTZs (26-29 μM).  Importantly, cell-based time-kill assays showed BTZs restored β-lactam susceptibility of Escherichia coli-producing MBLs (IMP-1, Sfh-1, BcII, and GOB-18) and, significantly, an extensively drug-resistant Stenotrophomonas maltophilia clin. isolate expressing L1.  BTZs therefore inhibit the full range of MBLs and potentiate β-lactam activity against producer pathogens.  X-ray crystal structures revealed insights into diverse BTZ binding modes, varying with orientation of the carboxylate and thiol moieties.  BTZs bound the di-zinc centers of B1 (IMP-1; BcII) and B3 (L1) MBLs via the free thiol, but oriented differently depending upon stereochem.  In contrast, the L-BTZ carboxylate dominated interactions with the mono-zinc B2 MBL Sfh-I, with the thiol uninvolved.  The D-BTZ complexes most closely resembled β-lactam binding to B1 MBLs, but featured an unprecedented disruption of the Asp-120-zinc interaction.  Cross-class MBL inhibition therefore arises from the unexpected versatility of BTZ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql0OqimvaJmrVg90H21EOLACvtfcHk0lht7KlWfz9Qeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D&md5=8b663adf29172ac32d41f6aad7d13513</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1601368113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1601368113%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DGonzalez%26aufirst%3DJ.%2BM.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DSaiz%26aufirst%3DC.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DTooke%26aufirst%3DC.%2BL.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DCross-class%2520metallo-%25CE%25B2-lactamase%2520inhibition%2520by%2520bisthiazolidines%2520reveals%2520multiple%2520binding%2520modes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE3745%26epage%3DE3754%26doi%3D10.1073%2Fpnas.1601368113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span> <span> </span><span class="NLM_article-title">Bisthiazolidines: a substrate-mimicking scaffold as an inhibitor of the NDM-1 carbapenemase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=544-554&author=M.+M.+Gonzalezauthor=M.+Kosmopoulouauthor=M.+F.+Mojicaauthor=V.+Castilloauthor=P.+Hinchliffeauthor=I.+Pettinatiauthor=J.+Bremauthor=C.+J.+Schofieldauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=L.+I.+Llarrullauthor=J.+Spencerauthor=A.+J.+Vila&title=Bisthiazolidines%3A+a+substrate-mimicking+scaffold+as+an+inhibitor+of+the+NDM-1+carbapenemase&doi=10.1021%2Facsinfecdis.5b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span></div><div class="casAuthors">Gonzalez, Mariano M.; Kosmopoulou, Magda; Mojica, Maria F.; Castillo, Valerie; Hinchliffe, Philip; Pettinati, Ilaria; Brem, Jurgen; Schofield, Christopher J.; Mahler, Graciela; Bonomo, Robert A.; Llarrull, Leticia I.; Spencer, James; Vila, Alejandro J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">544-554</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pathogenic Gram-neg. bacteria resistant to almost all β-lactam antibiotics are a major public health threat.  Zn(II)-dependent or metallo-β-lactamases (MBLs) produced by these bacteria inactivate most β-lactam antibiotics, including the carbapenems, which are "last line therapies" for life-threatening Gram-neg. infections.  NDM-1 is a carbapenemase belonging to the MBL family that is rapidly spreading worldwide.  Regrettably, inhibitors of MBLs are not yet developed.  Here the authors present the bisthiazolidine (BTZ) scaffold as a structure with some features of β-lactam substrates, which can be modified with metal-binding groups to target the MBL active site.  Inspired by known interactions of MBLs with β-lactams, the authors designed four BTZs that behave as in vitro NDM-1 inhibitors with Ki values in the low micromolar range (from 7±1 to 19±3 μM).  NMR spectroscopy demonstrated that they inhibit hydrolysis of imipenem in NDM-1-producing Escherichia coli.  In vitro time kill cell-based assays against a variety of bacterial strains harboring blaNDM-1 including Acinetobacter baumannii show that the compds. restore the antibacterial activity of imipenem.  A crystal structure of the most potent heterocycle (L-CS319) in complex with NDM-1 at 1.9 Å resoln. identified both structural determinants for inhibitor binding and opportunities for further improvements in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokg8f_hU7BV7Vg90H21EOLACvtfcHk0lifcfN6_GdvLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI&md5=3a13478a79bee2dddfad2137406d54a0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00046%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26atitle%3DBisthiazolidines%253A%2520a%2520substrate-mimicking%2520scaffold%2520as%2520an%2520inhibitor%2520of%2520the%2520NDM-1%2520carbapenemase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D544%26epage%3D554%26doi%3D10.1021%2Facsinfecdis.5b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajaksouzian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rather, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhavsar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeole, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Strategic approaches to overcome resistance against gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel diazabicyclooctanes WCK 5153, zidebactam (WCK 5107), and WCK 4234</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4067</span>– <span class="NLM_lpage">4086</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4067-4086&author=K.+M.+Papp-Wallaceauthor=N.+Q.+Nguyenauthor=M.+R.+Jacobsauthor=C.+R.+Bethelauthor=M.+D.+Barnesauthor=V.+Kumarauthor=S.+Bajaksouzianauthor=S.+D.+Rudinauthor=P.+N.+Ratherauthor=S.+Bhavsarauthor=T.+Ravikumarauthor=P.+K.+Deshpandeauthor=V.+Patilauthor=R.+Yeoleauthor=S.+S.+Bhagwatauthor=M.+V.+Patelauthor=F.+van+den+Akkerauthor=R.+A.+Bonomo&title=Strategic+approaches+to+overcome+resistance+against+gram-negative+pathogens+using+%CE%B2-lactamase+inhibitors+and+%CE%B2-lactam+enhancers%3A+activity+of+three+novel+diazabicyclooctanes+WCK+5153%2C+zidebactam+%28WCK+5107%29%2C+and+WCK+4234&doi=10.1021%2Facs.jmedchem.8b00091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Nguyen, Nhu Q.; Jacobs, Michael R.; Bethel, Christopher R.; Barnes, Melissa D.; Kumar, Vijay; Bajaksouzian, Saralee; Rudin, Susan D.; Rather, Philip N.; Bhavsar, Satish; Ravikumar, Tadiparthi; Deshpande, Prasad K.; Patil, Vijay; Yeole, Ravindra; Bhagwat, Sachin S.; Patel, Mahesh V.; van den Akker, Focco; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4067-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Limited treatment options exist to combat infections caused by multidrug-resistant (MDR) Gram-neg. bacteria possessing broad-spectrum β-lactamases.  The design of novel β-lactamase inhibitors is of paramount importance.  Here, three novel diazabicyclooctanes (DBOs), WCK 5153, zidebactam (WCK 5107), and WCK 4234 (compds. 1-3, resp.), were synthesized and biochem. characterized against clin. important bacteria.  Compd. 3 inhibited class A, C, and D β-lactamases with unprecedented k2/K values against OXA carbapenemases.  Compds. 1 and 2 acylated class A and C β-lactamses rapidly but not the tested OXAs.  Compds. 1-3 formed highly stable acyl-complexes as demonstrated by mass spectrometry.  Crystallog. revealed that 1-3 complexed with KPC-2 adopted a "chair conformation" with the sulfate occupying the carboxylate binding region.  The cefepime-2 and meropenem-3 combinations were effective in murine peritonitis and neutropenic lung infection models caused by MDR Acinetobacter baumannii.  Compds. 1-3 are novel β-lactamase inhibitors that demonstate potent cross-class inhibition, and clin. studies targeting MDR infections are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKL3--mMKuLLVg90H21EOLACvtfcHk0lifcfN6_GdvLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntF2ntL4%253D&md5=3f4189d431cb020d003d5494f3d57e9b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00091%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DJacobs%26aufirst%3DM.%2BR.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DBarnes%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DBajaksouzian%26aufirst%3DS.%26aulast%3DRudin%26aufirst%3DS.%2BD.%26aulast%3DRather%26aufirst%3DP.%2BN.%26aulast%3DBhavsar%26aufirst%3DS.%26aulast%3DRavikumar%26aufirst%3DT.%26aulast%3DDeshpande%26aufirst%3DP.%2BK.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DYeole%26aufirst%3DR.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26aulast%3DPatel%26aufirst%3DM.%2BV.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DStrategic%2520approaches%2520to%2520overcome%2520resistance%2520against%2520gram-negative%2520pathogens%2520using%2520%25CE%25B2-lactamase%2520inhibitors%2520and%2520%25CE%25B2-lactam%2520enhancers%253A%2520activity%2520of%2520three%2520novel%2520diazabicyclooctanes%2520WCK%25205153%252C%2520zidebactam%2520%2528WCK%25205107%2529%252C%2520and%2520WCK%25204234%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4067%26epage%3D4086%26doi%3D10.1021%2Facs.jmedchem.8b00091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismael, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopeit, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiros, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, A.</span></span> <span> </span><span class="NLM_article-title">A focused fragment library targeting the antibiotic resistance enzyme - oxacillinase-48: synthesis, structural evaluation and inhibitor design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.ejmech.2017.12.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29348071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVentLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=634-648&author=S.+Akhterauthor=B.+A.+Lundauthor=A.+Ismaelauthor=M.+Langerauthor=J.+Isakssonauthor=T.+Christopeitauthor=H.+S.+Leirosauthor=A.+Bayer&title=A+focused+fragment+library+targeting+the+antibiotic+resistance+enzyme+-+oxacillinase-48%3A+synthesis%2C+structural+evaluation+and+inhibitor+design&doi=10.1016%2Fj.ejmech.2017.12.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design</span></div><div class="casAuthors">Akhter, Sundus; Lund, Bjarte Aarmo; Ismael, Aya; Langer, Manuel; Isaksson, Johan; Christopeit, Tony; Leiros, Hanna-Kirsti S.; Bayer, Annette</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">634-648</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are of utmost importance when treating bacterial infections in the medical community.  However, currently their utility is threatened by the emergence and spread of β-lactam resistance.  The most prevalent resistance mechanism to β-lactam antibiotics is expression of β-lactamase enzymes.  One way to overcome resistance caused by β-lactamases, is the development of β-lactamase inhibitors and today several β-lactamase inhibitors e.g. avibactam, are approved in the clinic.  Our focus is the oxacillinase-48 (OXA-48), an enzyme reported to spread rapidly across the world and commonly identified in Escherichia coli and Klebsiella pneumoniae.  To guide inhibitor design, we used diversely substituted 3-aryl and 3-heteroaryl benzoic acids to probe the active site of OXA-48 for useful enzyme-inhibitor interactions.  In the presented study, a focused fragment library contg. 49 3-substituted benzoic acid derivs. were synthesized and biochem. characterized.  Based on crystallog. data from 33 fragment-enzyme complexes, the fragments could be classified into R1 or R2 binders by their overall binding conformation in relation to the binding of the R1 and R2 side groups of imipenem.  Moreover, binding interactions attractive for future inhibitor design were found and their usefulness explored by the rational design and evaluation of merged inhibitors from orthogonally binding fragments.  The best inhibitors among the resulting 3,5-disubstituted benzoic acids showed inhibitory potential in the low micromolar range (IC50 = 2.9 μM).  For these inhibitors, the complex X-ray structures revealed non-covalent binding to Arg250, Arg214 and Tyr211 in the active site and the interactions obsd. with the mono-substituted fragments were also identified in the merged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoADO0JKwowYrVg90H21EOLACvtfcHk0liFLB_nORJd3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVentLk%253D&md5=fba0b4c7b8c0c1bec4928b895d68c48d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DAkhter%26aufirst%3DS.%26aulast%3DLund%26aufirst%3DB.%2BA.%26aulast%3DIsmael%26aufirst%3DA.%26aulast%3DLanger%26aufirst%3DM.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DChristopeit%26aufirst%3DT.%26aulast%3DLeiros%26aufirst%3DH.%2BS.%26aulast%3DBayer%26aufirst%3DA.%26atitle%3DA%2520focused%2520fragment%2520library%2520targeting%2520the%2520antibiotic%2520resistance%2520enzyme%2520-%2520oxacillinase-48%253A%2520synthesis%252C%2520structural%2520evaluation%2520and%2520inhibitor%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D634%26epage%3D648%26doi%3D10.1016%2Fj.ejmech.2017.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouza, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallar, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of <i>Acinetobacter</i>-derived cephalosporinase: exploring the carboxylate recognition site using novel β-lactamase inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00153</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWnt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=337-348&author=E.+Caselliauthor=C.+Romagnoliauthor=R.+A.+Powersauthor=M.+A.+Taracilaauthor=A.+A.+Bouzaauthor=H.+C.+Swansonauthor=K.+A.+Smolenauthor=F.+Finiauthor=B.+J.+Wallarauthor=R.+A.+Bonomoauthor=F.+Prati&title=Inhibition+of+Acinetobacter-derived+cephalosporinase%3A+exploring+the+carboxylate+recognition+site+using+novel+%CE%B2-lactamase+inhibitors&doi=10.1021%2Facsinfecdis.7b00153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors</span></div><div class="casAuthors">Caselli, Emilia; Romagnoli, Chiara; Powers, Rachel A.; Taracila, Magdalena A.; Bouza, Alexandra A.; Swanson, Hollister C.; Smolen, Kali A.; Fini, Francesco; Wallar, Bradley J.; Bonomo, Robert A.; Prati, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids are attracting a lot of attention as β-lactamase inhibitors, and in particular compd. S02030 (Ki = 44 nM) proved to be a good lead compd. against ADC-7 (Acinetobacter Derived Cephalosporinase), one of the most significant resistance determinants in A. baumannii.  The at. structure of the ADC-7/S02030 complex highlighted the importance of crit. structural determinants for recognition of the boronic acids.  Herein, to elucidate the role in recognition of the R2-carboxylate, which mimics the C3/C4 found in β-lactams, we designed, synthesized, and characterized six derivs. of S02030 (3a).  Out of the six compds., the best inhibitors proved to be those with an explicit neg. charge (compds. 3a-c and 3h,j, Ki = 44-115 nM), which is in contrast to the derivs. where the neg. charge is omitted, such as the amide deriv. 3d (Ki = 224 nM) and the hydroxyamide deriv. 3e (Ki = 155 nM).  To develop a structural characterization of inhibitor binding in the active site, the X-ray crystal structures of ADC-7 in a complex with compds. 3c, SM23, and EC04 were detd.  All three compds. share the same structural features as in S02030, but only differ in the carboxy-R2 side chain, thereby providing the opportunity of exploring the distinct binding mode of the neg. charged R2 side chain.  This cephalosporinase demonstrates a high degree of versatility in recognition, employing different residues to directly interact with the carboxylate, thus suggesting the existence of a "carboxylate binding region" rather than binding site in ADC enzymes.  Furthermore, this class of compds. was tested against resistant clin. strains of A. baumannii and are effective at inhibiting bacterial growth in conjunction with a β-lactam antibiotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLiVb5ID7RX7Vg90H21EOLACvtfcHk0ljLBys0-uckUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWnt7nE&md5=d3f02a44ba426f305b6c43ea8f4b78fc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00153%26sid%3Dliteratum%253Aachs%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBouza%26aufirst%3DA.%2BA.%26aulast%3DSwanson%26aufirst%3DH.%2BC.%26aulast%3DSmolen%26aufirst%3DK.%2BA.%26aulast%3DFini%26aufirst%3DF.%26aulast%3DWallar%26aufirst%3DB.%2BJ.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520Acinetobacter-derived%2520cephalosporinase%253A%2520exploring%2520the%2520carboxylate%2520recognition%2520site%2520using%2520novel%2520%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D337%26epage%3D348%26doi%3D10.1021%2Facsinfecdis.7b00153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouza, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDine, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallar, B. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based analysis of boronic acids as inhibitors of <i>Acinetobacter</i>-derived cephalosporinase-7, a unique class C β-lactamase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00152</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00152" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=325-336&author=A.+A.+Bouzaauthor=H.+C.+Swansonauthor=K.+A.+Smolenauthor=A.+L.+VanDineauthor=M.+A.+Taracilaauthor=C.+Romagnoliauthor=E.+Caselliauthor=F.+Pratiauthor=R.+A.+Bonomoauthor=R.+A.+Powersauthor=B.+J.+Wallar&title=Structure-based+analysis+of+boronic+acids+as+inhibitors+of+Acinetobacter-derived+cephalosporinase-7%2C+a+unique+class+C+%CE%B2-lactamase&doi=10.1021%2Facsinfecdis.7b00152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase</span></div><div class="casAuthors">Bouza, Alexandra A.; Swanson, Hollister C.; Smolen, Kali A.; VanDine, Alison L.; Taracila, Magdalena A.; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Bonomo, Robert A.; Powers, Rachel A.; Wallar, Bradley J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-336</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acinetobacter baumannii is a multidrug resistant pathogen that infects more than 12,000 patients each year in the US.  Much of the resistance to β-lactam antibiotics in Acinetobacter spp. is a result of class C β-lactamases known as Acinetobacter-derived cephalosporinases (ADCs).  ADCs are unaffected by clin. used β-lactam-based β-lactamase inhibitors.  In this study, five boronic acid transition state analog inhibitors (BATSIs) were evaluated for inhibition of the class C cephalosporinase ADC-7.  Our goal was to explore the properties of BATSIs designed to probe the R1 binding site.  Ki values ranged from low micromolar to sub-nanomolar, and CD (CD) demonstrated that each inhibitor stabilizes the β-lactamase-inhibitor complexes.  Addnl., X-ray crystal structures of ADC-7 in complex with five inhibitors were detd. (resolns. from 1.80-2.09 Å).  In the ADC-7/CR192 complex, the BATSI with the lowest Ki (0.45 nM) and greatest ΔTm (+9 °C), a trifluoromethyl substituent interacts with Arg340.  Arg340 is unique to ADCs and may play an important role in the inhibition of ADC-7.  The ADC-7/BATSI complexes detd. in this study shed light into the unique recognition sites in ADC enzymes, and also offer insight into further structure-based optimization of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw1UA39oODrVg90H21EOLACvtfcHk0ljLBys0-uckUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWntrfF&md5=6453dfb5439845b40e5a9085470cf5ff</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00152%26sid%3Dliteratum%253Aachs%26aulast%3DBouza%26aufirst%3DA.%2BA.%26aulast%3DSwanson%26aufirst%3DH.%2BC.%26aulast%3DSmolen%26aufirst%3DK.%2BA.%26aulast%3DVanDine%26aufirst%3DA.%2BL.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26aulast%3DWallar%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520analysis%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520Acinetobacter-derived%2520cephalosporinase-7%252C%2520a%2520unique%2520class%2520C%2520%25CE%25B2-lactamase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D325%26epage%3D336%26doi%3D10.1021%2Facsinfecdis.7b00152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1002/pro.3100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fpro.3100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27997706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=515-526&author=J.+P.+Wernerauthor=J.+M.+Mitchellauthor=M.+A.+Taracilaauthor=R.+A.+Bonomoauthor=R.+A.+Powers&title=Exploring+the+potential+of+boronic+acids+as+inhibitors+of+OXA-24%2F40+%CE%B2-lactamase&doi=10.1002%2Fpro.3100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span></div><div class="casAuthors">Werner, Josephine P.; Mitchell, Joshua M.; Taracila, Magdalena A.; Bonomo, Robert A.; Powers, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are crucial to the management of bacterial infections in the medical community.  Due to overuse and misuse, clin. significant bacteria are now resistant to many com. available antibiotics.  The most widespread resistance mechanism to β-lactams is the expression of β-lactamase enzymes.  To overcome β-lactamase mediated resistance, inhibitors were designed to inactivate these enzymes.  However, current inhibitors (clavulanic acid, tazobactam, and sulbactam) for β-lactamases also contain the characteristic β-lactam ring, making them susceptible to resistance mechanisms employed by bacteria.  This presents a crit. need for novel, non-β-lactam inhibitors that can circumvent these resistance mechanisms.  The carbapenem-hydrolyzing class D β-lactamases (CHDLs) are of particular concern, given that they efficiently hydrolyze potent carbapenem antibiotics.  Unfortunately, these enzymes are not inhibited by clin. available β-lactamase inhibitors, nor are they effectively inhibited by the newest, non-β-lactam inhibitor, avibactam.  Boronic acids are known transition state analog inhibitors of class A and C β-lactamases, and are not extensively characterized as inhibitors of class D β-lactamases.  Importantly, boronic acids provide a novel way to potentially inhibit class D β-lactamases.  Sixteen boronic acids were selected and tested for inhibition of the CHDL OXA-24/40.  Several compds. were identified as effective inhibitors of OXA-24/40, with Ki values as low as 5 μM.  The X-ray crystal structures of OXA-24/40 in complex with BA3, BA4, BA8, and BA16 were detd. and revealed the importance of interactions with hydrophobic residues Tyr112 and Trp115.  These boronic acids serve as progenitors in optimization efforts of a novel series of inhibitors for class D β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGKFNJYCrO7Vg90H21EOLACvtfcHk0liRLwMERzH16Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D&md5=73c4063f4a06e5cf8bd8262e17b6e611</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fpro.3100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3100%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DJ.%2BP.%26aulast%3DMitchell%26aufirst%3DJ.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520potential%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520OXA-24%252F40%2520%25CE%25B2-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D515%26epage%3D526%26doi%3D10.1002%2Fpro.3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, F.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1128/AAC.02643-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02643-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26729491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1760-1766&author=N.+Q.+Nguyenauthor=N.+P.+Krishnanauthor=L.+J.+Rojasauthor=F.+Pratiauthor=E.+Caselliauthor=C.+Romagnoliauthor=R.+A.+Bonomoauthor=F.+van+den+Akker&title=Crystal+structures+of+KPC-2+and+SHV-1+%CE%B2-lactamases+in+complex+with+the+boronic+acid+transition+state+analog+S02030&doi=10.1128%2FAAC.02643-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030</span></div><div class="casAuthors">Nguyen, Nhu Q.; Krishnan, Nikhil P.; Rojas, Laura J.; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara; Bonomo, Robert A.; van den Akker, Focco</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1760-1766</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Resistance to expanded-spectrum cephalosporins and carbapenems has rendered certain strains of Klebsiella pneumoniae the most problematic pathogens infecting patients in the hospital and community.  This broad-spectrum resistance to β-lactamases emerges in part via the expression of KPC-2 and SHV-1 β-lactamases and variants thereof.  KPC-2 carbapenemase is particularly worrisome, as the genetic determinant encoding this β-lactamase is rapidly spread via plasmids.  Moreover, KPC-2, a class A enzyme, is difficult to inhibit with mechanism-based inactivators (e.g., clavulanate).  In order to develop new β-lactamase inhibitors (BLIs) to add to the limited available armamentarium that can inhibit KPC-2, we have structurally probed the boronic acid transition state analog S02030 for its inhibition of KPC-2 and SHV-1.  S02030 contains a boronic acid, a thiophene, and a carboxyl triazole moiety.  We present here the 1.54- and 1.87-Å resoln. crystal structures of S02030 bound to SHV-1 and KPC-2 β-lactamases, resp., as well as a comparative anal. of the S02030 binding modes, including a previously detd. S02030 class C ADC-7 β-lactamase complex.  S02030 is able to inhibit vastly different serine β-lactamases by interacting with the conserved features of these active sites, which includes (i) forming the bond with catalytic serine via the boron atom, (ii) positioning one of the boronic acid oxygens in the oxyanion hole, and (iii) utilizing its amide moiety to make conserved interactions across the width of the active site.  In addn., S02030 is able to overcome more distantly located structural differences between the β-lactamases.  This unique feature is achieved by repositioning the more polar carboxyl-triazole moiety, generated by click chem., to create polar interactions as well as reorient the more hydrophobic thiophene moiety.  The former is aided by the unusual polar nature of the triazole ring, allowing it to potentially form a unique C-H...O 2.9-Å hydrogen bond with S130 in KPC-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodGweMm-OAFbVg90H21EOLACvtfcHk0liRLwMERzH16Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtLzK&md5=f4ccda8606d59dfff5826da032927471</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1128%2FAAC.02643-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02643-15%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DKrishnan%26aufirst%3DN.%2BP.%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26atitle%3DCrystal%2520structures%2520of%2520KPC-2%2520and%2520SHV-1%2520%25CE%25B2-lactamases%2520in%2520complex%2520with%2520the%2520boronic%2520acid%2520transition%2520state%2520analog%2520S02030%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1760%26epage%3D1766%26doi%3D10.1128%2FAAC.02643-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1128/AAC.02641-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02641-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26729496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1751-1759&author=L.+J.+Rojasauthor=M.+A.+Taracilaauthor=K.+M.+Papp-Wallaceauthor=C.+R.+Bethelauthor=E.+Caselliauthor=C.+Romagnoliauthor=M.+L.+Winklerauthor=B.+Spellbergauthor=F.+Pratiauthor=R.+A.+Bonomo&title=Boronic+acid+transition+state+inhibitors+active+against+KPC+and+other+class+A+%CE%B2-lactamases%3A+structure-activity+relationships+as+a+guide+to+inhibitor+design&doi=10.1128%2FAAC.02641-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span></div><div class="casAuthors">Rojas, Laura J.; Taracila, Magdalena A.; Papp-Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1751-1759</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Boronic acid transition state inhibitors (BATSIs) are competitive, reversible β-lactamase inhibitors (BLIs).  In this study, a series of BATSIs with selectively modified regions (R1, R2, and amide group) were strategically designed and tested against representative class A β-lactamases of Klebsiella pneumoniae, KPC-2 and SHV-1.  Firstly, the R1 group of compds. 1a to 1c and 2a to 2e mimicked the side chain of cephalothin, whereas for compds. 3a to 3c, 4a, and 4b, the thiophene ring was replaced by a Ph, typical of benzylpenicillin.  Secondly, variations in the R2 groups which included substituted aryl side chains (compds. 1a, 1b, 1c, 3a, 3b, and 3c) and triazole groups (compds. 2a to 2e) were chosen to mimic the thiazolidine and dihydrothiazine ring of penicillins and cephalosporins, resp.  Thirdly, the amide backbone of the BATSI, which corresponds to the amide at C-6 or C-7 of β-lactams, was also changed to the following bioisosteric groups: urea (compd. 3b), thiourea (compd. 3c), and sulfonamide (compds. 4a and 4b).  Among the compds. that inhibited KPC-2 and SHV-1 β-lactamases, nine possessed 50% inhibitory concns. (IC50s) of ≤ 600 nM.  The most active compds. contained the thiopheneacetyl group at R1 and for the chiral BATSIs, a carboxy- or hydroxy-substituted aryl group at R2.  The most active sulfonamido deriv., compd. 4b, lacked an R2 group.  Compd. 2b (S02030) was the most active, with acylation rates (k2/K) of 1.2 ± 0.2 ± 104 M-1 s-1 for KPC-2 and 4.7 ± 0.6 × 103 M-1 s-1 for SHV-1, and demonstrated antimicrobial activity against Escherichia coli DH10B carrying blaSHV variants and blaKPC-2 or blaKPC-2 and against clin. strains of Klebsiella pneumoniae and E. coli producing different class A β-lactamase genes.  At most, MICs decreased from 16 to 0.5 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHumxGp1lHkrVg90H21EOLACvtfcHk0lgsebKgA7SXjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O&md5=490342c29e85e45e3bd1875eff15c583</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.02641-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02641-15%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DM.%2BL.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DBoronic%2520acid%2520transition%2520state%2520inhibitors%2520active%2520against%2520KPC%2520and%2520other%2520class%2520A%2520%25CE%25B2-lactamases%253A%2520structure-activity%2520relationships%2520as%2520a%2520guide%2520to%2520inhibitor%2520design%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1751%26epage%3D1759%26doi%3D10.1128%2FAAC.02641-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celenza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span> <span> </span><span class="NLM_article-title">First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1007/s10822-018-0182-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2Fs10822-018-0182-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=30603820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVWlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=295-305&author=F.+Spyrakisauthor=P.+Bellioauthor=A.+Quotadamoauthor=P.+Lincianoauthor=P.+Benedettiauthor=G.+D%E2%80%99Arrigoauthor=M.+Baroniauthor=L.+Cendronauthor=G.+Celenzaauthor=D.+Tondi&title=First+virtual+screening+and+experimental+validation+of+inhibitors+targeting+GES-5+carbapenemase&doi=10.1007%2Fs10822-018-0182-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase</span></div><div class="casAuthors">Spyrakis, Francesca; Bellio, Pierangelo; Quotadamo, Antonio; Linciano, Pasquale; Benedetti, Paolo; D'Arrigo, Giulia; Baroni, Massimo; Cendron, Laura; Celenza, Giuseppe; Tondi, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-305</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The worldwide spread of beta-lactamases with hydrolytic activity extended to last resort carbapenems is aggravating the antibiotic resistance problem and endangers the successful antimicrobial treatment of clin. relevant pathogens.  As recently highlighted by the World Health Organization, new strategies to contain antimicrobial resistance are urgently needed.  Class A carbapenemases include members of the KPC, GES and SFC families.  These enzymes have the ability to hydrolyze penicillins, cephalosporins and carbapenems, while also being less susceptible to available beta-lactam inhibitors, such as clavulanic acid.  The KPC family is the most prevalent.  It is mostly found on plasmids in Klebsiella pneumoniae, meaning that great amts. of attention, in terms of inhibitor design and structural biol., have been dedicated to it, whereas no efforts have yet been dedicated to GES-type enzymes, despite their ability to rapidly and horizontally disseminate.  We herein report the first in silico screening against GES-5, which is the most dangerous GES-type beta-lactamase, using a library of 800K com. available candidates that all share drug-like properties, such as their MW, logP, rotatable bonds and HBA/HBD atoms.  The best screening results were filtered to enrich the no. of different chemotypes, and then submitted to mol. docking.  The 34 most promising candidates were selected for in vitro validation in biochem. assays against recombinant GES-5.  Six hits acted as inhibitors, in the high micromolar range, towards GES-5 and led to the identification of the first, novel chemotypes with inhibitory activity against this clin. relevant carbapenemase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzOD4NfjpS9rVg90H21EOLACvtfcHk0lgsebKgA7SXjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVWlurY%253D&md5=508eb4df044bbe7fbb7cb2afc9d6cada</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs10822-018-0182-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-018-0182-2%26sid%3Dliteratum%253Aachs%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DBellio%26aufirst%3DP.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DBenedetti%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DG.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DCelenza%26aufirst%3DG.%26aulast%3DTondi%26aufirst%3DD.%26atitle%3DFirst%2520virtual%2520screening%2520and%2520experimental%2520validation%2520of%2520inhibitors%2520targeting%2520GES-5%2520carbapenemase%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2019%26volume%3D33%26spage%3D295%26epage%3D305%26doi%3D10.1007%2Fs10822-018-0182-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilvawala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammarata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbelt, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">A new covalent inhibitor of class C β-lactamases reveals extended active site specificity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7375</span>– <span class="NLM_lpage">7384</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWitLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=7375-7384&author=R.+Tilvawalaauthor=M.+Cammarataauthor=S.+A.+Adediranauthor=J.+S.+Brodbeltauthor=R.+F.+Pratt&title=A+new+covalent+inhibitor+of+class+C+%CE%B2-lactamases+reveals+extended+active+site+specificity&doi=10.1021%2Facs.biochem.5b01149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A New Covalent Inhibitor of Class C β-Lactamases Reveals Extended Active Site Specificity</span></div><div class="casAuthors">Tilvawala, Ronak; Cammarata, Michael; Adediran, S. A.; Brodbelt, Jennifer S.; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">7375-7384</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">O-Aryloxycarbonyl hydroxamates have previously been shown to efficiently inactivate class C β-lactamases by crosslinking serine and lysine residues in the active site.  A new analog of these inhibitors, D-(R)-O-(phenoxycarbonyl)-N-[(4-amino-4-carboxy-1-butyl)oxycarbonyl]hydroxylamine, designed to inactivate certain low-mol. mass DD-peptidases, has now been synthesized.  Although the new mol. was found to be only a poor inactivator of the latter enzymes, it proved, unexpectedly, to be a very effective inactivator (ki = 3.5 × 104 M-1s-1) of class C β-lactamases, more so than the original lead compd., O-phenoxycarbonyl-N-(benzyloxycarbonyl)hydroxylamine.  Furthermore, the mechanism of inactivation is different.  Mass spectrometry demonstrated that β-lactamase inactivation by the new mol. involved formation of an O-alkoxycarbonylhydroxamate with the nucleophilic active site serine residue.  This acyl-enzyme did not cyclize to crosslink the active site as did that from the lead compd.  Model building suggested that the rapid enzyme acylation by the new mol. may occur because of favorable interaction between the polar terminus of its side chain and elements of the Ω loop that abuts the active site, Arg 204 in particular.  This interaction should be considered in the design of new covalent β-lactamase inhibitors.  The initially formed acyl-enzyme partitions (ratio of ∼1) between hydrolysis, which regenerates the active enzyme, and formation of an inert second acyl-enzyme.  Structural modeling suggests that the latter intermediate arises from conformational movement of the acyl group away from the reaction center, probably enforced by the inflexibility of the acyl group.  The new mol. is thus a mechanism-based inhibitor in which an inert complex is formed by noncovalent rearrangement.  Phosphyl analogs of the new mol. were efficient inactivators of neither DD-peptidases nor β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94QaIWIJdXrVg90H21EOLACvtfcHk0lgjnsEMwL031A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWitLfN&md5=7c003a3fdf68d5740b69110dfe4490d7</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01149%26sid%3Dliteratum%253Aachs%26aulast%3DTilvawala%26aufirst%3DR.%26aulast%3DCammarata%26aufirst%3DM.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DBrodbelt%26aufirst%3DJ.%2BS.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DA%2520new%2520covalent%2520inhibitor%2520of%2520class%2520C%2520%25CE%25B2-lactamases%2520reveals%2520extended%2520active%2520site%2520specificity%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D7375%26epage%3D7384%26doi%3D10.1021%2Facs.biochem.5b01149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyrouthy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2172</span>, <span class="refDoi"> DOI: 10.1021/jm2014138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ehtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2163-2172&author=D.+A.+Nicholsauthor=P.+Jaishankarauthor=W.+Larsonauthor=E.+Smithauthor=G.+Liuauthor=R.+Beyrouthyauthor=R.+Bonnetauthor=A.+R.+Rensloauthor=Y.+Chen&title=Structure-based+design+of+potent+and+ligand-efficient+inhibitors+of+CTX-M+class+A+%CE%B2-lactamase&doi=10.1021%2Fjm2014138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Ligand-Efficient Inhibitors of CTX-M Class A β-Lactamase</span></div><div class="casAuthors">Nichols, Derek A.; Jaishankar, Priyadarshini; Larson, Wayne; Smith, Emmanuel; Liu, Guoqing; Beyrouthy, Racha; Bonnet, Richard; Renslo, Adam R.; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of CTX-M class A extended-spectrum β-lactamases poses a serious health threat to the public.  We have applied structure-based design to improve the potency of a novel noncovalent tetrazole-contg. CTX-M inhibitor (Ki = 21 μM) more than 200-fold via structural modifications targeting two binding hot spots, a hydrophobic shelf formed by Pro167 and a polar site anchored by Asp240.  Functional groups contacting each binding hot spot independently in initial designs were later combined to produce analogs with submicromolar potencies, including 6-trifluoromethyl-3H-benzoimidazole-4-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide, which had a Ki value of 89 nM and reduced the MIC of cefotaxime by 64-fold in CTX-M-9 expressing Escherichia coli.  The in vitro potency gains were accompanied by improvements in ligand efficiency (from 0.30 to 0.39) and LipE (from 1.37 to 3.86).  These new analogs represent the first nM-affinity noncovalent inhibitors of a class A β-lactamase.  Their complex crystal structures provide valuable information about ligand binding for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG6waxyEIRbVg90H21EOLACvtfcHk0lgjnsEMwL031A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ehtL8%253D&md5=401edc1ac861781d1cd8f6fc33fd6a9b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm2014138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014138%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BA.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DLarson%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DBeyrouthy%26aufirst%3DR.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520ligand-efficient%2520inhibitors%2520of%2520CTX-M%2520class%2520A%2520%25CE%25B2-lactamase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2163%26epage%3D2172%26doi%3D10.1021%2Fjm2014138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFrees, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Antibacterial spectrum of a tetrazole-based reversible inhibitor of serine β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>, <span class="NLM_elocation-id">e02563-17</span> <span class="refDoi"> DOI: 10.1128/AAC.02563-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02563-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29844038" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&author=O.+A.+Pembertonauthor=X.+Zhangauthor=D.+A.+Nicholsauthor=K.+DeFreesauthor=P.+Jaishankarauthor=R.+Bonnetauthor=J.+Adamsauthor=L.+N.+Shawauthor=A.+R.+Rensloauthor=Y.+Chen&title=Antibacterial+spectrum+of+a+tetrazole-based+reversible+inhibitor+of+serine+%CE%B2-lactamases&doi=10.1128%2FAAC.02563-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.02563-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02563-17%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DNichols%26aufirst%3DD.%2BA.%26aulast%3DDeFrees%26aufirst%3DK.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DAntibacterial%2520spectrum%2520of%2520a%2520tetrazole-based%2520reversible%2520inhibitor%2520of%2520serine%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26doi%3D10.1128%2FAAC.02563-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1038/nchem.2110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnchem.2110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=25411887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1084-1090&author=J.+Bremauthor=S.+S.+van+Berkelauthor=W.+Aikauthor=A.+M.+Rydzikauthor=M.+B.+Avisonauthor=I.+Pettinatiauthor=K.+D.+Umlandauthor=A.+Kawamuraauthor=J.+Spencerauthor=T.+D.+Claridgeauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=Rhodanine+hydrolysis+leads+to+potent+thioenolate+mediated+metallo-%CE%B2-lactamase+inhibition&doi=10.1038%2Fnchem.2110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition</span></div><div class="casAuthors">Brem, Jurgen; van Berkel, Sander S.; Aik, WeiShen; Rydzik, Anna M.; Avison, Matthew B.; Pettinati, Ilaria; Umland, Klaus-Daniel; Kawamura, Akane; Spencer, James; Claridge, Timothy D. W.; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The use of β-lactam antibiotics is compromised by bacterial resistance, which is provided by β-lactamases belonging to both metallo (MBL)- and serine (SBL)-β-lactamase subfamilies.  The rhodanines are one of very few compd. classes that inhibit penicillin-binding proteins (PBPs), SBLs and, as recently reported, MBLs.  Here, we describe crystallog. analyses of the mechanism of inhibition of the clin. relevant VIM-2 MBL by a rhodanine, which reveal that the rhodanine ring undergoes hydrolysis to give a thioenolate.  The thioenolate is found to bind via di-zinc chelation, mimicking the binding of intermediates in β-lactam hydrolysis.  Crystn. of VIM-2 in the presence of the intact rhodanine led to observation of a ternary complex of MBL, a thioenolate fragment and rhodanine.  The crystallog. observations are supported by kinetic and biophys. studies, including 19F NMR analyses, which reveal the rhodanine-derived thioenolate to be a potent broad-spectrum MBL inhibitor and a lead structure for the development of new types of clin. useful MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNzcR63eD9MbVg90H21EOLACvtfcHk0lhsQ_hiv7tv6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rK&md5=8a8dae4e6ccb450a06c56d7d80f896b6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2110%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3Dvan%2BBerkel%26aufirst%3DS.%2BS.%26aulast%3DAik%26aufirst%3DW.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DUmland%26aufirst%3DK.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DRhodanine%2520hydrolysis%2520leads%2520to%2520potent%2520thioenolate%2520mediated%2520metallo-%25CE%25B2-lactamase%2520inhibition%26jtitle%3DNat.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1084%26epage%3D1090%26doi%3D10.1038%2Fnchem.2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundriyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6229</span>– <span class="NLM_lpage">6232</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.bmcl.2012.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22921080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6229-6232&author=P.+Chenauthor=L.+B.+Hortonauthor=R.+L.+Mikulskiauthor=L.+Dengauthor=S.+Sundriyalauthor=T.+Palzkillauthor=Y.+Song&title=2-Substituted+4%2C5-dihydrothiazole-4-carboxylic+acids+are+novel+inhibitors+of+metallo-%CE%B2-lactamases&doi=10.1016%2Fj.bmcl.2012.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases</span></div><div class="casAuthors">Chen, Pinhong; Horton, Lori B.; Mikulski, Rose L.; Deng, Lisheng; Sundriyal, Sandeep; Palzkill, Timothy; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6229-6232</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bacterial resistance to β-lactam antibiotics caused by class B metallo-β-lactamases (MBL), esp. for certain hospital-acquired, Gram-neg. pathogens, poses a significant threat to public health.  We report several 2-substituted 4,5-dihydrothiazole-4-carboxylic acids to be novel MBL inhibitors.  Structure activity relationship (SAR) and mol. modeling studies were performed and implications for further inhibitor design are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm8WBZDmczb7Vg90H21EOLACvtfcHk0li54_WVU5VVlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksL7O&md5=29b1ffedd227a81e8a05e99a186cb603</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHorton%26aufirst%3DL.%2BB.%26aulast%3DMikulski%26aufirst%3DR.%2BL.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSundriyal%26aufirst%3DS.%26aulast%3DPalzkill%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26atitle%3D2-Substituted%25204%252C5-dihydrothiazole-4-carboxylic%2520acids%2520are%2520novel%2520inhibitors%2520of%2520metallo-%25CE%25B2-lactamases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6229%26epage%3D6232%26doi%3D10.1016%2Fj.bmcl.2012.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span> <span> </span><span class="NLM_article-title">In silico fragment-based design identifies subfamily B1 metallo-β-lactamase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1255-1260&author=R.+Cainauthor=J.+Bremauthor=D.+Zollmanauthor=M.+A.+McDonoughauthor=R.+M.+Johnsonauthor=J.+Spencerauthor=A.+Makenaauthor=M.+I.+Abboudauthor=S.+Cahillauthor=S.+Y.+Leeauthor=P.+J.+McHughauthor=C.+J.+Schofieldauthor=C.+W.+G.+Fishwick&title=In+silico+fragment-based+design+identifies+subfamily+B1+metallo-%CE%B2-lactamase+inhibitors&doi=10.1021%2Facs.jmedchem.7b01728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors</span></div><div class="casAuthors">Cain, Ricky; Brem, Jurgen; Zollman, David; McDonough, Michael A.; Johnson, Rachel M.; Spencer, James; Makena, Anne; Abboud, Martine I.; Cahill, Samuel; Lee, Sook Y.; McHugh, Peter J.; Schofield, Christopher J.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1255-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Zinc ion-dependent β-lactamases (MBLs) catalyze the hydrolysis of almost all β-lactam antibiotics and resist the action of clin. available β-lactamase inhibitors.  We report how application of in silico fragment-based mol. design employing thiol-mediated metal anchorage leads to potent MBL inhibitors.  The new inhibitors manifest potent inhibition of clin. important B1 subfamily MBLs, including the widespread NDM-1, IMP-1, and VIM-2 enzymes; with lower potency, some of them also inhibit clin. relevant Class A and D serine-β-lactamases.  The inhibitors show selectivity for bacterial MBL enzymes compared to that for human MBL fold nucleases.  Cocrystn. of one inhibitor, which shows potentiation of Meropenem activity against MBL-expressing Enterobacteriaceae, with VIM-2 reveals an unexpected binding mode, involving interactions with residues from conserved active site bordering loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGrruTiqpfGLVg90H21EOLACvtfcHk0lgi0Fn0Vu91Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaks7jE&md5=1b7a800b3104ceb1217775417cb55aff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01728%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DR.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DZollman%26aufirst%3DD.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BM.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DMakena%26aufirst%3DA.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DMcHugh%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26atitle%3DIn%2520silico%2520fragment-based%2520design%2520identifies%2520subfamily%2520B1%2520metallo-%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1255%26epage%3D1260%26doi%3D10.1021%2Facs.jmedchem.7b01728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Castellanos, J.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5806</span>– <span class="NLM_lpage">5809</span>, <span class="refDoi"> DOI: 10.1039/C7CC02394D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC7CC02394D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28470248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslWrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=5806-5809&author=G.+B.+Liauthor=J.+Bremauthor=R.+Lesniakauthor=M.+I.+Abboudauthor=C.+T.+Lohansauthor=I.+J.+Cliftonauthor=S.+Y.+Yangauthor=J.%0AC.+Jimenez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=Crystallographic+analyses+of+isoquinoline+complexes+reveal+a+new+mode+of+metallo-%CE%B2-lactamase+inhibition&doi=10.1039%2FC7CC02394D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition</span></div><div class="casAuthors">Li, Guo-Bo; Brem, Jurgen; Lesniak, Robert; Abboud, Martine I.; Lohans, Christopher T.; Clifton, Ian J.; Yang, Sheng-Yong; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">5806-5809</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Crystallog. analyses of VIM-5 metallo-β-lactamase (MBL) with isoquinoline inhibitors reveal non-Zn2+ ion binding modes.  Comparison with other MBL-inhibitor structures directed addn. of a Zn2+-binding thiol enabling identification of potent B1 MBL inhibitors.  The inhibitors potentiated meropenem activity against clin. isolates harboring MBLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-V5jcoISU0rVg90H21EOLACvtfcHk0lgi0Fn0Vu91Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslWrsbY%253D&md5=ee793982b9b0e10270e44de82b574d91</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2FC7CC02394D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02394D%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DLesniak%26aufirst%3DR.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DJimenez-Castellanos%26aufirst%3DJ.%2BC.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCrystallographic%2520analyses%2520of%2520isoquinoline%2520complexes%2520reveal%2520a%2520new%2520mode%2520of%2520metallo-%25CE%25B2-lactamase%2520inhibition%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D5806%26epage%3D5809%26doi%3D10.1039%2FC7CC02394D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianquinto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span> <span> </span><span class="NLM_article-title">Ten years with New Delhi Metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKnurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=9-34&author=P.+Lincianoauthor=L.+Cendronauthor=E.+Gianquintoauthor=F.+Spyrakisauthor=D.+Tondi&title=Ten+years+with+New+Delhi+Metallo-%CE%B2-lactamase-1+%28NDM-1%29%3A+from+structural+insights+to+inhibitor+design&doi=10.1021%2Facsinfecdis.8b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design</span></div><div class="casAuthors">Linciano, Pasquale; Cendron, Laura; Gianquinto, Eleonora; Spyrakis, Francesca; Tondi, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-34</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized the past decade, endangering efficacious antibacterial treatments.  No inhibitors for NDM-1 are available in therapy, nor are promising compds. in the pipeline for future NDM-1 inhibitors.  We report the studies dedicated to the design and development of effective NDM-1 inhibitors.  The discussion for each agent moves from the employed design strategy to the ability of the identified inhibitor to synergize β-lactam antibiotics.  A structural anal. of NDM-1 mechanism of action based on selected X-ray complexes is also reported: the intrinsic flexibility of the binding site and the comparison between penicillin/cephalosporin and carbapenem mechanisms of hydrolysis are evaluated.  Despite the valuable progress in terms of structural and mechanistic information, the design of a potent NDM-1 inhibitor to be introduced in therapy remains challenging.  Certainly, only the deep knowledge of NDM-1 architecture and of the variable mechanism of action that NDM-1 employs against different classes of substrates could orient a successful drug discovery campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokXul9Vl3087Vg90H21EOLACvtfcHk0lh5AP3guL7ozw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKnurjK&md5=de0c4542ca7fd9755620caef244bf2aa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00247%26sid%3Dliteratum%253Aachs%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DGianquinto%26aufirst%3DE.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DTondi%26aufirst%3DD.%26atitle%3DTen%2520years%2520with%2520New%2520Delhi%2520Metallo-%25CE%25B2-lactamase-1%2520%2528NDM-1%2529%253A%2520from%2520structural%2520insights%2520to%2520inhibitor%2520design%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D9%26epage%3D34%26doi%3D10.1021%2Facsinfecdis.8b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibacache, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span> <span> </span><span class="NLM_article-title">Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17716</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-17399-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fs41598-017-17399-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29255163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC1MzivFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17716&author=M.+Santucciauthor=F.+Spyrakisauthor=S.+Crossauthor=A.+Quotadamoauthor=D.+Farinaauthor=D.+Tondiauthor=F.+De+Lucaauthor=J.+D.+Docquierauthor=A.+I.+Prietoauthor=C.+Ibacacheauthor=J.+Blazquezauthor=A.+Venturelliauthor=G.+Crucianiauthor=M.+P.+Costi&title=Computational+and+biological+profile+of+boronic+acids+for+the+detection+of+bacterial+serine-+and+metallo-%CE%B2-lactamases&doi=10.1038%2Fs41598-017-17399-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases</span></div><div class="casAuthors">Santucci Matteo; Spyrakis Francesca; Quotadamo Antonio; Farina Davide; Tondi Donatella; Venturelli Alberto; Costi Maria Paola; Spyrakis Francesca; Cross Simon; De Luca Filomena; Docquier Jean-Denis; Prieto Ana Isabel; Blazquez Jesus; Ibacache Claudia; Blazquez Jesus; Venturelli Alberto; Cruciani Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17716</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Lactamases (BLs) able to hydrolyze β-lactam antibiotics and more importantly the last resort carbapenems, represent a major mechanism of resistance in Gram-negative bacteria showing multi-drug or extensively drug resistant phenotypes.  The early detection of BLs responsible of resistant infections is challenging: approaches aiming at the identification of new BLs inhibitors (BLI) can thus serve as the basis for the development of highly needed diagnostic tools.  Starting from benzo-[b]-thiophene-2-boronic acid (BZB), a nanomolar inhibitor of AmpC β-lactamase (K i  = 27 nM), we have identified and characterized a set of BZB analogues able to inhibit clinically-relevant β-lactamases, including AmpC, Extended-Spectrum BLs (ESBL), KPC- and OXA-type carbapenemases and metallo-β-lactamases (MBL).  A multiligand set of boronic acid (BA) β-lactamase inhibitors was obtained using covalent molecular modeling, synthetic chemistry, enzyme kinetics and antibacterial susceptibility testing.  Data confirmed the possibility to discriminate between clinically-relevant β-lactamases on the basis of their inhibition profile.  Interestingly, this work also allowed the identification of potent KPC-2 and NDM-1 inhibitors able to potentiate the activity of cefotaxime (CTX) and ceftazidime (CAZ) against resistant clinical isolates (MIC reduction, 32-fold).  Our results open the way to the potential use of our set of compounds as a diagnostic tool for the sensitive detection of clinically-relevant β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH6MmIE8u3OvcsfMJQC1ZdfW6udTcc2eZHkNLHbZ_zqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzivFaruw%253D%253D&md5=8801f8e77467d45ce1808121ce0fa5d1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-17399-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-17399-7%26sid%3Dliteratum%253Aachs%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DCross%26aufirst%3DS.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DTondi%26aufirst%3DD.%26aulast%3DDe%2BLuca%26aufirst%3DF.%26aulast%3DDocquier%26aufirst%3DJ.%2BD.%26aulast%3DPrieto%26aufirst%3DA.%2BI.%26aulast%3DIbacache%26aufirst%3DC.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26atitle%3DComputational%2520and%2520biological%2520profile%2520of%2520boronic%2520acids%2520for%2520the%2520detection%2520of%2520bacterial%2520serine-%2520and%2520metallo-%25CE%25B2-lactamases%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D17716%26doi%3D10.1038%2Fs41598-017-17399-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gretes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrienko, G. I.</span></span> <span> </span><span class="NLM_article-title">Cyclobutanone analogues of β-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-β-lactamases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1021/ja9086374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9086374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=2558-2560&author=J.+W.+Johnsonauthor=M.+Gretesauthor=V.+J.+Goodfellowauthor=L.+Marroneauthor=M.+L.+Heynenauthor=N.+C.+Strynadkaauthor=G.+I.+Dmitrienko&title=Cyclobutanone+analogues+of+%CE%B2-lactams+revisited%3A+insights+into+conformational+requirements+for+inhibition+of+serine-+and+metallo-%CE%B2-lactamases&doi=10.1021%2Fja9086374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutanone analogues of β-lactams revisited: Insights into conformational requirements for inhibition of serine- and metallo-β-lactamases</span></div><div class="casAuthors">Johnson, Jarrod W.; Gretes, Michael; Goodfellow, Valerie J.; Marrone, Laura; Heynen, Miriam L.; Strynadka, Natalie C. J.; Dmitrienko, Gary I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2558-2560</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most important mode of bacterial resistance to β-lactam antibiotics is the expression of β-lactamases.  New cyclobutanone analogs of penams and penems have been prepd. and evaluated for inhibition of class A, B, C, and D β-lactamases.  Inhibitors which favor conformations in which the C4 carboxylate is equatorial were found to be more potent than those in which the carboxylate is axial, and mol. modeling studies with enzyme inhibitor complexes indicate that an equatorial orientation of the carboxylate is required for binding to β-lactamases.  An X-ray structure of OXA-10 complexed with a cyclobutanone confirms that a serine hemiketal is formed in the active site and that the inhibitor adopts the exo envelope.  An unsatd. penem analog was also found to enhance the potency of meropenem against carbapenem-resistant MBL-producing strains of Chryseobacterium meningosepticum and Stenotrophomonas maltophilia.  These cyclobutanones represent the first type of reversible inhibitors to show moderate (low micromolar) inhibition of both serine- and metallo-β-lactamases and should be considered for further development into practical inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqKuq7N7EiPbVg90H21EOLACvtfcHk0lj9STYjZ67a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslSiurc%253D&md5=5247e08059abf08178fd0c522adabd93</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja9086374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9086374%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DGretes%26aufirst%3DM.%26aulast%3DGoodfellow%26aufirst%3DV.%2BJ.%26aulast%3DMarrone%26aufirst%3DL.%26aulast%3DHeynen%26aufirst%3DM.%2BL.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DDmitrienko%26aufirst%3DG.%2BI.%26atitle%3DCyclobutanone%2520analogues%2520of%2520%25CE%25B2-lactams%2520revisited%253A%2520insights%2520into%2520conformational%2520requirements%2520for%2520inhibition%2520of%2520serine-%2520and%2520metallo-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D2558%26epage%3D2560%26doi%3D10.1021%2Fja9086374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutledge, P. J.</span></span> <span> </span><span class="NLM_article-title">Cyclobutanone analogues of β-lactam antibiotics: β-lactamase inhibitors with untapped potential?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fcbic.201600529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27992105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFGms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=338-351&author=P.+Deviauthor=P.+J.+Rutledge&title=Cyclobutanone+analogues+of+%CE%B2-lactam+antibiotics%3A+%CE%B2-lactamase+inhibitors+with+untapped+potential%3F&doi=10.1002%2Fcbic.201600529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?</span></div><div class="casAuthors">Devi, Prarthana; Rutledge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-351</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">β-Lactam antibiotics have been used for many years to treat bacterial infections.  However the effective treatment of an increasing range of microbial infections is threatened by bacterial resistance to β-lactams: the prolonged, widespread (and at times reckless) use of these drugs has spawned widespread resistance, which renders them ineffective against many bacterial strains.  The cyclobutanone ring system is isosteric with β-lactam: in cyclobutanone analogs, the eponymous cyclic amide is replaced with an all-carbon ring, the amide N is substituted by a tertiary C-H α to a ketone.  Cyclobutanone analogs of various β-lactam antibiotics have been investigated over the last 35 years, initially as prospective antibiotics in their own right and inhibitors of the β-lactamase enzymes that impart resistance to β-lactams.  More recently they have been tested as inhibitors of other serine proteases and as mechanistic probes of β-lactam biosynthesis.  Cyclobutanone analogs of the penam ring system are the first reversible inhibitors with moderate activity against all classes of β-lactamase; other compds. from this family inhibit Streptomyces R61 DD-carboxypeptidase/transpeptidase, human neutrophil elastase and porcine pancreatic elastase.  But has their potential as enzyme inhibitors been fully exploited.  Challenges in synthesizing diversely functionalized cyclobutanone derivs. mean that only a limited no. have been made (with limited structural diversity) and evaluated.  This review surveys the different synthetic approaches that have been taken to these compds., the investigations made to evaluate their biol. activity and prospects for future developments in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9NfgXFAxC7Vg90H21EOLACvtfcHk0lj9STYjZ67a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFGms7w%253D&md5=e8e299c02ced6c277771bc210bb6a0c0</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600529%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DP.%26aulast%3DRutledge%26aufirst%3DP.%2BJ.%26atitle%3DCyclobutanone%2520analogues%2520of%2520%25CE%25B2-lactam%2520antibiotics%253A%2520%25CE%25B2-lactamase%2520inhibitors%2520with%2520untapped%2520potential%253F%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D338%26epage%3D351%26doi%3D10.1002%2Fcbic.201600529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geibel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span> <span> </span><span class="NLM_article-title">1401. A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of single and repeat doses of VNRX-5133 in healthy subjects</span>. <i>Open Forum Infectious Diseases</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S431</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fofid%2Fofy210.1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S431&author=B.+Geibelauthor=J.+Dowellauthor=D.+Dickersonauthor=T.+Henkel&title=1401.+A+randomized%2C+double-blind%2C+placebo-controlled+study+of+the+safety+and+pharmacokinetics+of+single+and+repeat+doses+of+VNRX-5133+in+healthy+subjects&doi=10.1093%2Fofid%2Fofy210.1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1232%26sid%3Dliteratum%253Aachs%26aulast%3DGeibel%26aufirst%3DB.%26aulast%3DDowell%26aufirst%3DJ.%26aulast%3DDickerson%26aufirst%3DD.%26aulast%3DHenkel%26aufirst%3DT.%26atitle%3D1401.%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520single%2520and%2520repeat%2520doses%2520of%2520VNRX-5133%2520in%2520healthy%2520subjects%26jtitle%3DOpen%2520Forum%2520Infectious%2520Diseases%26date%3D2018%26volume%3D5%26spage%3DS431%26doi%3D10.1093%2Fofid%2Fofy210.1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of substrate recognition and product release by the <i>Klebsiella pneumoniae</i> Carbapenemase (KPC-2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00158</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00158" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3525-3530&author=O.+A.+Pembertonauthor=X.+Zhangauthor=Y.+Chen&title=Molecular+basis+of+substrate+recognition+and+product+release+by+the+Klebsiella+pneumoniae+Carbapenemase+%28KPC-2%29&doi=10.1021%2Facs.jmedchem.7b00158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span></div><div class="casAuthors">Pemberton, Orville A.; Zhang, Xiujun; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3525-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the prodn. of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase.  Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics contg. hydrolyzed cefotaxime and faropenem.  They provide exptl. insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity.  These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRxiGIa-agP7Vg90H21EOLACvtfcHk0lijOIAuKH9M_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D&md5=4ec87803561ad874f178f1345e9a3dda</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00158%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMolecular%2520basis%2520of%2520substrate%2520recognition%2520and%2520product%2520release%2520by%2520the%2520Klebsiella%2520pneumoniae%2520Carbapenemase%2520%2528KPC-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3525%26epage%3D3530%26doi%3D10.1021%2Facs.jmedchem.7b00158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the inhibition of CTX-M-9 by β-lactamase inhibitors and carbapenems</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3465</span>– <span class="NLM_lpage">3475</span>, <span class="refDoi"> DOI: 10.1128/AAC.00089-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00089-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21555770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=3465-3475&author=C.+R.+Bethelauthor=M.+Taracilaauthor=T.+Shyrauthor=J.+M.+Thomsonauthor=A.+M.+Distlerauthor=K.+M.+Hujerauthor=A.+M.+Hujerauthor=A.+Endimianiauthor=K.+Papp-Wallaceauthor=R.+Bonnetauthor=R.+A.+Bonomo&title=Exploring+the+inhibition+of+CTX-M-9+by+%CE%B2-lactamase+inhibitors+and+carbapenems&doi=10.1128%2FAAC.00089-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the inhibition of CTX-M-9 by β-lactamase inhibitors and carbapenems</span></div><div class="casAuthors">Bethel, Christopher R.; Taracila, Magdalena; Shyr, Teresa; Thomson, Jodi M.; Distler, Anne M.; Hujer, Kristine M.; Hujer, Andrea M.; Endimiani, Andrea; Papp-Wallace, Krisztina; Bonnet, Richard; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3465-3475</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Currently, CTX-M β-lactamases are among the most prevalent and most heterogeneous extended-spectrum β-lactamases (ESBLs).  In general, CTX-M enzymes are susceptible to inhibition by β-lactamase inhibitors.  However, it is unknown if the pathway to inhibition by β-lactamase inhibitors for CTX-M ESBLs is similar to TEM and SHV β-lactamases and why bacteria possessing only CTX-M ESBLs are so susceptible to carbapenems.  Here, we have performed a kinetic anal. and timed electrospray ionization mass spectrometry (ESI-MS) studies to reveal the intermediates of inhibition of CTX-M-9, an ESBL representative of this family of enzymes.  CTX-M-9 β-lactamase was inactivated by sulbactam, tazobactam, clavulanate, meropenem, doripenem, ertapenem, and a 6-methylidene penem, penem 1.  Ki values ranged from 1.6 ± 0.3 μM (mean ± std. error) for tazobactam to 0.02 ± 0.01 μM for penem 1.  Before and after tryptic digestion of the CTX-M-9 β-lactamase apo-enzyme and CTX-M-9 inactivation by inhibitors (meropenem, clavulanate, sulbactam, tazobactam, and penem 1), ESI-MS and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) identified different adducts attached to the peptide contg. the active site Ser70 (+52, 70, 88, and 156 ± 3 amu).  This study shows that a multistep inhibition pathway results from modification or fragmentation with clavulanate, sulbactam, and tazobactam, while a single acyl enzyme intermediate is detected when meropenem and penem 1 inactivate CTX-M-9 β-lactamase.  More generally, we propose that Arg276 in CTX-M-9 plays an essential role in the recognition of the C3 carboxylate of inhibitors and that the localization of this pos. charge to a "region of the active site" rather than a specific residue represents an important evolutionary strategy used by β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjoVQ_gJpbkrVg90H21EOLACvtfcHk0liMHj9kQJaUDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OrtLY%253D&md5=c58179b2f00181bd04e2b5fe202f8a3d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1128%2FAAC.00089-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00089-11%26sid%3Dliteratum%253Aachs%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DTaracila%26aufirst%3DM.%26aulast%3DShyr%26aufirst%3DT.%26aulast%3DThomson%26aufirst%3DJ.%2BM.%26aulast%3DDistler%26aufirst%3DA.%2BM.%26aulast%3DHujer%26aufirst%3DK.%2BM.%26aulast%3DHujer%26aufirst%3DA.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520inhibition%2520of%2520CTX-M-9%2520by%2520%25CE%25B2-lactamase%2520inhibitors%2520and%2520carbapenems%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D3465%26epage%3D3475%26doi%3D10.1128%2FAAC.00089-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomanicek, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrader, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, L.</span></span> <span> </span><span class="NLM_article-title">Neutron and X-ray crystal structures of a perdeuterated enzyme inhibitor complex reveal the catalytic proton network of the Toho-1 β-lactamase for the acylation reaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">4715</span>– <span class="NLM_lpage">4722</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.436238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1074%2Fjbc.M112.436238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23255594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=4715-4722&author=S.+J.+Tomanicekauthor=R.+F.+Standaertauthor=K.+L.+Weissauthor=A.+Ostermannauthor=T.+E.+Schraderauthor=J.+D.+Ngauthor=L.+Coates&title=Neutron+and+X-ray+crystal+structures+of+a+perdeuterated+enzyme+inhibitor+complex+reveal+the+catalytic+proton+network+of+the+Toho-1+%CE%B2-lactamase+for+the+acylation+reaction&doi=10.1074%2Fjbc.M112.436238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Neutron and X-ray Crystal Structures of a Perdeuterated Enzyme Inhibitor Complex Reveal the Catalytic Proton Network of the Toho-1 β-Lactamase for the Acylation Reaction</span></div><div class="casAuthors">Tomanicek, Stephen J.; Standaert, Robert F.; Weiss, Kevin L.; Ostermann, Andreas; Schrader, Tobias E.; Ng, Joseph D.; Coates, Leighton</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4715-4722</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism by which class A β-lactamases hydrolyze β-lactam antibiotics has been the subject of intensive investigation using many different exptl. techniques.  Here, we report on the novel use of both neutron and high resoln. x-ray diffraction to help elucidate the identity of the catalytic base in the acylation part of the catalytic cycle, wherein the β-lactam ring is opened and an acyl-enzyme intermediate forms.  To generate protein crystals optimized for neutron diffraction, we produced a perdeuterated form of the Toho-1 β-lactamase R274N/R276N mutant.  Protein perdeuteration, which involves replacing all of the hydrogen atoms in a protein with deuterium, gives a much stronger signal in neutron diffraction and enables the positions of individual deuterium atoms to be located.  We also synthesized a perdeuterated acylation transition state analog, benzothiophene-2-boronic acid, which was also isotopically enriched with 11B, as 10B is a known neutron absorber.  Using the neutron diffraction data from the perdeuterated enzyme-inhibitor complex, we were able to det. the positions of deuterium atoms in the active site directly rather than by inference.  The neutron diffraction results, along with supporting bond-length anal. from high resoln. x-ray diffraction, strongly suggest that Glu-166 acts as the general base during the acylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1N46HO6A-bVg90H21EOLACvtfcHk0liMHj9kQJaUDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLc%253D&md5=7788933f2cc2194f7aa701272df7c5f7</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.436238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.436238%26sid%3Dliteratum%253Aachs%26aulast%3DTomanicek%26aufirst%3DS.%2BJ.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DWeiss%26aufirst%3DK.%2BL.%26aulast%3DOstermann%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BE.%26aulast%3DNg%26aufirst%3DJ.%2BD.%26aulast%3DCoates%26aufirst%3DL.%26atitle%3DNeutron%2520and%2520X-ray%2520crystal%2520structures%2520of%2520a%2520perdeuterated%2520enzyme%2520inhibitor%2520complex%2520reveal%2520the%2520catalytic%2520proton%2520network%2520of%2520the%2520Toho-1%2520%25CE%25B2-lactamase%2520for%2520the%2520acylation%2520reaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D4715%26epage%3D4722%26doi%3D10.1074%2Fjbc.M112.436238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, J. D.</span></span> <span> </span><span class="NLM_article-title">Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and <i>Pseudomonas aeruginosa</i> AmpC β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2496</span>– <span class="NLM_lpage">2505</span>, <span class="refDoi"> DOI: 10.1128/AAC.02247-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02247-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23439634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2496-2505&author=S.+D.+Lahiriauthor=S.+Manganiauthor=T.+Durand-Revilleauthor=M.+Benvenutiauthor=F.+De+Lucaauthor=G.+Sanyalauthor=J.+D.+Docquier&title=Structural+insight+into+potent+broad-spectrum+inhibition+with+reversible+recyclization+mechanism%3A+avibactam+in+complex+with+CTX-M-15+and+Pseudomonas+aeruginosa+AmpC+%CE%B2-lactamases&doi=10.1128%2FAAC.02247-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases</span></div><div class="casAuthors">Lahiri, Sushmita D.; Mangani, Stefano; Durand-Reville, Thomas; Benvenuti, Manuela; De Luca, Filomena; Sanyal, Gautam; Docquier, Jean-Denis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2496-2505</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Although β-lactams have been the most effective class of antibacterial agents used in clin. practice for the past half century, their effectiveness on Gram-neg. bacteria has been eroded due to the emergence and spread of β-lactamase enzymes that are not affected by currently marketed β-lactam/β-lactamase inhibitor combinations.  Avibactam is a novel, covalent, non-β-lactam β-lactamase inhibitor presently in clin. development in combination with either ceftaroline or ceftazidime.  In vitro studies show that avibactam may restore the broad-spectrum activity of cephalosporins against class A, class C, and some class D β-lactamases.  Here we describe the structures of two clin. important β-lactamase enzymes bound to avibactam, the class A CTX-M-15 extended-spectrum β-lactamase and the class C Pseudomonas aeruginosa AmpC β-lactamase, which together provide insight into the binding modes for the resp. enzyme classes.  The structures reveal similar binding modes in both enzymes and thus provide a rationale for the broad-spectrum inhibitory activity of avibactam.  Identification of the key residues surrounding the binding pocket allows for a better understanding of the potency of this scaffold.  Finally, avibactam has recently been shown to be a reversible inhibitor, and the structures provide insights into the mechanism of avibactam recyclization.  Anal. of the ultra-high-resoln. CTX-M-15 structure suggests how the deacylation mechanism favors recyclization over hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBwwMi5MIpF7Vg90H21EOLACvtfcHk0lg4nPSE1on8sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslyrsrY%253D&md5=c8a5fa5871f2b5d9efc78b6c4c5d7742</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1128%2FAAC.02247-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02247-12%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DMangani%26aufirst%3DS.%26aulast%3DDurand-Reville%26aufirst%3DT.%26aulast%3DBenvenuti%26aufirst%3DM.%26aulast%3DDe%2BLuca%26aufirst%3DF.%26aulast%3DSanyal%26aufirst%3DG.%26aulast%3DDocquier%26aufirst%3DJ.%2BD.%26atitle%3DStructural%2520insight%2520into%2520potent%2520broad-spectrum%2520inhibition%2520with%2520reversible%2520recyclization%2520mechanism%253A%2520avibactam%2520in%2520complex%2520with%2520CTX-M-15%2520and%2520Pseudomonas%2520aeruginosa%2520AmpC%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2496%26epage%3D2505%26doi%3D10.1128%2FAAC.02247-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub><i>I</i></sub>) and the concentration of inhibitor which causes 50 percent inhibition (<i>I</i><sub><i>50</i></sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50+percent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgncCEqrQs8Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520percent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mysinger, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colizzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wassam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span> <span> </span><span class="NLM_article-title">Automated docking screens: a feasibility study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5712</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1021/jm9006966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5712-5720&author=J.+J.+Irwinauthor=B.+K.+Shoichetauthor=M.+M.+Mysingerauthor=N.+Huangauthor=F.+Colizziauthor=P.+Wassamauthor=Y.+Cao&title=Automated+docking+screens%3A+a+feasibility+study&doi=10.1021%2Fjm9006966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Docking Screens: A Feasibility Study</span></div><div class="casAuthors">Irwin, John J.; Shoichet, Brian K.; Mysinger, Michael M.; Huang, Niu; Colizzi, Francesco; Wassam, Pascal; Cao, Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5712-5720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. docking is the most practical approach to leverage protein structure for ligand discovery, but the technique retains important liabilities that make it challenging to deploy on a large scale.  We have therefore created an expert system, DOCK Blaster, to investigate the feasibility of full automation.  The method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full screen of large libraries.  A crit. feature is self-assessment, which ests. the anticipated reliability of the automated screening results using pose fidelity and enrichment.  Against common benchmarks, DOCK Blaster recapitulates the crystal ligand pose within 2 Å rmsd 50-60% of the time; inferior to an expert, but respectable.  Half the time the ligand also ranked among the top 5% of 100 phys. matched decoys chosen on the fly.  Further tests were undertaken culminating in a study of 7755 eligible PDB structures.  In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched decoys while also posing within 2 Å rmsd, suggesting that unsupervised prospective docking is viable.  DOCK Blaster is available at http://blaster.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPZAd6CrHGp7Vg90H21EOLACvtfcHk0licBgnNxX_KAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN&md5=f302db1f77b87f26d1fa2fece55bca96</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm9006966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006966%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DMysinger%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DWassam%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DY.%26atitle%3DAutomated%2520docking%2520screens%253A%2520a%2520feasibility%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5712%26epage%3D5720%26doi%3D10.1021%2Fjm9006966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorber, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Protein-protein docking with multiple residue conformations and residue substitutions</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1408</span>, <span class="refDoi"> DOI: 10.1110/ps.2830102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1110%2Fps.2830102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=12021438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1393-1408&author=D.+M.+Lorberauthor=M.+K.+Udoauthor=B.+K.+Shoichet&title=Protein-protein+docking+with+multiple+residue+conformations+and+residue+substitutions&doi=10.1110%2Fps.2830102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein docking with multiple residue conformations and residue substitutions</span></div><div class="casAuthors">Lorber, David M.; Udo, Maria K.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1393-1408</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The protein docking problem has two major aspects: sampling conformations and orientations, and scoring them for fit.  To investigate the extent to which the protein docking problem may be attributed to the sampling of ligand side-chain conformations, multiple conformations of multiple residues were calcd. for the uncomplexed (unbound) structures of protein ligands.  These ligand conformations were docked into both the complexed (bound) and unbound conformations of the cognate receptors, and their energies were evaluated using an atomistic potential function.  The following questions were considered: (1) does the ensemble of precalcd. ligand conformations contain a structure similar to the bound form of the ligand (2) Can the large no. of conformations that are calcd. be efficiently docked into the receptors (3) Can near-native complexes be distinguished from non-native complexes Results from seven test systems suggest that the precalcd. ensembles do include side-chain conformations similar to those adopted in the exptl. complexes.  By assuming additivity among the side chains, the ensemble can be docked in less than 12 h on a desktop computer.  These multiconformer dockings produce near-native complexes and also non-native complexes.  When docked against the bound conformations of the receptors, the near-native complexes of the unbound ligand were always distinguishable from the non-native complexes.  When docked against the unbound conformations of the receptors, the near-native dockings could usually, but not always, be distinguished from the non-native complexes.  In every case, docking the unbound ligands with flexible side chains led to better energies and a better distinction between near-native and non-native fits.  An extension of this algorithm allowed for docking multiple residue substitutions (mutants) in addn. to multiple conformations.  The rankings of the docked mutant proteins correlated with exptl. binding affinities.  These results suggest that sampling multiple residue conformations and residue substitutions of the unbound ligand contributes to, but does not fully provide, a soln. to the protein docking problem.  Conformational sampling allows a classical atomistic scoring function to be used; such a function may contribute to better selectivity between near-native and non-native complexes.  Allowing for receptor flexibility may further extend these results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBFjIchqgD47Vg90H21EOLACvtfcHk0lgNzW_7oI2oSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFWgsr8%253D&md5=aacce8d982110403befeeb033d4557c2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1110%2Fps.2830102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.2830102%26sid%3Dliteratum%253Aachs%26aulast%3DLorber%26aufirst%3DD.%2BM.%26aulast%3DUdo%26aufirst%3DM.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DProtein-protein%2520docking%2520with%2520multiple%2520residue%2520conformations%2520and%2520residue%2520substitutions%26jtitle%3DProtein%2520Sci.%26date%3D2002%26volume%3D11%26spage%3D1393%26epage%3D1408%26doi%3D10.1110%2Fps.2830102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span> <span> </span><span class="NLM_article-title">iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&author=T.%0AG.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+Leslie&title=iMOSFLM%3A+a+new+graphical+interface+for+diffraction-image+processing+with+MOSFLM&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0lgNzW_7oI2oSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26atitle%3DiMOSFLM%253A%2520a%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520MOSFLM%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0liFj2LN8EajPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liFj2LN8EajPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhl1FNNRJ5vPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0liz3KVgEDIxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0liz3KVgEDIxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh4vznE9VfJkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span> <span> </span><span class="NLM_article-title">Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1107/S0907444908004319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444908004319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=18453687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlagt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=515-524&author=T.+C.+Terwilligerauthor=R.+W.+Grosse-Kunstleveauthor=P.+V.+Afonineauthor=N.+W.+Moriartyauthor=P.+D.+Adamsauthor=R.+J.+Readauthor=P.+H.+Zwartauthor=L.+W.+Hung&title=Iterative-build+OMIT+maps%3A+map+improvement+by+iterative+model+building+and+refinement+without+model+bias&doi=10.1107%2FS0907444908004319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias</span></div><div class="casAuthors">Terwilliger, Thomas C.; Grosse-Kunstleve, Ralf W.; Afonine, Pavel V.; Moriarty, Nigel W.; Adams, Paul D.; Read, Randy J.; Zwart, Peter H.; Hung, Li Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">515-524</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A procedure for carrying out iterative model building, d. modification and refinement is presented in which the d. in an OMIT region is essentially unbiased by an at. model.  D. from a set of overlapping OMIT regions can be combined to create a composite 'iterative-build' OMIT map that is everywhere unbiased by an at. model but also everywhere benefiting from the model-based information present elsewhere in the unit cell.  The procedure may have applications in the validation of specific features in at. models as well as in overall model validation.  The procedure is demonstrated with a mol.-replacement structure and with an exptl. phased structure and a variation on the method is demonstrated by removing model bias from a structure from the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Xrehe6KWKLVg90H21EOLACvtfcHk0lh4vznE9VfJkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlagt78%253D&md5=fdb2b503063ca565775d5d9c51aed5e5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1107%2FS0907444908004319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908004319%26sid%3Dliteratum%253Aachs%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DHung%26aufirst%3DL.%2BW.%26atitle%3DIterative-build%2520OMIT%2520maps%253A%2520map%2520improvement%2520by%2520iterative%2520model%2520building%2520and%2520refinement%2520without%2520model%2520bias%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D515%26epage%3D524%26doi%3D10.1107%2FS0907444908004319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lg0XtHxNw9aFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eZUS9Nb01aEj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, M. J.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial susceptibility testing: a review of general principles and contemporary practices</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1086/647952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1086%2F647952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19857164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sjt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1749-1755&author=J.+H.+Jorgensenauthor=M.+J.+Ferraro&title=Antimicrobial+susceptibility+testing%3A+a+review+of+general+principles+and+contemporary+practices&doi=10.1086%2F647952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial susceptibility testing: a review of general principles and contemporary practices</span></div><div class="casAuthors">Jorgensen, James H.; Ferraro, Mary Jane</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1749-1755</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  An important task of the clin. microbiol. lab. is the performance of antimicrobial susceptibility testing of significant bacterial isolates.  The goals of testing are to detect possible drug resistance in common pathogens and to assure susceptibility to drugs of choice for particular infections.  The most widely used testing methods include broth microdilution or rapid automated instrument methods that use com. marketed materials and devices.  Manual methods that provide flexibility and possible cost savings include the disk diffusion and gradient diffusion methods.  Each method has strengths and weaknesses, including organisms that may be accurately tested by the method.  Some methods provide quant. results (eg, min. inhibitory concn.), and all provide qual. assessments using the categories susceptible, intermediate, or resistant.  In general, current testing methods provide accurate detection of common antimicrobial resistance mechanisms.  However, newer or emerging mechanisms of resistance require const. vigilance regarding the ability of each test method to accurately detect resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowA9YEcYMoYLVg90H21EOLACvtfcHk0lhyUN8cBrfUPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sjt7fI&md5=8a4a78feca6b9fe7140805044fd50ccf</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1086%2F647952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F647952%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BH.%26aulast%3DFerraro%26aufirst%3DM.%2BJ.%26atitle%3DAntimicrobial%2520susceptibility%2520testing%253A%2520a%2520review%2520of%2520general%2520principles%2520and%2520contemporary%2520practices%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D49%26spage%3D1749%26epage%3D1755%26doi%3D10.1086%2F647952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleeman, R.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debevec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welmaker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghten, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giulianotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel polyamine scaffold with potent efflux pump inhibition activity toward multi-drug resistant bacterial pathogens</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1301</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.01301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.3389%2Ffmicb.2018.01301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29963035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1301&author=R.%0AM.+Fleemanauthor=G.+Debevecauthor=K.+Antonenauthor=J.+L.+Adamsauthor=R.+G.+Santosauthor=G.+S.+Welmakerauthor=R.+A.+Houghtenauthor=M.+A.+Giulianottiauthor=L.+N.+Shaw&title=Identification+of+a+novel+polyamine+scaffold+with+potent+efflux+pump+inhibition+activity+toward+multi-drug+resistant+bacterial+pathogens&doi=10.3389%2Ffmicb.2018.01301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens</span></div><div class="casAuthors">Fleeman Renee M; Antonen Kirsten; Adams Jessie L; Shaw Lindsey N; Debevec Ginamarie; Santos Radleigh G; Welmaker Gregory S; Houghten Richard A; Giulianotti Marc A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1301</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">We have previously reported the use of combinatorial chemistry to identify broad-spectrum antibacterial agents.  Herein, we extend our analysis of this technology toward the discovery of anti-resistance molecules, focusing on efflux pump inhibitors.  Using high-throughput screening against multi-drug resistant Pseudomonas aeruginosa, we identified a polyamine scaffold that demonstrated strong efflux pump inhibition without possessing antibacterial effects.  We determined that these molecules were most effective with an amine functionality at R1 and benzene functionalities at R2 and R3.  From a library of 188 compounds, we studied the properties of 5 lead agents in detail, observing a fivefold to eightfold decrease in the 90% effective concentration of tetracycline, chloramphenicol, and aztreonam toward P. aeruginosa isolates.  Additionally, we determined that our molecules were not only active toward P. aeruginosa, but toward Acinetobacter baumannii and Staphylococcus aureus as well.  The specificity of our molecules to efflux pump inhibition was confirmed using ethidium bromide accumulation assays, and in studies with strains that displayed varying abilities in their efflux potential.  When assessing off target effects we observed no disruption of bacterial membrane polarity, no general toxicity toward mammalian cells, and no inhibition of calcium channel activity in human kidney cells.  Finally, combination treatment with our lead agents engendered a marked increase in the bactericidal capacity of tetracycline, and significantly decreased viability within P. aeruginosa biofilms.  As such, we report a unique polyamine scaffold that has strong potential for the future development of novel and broadly active efflux pump inhibitors targeting multi-drug resistant bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfwniovcBepP_I8Jvzw4xCfW6udTcc2eZVGpzSoMbcAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjvVequg%253D%253D&md5=5ffeac572333ace791f89a430ceb27a4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.01301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.01301%26sid%3Dliteratum%253Aachs%26aulast%3DFleeman%26aufirst%3DR.%2BM.%26aulast%3DDebevec%26aufirst%3DG.%26aulast%3DAntonen%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DSantos%26aufirst%3DR.%2BG.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26atitle%3DIdentification%2520of%2520a%2520novel%2520polyamine%2520scaffold%2520with%2520potent%2520efflux%2520pump%2520inhibition%2520activity%2520toward%2520multi-drug%2520resistant%2520bacterial%2520pathogens%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1301%26doi%3D10.3389%2Ffmicb.2018.01301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Guillermo Bahr, Lisandro J. González, <span class="NLM_string-name hlFld-ContribAuthor">Alejandro J. Vila</span>. </span><span class="cited-content_cbyCitation_article-title">Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (13)
                                     , 7957-8094. <a href="https://doi.org/10.1021/acs.chemrev.1c00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.1c00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.1c00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.1c00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMetallo-%2525CE%2525B2-lactamases%252Bin%252Bthe%252BAge%252Bof%252BMultidrug%252BResistance%25253A%252BFrom%252BStructure%252Band%252BMechanism%252Bto%252BEvolution%25252C%252BDissemination%25252C%252Band%252BInhibitor%252BDesign%26aulast%3DBahr%26aufirst%3DGuillermo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D15062021%26volume%3D121%26issue%3D13%26spage%3D7957%26epage%3D8094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya, David C. Griffith, Debora Rubio-Aparicio, Kirk Nelson, Ruslan Tsivkovski, Dongxu Sun, Mojgan Sabet, Ziad Tarazi, Jonathan Parkinson, Maxim Totrov, Serge H. Boyer, Tomasz W. Glinka, Orville A. Pemberton, Yu Chen, <span class="NLM_string-name hlFld-ContribAuthor">Michael N. Dudley</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7491-7507. <a href="https://doi.org/10.1021/acs.jmedchem.9b01976" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01976%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCyclic%252BBoronic%252BAcid%252BQPX7728%25252C%252Ban%252BUltrabroad-Spectrum%252BInhibitor%252Bof%252BSerine%252Band%252BMetallo-%2525CE%2525B2-lactamases%26aulast%3DHecker%26aufirst%3DScott%2BJ.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27112019%26date%3D02042020%26date%3D09032020%26volume%3D63%26issue%3D14%26spage%3D7491%26epage%3D7507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kamaleddin H. M. E. Tehrani, Nora C. Brüchle, Nicola Wade, Vida Mashayekhi, Diego Pesce, Matthijs J. van Haren, <span class="NLM_string-name hlFld-ContribAuthor">Nathaniel I. Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (6)
                                     , 1366-1371. <a href="https://doi.org/10.1021/acsinfecdis.9b00459" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00459%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DSmall%252BMolecule%252BCarboxylates%252BInhibit%252BMetallo-%2525CE%2525B2-lactamases%252Band%252BResensitize%252BCarbapenem-Resistant%252BBacteria%252Bto%252BMeropenem%26aulast%3DTehrani%26aufirst%3DKamaleddin%2BH.%2BM.%2BE.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25112019%26date%3D03042020%26date%3D31032020%26volume%3D6%26issue%3D6%26spage%3D1366%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yonglin Zhou, Yan Guo, Xiaodi Sun, Rui Ding, Yanling Wang, Xiaodi Niu, Jianfeng Wang, <span class="NLM_string-name hlFld-ContribAuthor">Xuming Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Oleanolic Acid and Its Analogues in Combating Pathogenic Bacteria In Vitro/Vivo by a Two-Pronged Strategy of β-Lactamases and Hemolysins. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (20)
                                     , 11424-11438. <a href="https://doi.org/10.1021/acsomega.0c00460" title="DOI URL">https://doi.org/10.1021/acsomega.0c00460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c00460%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DApplication%252Bof%252BOleanolic%252BAcid%252Band%252BIts%252BAnalogues%252Bin%252BCombating%252BPathogenic%252BBacteria%252BIn%252BVitro%25252FVivo%252Bby%252Ba%252BTwo-Pronged%252BStrategy%252Bof%252B%2525CE%2525B2-Lactamases%252Band%252BHemolysins%26aulast%3DZhou%26aufirst%3DYonglin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01022020%26date%3D30042020%26date%3D12052020%26volume%3D5%26issue%3D20%26spage%3D11424%26epage%3D11438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugénie  Romero</span>, <span class="hlFld-ContribAuthor ">Saoussen  Oueslati</span>, <span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Agathe C.A.  D’Hollander</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ventre</span>, <span class="hlFld-ContribAuthor ">Kamsana  Vijayakumar</span>, <span class="hlFld-ContribAuthor ">Corinne  Minard</span>, <span class="hlFld-ContribAuthor ">Cynthia  Exilie</span>, <span class="hlFld-ContribAuthor ">Linda  Tlili</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Agustin  Zavala</span>, <span class="hlFld-ContribAuthor ">Eddy  Elisée</span>, <span class="hlFld-ContribAuthor ">Edithe  Selwa</span>, <span class="hlFld-ContribAuthor ">Laetitia A.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Alain  Pruvost</span>, <span class="hlFld-ContribAuthor ">Thierry  Naas</span>, <span class="hlFld-ContribAuthor ">Bogdan I.  Iorga</span>, <span class="hlFld-ContribAuthor ">Robert H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Kevin  Cariou</span>. </span><span class="cited-content_cbyCitation_article-title">Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113418. <a href="https://doi.org/10.1016/j.ejmech.2021.113418" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113418%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAzetidinimines%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252Bnon-covalent%252Bbroad-spectrum%252Binhibitors%252Bof%252B%2525CE%2525B2-lactamases%252Bwith%252Bsubmicromolar%252Bactivities%252Bagainst%252Bcarbapenemases%252BKPC-2%252B%252528class%252BA%252529%25252C%252BNDM-1%252B%252528class%252BB%252529%252Band%252BOXA-48%252B%252528class%252BD%252529%26aulast%3DRomero%26aufirst%3DEug%25C3%25A9nie%26date%3D2021%26volume%3D219%26spage%3D113418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Sofia F.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Giovanni  Ciccotti</span>, <span class="hlFld-ContribAuthor ">Shozeb  Haider</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mulholland</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamical nonequilibrium molecular dynamics reveals the structural basis for allostery and signal propagation in biomolecular systems. </span><span class="cited-content_cbyCitation_journal-name">The European Physical Journal B</span><span> <strong>2021,</strong> <em>94 </em>
                                    (7)
                                     <a href="https://doi.org/10.1140/epjb/s10051-021-00157-0" title="DOI URL">https://doi.org/10.1140/epjb/s10051-021-00157-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1140/epjb/s10051-021-00157-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1140%2Fepjb%2Fs10051-021-00157-0%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520European%2520Physical%2520Journal%2520B%26atitle%3DDynamical%252Bnonequilibrium%252Bmolecular%252Bdynamics%252Breveals%252Bthe%252Bstructural%252Bbasis%252Bfor%252Ballostery%252Band%252Bsignal%252Bpropagation%252Bin%252Bbiomolecular%252Bsystems%26aulast%3DOliveira%26aufirst%3DA.%2BSofia%2BF.%26date%3D2021%26date%3D2021%26volume%3D94%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian A.  Testero</span>, <span class="hlFld-ContribAuthor ">Leticia I.  Llarrull</span>, <span class="hlFld-ContribAuthor ">Jed F.  Fisher</span>, <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of β‐Lactam Antibiotics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-188. <a href="https://doi.org/10.1002/0471266949.bmc226.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc226.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc226.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc226.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Lactam%252BAntibiotics%26aulast%3DTestero%26aufirst%3DSebastian%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D188%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fátima C.  Teixeira</span>, <span class="hlFld-ContribAuthor ">Carla  Lucas</span>, <span class="hlFld-ContribAuthor ">M. João M.  Curto</span>, <span class="hlFld-ContribAuthor ">Vânia  André</span>, <span class="hlFld-ContribAuthor ">M. Teresa  Duarte</span>, <span class="hlFld-ContribAuthor ">António P. S.  Teixeira</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel pyrazolo[3,4-
              b
              ]quinolinebisphosphonic acids and an unexpected intramolecular cyclization and phosphonylation reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (11)
                                     , 2533-2545. <a href="https://doi.org/10.1039/D1OB00025J" title="DOI URL">https://doi.org/10.1039/D1OB00025J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00025J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00025J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252Bpyrazolo%25255B3%25252C4-%252Bb%252B%25255Dquinolinebisphosphonic%252Bacids%252Band%252Ban%252Bunexpected%252Bintramolecular%252Bcyclization%252Band%252Bphosphonylation%252Breaction%26aulast%3DTeixeira%26aufirst%3DF%25C3%25A1tima%2BC.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D11%26spage%3D2533%26epage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis  Galdadas</span>, <span class="hlFld-ContribAuthor ">Shen  Qu</span>, <span class="hlFld-ContribAuthor ">Ana Sofia F  Oliveira</span>, <span class="hlFld-ContribAuthor ">Edgar  Olehnovics</span>, <span class="hlFld-ContribAuthor ">Andrew R  Mack</span>, <span class="hlFld-ContribAuthor ">Maria F  Mojica</span>, <span class="hlFld-ContribAuthor ">Pratul K  Agarwal</span>, <span class="hlFld-ContribAuthor ">Catherine L  Tooke</span>, <span class="hlFld-ContribAuthor ">Francesco Luigi  Gervasio</span>, <span class="hlFld-ContribAuthor ">James  Spencer</span>, <span class="hlFld-ContribAuthor ">Robert A  Bonomo</span>, <span class="hlFld-ContribAuthor ">Adrian J  Mulholland</span>, <span class="hlFld-ContribAuthor ">Shozeb  Haider</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.7554/eLife.66567" title="DOI URL">https://doi.org/10.7554/eLife.66567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.66567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.66567%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DAllosteric%252Bcommunication%252Bin%252Bclass%252BA%252B%2525CE%2525B2-lactamases%252Boccurs%252Bvia%252Bcooperative%252Bcoupling%252Bof%252Bloop%252Bdynamics%26aulast%3DGaldadas%26aufirst%3DIoannis%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Ke-Wu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of covalent inhibitors targeting metallo-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112573. <a href="https://doi.org/10.1016/j.ejmech.2020.112573" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112573%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252Bcovalent%252Binhibitors%252Btargeting%252Bmetallo-%2525CE%2525B2-lactamases%26aulast%3DChen%26aufirst%3DCheng%26date%3D2020%26volume%3D203%26spage%3D112573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu‐Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Gen  Li</span>, <span class="hlFld-ContribAuthor ">Guo‐Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 1558-1592. <a href="https://doi.org/10.1002/med.21665" title="DOI URL">https://doi.org/10.1002/med.21665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21665%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DPrinciples%252Band%252Bcurrent%252Bstrategies%252Btargeting%252Bmetallo%2525E2%252580%252590%2525CE%2525B2%2525E2%252580%252590lactamase%252Bmediated%252Bantibacterial%252Bresistance%26aulast%3DYan%26aufirst%3DYu%25E2%2580%2590Hang%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D1558%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures reveal binding mode of coumarin phosphonate analogs <b>1</b> and <b>6</b> to KPC-2. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps are colored in gray and contoured at 3σ. Water molecules are shown as red spheres. Black dashed lines represent hydrogen bonds. (a) Compound <b>1</b> bound to KPC-2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15">6D15</a>). (b) Compound <b>6</b> bound to KPC-2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18">6D18</a>). (c) Compound <b>1</b> complex (white and green) superimposed onto KPC-2 apo structure (purple, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8">5UL8</a>). (d) Compound <b>1</b> complex (white and green) superimposed onto compound <b>6</b> complex (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structures of NDM-1 and VIM-2 bound to coumarin phosphonate derivatives. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps, determined at 1.15–1.50 Å resolutions, are colored in gray and contoured at 3σ except panel d, which has been contoured at 2σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) NDM-1 with <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A">6D1A</a>). (b) NDM-1 with <b>6</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D">6D1D</a>). (c) NDM-1 with <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F">6D1F</a>). (d) VIM-2 with <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0">6DD0</a>). F70 of NDM-1 adopts two conformations (labeled F70-conf A and F70-conf B) in the complex structures of <b>6</b> and <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structures of NDM-1 bound to phosphonate derivatives at pH 7.5. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit maps, determined at 1.30–1.40 Å resolutions, are colored in gray and contoured at 3σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) NDM-1 with <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>). (b) NDM-1 with <b>7</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a>). (c) NDM-1 with <b>16</b> (light blue and green), superimposed with the NDM-1 complex with <b>9</b> determined at pH 3.8 (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G">6D1G</a>). (d) NDM-1 with <b>7</b> (light blue and green), superimposed with the same complex determined at pH 3.8 (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of VIM-2 bound to phosphonate derivative <b>16</b> at pH 7.5. The composite simulated annealing mF<sub>o</sub> – DF<sub>c</sub> omit map, determined at 2.1 Å resolution, is colored in gray and contoured at 2σ. Black dashed lines represent hydrogen bonds. Zinc coordination is shown as thin sticks. (a) VIM-2 with <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T">6O5T</a>). (b) VIM-2 with <b>16</b> (orange and green) superimposed with the complex of NDM-1 and <b>16</b> (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/medium/jm9b00728_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superimposition of carbapenemase inhibitor and product complexes. (a) Superimposition of KPC-2/compound <b>9</b> (white and green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19">6D19</a>) and KPC-2/cefotaxime product (purple, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJ3">5UJ3</a>). (b) Superimposition of NDM-1/compound <b>16</b> (light blue and green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a>) and NDM-1/ampicillin product (yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HL2">4HL2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00728/20190920/images/large/jm9b00728_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00728&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 85 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, T. G.</span></span> <span> </span><span class="NLM_article-title">β-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1311</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.cell.2014.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=25480295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOrt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=1300-1311&author=H.+Choauthor=T.+Ueharaauthor=T.+G.+Bernhardt&title=%CE%B2-lactam+antibiotics+induce+a+lethal+malfunctioning+of+the+bacterial+cell+wall+synthesis+machinery&doi=10.1016%2Fj.cell.2014.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis Machinery</span></div><div class="casAuthors">Cho, Hongbaek; Uehara, Tsuyoshi; Bernhardt, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1300-1311</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Penicillin and related beta-lactams comprise one of our oldest and most widely used antibiotic therapies.  These drugs have long been known to target enzymes called penicillin-binding proteins (PBPs) that build the bacterial cell wall.  Investigating the downstream consequences of target inhibition and how they contribute to the lethal action of these important drugs, we demonstrate that beta-lactams do more than just inhibit the PBPs as is commonly believed.  Rather, they induce a toxic malfunctioning of their target biosynthetic machinery involving a futile cycle of cell wall synthesis and degrdn., thereby depleting cellular resources and bolstering their killing activity.  Characterization of this mode of action addnl. revealed a quality control function for enzymes that cleave bonds in the cell wall matrix.  The results thus provide insight into the mechanism of cell wall assembly and suggest how best to interfere with the process for future antibiotic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEc7F45dT_7LVg90H21EOLACvtfcHk0ljrXW1gXPwCxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOrt7bO&md5=b7a3b2273f62c322bdfc78554301ffa3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DBernhardt%26aufirst%3DT.%2BG.%26atitle%3D%25CE%25B2-lactam%2520antibiotics%2520induce%2520a%2520lethal%2520malfunctioning%2520of%2520the%2520bacterial%2520cell%2520wall%2520synthesis%2520machinery%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D1300%26epage%3D1311%26doi%3D10.1016%2Fj.cell.2014.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span></span> <span> </span><span class="NLM_article-title">Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria</span>. <i>Annu. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1146/annurev-micro-090110-102911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1146%2Fannurev-micro-090110-102911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21740228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=455-478&author=K.+Bushauthor=J.+F.+Fisher&title=Epidemiological+expansion%2C+structural+studies%2C+and+clinical+challenges+of+new+%CE%B2-lactamases+from+gram-negative+bacteria&doi=10.1146%2Fannurev-micro-090110-102911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria</span></div><div class="casAuthors">Bush, Karen; Fisher, Jed F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455-478</span>CODEN:
                <span class="NLM_cas:coden">ARMIAZ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4227</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  β-Lactamase evolution presents to the infectious disease community a major challenge in the treatment of infections caused by multidrug-resistant gram-neg. bacteria.  Because >1000 of these naturally occurring β-lactamases exist, attempts to correlate structure and function have become daunting.  Although new enzymes in the extended-spectrum β-lactamase (ESBL) families are frequently identified, the older CTX-M-14 and CTX-M-15 enzymes have become the most prevalent ESBLs in global surveillance.  Carbapenemases with either Ser-based or Zn-facilitated hydrolysis mechanisms are posing some of the most crit. problems.  Most geog. regions now report KPC serine carbapenemases and the metallo-β-lactamases VIM, IMP, and NDM-1, even though NDM-1 was only recently identified.  The rapid emergence of these newer enzymes, with multiple β-lactamases appearing in a single organism, makes the design of new β-lactamase inactivators or β-lactamase-stable β-lactams all the more difficult.  Combination therapy will likely be required to counteract the continuing evolution of these insidious enzymes in multidrug-resistant pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-Qqd_9pw7bVg90H21EOLACvtfcHk0lhUwDtdjkGusw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLbI&md5=7a836d327e02fd6a7c0c2a09ba646191</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev-micro-090110-102911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-micro-090110-102911%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26atitle%3DEpidemiological%2520expansion%252C%2520structural%2520studies%252C%2520and%2520clinical%2520challenges%2520of%2520new%2520%25CE%25B2-lactamases%2520from%2520gram-negative%2520bacteria%26jtitle%3DAnnu.%2520Rev.%2520Microbiol.%26date%3D2011%26volume%3D65%26spage%3D455%26epage%3D478%26doi%3D10.1146%2Fannurev-micro-090110-102911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, G. A.</span></span> <span> </span><span class="NLM_article-title">Updated functional classification of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1128/AAC.01009-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.01009-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19995920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=969-976&author=K.+Bushauthor=G.+A.+Jacoby&title=Updated+functional+classification+of+%CE%B2-lactamases&doi=10.1128%2FAAC.01009-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Updated functional classification of β-lactamases</span></div><div class="casAuthors">Bush, Karen; Jacoby, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">969-976</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Two classification schemes for β-lactamases are currently in use.  The mol. classification is based on the amino acid sequence and divides β-lactamases into class A, C, and D enzymes which utilize serine for β-lactam hydrolysis and class B metalloenzymes which require Zn2+ ions for substrate hydrolysis.  The functional classification scheme updated here is based on the proposal by K. Bush et al. (1995).  It takes into account substrate and inhibitor profiles in an attempt to group the enzymes in ways that can be correlated with their phenotype in clin. isolates.  Major groupings generally correlate with the more broadly based mol. classification.  The updated system includes group 1 (class C) cephalosporinases; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum β-lactamases and serine carbapenemases; and group 3 metallo-β-lactamases.  Several new subgroups of each of the major groups are described, based on specific attributes of individual enzymes.  A list of attributes is also suggested for the description of a new β-lactamase, including the requisite microbiol. properties, substrate and inhibitor profiles, and mol. sequence data that provide an adequate characterization for a new β-lactam-hydrolyzing enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofIL9Nvv4cdbVg90H21EOLACvtfcHk0lhUwDtdjkGusw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsr4%253D&md5=89b376d90ff64b78f81bd43ed5925ea2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.01009-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01009-09%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DK.%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DUpdated%2520functional%2520classification%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D969%26epage%3D976%26doi%3D10.1128%2FAAC.01009-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamase structure and function</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1277</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2012.06796.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1111%2Fj.1749-6632.2012.06796.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23163348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1277&publication_year=2013&pages=91-104&author=T.+Palzkill&title=Metallo-%CE%B2-lactamase+structure+and+function&doi=10.1111%2Fj.1749-6632.2012.06796.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase structure and function</span></div><div class="casAuthors">Palzkill, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1277</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">91-104</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Lactam antibiotics are the most commonly used antibacterial agents and growing resistance to these drugs is a concern.  Metallo-β-lactamases are a diverse set of enzymes that catalyze the hydrolysis of a broad range of β-lactam drugs including carbapenems.  This diversity is reflected in the observation that the enzyme mechanisms differ based on whether one or two zincs are bound in the active site that, in turn, is dependent on the subclass of β-lactamase.  The dissemination of the genes encoding these enzymes among Gram-neg. bacteria has made them an important cause of resistance.  In addn., there are currently no clin. available inhibitors to block metallo-β-lactamase action.  This review summarizes the numerous studies that have yielded insights into the structure, function, and mechanism of action of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKW_XazIQODLVg90H21EOLACvtfcHk0lgT04ZxY6wBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgtb4%253D&md5=ceb4276f35d73e361e2c2fe27015ab8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2012.06796.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2012.06796.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DMetallo-%25CE%25B2-lactamase%2520structure%2520and%2520function%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1277%26spage%3D91%26epage%3D104%26doi%3D10.1111%2Fj.1749-6632.2012.06796.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dortet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance in <i>Enterobacteriaceae</i>: here is the storm!</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.molmed.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22480775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=263-272&author=P.+Nordmannauthor=L.+Dortetauthor=L.+Poirel&title=Carbapenem+resistance+in+Enterobacteriaceae%3A+here+is+the+storm%21&doi=10.1016%2Fj.molmed.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance in Enterobacteriaceae: here is the storm</span></div><div class="casAuthors">Nordmann, Patrice; Dortet, Laurent; Poirel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The current worldwide emergence of resistance to the powerful antibiotic carbapenem in Enterobacteriaceae constitutes an important growing public health threat.  Sporadic outbreaks or endemic situations with enterobacterial isolates not susceptible to carbapenems are now reported not only in hospital settings but also in the community.  Acquired class A (KPC), class B (IMP, VIM, NDM), or class D (OXA-48, OXA-181) carbapenemases, are the most important determinants sustaining resistance to carbapenems.  The corresponding genes are mostly plasmid-located and assocd. with various mobile genetic structures (insertion sequences, integrons, transposons), further enhancing their spread.  This review summarizes the current knowledge on carbapenem resistance in Enterobacteriaceae, including activity, distribution, clin. impact, and possible novel antibiotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw3NvxiXmzF7Vg90H21EOLACvtfcHk0lgT04ZxY6wBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D&md5=afb14fc82cdcf73cb9c1fdf17b3c1a2d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DNordmann%26aufirst%3DP.%26aulast%3DDortet%26aufirst%3DL.%26aulast%3DPoirel%26aufirst%3DL.%26atitle%3DCarbapenem%2520resistance%2520in%2520Enterobacteriaceae%253A%2520here%2520is%2520the%2520storm%2521%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.molmed.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trecarichi, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumbarello, M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic options for carbapenem-resistant <i>Enterobacteriaceae</i> infections</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1080/21505594.2017.1292196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1080%2F21505594.2017.1292196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28276996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=470-484&author=E.+M.+Trecarichiauthor=M.+Tumbarello&title=Therapeutic+options+for+carbapenem-resistant+Enterobacteriaceae+infections&doi=10.1080%2F21505594.2017.1292196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options for carbapenem-resistant Enterobacteriaceae infections</span></div><div class="casAuthors">Trecarichi, Enrico Maria; Tumbarello, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">470-484</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health.  The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clin. trials have been performed with this objective.  We aimed to summarize in the present review data provided by previous observational clin. studies that have investigated the impact of different treatment strategies on the outcome of CRE infections.  Most of these studies reported that combination therapy with 2 or more drugs is superior to monotherapy in providing a survival benefit.  The use of carbapenems in assocn. with other active drugs is likely ineffective for CRE isolates with carbapenem Min. Inhibitory Concns. (MICs) >8 mg/l.  The effectiveness of further therapeutic options for the treatment of extensively or pan-drug-resistant Enterobacteriaceae infections has been reported in vivo and in vitro, although few cases/case series have been reported.  Novel antimicrobials that are effective against CRE are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD0gIPYMLuGbVg90H21EOLACvtfcHk0lgT04ZxY6wBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOlt7g%253D&md5=d65653474f068d5ed3c884c15f372444</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F21505594.2017.1292196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2017.1292196%26sid%3Dliteratum%253Aachs%26aulast%3DTrecarichi%26aufirst%3DE.%2BM.%26aulast%3DTumbarello%26aufirst%3DM.%26atitle%3DTherapeutic%2520options%2520for%2520carbapenem-resistant%2520Enterobacteriaceae%2520infections%26jtitle%3DVirulence%26date%3D2017%26volume%3D8%26spage%3D470%26epage%3D484%26doi%3D10.1080%2F21505594.2017.1292196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenems: past, present, and future</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4943</span>– <span class="NLM_lpage">4960</span>, <span class="refDoi"> DOI: 10.1128/AAC.00296-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00296-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21859938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=4943-4960&author=K.+M.+Papp-Wallaceauthor=A.+Endimianiauthor=M.+A.+Taracilaauthor=R.+A.+Bonomo&title=Carbapenems%3A+past%2C+present%2C+and+future&doi=10.1128%2FAAC.00296-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems: past, present, and future</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Endimiani, Andrea; Taracila, Magdalena A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4943-4960</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In this review, we summarize the current "state of the art" of carbapenem antibiotics and their role in our antimicrobial armamentarium.  Among the β-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most β-lactamases, in some cases act as "slow substrates" or inhibitors of β-lactamases, and still target penicillin binding proteins.  This "value-added feature" of inhibiting β-lactamases serves as a major rationale for expansion of this class of β-lactams.  We describe the initial discovery and development of the carbapenem family of β-lactams.  Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compd. for all subsequent carbapenems.  To date, more than 80 compds. with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature.  We also highlight important features of the carbapenems that are presently in clin. use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem.  In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compds., as they have served us well for more than 3 decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Y-IuobRax7Vg90H21EOLACvtfcHk0liqklNWc7MAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSru7rJ&md5=5104ffe81fe097b4ae11a5c6a8fc7fb0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.00296-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00296-11%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenems%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D4943%26epage%3D4960%26doi%3D10.1128%2FAAC.00296-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Duin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Carbapenem-resistant <i>Enterobacteriaceae</i>: a review of treatment and outcomes</span>. <i>Diagn. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.diagmicrobio.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23290507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=115-120&author=D.+van%0ADuinauthor=K.+S.+Kayeauthor=E.+A.+Neunerauthor=R.+A.+Bonomo&title=Carbapenem-resistant+Enterobacteriaceae%3A+a+review+of+treatment+and+outcomes&doi=10.1016%2Fj.diagmicrobio.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes</span></div><div class="casAuthors">van Duin, David; Kaye, Keith S.; Neuner, Elizabeth A.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-120</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The emergence of carbapenem resistance in Enterobacteriaceae is an important threat to global health.  Reported outcomes of infections with carbapenem-resistant Enterobacteriaceae (CRE) are poor.  Very few options remain for the treatment of these virulent organisms.  Antibiotics which are currently in use to treat CRE infections include aminoglycosides, polymyxins, tigecycline, fosfomycin, and temocillin.  In addn., the role of combination therapy, including carbapenem contg. regimens, remains to be defined.  There are several important concerns regarding all of these treatment options such as limited efficacy, increasing reports of resistance, and specific toxicities.  Data from retrospective studies favor combination therapy over single-agent therapy for the treatment of CRE bloodstream infections.  In summary, new antibiotics are greatly needed, as is addnl. prospective research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTAz43e4L1XbVg90H21EOLACvtfcHk0liqklNWc7MAnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2huw%253D%253D&md5=b0d55d693602502f5dc2e43dfc046ecb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDuin%26aufirst%3DD.%26aulast%3DKaye%26aufirst%3DK.%2BS.%26aulast%3DNeuner%26aufirst%3DE.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DCarbapenem-resistant%2520Enterobacteriaceae%253A%2520a%2520review%2520of%2520treatment%2520and%2520outcomes%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D75%26spage%3D115%26epage%3D120%26doi%3D10.1016%2Fj.diagmicrobio.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrill, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, K. L.</span></span> <span> </span><span class="NLM_article-title">Treatment options for carbapenem-resistant <i>Enterobacteriaceae</i> infections</span>. <i>Open Forum Infect Dis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">ofv050</span> <span class="refDoi"> DOI: 10.1093/ofid/ofv050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fofid%2Fofv050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26125030" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=H.+J.+Morrillauthor=J.+M.+Pogueauthor=K.+S.+Kayeauthor=K.+L.+LaPlante&title=Treatment+options+for+carbapenem-resistant+Enterobacteriaceae+infections&doi=10.1093%2Fofid%2Fofv050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofv050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofv050%26sid%3Dliteratum%253Aachs%26aulast%3DMorrill%26aufirst%3DH.%2BJ.%26aulast%3DPogue%26aufirst%3DJ.%2BM.%26aulast%3DKaye%26aufirst%3DK.%2BS.%26aulast%3DLaPlante%26aufirst%3DK.%2BL.%26atitle%3DTreatment%2520options%2520for%2520carbapenem-resistant%2520Enterobacteriaceae%2520infections%26jtitle%3DOpen%2520Forum%2520Infect%2520Dis%26date%3D2015%26volume%3D2%26doi%3D10.1093%2Fofid%2Fofv050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloush, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navon-Venezia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigman-Igra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabili, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeli, Y.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant <i>Pseudomonas aeruginosa</i>: risk factors and clinical impact</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1128/AAC.50.1.43-48.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.50.1.43-48.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=16377665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=43-48&author=V.+Aloushauthor=S.+Navon-Veneziaauthor=Y.+Seigman-Igraauthor=S.+Cabiliauthor=Y.+Carmeli&title=Multidrug-resistant+Pseudomonas+aeruginosa%3A+risk+factors+and+clinical+impact&doi=10.1128%2FAAC.50.1.43-48.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact</span></div><div class="casAuthors">Aloush, Valerie; Navon-Venezia, Shiri; Seigman-Igra, Yardena; Cabili, Shaltiel; Carmeli, Yehuda</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug resistant (MDR).  Its rate of occurrence, the individual risk factors among affected patients, and the clin. impact of infection are undetd.  We conducted an epidemiol. evaluation and mol. typing using pulsed-field gel electrophoresis (PFGE) of 36 isolates for 82 patients with MDR P. aeruginosa and 82 controls matched by ward, length of hospital stay, and calendar time.  A matched case-control study identified individual risk factors for having MDR P. aeruginosa, and a retrospective matched-cohort study examd. clin. outcomes of such infections.  The 36 isolates belonged to 12 PFGE clones.  Two clones dominated, with one originating in an intensive care unit (ICU).  Cases and controls had similar demog. characteristics and nos. of comorbid conditions.  A multivariate model identified ICU stay, being bedridden, having high invasive devices scores, and being treated with broad-spectrum cephalosporins and with aminoglycosides as significant risk factors for isolating MDR P. aeruginosa.  Having a malignant disease was a protective factor (odds ratio [OR] = 0.2; P = 0.03).  MDR P. aeruginosa was assocd. with severe outcomes compared to controls, including increased mortality (OR = 4.4; P = 0.04), hospital stay (hazard ratio, 2; P = 0.001), and requirement for procedures (OR = 5.4; P = 0.001).  The survivors functioned more poorly at discharge than the controls, and more of the survivors were discharged to rehabilitation centers or chronic care facilities.  The epidemiol. of MDR P. aeruginosa is complex.  Critically ill patients that require intensive care and are treated with multiple antibiotic agents are at high risk.  MDR P. aeruginosa infections are assocd. with severe adverse clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkTvWGwAH5T7Vg90H21EOLACvtfcHk0li8U8-KgGHrGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVGmtg%253D%253D&md5=376579c57953162bf82f4b201c3fa978</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.1.43-48.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.1.43-48.2006%26sid%3Dliteratum%253Aachs%26aulast%3DAloush%26aufirst%3DV.%26aulast%3DNavon-Venezia%26aufirst%3DS.%26aulast%3DSeigman-Igra%26aufirst%3DY.%26aulast%3DCabili%26aufirst%3DS.%26aulast%3DCarmeli%26aufirst%3DY.%26atitle%3DMultidrug-resistant%2520Pseudomonas%2520aeruginosa%253A%2520risk%2520factors%2520and%2520clinical%2520impact%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D43%26epage%3D48%26doi%3D10.1128%2FAAC.50.1.43-48.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutgring, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limbago, B. M.</span></span> <span> </span><span class="NLM_article-title">The problem of carbapenemase-producing-carbapenem-resistant-<i>Enterobacteriaceae</i> detection</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1128/JCM.02771-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FJCM.02771-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26739152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1emsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=529-534&author=J.+D.+Lutgringauthor=B.+M.+Limbago&title=The+problem+of+carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae+detection&doi=10.1128%2FJCM.02771-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection</span></div><div class="casAuthors">Lutgring, Joseph D.; Limbago, Brandi M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-534</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">1098-660X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The emergence and spread of carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) are a significant clin. and public health concern.  Reliable detection of CP-CRE is the first step in combating this problem.  There are both phenotypic and mol. methods available for CP-CRE detection.  There is no single detection method that is ideal for all situations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqltwoZJa5INbVg90H21EOLACvtfcHk0ljUw4Yojw5BfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1emsb4%253D&md5=ec87e3987d31569ebc3f357c31b82d71</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FJCM.02771-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.02771-15%26sid%3Dliteratum%253Aachs%26aulast%3DLutgring%26aufirst%3DJ.%2BD.%26aulast%3DLimbago%26aufirst%3DB.%2BM.%26atitle%3DThe%2520problem%2520of%2520carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae%2520detection%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2016%26volume%3D54%26spage%3D529%26epage%3D534%26doi%3D10.1128%2FJCM.02771-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meletis, G.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance: overview of the problem and future perspectives</span>. <i>Ther. Adv. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1177/2049936115621709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1177%2F2049936115621709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26862399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisFWhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=15-21&author=G.+Meletis&title=Carbapenem+resistance%3A+overview+of+the+problem+and+future+perspectives&doi=10.1177%2F2049936115621709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance: overview of the problem and future perspectives</span></div><div class="casAuthors">Meletis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Infectious Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">TAIDAM</span>;
        ISSN:<span class="NLM_cas:issn">2049-937X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Carbapenem resistance, mainly among Gram-neg. pathogens, is an ongoing public-health problem of global dimensions.  This type of antimicrobial resistance, esp. when mediated by transferable carbapenemase-encoding genes, is spreading rapidly causing serious outbreaks and dramatically limiting treatment options.  In this article, important key points related to carbapenem resistance are reviewed and future perspectives are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLotqN8h2BErVg90H21EOLACvtfcHk0ljUw4Yojw5BfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisFWhu7g%253D&md5=fecc102d03d26f57f91dd566c36395ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1177%2F2049936115621709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2049936115621709%26sid%3Dliteratum%253Aachs%26aulast%3DMeletis%26aufirst%3DG.%26atitle%3DCarbapenem%2520resistance%253A%2520overview%2520of%2520the%2520problem%2520and%2520future%2520perspectives%26jtitle%3DTher.%2520Adv.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D15%26epage%3D21%26doi%3D10.1177%2F2049936115621709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V. C.</span></span> <span> </span><span class="NLM_article-title">Characterization of carbapenem-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> from a healthcare region in Hong Kong</span>. <i>Eur. J. Clin. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1007/s10096-015-2550-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2Fs10096-015-2550-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26740321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFKmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=379-385&author=P.+L.+Hoauthor=Y.+Y.+Cheungauthor=Y.+Wangauthor=W.+U.+Loauthor=E.+L.+Laiauthor=K.+H.+Chowauthor=V.+C.+Cheng&title=Characterization+of+carbapenem-resistant+Escherichia+coli+and+Klebsiella+pneumoniae+from+a+healthcare+region+in+Hong+Kong&doi=10.1007%2Fs10096-015-2550-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong</span></div><div class="casAuthors">Ho, P. L.; Cheung, Y. Y.; Wang, Y.; Lo, W. U.; Lai, E. L. Y.; Chow, K. H.; Cheng, V. C. C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Microbiology & Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">EJCDEU</span>;
        ISSN:<span class="NLM_cas:issn">0934-9723</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae represents a major public health issue.  This study investigated the clonality and resistance mechanisms of 92 carbapenem-resistant E. coli (n = 21) and K. pneumoniae (n = 71) isolates collected consecutively from clin. specimens and patients at high risk of carriage between 2010 and 2012 in a healthcare region in Hong Kong.  Combined disk tests (CDTs) and the Carba NP test were used for phenotypic detection of carbapenemases.  PCR assays were used to detect carbapenemase genes.  All isolates were intermediate or resistant to at least one carbapenem.  Nine (9.8 %) isolates were genotypic carbapenemase producers and included six K. pneumoniae (one ST1306/blaIMP-4, one ST889/blaIMP-4, two ST11/blaKPC-2, one ST258/blaKPC-2, one ST483/blaNDM-1) and three E. coli (one ST131/blaIMP-4, two ST744/ blaNDM-1) isolates.  All nine isolates carrying carbapenemase genes could be detected by the CDTs and the Carba NP test.  PCR identified blaCTX-M and blaAmpC alone or in combination in 77.8 % (7/9) and 96.4 % (80/83) of the carbapenemase-producers and non-producers, resp.  Porin loss was detected in 22.2 % (2/9) and 59.0 % (49/83) of the carbapenemase-producers and non-producers, resp.  Overall, the E. coli clones were diverse (14 different STs), but 36.6 % (26/71) of the K. pneumoniae isolates belonged to ST11.  In conclusion, the prevalence of carbapenemases among carbapenem-nonsusceptible E. coli and K. pneumoniae remained low in Hong Kong.  Porin loss combined with AmpC and/or CTX-M type ESBL was the major mechanism of carbapenem resistance in the study population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwd8PzWXxp7Vg90H21EOLACvtfcHk0liuS9tCAAjyZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvFKmsA%253D%253D&md5=6549799a45414079248f02881981eb8b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs10096-015-2550-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-015-2550-3%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DP.%2BL.%26aulast%3DCheung%26aufirst%3DY.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DW.%2BU.%26aulast%3DLai%26aufirst%3DE.%2BL.%26aulast%3DChow%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DV.%2BC.%26atitle%3DCharacterization%2520of%2520carbapenem-resistant%2520Escherichia%2520coli%2520and%2520Klebsiella%2520pneumoniae%2520from%2520a%2520healthcare%2520region%2520in%2520Hong%2520Kong%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D35%26spage%3D379%26epage%3D385%26doi%3D10.1007%2Fs10096-015-2550-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Queenan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span> <span> </span><span class="NLM_article-title">Carbapenemases: the versatile β-lactamases</span>. <i>Clin Microbiol Rev</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1128/CMR.00001-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FCMR.00001-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=17630334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFGktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=440-458&author=A.+M.+Queenanauthor=K.+Bush&title=Carbapenemases%3A+the+versatile+%CE%B2-lactamases&doi=10.1128%2FCMR.00001-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenemases: the versatile β-lactamases</span></div><div class="casAuthors">Queenan, Anne Marie; Bush, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-458</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Carbapenemases are β-lactamases with versatile hydrolytic capacities.  They have the ability to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems.  Bacteria producing these β-lactamases may cause serious infections in which the carbapenemase activity renders many β-lactams ineffective.  Carbapenemases are members of β-lactamase classes A, B, and D.  The class A and D enzymes have a serine-based hydrolytic mechanism, whereas the class B enzymes are metallo-β-lactamases that contain Zn in their active site.  The class A carbapenemase group includes members of the SME, IMI, NMC, GES, and KPC families.  Of these, the KPC carbapenemases are the most prevalent, found mostly on plasmids in Klebsiella pneumoniae.  The class D carbapenemases consist of OXA-type β-lactamases frequently detected in Acinetobacter baumannii.  The metallo-β-lactamases belong to the IMP, VIM, SPM, GIM, and SIM families and have been detected primarily in Pseudomonas aeruginosa; however, there are increasing nos. of reports worldwide of this group of β-lactamases in the Enterobacteriaceae.  This review updates the characteristics, epidemiol., and detection of the carbapenemases found in pathogenic bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHaonkCvu6ArVg90H21EOLACvtfcHk0liuS9tCAAjyZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFGktbY%253D&md5=fa85fc692f3d997feec7b2daea4f7c47</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FCMR.00001-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00001-07%26sid%3Dliteratum%253Aachs%26aulast%3DQueenan%26aufirst%3DA.%2BM.%26aulast%3DBush%26aufirst%3DK.%26atitle%3DCarbapenemases%253A%2520the%2520versatile%2520%25CE%25B2-lactamases%26jtitle%3DClin%2520Microbiol%2520Rev%26date%3D2007%26volume%3D20%26spage%3D440%26epage%3D458%26doi%3D10.1128%2FCMR.00001-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toleman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamases: the quiet before the storm?</span>. <i>Clin Microbiol Rev</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1128/CMR.18.2.306-325.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FCMR.18.2.306-325.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=15831827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVymtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=306-325&author=T.+R.+Walshauthor=M.+A.+Tolemanauthor=L.+Poirelauthor=P.+Nordmann&title=Metallo-%CE%B2-lactamases%3A+the+quiet+before+the+storm%3F&doi=10.1128%2FCMR.18.2.306-325.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamases: the quiet before the storm?</span></div><div class="casAuthors">Walsh, Timothy R.; Toleman, Mark A.; Poirel, Laurent; Nordmann, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">306-325</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The ascendancy of metallo-β-lactamases within the clin. sector, while not ubiquitous, has nonetheless been dramatic; some reports indicate that nearly 30% of imipenem-resistant Pseudomonas aeruginosa strains possess a metallo-β-lactamase.  Acquisition of a metallo-β-lactamase gene will invariably mediate broad-spectrum β-lactam resistance in P. aeruginosa, but the level of in vitro resistance in Acinetobacter spp. and Enterobacteriaceae is less dependable.  Their clin. significance is further embellished by their ability to hydrolyze all β-lactams and by the fact that there is currently no clin. inhibitor, nor is there likely to be for the foreseeable future.  The genes encoding metallo-β-lactamases are often procured by class 1 (sometimes class 3) integrons, which, in turn, are embedded in transposons, resulting in a highly transmissible genetic app.  Moreover, other gene cassettes within the integrons often confer resistance to aminoglycosides, precluding their use as an alternative treatment.  Thus far, the metallo-β-lactamases encoded on transferable genes include IMP, VIM, SPM, and GIM and have been reported from 28 countries.  Their rapid dissemination is worrisome and necessitates the implementation of not just surveillance studies but also metallo-β-lactamase inhibitor studies securing the longevity of important anti-infectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0boLu0SgxJbVg90H21EOLACvtfcHk0liuS9tCAAjyZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVymtb0%253D&md5=0a1581aa83ff119104c82d855da5bc86</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FCMR.18.2.306-325.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.18.2.306-325.2005%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DToleman%26aufirst%3DM.%2BA.%26aulast%3DPoirel%26aufirst%3DL.%26aulast%3DNordmann%26aufirst%3DP.%26atitle%3DMetallo-%25CE%25B2-lactamases%253A%2520the%2520quiet%2520before%2520the%2520storm%253F%26jtitle%3DClin%2520Microbiol%2520Rev%26date%3D2005%26volume%3D18%26spage%3D306%26epage%3D325%26doi%3D10.1128%2FCMR.18.2.306-325.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">New β-lactamase inhibitors in the clinic</span>. <i>Infect Dis Clin North Am</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2016.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.idc.2016.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27208767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitFGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=441-464&author=K.+M.+Papp-Wallaceauthor=R.+A.+Bonomo&title=New+%CE%B2-lactamase+inhibitors+in+the+clinic&doi=10.1016%2Fj.idc.2016.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">New β-Lactamase Inhibitors in the Clinic</span></div><div class="casAuthors">Papp-Wallace Krisztina M; Bonomo Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-464</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Given the serious medical burden of β-lactamases, many approaches are being used identify candidate agents for β-lactamase inhibition.  Here, we review two β-lactam-β-lactamase inhibitor (BL-BLI) combinations, ceftolozane-tazobactam and ceftazidime-avibactam that recently entered the clinic.  In addition, we focus on BL-BLI combinations in preclinical development that have demonstrated activity in clinical isolates via susceptibility testing and/or in in vivo models of infection.  We highlight only the BLIs that are able to reduce the Clinical Laboratory Standards Institute (CLSI) breakpoints for the BL partner into the susceptible range.  Our analysis includes the primary literature, meeting abstracts, as well as the patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpoedonpWcg3wOGIfWJ7-GfW6udTcc2ebj_qo4Cy1-qLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitFGitw%253D%253D&md5=45cdda811f0eeb65c7026034e399b87a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2016.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2016.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DNew%2520%25CE%25B2-lactamase%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DInfect%2520Dis%2520Clin%2520North%2520Am%26date%3D2016%26volume%3D30%26spage%3D441%26epage%3D464%26doi%3D10.1016%2Fj.idc.2016.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span> <span> </span><span class="NLM_article-title">Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4524</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06839-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fs41467-018-06839-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=30375382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4524&author=Z.+Sunauthor=L.+Huauthor=B.+Sankaranauthor=B.+V.+V.+Prasadauthor=T.+Palzkill&title=Differential+active+site+requirements+for+NDM-1+%CE%B2-lactamase+hydrolysis+of+carbapenem+versus+penicillin+and+cephalosporin+antibiotics&doi=10.1038%2Fs41467-018-06839-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics</span></div><div class="casAuthors">Sun Zhizeng; Palzkill Timothy; Hu Liya; Prasad B V Venkataram; Palzkill Timothy; Sankaran Banumathi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4524</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New Delhi metallo-β-lactamase-1 exhibits a broad substrate profile for hydrolysis of the penicillin, cephalosporin and 'last resort' carbapenems, and thus confers bacterial resistance to nearly all β-lactam antibiotics.  Here we address whether the high catalytic efficiency for hydrolysis of these diverse substrates is reflected by similar sequence and structural requirements for catalysis, i.e., whether the same catalytic machinery is used to achieve hydrolysis of each class.  Deep sequencing of randomized single codon mutation libraries that were selected for resistance to representative antibiotics reveal stringent sequence requirements for carbapenem versus penicillin or cephalosporin hydrolysis.  Further, the residue positions required for hydrolysis of penicillins and cephalosporins are a subset of those required for carbapenem hydrolysis.  Thus, while a common core of residues is used for catalysis of all substrates, carbapenem hydrolysis requires an additional set of residues to achieve catalytic efficiency comparable to that for penicillins and cephalosporins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481cRAV4D_Ins_fW6udTcc2ebj_qo4Cy1-qLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslemtA%253D%253D&md5=3439e00b99a221418093d84743ebed31</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06839-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06839-1%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSankaran%26aufirst%3DB.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DPalzkill%26aufirst%3DT.%26atitle%3DDifferential%2520active%2520site%2520requirements%2520for%2520NDM-1%2520%25CE%25B2-lactamase%2520hydrolysis%2520of%2520carbapenem%2520versus%2520penicillin%2520and%2520cephalosporin%2520antibiotics%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4524%26doi%3D10.1038%2Fs41467-018-06839-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid-Yu, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombes, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/nature13445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnature13445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24965651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=503-506&author=A.+M.+Kingauthor=S.+A.+Reid-Yuauthor=W.+Wangauthor=D.+T.+Kingauthor=G.+De+Pascaleauthor=N.+C.+Strynadkaauthor=T.+R.+Walshauthor=B.+K.+Coombesauthor=G.+D.+Wright&title=Aspergillomarasmine+A+overcomes+metallo-%CE%B2-lactamase+antibiotic+resistance&doi=10.1038%2Fnature13445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance</span></div><div class="casAuthors">King, Andrew M.; Reid-Yu, Sarah A.; Wang, Wenliang; King, Dustin T.; De Pascale, Gianfranco; Strynadka, Natalie C.; Walsh, Timothy R.; Coombes, Brian K.; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7506</span>),
    <span class="NLM_cas:pages">503-506</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The emergence and spread of carbapenem-resistant Gram-neg. pathogens is a global public health problem.  The acquisition of metallo-β-lactamases (MBLs) such as NDM-1 is a principle contributor to the emergence of carbapenem-resistant Gram-neg. pathogens that threatens the use of penicillin, cephalosporin and carbapenem antibiotics to treat infections.  To date, a clin. inhibitor of MBLs that could reverse resistance and re-sensitize resistant Gram-neg. pathogens to carbapenems has not been found.  Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clin. relevant MBL, VIM-2.  AMA also fully restored the activity of meropenem against Enterobacteriaceae, Acinetobacter spp. and Pseudomonas spp. possessing either VIM or NDM-type alleles.  In mice infected with NDM-1-expressing Klebsiella pneumoniae, AMA efficiently restored meropenem activity, demonstrating that a combination of AMA and a carbapenem antibiotic has therapeutic potential to address the clin. challenge of MBL-pos. carbapenem-resistant Gram-neg. pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSvWnWWDz9e7Vg90H21EOLACvtfcHk0lhRot06PxClAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7fN&md5=d60cc033c506e48e3c4d7b71f003181a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature13445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13445%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BM.%26aulast%3DReid-Yu%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKing%26aufirst%3DD.%2BT.%26aulast%3DDe%2BPascale%26aufirst%3DG.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DCoombes%26aufirst%3DB.%2BK.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DAspergillomarasmine%2520A%2520overcomes%2520metallo-%25CE%25B2-lactamase%2520antibiotic%2520resistance%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D503%26epage%3D506%26doi%3D10.1038%2Fnature13445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drawz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">392</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2013.00392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.3389%2Ffmicb.2013.00392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24399995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC2czot1WltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=392&author=R.+R.+Watkinsauthor=K.+M.+Papp-Wallaceauthor=S.+M.+Drawzauthor=R.+A.+Bonomo&title=Novel+%CE%B2-lactamase+inhibitors%3A+a+therapeutic+hope+against+the+scourge+of+multidrug+resistance&doi=10.3389%2Ffmicb.2013.00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance</span></div><div class="casAuthors">Watkins Richard R; Papp-Wallace Krisztina M; Drawz Sarah M; Bonomo Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">The increasing incidence and prevalence of multi-drug resistance (MDR) among contemporary Gram-negative bacteria represents a significant threat to human health.  Since their discovery, β-lactam antibiotics have been a major component of the armamentarium against these serious pathogens.  Unfortunately, a wide range of β-lactamase enzymes have emerged that are capable of inactivating these powerful drugs.  In the past 30 years, a major advancement in the battle against microbes has been the development of β-lactamase inhibitors, which restore the efficacy of β-lactam antibiotics (e.g., ampicillin/sulbactam, amoxicillin/clavulanate, ticarcillin/clavulanate, and piperacillin/tazobactam).  Unfortunately, many newly discovered β-lactamases are not inactivated by currently available inhibitors.  Is there hope? For the first time in many years, we can anticipate the development and introduction into clinical practice of novel inhibitors.  Although these inhibitors may still not be effective for all β-lactamases, their introduction is still welcome.  This review focuses on the novel β-lactamase inhibitors that are closest to being introduced in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwYm1s3okRRH6HPRus0rAafW6udTcc2eZPjKk3Efzh6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czot1WltQ%253D%253D&md5=3f3db2146597ac5cbd25bb4254a1ee40</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2013.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2013.00392%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BR.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DDrawz%26aufirst%3DS.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DNovel%2520%25CE%25B2-lactamase%2520inhibitors%253A%2520a%2520therapeutic%2520hope%2520against%2520the%2520scourge%2520of%2520multidrug%2520resistance%26jtitle%3DFront.%2520Microbiol.%26date%3D2013%26volume%3D4%26spage%3D392%26doi%3D10.3389%2Ffmicb.2013.00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S. L.</span></span> <span> </span><span class="NLM_article-title">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">11663</span>– <span class="NLM_lpage">11668</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205073109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.1205073109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22753474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=11663-11668&author=D.+E.+Ehmannauthor=H.+Jahicauthor=P.+L.+Rossauthor=R.+F.+Guauthor=J.+Huauthor=G.+Kernauthor=G.+K.+Walkupauthor=S.+L.+Fisher&title=Avibactam+is+a+covalent%2C+reversible%2C+non-%CE%B2-lactam+%CE%B2-lactamase+inhibitor&doi=10.1073%2Fpnas.1205073109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor</span></div><div class="casAuthors">Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Kern, Gunther; Walkup, Grant K.; Fisher, Stewart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11663-11668, S11663/1-S11663/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Avibactam is a β-lactamase inhibitor that is in clin. development, combined with P-lactam partners, for the treatment of bacterial infections comprising Gram-neg. organisms.  Avibactam is a structural class of inhibitor that does not contain a β-lactam core but maintains the capacity to covalently acylate its β-lactamase targets.  Using the TEM-1 enzyme, we characterized avibactam inhibition by measuring the on-rate for acylation and the off-rate for deacylation.  The deacylation off-rate was 0.045 min-1, which allowed investigation of the deacylation route from TEM-1.  Using NMR and MS, we showed that deacylation proceeds through regeneration of intact avibactam and not hydrolysis.  Other than TEM-1, four addnl. clin. relevant β-lactamases were shown to release intact avibactam after being acylated.  We showed that avibactam is a covalent, slowly reversible inhibitor, which is a unique mechanism of inhibition among β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDBeJlngFA5LVg90H21EOLACvtfcHk0lirOcOGHbCv1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ciu73K&md5=4da3c333df0a1eeb6ab84cabd65ab8ec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205073109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205073109%26sid%3Dliteratum%253Aachs%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKern%26aufirst%3DG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26atitle%3DAvibactam%2520is%2520a%2520covalent%252C%2520reversible%252C%2520non-%25CE%25B2-lactam%2520%25CE%25B2-lactamase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D11663%26epage%3D11668%26doi%3D10.1073%2Fpnas.1205073109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damblon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smargiasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span> <span> </span><span class="NLM_article-title">Interaction of avibactam with class B metallo-β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5655</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1128/AAC.00897-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00897-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27401561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5655-5662&author=M.+I.+Abboudauthor=C.+Damblonauthor=J.+Bremauthor=N.+Smargiassoauthor=P.+Mercuriauthor=B.+Gilbertauthor=A.+M.+Rydzikauthor=T.+D.+Claridgeauthor=C.+J.+Schofieldauthor=J.+M.+Frere&title=Interaction+of+avibactam+with+class+B+metallo-%CE%B2-lactamases&doi=10.1128%2FAAC.00897-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Avibactam with class B metallo-β-lactamases</span></div><div class="casAuthors">Abboud, Martine I.; Damblon, Christian; Brem, Jurgen; Smargiasso, Nicolas; Mercuri, Paola; Gilbert, Bernard; Rydzik, Anna M.; Claridge, Timothy D. W.; Schofield, Christopher J.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5655-5662</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials.  There are two mechanistic classes of β-lactamases: the serine β-lactamases (SBLs) and the zinc-dependent metallo-β-lactamases (MBLs).  Avibactam, the first clin. useful non-β-lactam β-lactamase inhibitor, is a broad-spectrum SBL inhibitor, which is used in combination with a cephalosporin antibiotic (ceftazidime).  There are multiple reports on the interaction of avibactam with SBLs but few such studies with MBLs.  We report biochem. and biophys. studies on the binding and reactivity of avibactam with representatives from all 3 MBL subfamilies (B1, B2, and B3).  Avibactam has only limited or no activity vs. MBL-mediated resistance in pathogens.  Avibactam does not inhibit MBLs and binds only weakly to most of the MBLs tested; in some cases, avibactam undergoes slow hydrolysis of one of its urea N-CO bonds followed by loss of CO2, in a process different from that obsd. with the SBLs studied.  The results suggest that while the evolution of MBLs that more efficiently catalyze avibactam hydrolysis should be anticipated, pursuing the development of dual-action SBL and MBL inhibitors based on the diazabicyclooctane core of avibactam may be productive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSoutDc696brVg90H21EOLACvtfcHk0lj8_mb7BPPZGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKkt74%253D&md5=e789376f6e1f32c28b2b26f3ed89e926</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.00897-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00897-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DDamblon%26aufirst%3DC.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSmargiasso%26aufirst%3DN.%26aulast%3DMercuri%26aufirst%3DP.%26aulast%3DGilbert%26aufirst%3DB.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26atitle%3DInteraction%2520of%2520avibactam%2520with%2520class%2520B%2520metallo-%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5655%26epage%3D5662%26doi%3D10.1128%2FAAC.00897-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanheira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamm, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Effect of the β-lactamase inhibitor vaborbactam combined with Meropenem against serine carbapenemase-producing <i>Enterobacteriaceae</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5454</span>– <span class="NLM_lpage">5458</span>, <span class="refDoi"> DOI: 10.1128/AAC.00711-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00711-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27381386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=5454-5458&author=M.+Castanheiraauthor=P.+R.+Rhombergauthor=R.+K.+Flammauthor=R.+N.+Jones&title=Effect+of+the+%CE%B2-lactamase+inhibitor+vaborbactam+combined+with+Meropenem+against+serine+carbapenemase-producing+Enterobacteriaceae&doi=10.1128%2FAAC.00711-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the β-lactamase inhibitor vaborbactam combined with meropenem against serine carbapenemase-producing Enterobacteriaceae</span></div><div class="casAuthors">Castanheira, Mariana; Rhomberg, Paul R.; Flamm, Robert K.; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5454-5458</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Klebsiella pneumoniae carbapenemase (KPC)-producing isolates have become increasingly prevalent worldwide, and these organisms are often multidrug resistant, limiting the therapeutic options available for treating infections.  We evaluated the activity of meropenem combined with the serine β-lactamase inhibitor vaborbactam (formerly RPX7009) against 315 serine carbapenemase-producing Enterobacteriaceae (CPE) isolates by use of checkerboard-designed panels to assess the optimal inhibitor concn. (range tested, 0.5-32 μg/mL).  Overall, meropenem alone (MIC50 and MIC90, 16 and >64 μg/mL, resp.) inhibited only 2.2% of the isolates at ≤1 μg/mL (the CLSI susceptibility breakpoint) and 7.3% of the isolates at ≤2 μg/mL (the EUCAST breakpoint).  Vaborbactam restored meropenem activity for 72.7-98.1% of CPE isolates at ≤2 μg/mL, and max. potentiation was achieved with fixed concns. of ≥8 μg/mL of the inhibitor (≥96.5% of isolates were inhibited at ≤2 μg/mL of meropenem-vaborbactam).  Meropenem-vaborbactam with a fixed concn. of 8 μg/mL of the inhibitor (MIC50, ≤0.06 μg/mL for all organisms) inhibited 93.7% of the CPE isolates displaying elevated meropenem MICs at ≤1 μg/mL.  Meropenem-vaborbactam MICs were elevated for isolates producing metallo-β-lactamases (MIC, 16 to >64 μg/mL) or displaying decreased expression of OmpK37 and(or) elevated expression of the AcrAB-TolC efflux system (MIC, 16 μg/mL).  Vaborbactam showed no antibacterial activity alone (all MICs, >64 μg/mL).  Meropenem-vaborbactam appears to be a good candidate for further development and it could increase the options for treatment of serious infections caused by carbapenemase-producing pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnr5l96JEPFLVg90H21EOLACvtfcHk0lj8_mb7BPPZGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKlurc%253D&md5=a4de13834f14ba25527ffcd4280584e6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.00711-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00711-16%26sid%3Dliteratum%253Aachs%26aulast%3DCastanheira%26aufirst%3DM.%26aulast%3DRhomberg%26aufirst%3DP.%2BR.%26aulast%3DFlamm%26aufirst%3DR.%2BK.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DEffect%2520of%2520the%2520%25CE%25B2-lactamase%2520inhibitor%2520vaborbactam%2520combined%2520with%2520Meropenem%2520against%2520serine%2520carbapenemase-producing%2520Enterobacteriaceae%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D5454%26epage%3D5458%26doi%3D10.1128%2FAAC.00711-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Castellanos, J.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12406</span>, <span class="refDoi"> DOI: 10.1038/ncomms12406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fncomms12406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27499424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12406&author=J.+Bremauthor=R.+Cainauthor=S.+Cahillauthor=M.+A.+McDonoughauthor=I.+J.+Cliftonauthor=J.%0AC.+Jimenez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=C.+W.+Fishwickauthor=C.+J.+Schofield&title=Structural+basis+of+metallo-%CE%B2-lactamase%2C+serine-%CE%B2-lactamase+and+penicillin-binding+protein+inhibition+by+cyclic+boronates&doi=10.1038%2Fncomms12406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates</span></div><div class="casAuthors">Brem, Jurgen; Cain, Ricky; Cahill, Samuel; McDonough, Michael A.; Clifton, Ian J.; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; Fishwick, Colin W. G.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12406</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lactamases enable resistance to almost all β-lactam antibiotics.  Pioneering work revealed that acyclic boronic acids can act as 'transition state analog' inhibitors of nucleophilic serine enzymes, including serine-β-lactamases.  Here we report biochem. and biophys. analyses revealing that cyclic boronates potently inhibit both nucleophilic serine and zinc-dependent β-lactamases by a mechanism involving mimicking of the common tetrahedral intermediate.  Cyclic boronates also potently inhibit the non-essential penicillin-binding protein PBP 5 by the same mechanism of action.  The results open the way for development of dual action inhibitors effective against both serine- and metallo-β-lactamases, and which could also have antimicrobial activity through inhibition of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod70NVhmwa-7Vg90H21EOLACvtfcHk0lgm53bf-tLbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaks7fM&md5=ec35f6a2ffbfe52b9046821526658492</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fncomms12406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12406%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DJimenez-Castellanos%26aufirst%3DJ.%2BC.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520metallo-%25CE%25B2-lactamase%252C%2520serine-%25CE%25B2-lactamase%2520and%2520penicillin-binding%2520protein%2520inhibition%2520by%2520cyclic%2520boronates%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12406%26doi%3D10.1038%2Fncomms12406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic boronates inhibit all classes of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e02260-16</span> <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28115348" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+boronates+inhibit+all+classes+of+%CE%B2-lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520boronates%2520inhibit%2520all%2520classes%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Antibacterial drug discovery in the resistance era</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>529</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/nature17042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnature17042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26791724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=529&publication_year=2016&pages=336-343&author=E.+D.+Brownauthor=G.+D.+Wright&title=Antibacterial+drug+discovery+in+the+resistance+era&doi=10.1038%2Fnature17042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial drug discovery in the resistance era</span></div><div class="casAuthors">Brown, Eric D.; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">529</span>
        (<span class="NLM_cas:issue">7586</span>),
    <span class="NLM_cas:pages">336-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The looming antibiotic resistance crisis has penetrated the consciousness of clinicians, researchers, policymakers, politicians and the public at large.  The evolution and widespread distribution of antibiotic resistance elements in bacterial pathogens has made diseases that were once easily treatable deadly again.  Unfortunately, accompanying the rise in global resistance is a failure in antibacterial drug discovery.  Lessons from the history of antibiotic discovery and fresh understanding of antibiotic action and the cell biol. of microorganisms have the potential to deliver twenty-first century medicines that are able to control infection in the resistance era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJH_K99a5abVg90H21EOLACvtfcHk0lgm53bf-tLbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oisro%253D&md5=62e0454601a242db039e60d77be26406</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature17042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17042%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DAntibacterial%2520drug%2520discovery%2520in%2520the%2520resistance%2520era%26jtitle%3DNature%26date%3D2016%26volume%3D529%26spage%3D336%26epage%3D343%26doi%3D10.1038%2Fnature17042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency metrics: why all the fuss?</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.4155%2Ffmc.15.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26230875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1363-1365&author=C.+H.+Reynolds&title=Ligand+efficiency+metrics%3A+why+all+the+fuss%3F&doi=10.4155%2Ffmc.15.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency metrics: why all the fuss?</span></div><div class="casAuthors">Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1365</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRoxxN9bLP5rVg90H21EOLACvtfcHk0lhQXNqZR3GRbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvL&md5=62d01378f043e2bda9f26248886567df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.70%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DLigand%2520efficiency%2520metrics%253A%2520why%2520all%2520the%2520fuss%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1363%26epage%3D1365%26doi%3D10.4155%2Ffmc.15.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Someya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors</span>. <i>Chem Sci</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1039/C6SC04524C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC6SC04524C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28451231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=928-937&author=G.+B.+Liauthor=M.+I.+Abboudauthor=J.+Bremauthor=H.+Someyaauthor=C.+T.+Lohansauthor=S.+Y.+Yangauthor=J.+Spencerauthor=D.+W.+Warehamauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=NMR-filtered+virtual+screening+leads+to+non-metal+chelating+metallo-%CE%B2-lactamase+inhibitors&doi=10.1039%2FC6SC04524C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors</span></div><div class="casAuthors">Li, Guo-Bo; Abboud, Martine I.; Brem, Jurgen; Someya, Hidenori; Lohans, Christopher T.; Yang, Sheng-Yong; Spencer, James; Wareham, David W.; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">928-937</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">There are no clin. useful inhibitors of metallo-β-lactamases (MBLs), which are a growing problem because they hydrolyze almost all β-lactam antibacterials.  Inhibition by most reported MBL inhibitors involves zinc ion chelation.  A structure-based virtual screening approach combined with NMR filtering led to the identification of inhibitors of the clin. relevant Verona Integron-encoded MBL (VIM)-2.  Crystallog. analyses reveal a new mode of MBL inhibition involving binding adjacent to the active site zinc ions, but which does not involve metal chelation.  The results will aid efforts to develop new types of clin. useful inhibitors targeting MBLs/MBL-fold metallo-enzymes involved in antibacterial and anticancer drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7UmnEg9kLNrVg90H21EOLACvtfcHk0lhQXNqZR3GRbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOksrjI&md5=82e39be35ca8dca01edc6213a67fe9d3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC6SC04524C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC04524C%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSomeya%26aufirst%3DH.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DNMR-filtered%2520virtual%2520screening%2520leads%2520to%2520non-metal%2520chelating%2520metallo-%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DChem%2520Sci%26date%3D2017%26volume%3D8%26spage%3D928%26epage%3D937%26doi%3D10.1039%2FC6SC04524C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">ZINC--a free database of commercially available compounds for virtual screening</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1021/ci049714+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049714%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=177-182&author=J.+J.+Irwinauthor=B.+K.+Shoichet&title=ZINC%2D%2Da+free+database+of+commercially+available+compounds+for+virtual+screening&doi=10.1021%2Fci049714%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">ZINC--a free database of commercially available compounds for virtual screening</span></div><div class="casAuthors">Irwin John J; Shoichet Brian K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical information and modeling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">177-82</span>
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    </div><div class="casAbstract">A critical barrier to entry into structure-based virtual screening is the lack of a suitable, easy to access database of purchasable compounds.  We have therefore prepared a library of 727,842 molecules, each with 3D structure, using catalogs of compounds from vendors (the size of this library continues to grow).  The molecules have been assigned biologically relevant protonation states and are annotated with properties such as molecular weight, calculated LogP, and number of rotatable bonds.  Each molecule in the library contains vendor and purchasing information and is ready for docking using a number of popular docking programs.  Within certain limits, the molecules are prepared in multiple protonation states and multiple tautomeric forms.  In one format, multiple conformations are available for the molecules.  This database is available for free download (http://zinc.docking.org) in several common file formats including SMILES, mol2, 3D SDF, and DOCK flexibase format.  A Web-based query tool incorporating a molecular drawing interface enables the database to be searched and browsed and subsets to be created.  Users can process their own molecules by uploading them to a server.  Our hope is that this database will bring virtual screening libraries to a wide community of structural biologists and medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVi_-excgTX-_Q9URG6Dx8fW6udTcc2eY28V6Cx77x_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FktVKrtA%253D%253D&md5=9f2e3ec06d53276884fc17b9aad47e61</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci049714%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049714%252B%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DZINC--a%2520free%2520database%2520of%2520commercially%2520available%2520compounds%2520for%2520virtual%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2005%26volume%3D45%26spage%3D177%26epage%3D182%26doi%3D10.1021%2Fci049714%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huggins, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidor, B.</span></span> <span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1021/jm2010332</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design&doi=10.1021%2Fjm2010332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0lgwODrROpLEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444%26doi%3D10.1021%2Fjm2010332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Q.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2574</span>– <span class="NLM_lpage">2582</span>, <span class="refDoi"> DOI: 10.1096/fj.11-184036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1096%2Ffj.11-184036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21507902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2574-2582&author=H.+Zhangauthor=Q.+Hao&title=Crystal+structure+of+NDM-1+reveals+a+common+%CE%B2-lactam+hydrolysis+mechanism&doi=10.1096%2Ffj.11-184036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism</span></div><div class="casAuthors">Zhang, Hong Min; Hao, Quan</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2574-2582, 10.1096/fj.11-184036</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze most β-lactam antibiotics, and bacteria contg. this kind of enzyme pose a serious threat to the public health.  The newly identified New Delhi MBL (NDM-1) is a new member of this family that shows tight binding to penicillin and cephalosporins.  The rapid dissemination of NDM-1 in clin. relevant bacteria has become a global concern.  However, no clin. useful inhibitors against MBLs exist, partly due to the lack of knowledge about the catalysis mechanism of this kind of enzyme.  Here we report the crystal structure of this novel enzyme in complex with a hydrolyzed ampicillin at its active site at 1.3-Å resoln.  Structural comparison with other MBLs revealed a new hydrolysis mechanism applicable to all three subclasses of MBLs, which might help the design of mechanism-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZmgVz8KyqbVg90H21EOLACvtfcHk0lh5mbcUPBxjAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFersrk%253D&md5=32c83d7babafe70cef7ff785b855e142</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-184036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-184036%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DQ.%26atitle%3DCrystal%2520structure%2520of%2520NDM-1%2520reveals%2520a%2520common%2520%25CE%25B2-lactam%2520hydrolysis%2520mechanism%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2574%26epage%3D2582%26doi%3D10.1096%2Ffj.11-184036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">14694</span>– <span class="NLM_lpage">14697</span>, <span class="refDoi"> DOI: 10.1021/ja508388e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja508388e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14694-14697&author=H.+Fengauthor=J.+Dingauthor=D.+Zhuauthor=X.+Liuauthor=X.+Xuauthor=Y.+Zhangauthor=S.+Zangauthor=D.+C.+Wangauthor=W.+Liu&title=Structural+and+mechanistic+insights+into+NDM-1+catalyzed+hydrolysis+of+cephalosporins&doi=10.1021%2Fja508388e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Mechanistic Insights into NDM-1 Catalyzed Hydrolysis of Cephalosporins</span></div><div class="casAuthors">Feng, Han; Ding, Jingjin; Zhu, Deyu; Liu, Xuehui; Xu, Xueyong; Zhang, Ying; Zang, Shanshan; Wang, Da-Cheng; Liu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14694-14697</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cephalosporins constitute a large class of β-lactam antibiotics clin. used as antimicrobial drugs.  New Delhi metallo-β-lactamase (NDM-1) poses a global threat to human health as it confers on bacterial pathogens resistance to almost all β-lactams, including penicillins, cephalosporins, and carbapenems.  Here we report the first crystal structures of NDM-1 in complex with cefuroxime and cephalexin, as well as NMR spectra monitoring cefuroxime and cefixime hydrolysis catalyzed by NDM-1.  Surprisingly, cephalosporoate intermediates were captured in both crystal structures detd. at 1.3 and 2.0 Å.  These results provide detailed information concerning the mechanism and pathways of cephalosporin hydrolysis.  We also present the crystal structure and enzyme assays of a D124N mutant, which reveals that D124 most likely plays a more structural than catalytic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor8vkfYEWv6LVg90H21EOLACvtfcHk0lh5mbcUPBxjAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrbK&md5=66868127d02c17abad6d0da6354ddcf6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja508388e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508388e%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520NDM-1%2520catalyzed%2520hydrolysis%2520of%2520cephalosporins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14694%26epage%3D14697%26doi%3D10.1021%2Fja508388e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesay, D. R.</span></span> <span> </span><span class="NLM_article-title">A case study comparing quantitative stability-flexibility relationships across five metallo-β-lactamases highlighting differences within NDM-1</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1084</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-658-0_12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2F978-1-62703-658-0_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=24061924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1Crt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1084&publication_year=2014&pages=227-238&author=M.+C.+Brownauthor=D.+Vermaauthor=C.+Russellauthor=D.+J.+Jacobsauthor=D.+R.+Livesay&title=A+case+study+comparing+quantitative+stability-flexibility+relationships+across+five+metallo-%CE%B2-lactamases+highlighting+differences+within+NDM-1&doi=10.1007%2F978-1-62703-658-0_12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Case Study Comparing Quantitative Stability-Flexibility Relationships Across Five Metallo-β-Lactamases Highlighting Differences Within NDM-1</span></div><div class="casAuthors">Brown, Matthew C.; Verma, Deeptak; Russell, Christian; Jacobs, Donald J.; Livesay, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1084</span>
        (<span class="NLM_cas:issue">Protein Dynamics</span>),
    <span class="NLM_cas:pages">227-238</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The Distance Constraint Model (DCM) is an ensemble-based biophys. model that integrates thermodn. and mech. viewpoints of protein structure.  The DCM outputs a large no. of structural characterizations that collectively allow for Quantified Stability-Flexibility Relationships (QSFR) to be identified and compared across protein families.  Using five metallo-β-lactamases (MBLs) as a representative set, we demonstrate how QSFR properties are both conserved and varied across protein families.  Similar to our characterizations on other protein families, the backbone flexibility of the five MBLs are overall visually conserved, yet there are interesting specific quant. differences.  For example, the plasmid-encoded NDM-1 enzyme, which leads to a fast spreading drug-resistant version of Klebsiella pneumoniae, has several regions of significantly increased rigidity relative to the other four.  In addn., the set of intramol. couplings within NDM-1 are also atypical.  While long-range couplings frequently vary significantly across protein families, NDM-1 is distinct because it has limited correlated flexibility, which is isolated within the active site S3/S4 and S11/H6 loops.  These loops are flexibly correlated in the other members, suggesting it is important to function, but the others also have significant amts. of correlated flexibility throughout the rest of their structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiyhaOaS1-7Vg90H21EOLACvtfcHk0lgA0HI0WJ3zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1Crt7s%253D&md5=59ce92ae09f3cc726c96a996063de0cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-658-0_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-658-0_12%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%2BC.%26aulast%3DVerma%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DC.%26aulast%3DJacobs%26aufirst%3DD.%2BJ.%26aulast%3DLivesay%26aufirst%3DD.%2BR.%26atitle%3DA%2520case%2520study%2520comparing%2520quantitative%2520stability-flexibility%2520relationships%2520across%2520five%2520metallo-%25CE%25B2-lactamases%2520highlighting%2520differences%2520within%2520NDM-1%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2014%26volume%3D1084%26spage%3D227%26epage%3D238%26doi%3D10.1007%2F978-1-62703-658-0_12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Elucidating the role of Trp105 in the KPC-2 β-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1727</span>, <span class="refDoi"> DOI: 10.1002/pro.454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fpro.454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20662006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2gsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1714-1727&author=K.+M.+Papp-Wallaceauthor=M.+Taracilaauthor=C.+J.+Wallaceauthor=K.+M.+Hujerauthor=C.+R.+Bethelauthor=J.+M.+Hornickauthor=R.+A.+Bonomo&title=Elucidating+the+role+of+Trp105+in+the+KPC-2+%CE%B2-lactamase&doi=10.1002%2Fpro.454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating the role of Trp105 in the KPC-2 β-lactamase</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Taracila, Magdalena; Wallace, Christopher J.; Hujer, Kristine M.; Bethel, Christopher R.; Hornick, John M.; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1714-1727</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The mol. basis of resistance to β-lactams and β-lactam-β-lactamase inhibitor combinations in the KPC family of class A enzymes is of extreme importance to the future design of effective β-lactam therapy.  Recent crystal structures of KPC-2 and other class A β-lactamases suggest that Ambler position Trp105 may be of importance in binding β-lactam compds.  Based on this notion, we explored the role of residue Trp105 in KPC-2 by conducting site-satn. mutagenesis at this position.  Escherichia coli DH10B cells expressing the Trp105Phe, -Tyr, -Asn, and -His KPC-2 variants possessed minimal inhibitory concns. (MICs) similar to E. coli cells expressing wild type (WT) KPC-2.  Interestingly, most of the variants showed increased MICs to ampicillin-clavulanic acid but not to ampicillin-sulbactam or piperacillin-tazobactam.  To explain the biochem. basis of this behavior, four variants (Trp105Phe, -Asn, -Leu, and -Val) were studied in detail.  Consistent with the MIC data, the Trp105Phe β-lactamase displayed improved catalytic efficiencies, kcat/Km, toward piperacillin, cephalothin, and nitrocefin, but slightly decreased kcat/Km toward cefotaxime and imipenem when compared to WT β-lactamase.  The Trp105Asn variant exhibited increased Kms for all substrates.  In contrast, the Trp105Leu and -Val substituted enzymes demonstrated notably decreased catalytic efficiencies (kcat/Km) for all substrates.  With respect to clavulanic acid, the Kis and partition ratios were increased for the Trp105Phe, -Asn, and -Val variants.  We conclude that interactions between Trp105 of KPC-2 and the β-lactam are essential for hydrolysis of substrates.  Taken together, kinetic and mol. modeling studies define the role of Trp105 in β-lactam and β-lactamase inhibitor discrimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gp2YXB8MvLVg90H21EOLACvtfcHk0li1YjwbZg3UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2gsLrL&md5=97d5257eb1e887e6f8da804e262e6327</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fpro.454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.454%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DC.%2BJ.%26aulast%3DHujer%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DHornick%26aufirst%3DJ.%2BM.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DElucidating%2520the%2520role%2520of%2520Trp105%2520in%2520the%2520KPC-2%2520%25CE%25B2-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D1714%26epage%3D1727%26doi%3D10.1002%2Fpro.454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borosky, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubrowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferkany, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbon, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and glutamate antagonist activity of 4-phosphonoalkylquinoline derivatives: a novel class of non-NMDA antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2035</span>– <span class="NLM_lpage">2040</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80558-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2FS0960-894X%2801%2980558-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2035-2040&author=G.+S.+Hamiltonauthor=D.+Bednarauthor=S.+A.+Boroskyauthor=Z.+Huangauthor=R.+Zubrowskiauthor=J.+W.+Ferkanyauthor=E.+W.+Karbon&title=Synthesis+and+glutamate+antagonist+activity+of+4-phosphonoalkylquinoline+derivatives%3A+a+novel+class+of+non-NMDA+antagonist&doi=10.1016%2FS0960-894X%2801%2980558-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980558-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980558-8%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%2BS.%26aulast%3DBednar%26aufirst%3DD.%26aulast%3DBorosky%26aufirst%3DS.%2BA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZubrowski%26aufirst%3DR.%26aulast%3DFerkany%26aufirst%3DJ.%2BW.%26aulast%3DKarbon%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520glutamate%2520antagonist%2520activity%2520of%25204-phosphonoalkylquinoline%2520derivatives%253A%2520a%2520novel%2520class%2520of%2520non-NMDA%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2035%26epage%3D2040%26doi%3D10.1016%2FS0960-894X%2801%2980558-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nchembio.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnchembio.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19305397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=358-364&author=Y.+Chenauthor=B.+K.+Shoichet&title=Molecular+docking+and+ligand+specificity+in+fragment-based+inhibitor+discovery&doi=10.1038%2Fnchembio.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span></div><div class="casAuthors">Chen, Yu; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000-10,000 compds.).  This raises two questions: would other noteworthy chemotypes be found were one to screen all com. available fragments (>300,000), and does the success rate imply low specificity of fragments.  We used mol. docking to screen large libraries of fragments against CTX-M β-lactamase.  We identified ten millimolar-range inhibitors from the 69 compds. tested.  The docking poses corresponded closely to the crystallog. structures subsequently detd.  Notably, these initial low-affinity hits showed little specificity between CTX-M and an unrelated β-lactamase, AmpC, which is unusual among β-lactamase inhibitors.  This is consistent with the idea that the high hit rates among fragments correlate to a low initial specificity.  As the inhibitors were progressed, both specificity and affinity rose together, yielding to our knowledge the first micromolar-range noncovalent inhibitors against a class A β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8zTkq9kMAbVg90H21EOLACvtfcHk0li1YjwbZg3UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D&md5=6ee8dd19d0b99599ea74eaf735483b1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.155%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DMolecular%2520docking%2520and%2520ligand%2520specificity%2520in%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teotico, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Docking for fragment inhibitors of AmpC β-lactamase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">7455</span>– <span class="NLM_lpage">7460</span>, <span class="refDoi"> DOI: 10.1073/pnas.0813029106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.0813029106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19416920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1Khtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=7455-7460&author=D.+G.+Teoticoauthor=K.+Babaogluauthor=G.+J.+Rocklinauthor=R.+S.+Ferreiraauthor=A.+M.+Giannettiauthor=B.+K.+Shoichet&title=Docking+for+fragment+inhibitors+of+AmpC+%CE%B2-lactamase&doi=10.1073%2Fpnas.0813029106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Docking for fragment inhibitors of AmpC 83-lactamase</span></div><div class="casAuthors">Teotico, Denise G.; Babaoglu, Kerim; Rocklin, Gabriel J.; Ferreira, Rafaela S.; Giannetti, Anthony M.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7455-7460</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fragment screens for new ligands have had wide success, not withstanding their constraint to libraries of 1000-10,000 mols.  Larger libraries would be addressable were mol. docking reliable for fragment screens, but this has not been widely accepted.  To investigate docking's ability to prioritize fragments, a library of >137,000 such mols. were docked against the structure of β-lactamase.  Forty-eight fragments highly ranked by docking were acquired and tested; 23 had Ki values ranging from 0.7 to 9.2 mM.  X-ray crystal structures of the enzyme-bound complexes were detd. for 8 of the fragments.  For 4, the correspondence between the predicted and exptl. structures was high (RMSD between 1.2 and 1.4 Å), whereas for another 2, the fidelity was lower but retained most key interactions (RMSD 2.4-2.6 Å).  Two of the 8 fragments adopted very different poses in the active site owing to enzyme conformational changes.  The 48% hit rate of the fragment docking compares very favorably with "lead-like" docking and high-throughput screening against the same enzyme.  To understand this, we investigated the occurrence of the fragment scaffolds among larger, lead-like mols.  Approx. 1% of com. available fragments contain these inhibitors whereas only 10-7% of lead-like mols. do.  This suggests that many more chemotypes and combinations of chemotypes are present among fragments than are available among lead-like mols., contributing to the higher hit rates.  The ability of docking to prioritize these fragments suggests that the technique can be used to exploit the better chemotype coverage that exists at the fragment level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpafzXv4ydrVg90H21EOLACvtfcHk0li-RDHoCpVqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1Khtrg%253D&md5=d2df01432d5381c226e8aa7e008457b5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0813029106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0813029106%26sid%3Dliteratum%253Aachs%26aulast%3DTeotico%26aufirst%3DD.%2BG.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DRocklin%26aufirst%3DG.%2BJ.%26aulast%3DFerreira%26aufirst%3DR.%2BS.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DDocking%2520for%2520fragment%2520inhibitors%2520of%2520AmpC%2520%25CE%25B2-lactamase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D7455%26epage%3D7460%26doi%3D10.1073%2Fpnas.0813029106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Phosphonate monoester inhibitors of class A β-lactamases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1042/bj2750793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1042%2Fbj2750793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1903928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaK3MXksVCqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1991&pages=793-795&author=J.+Rahilauthor=R.+F.+Pratt&title=Phosphonate+monoester+inhibitors+of+class+A+%CE%B2-lactamases&doi=10.1042%2Fbj2750793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonate monoester inhibitors of class A β-lactamases</span></div><div class="casAuthors">Rahil, Jubrail; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">793-5</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Phosphonate monoesters with the general structure (I, R1 = H, NO2) are inhibitors of representative class A and class C β-lactamases.  This result extends the range of this type of inhibitor to the class A enzymes.  Compds. where R1 is an electron-withdrawing substituent are better inhibitors than the unsubstituted analog (R1 = H), and enzyme inhibition is concerted with stoichiometric release of the substituted phenol.  Slow turnover of the phosphonates also occurs.  These observations support the proposition that the mechanism of action of these inhibitors involves phosphorylation of the β-lactamase active site.  The inhibitory ability of these phosphonates suggests that the β-lactamase active site is very effective at stabilizing neg. charged transition states.  One of the compds. described also inactivated the Streptomyces R61 D-alanyl-D-alanine carboxypeptidase/transpeptidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4uRdqMKHvbLVg90H21EOLACvtfcHk0li-RDHoCpVqAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVCqsLk%253D&md5=cb5a248bbbbb5281bfe95a7d39149937</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1042%2Fbj2750793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2750793%26sid%3Dliteratum%253Aachs%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DPhosphonate%2520monoester%2520inhibitors%2520of%2520class%2520A%2520%25CE%25B2-lactamases%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D275%26spage%3D793%26epage%3D795%26doi%3D10.1042%2Fbj2750793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobkovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billings, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moews, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J. R.</span></span> <span> </span><span class="NLM_article-title">Crystallographic structure of a phosphonate derivative of the <i>Enterobacter cloacae</i> P99 cephalosporinase: mechanistic interpretation of a β-lactamase transition-state analog</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">6762</span>– <span class="NLM_lpage">6772</span>, <span class="refDoi"> DOI: 10.1021/bi00188a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00188a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1994&pages=6762-6772&author=E.+Lobkovskyauthor=E.+M.+Billingsauthor=P.+C.+Moewsauthor=J.+Rahilauthor=R.+F.+Prattauthor=J.+R.+Knox&title=Crystallographic+structure+of+a+phosphonate+derivative+of+the+Enterobacter+cloacae+P99+cephalosporinase%3A+mechanistic+interpretation+of+a+%CE%B2-lactamase+transition-state+analog&doi=10.1021%2Fbi00188a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Structure of a Phosphonate Derivative of the Enterobacter cloacae P99 Cephalosporinase: Mechanistic Interpretation of a β-Lactamase Transition-State Analog</span></div><div class="casAuthors">Lobkovsky, Emil; Billings, Eric M.; Moews, Paul C.; Rahil, Jubrail; Pratt, R. F.; Knox, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6762-72</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The crystal structure of a complex formed on reaction of the Enterobacter cloacae P99 cephalosporinase (β-lactamase) with a phosphonate monoester inhibitor, m-carboxyphenyl [[N-[(p-iodophenyl)acetyl]amino]methyl]phosphonate, has been obtained at 2.3-Å resoln.  The structure shows that the inhibitor has phosphonylated the active site serine (Ser64) with loss of the m-carboxyphenol leaving group.  The inhibitor is positioned in the active site in a way that can be interpreted in terms of a transition-state analog.  The arylacetamido side chain is placed as anticipated from analogous β-lactamoyl complexes of penicillin-recognizing enzymes, with the amido group hydrogen-bonded to the backbone carbonyl of Ser318 (of the B3 β-strand) and to the amides of Gln120 and Asn152.  There is support in the asymmetry of the hydrogen bonding of this side chain to the protein and in the 2-fold disorder of the benzyl group for the considerable breadth in substrate specificity exhibited by class C β-lactamases.  One phosphonyl oxygen atom is in the oxyanion hole, hydrogen-bonded to main-chain NH groups of Ser318 and Ser64, while the other oxygen is solvated, not within hydrogen-bonding distance of any amino acid side chain.  The closest active site functional group to the solvated oxygen atom is the Tyr150 hydroxyl group (3.4 Å); Lys67 and Lys315 are quite distant (4.3 and 5.7 Å, resp.).  Rather, Tyr150 and Lys67 are more closely assocd. with Ser64Oγ (2.9 and 3.3 Å).  This arrangement is interpreted in terms of the transition state for breakdown of the tetrahedral intermediate in the deacylation step of catalysis, where the Tyr150 phenol seems the most likely general acid.  Thus, Tyr150, as the phenoxide anion, would be the general base catalyst in acylation, as proposed by Oefner et al. [Nature (1990) 343, 284-288].  The structure is compared with that of a similar phosphonate deriv. of a class A β-lactamase [Chen et al. (1993) J. Mol. Biol. 234, 165-178], and mechanistic comparisons are made.  The sensitivity of serine β-lactamases, as opposed to serine proteinases, toward inhibition by phosphonate monoanions is supported by electrostatic calcns. showing a net pos. potential only in the catalytic sites of the β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhBObjYH0hQ7Vg90H21EOLACvtfcHk0lg74C04uEJngA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOisL0%253D&md5=e65cc066a080253acce6b06e42c88739</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi00188a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00188a004%26sid%3Dliteratum%253Aachs%26aulast%3DLobkovsky%26aufirst%3DE.%26aulast%3DBillings%26aufirst%3DE.%2BM.%26aulast%3DMoews%26aufirst%3DP.%2BC.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DKnox%26aufirst%3DJ.%2BR.%26atitle%3DCrystallographic%2520structure%2520of%2520a%2520phosphonate%2520derivative%2520of%2520the%2520Enterobacter%2520cloacae%2520P99%2520cephalosporinase%253A%2520mechanistic%2520interpretation%2520of%2520a%2520%25CE%25B2-lactamase%2520transition-state%2520analog%26jtitle%3DBiochemistry%26date%3D1994%26volume%3D33%26spage%3D6762%26epage%3D6772%26doi%3D10.1021%2Fbi00188a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nukaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Kinetics of turnover of cefotaxime by the <i>Enterobacter cloacae</i> P99 and GCl β-lactamases: two free enzyme forms of the P99 β-lactamase detected by a combination of pre- and post-steady state kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2664</span>– <span class="NLM_lpage">2672</span>, <span class="refDoi"> DOI: 10.1021/bi030212j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi030212j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=2664-2672&author=S.+Kumarauthor=S.+A.+Adediranauthor=M.+Nukagaauthor=R.+F.+Pratt&title=Kinetics+of+turnover+of+cefotaxime+by+the+Enterobacter+cloacae+P99+and+GCl+%CE%B2-lactamases%3A+two+free+enzyme+forms+of+the+P99+%CE%B2-lactamase+detected+by+a+combination+of+pre-+and+post-steady+state+kinetics&doi=10.1021%2Fbi030212j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of Turnover of Cefotaxime by the Enterobacter cloacae P99 and GCl β-Lactamases: Two Free Enzyme Forms of the P99 β-Lactamase Detected by a Combination of Pre- and Post-Steady State Kinetics</span></div><div class="casAuthors">Kumar, Sanjai; Adediran, S. A.; Nukaga, Michiyoshi; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2664-2672</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Third-generation cephalosporins bearing oximino side chains are resistant to hydrolysis by class C β-lactamases such as that from Enterobacter cloacae P99.  For example, steady state parameters for hydrolysis of cefotaxime by this enzyme are as follows: kcat = 0.41 s-1, Km = 17.2 μM, and kcat/Km = 2.3×104 s-1 M-1.  On the other hand, however, the Ki value for cefotaxime as an inhibitor of cephalothin hydrolysis is 27 nM.  The discrepancy between Km and Ki indicated that a real steady state had not been achieved in at least one of these expts.  Anal. indicated that only two to three cefotaxime turnovers occurred during the Ki detn.  This suggested that the first few turnovers of cefotaxime by the P99 β-lactamase may be different from those in the subsequent steady state.  A direct pre-steady state expt. confirmed this hypothesis.  The simplest reaction scheme that fitted the data involved replacement of the initial enzyme form, E, which bound cefotaxime tightly, with a second more weakly binding form, E', by partitioning of the acyl-enzyme intermediate during the first few turnovers.  Steady state turnover of cefotaxime then largely involved E' as the free enzyme form. E' slowly reverted to E in the post-steady state regime.  Further evidence for this scheme included quant. anal. of the post-steady state and observation of a difference in the catalytic activity of E and E' in 2 M ammonium sulfate.  The kinetics of P99 β-lactamase-catalyzed hydrolysis of an acyclic depsipeptide substrate bearing a third-generation cephalosporin side chain showed that the side chain is necessary but not sufficient for prodn. of resistance to β-lactamase; a combination of the side chain and the dihydrothiazine ring of a cephalosporin is required.  The β-lactamase of E. cloacae GC1, an extended spectrum mutant of the P99 enzyme, rapidly hydrolyzes third-generation cephalosporins, without the structural transition described above.  The flexibility of the extended Ω loop of the GC1 enzyme probably leads to this situation.  Conformational restriction of the loop in the P99 enzyme is probably responsible for the long-lived acyl-enzyme intermediate and the transition to E' induced by cefotaxime.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOfHVlut0FrVg90H21EOLACvtfcHk0lg74C04uEJngA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagsLk%253D&md5=d3f5886debb44bf380cc80072d4ef5fd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi030212j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030212j%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DNukaga%26aufirst%3DM.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DKinetics%2520of%2520turnover%2520of%2520cefotaxime%2520by%2520the%2520Enterobacter%2520cloacae%2520P99%2520and%2520GCl%2520%25CE%25B2-lactamases%253A%2520two%2520free%2520enzyme%2520forms%2520of%2520the%2520P99%2520%25CE%25B2-lactamase%2520detected%2520by%2520a%2520combination%2520of%2520pre-%2520and%2520post-steady%2520state%2520kinetics%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D2664%26epage%3D2672%26doi%3D10.1021%2Fbi030212j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvaggi, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. A.</span></span> <span> </span><span class="NLM_article-title">Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/β-lactamase inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">7046</span>– <span class="NLM_lpage">7053</span>, <span class="refDoi"> DOI: 10.1021/bi049612c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049612c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslKqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=7046-7053&author=N.+R.+Silvaggiauthor=K.+Kaurauthor=S.+A.+Adediranauthor=R.+F.+Prattauthor=J.+A.+Kelly&title=Toward+better+antibiotics%3A+crystallographic+studies+of+a+novel+class+of+DD-peptidase%2F%CE%B2-lactamase+inhibitors&doi=10.1021%2Fbi049612c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Toward Better Antibiotics: Crystallographic Studies of a Novel Class of DD-Peptidase/β-Lactamase Inhibitors</span></div><div class="casAuthors">Silvaggi, Nicholas R.; Kaur, Kamaljit; Adediran, S. A.; Pratt, R. F.; Kelly, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7046-7053</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are vital weapons in the treatment of bacterial infections, but their future is under increasing threat from β-lactamases.  These bacterial enzymes hydrolyze and inactivate β-lactam antibiotics, rendering the host cell resistant to the bactericidal effects of the drugs.  Nevertheless, the bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases), the killing targets of β-lactams, remain attractive targets for antibiotic compds.  Cyclic acyl phosph(on)ates have been developed and investigated as potential inhibitors of both transpeptidases and β-lactamases.  The x-ray crystal structures of the complexes of the Streptomyces strain R61 DD-peptidase inhibited by a bicyclic [1-hydroxy-4,5-benzo-2,6-dioxaphosphorinanone(3)-1-oxide] and a monocyclic [1-hydroxy-4-phenyl-2,6-dioxaphosphorinanone(3)-1-oxide] acyl phosphate were detd. to investigate the mode of action of these novel inhibitors.  The structures show, first, that these inhibitors form covalent bonds with the active site serine residue of the enzyme and that the refractory complexes thus formed are phosphoryl-enzyme species rather than acyl enzymes.  The complexes are long-lived largely because, after ring opening, the ligands adopt conformations that cannot directly recyclize, the latter a phenomenon previously obsd. with cyclic acyl phosph(on)ates.  While the two inhibitors bind in nearly identical conformations, the phosphoryl-enzyme complex formed from the monocyclic compd. is significantly less mobile than that formed from the bicyclic compd.  Despite this difference, the complex with the bicyclic compd. breaks down to regenerate free enzyme somewhat more slowly than that of the monocyclic.  This may be because of steric problems assocd. with the reorientation of the larger bicyclic ligand required for reactivation.  The structures are strikingly different in the orientation of the phosphoryl moiety from those generated using more specific phosph(on)ates.  Models of the noncovalent complexes of the monocyclic compd. with the R61 DD-peptidase and a structurally very similar class C β-lactamase suggest reasons why the former enzyme is phosphorylated by this compd., while the latter is acylated.  Finally, this paper provides information that will help in the design of addnl. DD-peptidase inhibitors with the potential to serve as leads in the development of novel antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMgbkglpwDYLVg90H21EOLACvtfcHk0ljc8LCI1o1shQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslKqtL0%253D&md5=3cb8e48467adab5ebae264668f8857d1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi049612c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049612c%26sid%3Dliteratum%253Aachs%26aulast%3DSilvaggi%26aufirst%3DN.%2BR.%26aulast%3DKaur%26aufirst%3DK.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26aulast%3DKelly%26aufirst%3DJ.%2BA.%26atitle%3DToward%2520better%2520antibiotics%253A%2520crystallographic%2520studies%2520of%2520a%2520novel%2520class%2520of%2520DD-peptidase%252F%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D7046%26epage%3D7053%26doi%3D10.1021%2Fbi049612c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbruck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercuri, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsfall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehareng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frere, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galleni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebrone, C.</span></span> <span> </span><span class="NLM_article-title">Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-β-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4862</span>– <span class="NLM_lpage">4876</span>, <span class="refDoi"> DOI: 10.1021/jm100213c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100213c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntF2ju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4862-4876&author=P.+Lassauxauthor=M.+Hamelauthor=M.+Guleaauthor=H.+Delbruckauthor=P.+S.+Mercuriauthor=L.+Horsfallauthor=D.+Deharengauthor=M.+Kupperauthor=J.+M.+Frereauthor=K.+Hoffmannauthor=M.+Galleniauthor=C.+Bebrone&title=Mercaptophosphonate+compounds+as+broad-spectrum+inhibitors+of+the+metallo-%CE%B2-lactamases&doi=10.1021%2Fjm100213c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mercaptophosphonate Compounds as Broad-Spectrum Inhibitors of the Metallo-β-lactamases</span></div><div class="casAuthors">Lassaux, Patricia; Hamel, Matthieu; Gulea, Mihaela; Delbruck, Heinrich; Mercuri, Paola Sandra; Horsfall, Louise; Dehareng, Dominique; Kupper, Michael; Frere, Jean-Marie; Hoffmann, Kurt; Galleni, Moreno; Bebrone, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4862-4876</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although commercialized inhibitors of active site serine β-lactamases are currently used in coadministration with antibiotic therapy, no clin. useful inhibitors of metallo-β-lactamases (MBLs) have yet been discovered.  In this paper, we investigated the inhibitory effect of mercaptophosphonate derivs. against the three subclasses of MBLs (B1, B2, and B3).  All 14 tested mercaptophosphonates, with the exception of 1a, behaved as competitive inhibitors for the three subclasses.  Apart from 13 and 21, all the mercaptophosphonates tested exhibit a good inhibitory effect on the subclass B2 MBL CphA with low inhibition consts. (Ki < 15 μM).  Interestingly, compd. 18 turned out to be a potent broad spectrum MBL inhibitor.  The crystallog. structures of the CphA-10a and CphA-18 complexes indicated that the sulfur atom of 10a and the phosphonato group of 18 interact with the Zn2+ ion, resp.  Mol. modeling studies of the interactions between compds. 10a and 18 and the VIM-4 (B1), CphA (B2), and FEZ-1 (B3) enzymes brought to light different binding modes depending on the enzyme and the inhibitor, consistent with the crystallog. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTg_BxmfSurVg90H21EOLACvtfcHk0ljc8LCI1o1shQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntF2ju74%253D&md5=c0161b56023beeefe300d50ae2fc43d9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm100213c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100213c%26sid%3Dliteratum%253Aachs%26aulast%3DLassaux%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DM.%26aulast%3DGulea%26aufirst%3DM.%26aulast%3DDelbruck%26aufirst%3DH.%26aulast%3DMercuri%26aufirst%3DP.%2BS.%26aulast%3DHorsfall%26aufirst%3DL.%26aulast%3DDehareng%26aufirst%3DD.%26aulast%3DKupper%26aufirst%3DM.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26aulast%3DHoffmann%26aufirst%3DK.%26aulast%3DGalleni%26aufirst%3DM.%26aulast%3DBebrone%26aufirst%3DC.%26atitle%3DMercaptophosphonate%2520compounds%2520as%2520broad-spectrum%2520inhibitors%2520of%2520the%2520metallo-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4862%26epage%3D4876%26doi%3D10.1021%2Fjm100213c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagseth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauksund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiros, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, A.</span></span> <span> </span><span class="NLM_article-title">Metallo-β-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.ejmech.2017.04.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28445786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslOitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=159-173&author=S.+Skagsethauthor=S.+Akhterauthor=M.+H.+Paulsenauthor=Z.+Muhammadauthor=S.+Lauksundauthor=O.+Samuelsenauthor=H.+S.+Leirosauthor=A.+Bayer&title=Metallo-%CE%B2-lactamase+inhibitors+by+bioisosteric+replacement%3A+preparation%2C+activity+and+binding&doi=10.1016%2Fj.ejmech.2017.04.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding</span></div><div class="casAuthors">Skagseth, Susann; Akhter, Sundus; Paulsen, Marianne H.; Muhammad, Zeeshan; Lauksund, Silje; Samuelsen, Oerjan; Leiros, Hanna-Kirsti S.; Bayer, Annette</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Bacterial resistance is compromising the use of β-lactam antibiotics including carbapenems.  The main resistance mechanism against β-lactams is hydrolysis of the β-lactam ring mediated by serine- or metallo-β-lactamases (MBLs).  Although several inhibitors of MBLs have been reported, none has been developed into a clin. useful inhibitor.  Mercaptocarboxylic acids are among the most prominent scaffolds reported as MBL inhibitors.  In this study, the carboxylate group of mercaptocarboxylic acids was replaced with bioisosteric groups like phosphonate esters, phosphonic acids and NH-tetrazoles.  The influence of the replacement on the bioactivity and inhibitor binding was evaluated.  A series of bioisosteres of previously reported inhibitors was synthesized and evaluated against the MBLs VIM-2, NDM-1 and GIM-1.  The most active inhibitors combined a mercapto group and a phosphonate ester or acid, with two/three carbon chains connecting a Ph group.  Surprisingly, also compds. contg. thioacetate groups instead of thiols showed low IC50 values.  High-resoln. crystal structures of three inhibitors in complex with VIM-2 revealed hydrophobic interactions for the di-Et groups in the phosphonate ester (inhibitor 2b), the mercapto bridging the two active site zinc ions, and tight stacking of the benzene ring to the inhibitor between Phe62, Tyr67, Arg228 and His263.  The inhibitors show reduced enzyme activity in Escherichia coli cells harboring MBL.  The obtained results will be useful for further structural guided design of MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrETOxPVcXLKbVg90H21EOLACvtfcHk0ljkKq6k7f2lpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslOitb4%253D&md5=fdcbe36f5777a32eaed8c3059c2d4e6d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.035%26sid%3Dliteratum%253Aachs%26aulast%3DSkagseth%26aufirst%3DS.%26aulast%3DAkhter%26aufirst%3DS.%26aulast%3DPaulsen%26aufirst%3DM.%2BH.%26aulast%3DMuhammad%26aufirst%3DZ.%26aulast%3DLauksund%26aufirst%3DS.%26aulast%3DSamuelsen%26aufirst%3DO.%26aulast%3DLeiros%26aufirst%3DH.%2BS.%26aulast%3DBayer%26aufirst%3DA.%26atitle%3DMetallo-%25CE%25B2-lactamase%2520inhibitors%2520by%2520bioisosteric%2520replacement%253A%2520preparation%252C%2520activity%2520and%2520binding%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D159%26epage%3D173%26doi%3D10.1016%2Fj.ejmech.2017.04.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krismanich, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desoky, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittle, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bols, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrienko, G. I.</span></span> <span> </span><span class="NLM_article-title">Structural and kinetic studies of the potent inhibition of metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlGrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1880-1892&author=P.+Hinchliffeauthor=C.+A.+Tannerauthor=A.+P.+Krismanichauthor=G.+Labbeauthor=V.+J.+Goodfellowauthor=L.+Marroneauthor=A.+Y.+Desokyauthor=K.+Calvopinaauthor=E.+E.+Whittleauthor=F.+Zengauthor=M.+B.+Avisonauthor=N.+C.+Bolsauthor=S.+Siemannauthor=J.+Spencerauthor=G.+I.+Dmitrienko&title=Structural+and+kinetic+studies+of+the+potent+inhibition+of+metallo-%CE%B2-lactamases+by+6-Phosphonomethylpyridine-2-carboxylates&doi=10.1021%2Facs.biochem.7b01299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates</span></div><div class="casAuthors">Hinchliffe, Philip; Tanner, Carol A.; Krismanich, Anthony P.; Labbe, Genevieve; Goodfellow, Valerie J.; Marrone, Laura; Desoky, Ahmed Y.; Calvopina, Karina; Whittle, Emily E.; Zeng, Fanxing; Avison, Matthew B.; Bols, Niels C.; Siemann, Stefan; Spencer, James; Dmitrienko, Gary I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1880-1892</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no clin. available inhibitors of metallo-β-lactamases (MBLs), enzymes which hydrolyze β-lactam antibiotics and confer resistance on Gram-neg. bacteria.  Here we present 6-phosphonomethylpyridine-2-carboxylates (PMPCs) as potent inhibitors of subclass B1 (IMP-1, VIM-2, NDM-1) and B3 (L1) MBLs.  Inhibition followed a competitive, slow-binding model without an isomerization step (IC50 values 0.3 - 7.2 μM; Ki 0.03 - 1.5 μM).  Min. inhibitory concn. assays demonstrated potentiation of β-lactam (meropenem) activity against MBL-producing bacteria, including clin. isolates, at concns. where eukaryotic cells remain viable.  Crystal structures revealed unprecedented modes of inhibitor binding to B1 (IMP-1) and B3 (L1) MBLs.  In IMP-1, binding does not replace the nucleophilic hydroxide and the PMPC carboxylate and pyridine nitrogen interact closely (2.3 and 2.7 Å, resp.) with the Zn2 ion of the binuclear metal site.  The phosphonate group makes limited interactions, but is 2.6 Å from the nucleophilic hydroxide.  Furthermore, the presence of a water mol. interacting with the PMPC phosphonate and pyridine N-C2 π-bond, as well as the nucleophilic hydroxide, suggests that the PMPC binds to the MBL active site as its hydrate.  Binding is markedly different in L1, with the phosphonate displacing both Zn2, forming a monozinc enzyme, and the nucleophilic hydroxide, while also making multiple interactions with the protein main chain and Zn1.  The carboxylate and pyridine nitrogen interact with Ser221/223, resp. (3 Å distance).  The potency, low toxicity, cellular activity and amenability to further modification of PMPCs indicate these and similar phosphonate compds. can be further considered for future MBL inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Msvht-yg4bVg90H21EOLACvtfcHk0lg71ezT_xwAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlGrtrs%253D&md5=f4fbb072f4bed72adf8d7e643cd684bb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01299%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DTanner%26aufirst%3DC.%2BA.%26aulast%3DKrismanich%26aufirst%3DA.%2BP.%26aulast%3DLabbe%26aufirst%3DG.%26aulast%3DGoodfellow%26aufirst%3DV.%2BJ.%26aulast%3DMarrone%26aufirst%3DL.%26aulast%3DDesoky%26aufirst%3DA.%2BY.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DWhittle%26aufirst%3DE.%2BE.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DBols%26aufirst%3DN.%2BC.%26aulast%3DSiemann%26aufirst%3DS.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DDmitrienko%26aufirst%3DG.%2BI.%26atitle%3DStructural%2520and%2520kinetic%2520studies%2520of%2520the%2520potent%2520inhibition%2520of%2520metallo-%25CE%25B2-lactamases%2520by%25206-Phosphonomethylpyridine-2-carboxylates%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D1880%26epage%3D1892%26doi%3D10.1021%2Facs.biochem.7b01299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Y.-c.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Rh(iii)-catalyzed directed C–H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and serine-β-lactamases</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1039/C8QO00009C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC8QO00009C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=1288-1292&author=C.+Zhangauthor=Y.-c.+Puauthor=Z.-J.+Yuauthor=C.-y.+Wuauthor=J.+Bremauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=G.-B.+Liauthor=Y.+Wu&title=Rh%28iii%29-catalyzed+directed+C%E2%80%93H+carbenoid+coupling+reveals+aromatic+bisphosphonates+inhibiting+metallo-+and+serine-%CE%B2-lactamases&doi=10.1039%2FC8QO00009C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Rh(III)-Catalyzed directed C-H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and Serine-β-lactamases</span></div><div class="casAuthors">Zhang, Chen; Pu, Yan-chi; Yu, Zhu-Jun; Wu, Cheng-yong; Brem, Jurgen; McDonough, Michael A.; Schofield, Christopher J.; Li, Guo-Bo; Wu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1288-1292</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the highly efficient and scalable Rh(III)-catalyzed C-H coupling of arenes with diazo-methylene-diphosphonates to give structurally diverse arom. bisphosphonates in good to excellent yields.  These bisphosphonates are one of the very few classes of inhibitors acting against the mechanistically distinct metallo-β-lactamases and serine-β-lactamases and thus represent good starting points for the development of broad spectrum β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouKaH5Ab53CbVg90H21EOLACvtfcHk0lg71ezT_xwAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yqt7g%253D&md5=512e68684f75728af5f627492cd5ed82</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC8QO00009C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QO00009C%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPu%26aufirst%3DY.-c.%26aulast%3DYu%26aufirst%3DZ.-J.%26aulast%3DWu%26aufirst%3DC.-y.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DLi%26aufirst%3DG.-B.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DRh%2528iii%2529-catalyzed%2520directed%2520C%25E2%2580%2593H%2520carbenoid%2520coupling%2520reveals%2520aromatic%2520bisphosphonates%2520inhibiting%2520metallo-%2520and%2520serine-%25CE%25B2-lactamases%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2018%26volume%3D5%26spage%3D1288%26epage%3D1292%26doi%3D10.1039%2FC8QO00009C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E3745</span>– <span class="NLM_lpage">E3754</span>, <span class="refDoi"> DOI: 10.1073/pnas.1601368113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1073%2Fpnas.1601368113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27303030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E3745-E3754&author=P.+Hinchliffeauthor=M.+M.+Gonzalezauthor=M.+F.+Mojicaauthor=J.+M.+Gonzalezauthor=V.+Castilloauthor=C.+Saizauthor=M.+Kosmopoulouauthor=C.+L.+Tookeauthor=L.+I.+Llarrullauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=A.+J.+Vilaauthor=J.+Spencer&title=Cross-class+metallo-%CE%B2-lactamase+inhibition+by+bisthiazolidines+reveals+multiple+binding+modes&doi=10.1073%2Fpnas.1601368113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span></div><div class="casAuthors">Hinchliffe, Philip; Gonzalez, Mariano M.; Mojica, Maria F.; Gonzalez, Javier M.; Castillo, Valerie; Saiz, Cecilia; Kosmopoulou, Magda; Tooke, Catherine L.; Llarrull, Leticia I.; Mahler, Graciela; Bonomo, Robert A.; Vila, Alejandro J.; Spencer, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E3745-E3754</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze almost all β-lactam antibiotics and are unaffected by clin. available β-lactamase inhibitors (βLIs).  Active site architecture divides MBLs into 3 classes (B1, B2, and B3), complicating the development of βLIs effective against all enzymes.  Bisthiazolidines (BTZs) are carboxylate-contg., bicyclic compds., considered as penicillin analogs with an addnl. free thiol.  Here, the authors show both L- and D-BTZ enantiomers are micromolar competitive βLIs of all MBL classes in vitro, with Ki values of 6-15 or 36-84 μM for subclass B1 MBLs (IMP-1 and BcII, resp.), and 10-12 μM for B3 enzyme L1.  Against B2 MBL Sfh-I, the L-BTZ enantiomers exhibited 100-fold lower Ki values (0.26-0.36 μM) than D-BTZs (26-29 μM).  Importantly, cell-based time-kill assays showed BTZs restored β-lactam susceptibility of Escherichia coli-producing MBLs (IMP-1, Sfh-1, BcII, and GOB-18) and, significantly, an extensively drug-resistant Stenotrophomonas maltophilia clin. isolate expressing L1.  BTZs therefore inhibit the full range of MBLs and potentiate β-lactam activity against producer pathogens.  X-ray crystal structures revealed insights into diverse BTZ binding modes, varying with orientation of the carboxylate and thiol moieties.  BTZs bound the di-zinc centers of B1 (IMP-1; BcII) and B3 (L1) MBLs via the free thiol, but oriented differently depending upon stereochem.  In contrast, the L-BTZ carboxylate dominated interactions with the mono-zinc B2 MBL Sfh-I, with the thiol uninvolved.  The D-BTZ complexes most closely resembled β-lactam binding to B1 MBLs, but featured an unprecedented disruption of the Asp-120-zinc interaction.  Cross-class MBL inhibition therefore arises from the unexpected versatility of BTZ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql0OqimvaJmrVg90H21EOLACvtfcHk0liWkBdsdaqGKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D&md5=8b663adf29172ac32d41f6aad7d13513</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1601368113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1601368113%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DGonzalez%26aufirst%3DJ.%2BM.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DSaiz%26aufirst%3DC.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DTooke%26aufirst%3DC.%2BL.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DCross-class%2520metallo-%25CE%25B2-lactamase%2520inhibition%2520by%2520bisthiazolidines%2520reveals%2520multiple%2520binding%2520modes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE3745%26epage%3DE3754%26doi%3D10.1073%2Fpnas.1601368113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span> <span> </span><span class="NLM_article-title">Bisthiazolidines: a substrate-mimicking scaffold as an inhibitor of the NDM-1 carbapenemase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=544-554&author=M.+M.+Gonzalezauthor=M.+Kosmopoulouauthor=M.+F.+Mojicaauthor=V.+Castilloauthor=P.+Hinchliffeauthor=I.+Pettinatiauthor=J.+Bremauthor=C.+J.+Schofieldauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=L.+I.+Llarrullauthor=J.+Spencerauthor=A.+J.+Vila&title=Bisthiazolidines%3A+a+substrate-mimicking+scaffold+as+an+inhibitor+of+the+NDM-1+carbapenemase&doi=10.1021%2Facsinfecdis.5b00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase</span></div><div class="casAuthors">Gonzalez, Mariano M.; Kosmopoulou, Magda; Mojica, Maria F.; Castillo, Valerie; Hinchliffe, Philip; Pettinati, Ilaria; Brem, Jurgen; Schofield, Christopher J.; Mahler, Graciela; Bonomo, Robert A.; Llarrull, Leticia I.; Spencer, James; Vila, Alejandro J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">544-554</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pathogenic Gram-neg. bacteria resistant to almost all β-lactam antibiotics are a major public health threat.  Zn(II)-dependent or metallo-β-lactamases (MBLs) produced by these bacteria inactivate most β-lactam antibiotics, including the carbapenems, which are "last line therapies" for life-threatening Gram-neg. infections.  NDM-1 is a carbapenemase belonging to the MBL family that is rapidly spreading worldwide.  Regrettably, inhibitors of MBLs are not yet developed.  Here the authors present the bisthiazolidine (BTZ) scaffold as a structure with some features of β-lactam substrates, which can be modified with metal-binding groups to target the MBL active site.  Inspired by known interactions of MBLs with β-lactams, the authors designed four BTZs that behave as in vitro NDM-1 inhibitors with Ki values in the low micromolar range (from 7±1 to 19±3 μM).  NMR spectroscopy demonstrated that they inhibit hydrolysis of imipenem in NDM-1-producing Escherichia coli.  In vitro time kill cell-based assays against a variety of bacterial strains harboring blaNDM-1 including Acinetobacter baumannii show that the compds. restore the antibacterial activity of imipenem.  A crystal structure of the most potent heterocycle (L-CS319) in complex with NDM-1 at 1.9 Å resoln. identified both structural determinants for inhibitor binding and opportunities for further improvements in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokg8f_hU7BV7Vg90H21EOLACvtfcHk0liWkBdsdaqGKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLbI&md5=3a13478a79bee2dddfad2137406d54a0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00046%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26atitle%3DBisthiazolidines%253A%2520a%2520substrate-mimicking%2520scaffold%2520as%2520an%2520inhibitor%2520of%2520the%2520NDM-1%2520carbapenemase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D544%26epage%3D554%26doi%3D10.1021%2Facsinfecdis.5b00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajaksouzian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rather, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhavsar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeole, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagwat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Strategic approaches to overcome resistance against gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel diazabicyclooctanes WCK 5153, zidebactam (WCK 5107), and WCK 4234</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4067</span>– <span class="NLM_lpage">4086</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4067-4086&author=K.+M.+Papp-Wallaceauthor=N.+Q.+Nguyenauthor=M.+R.+Jacobsauthor=C.+R.+Bethelauthor=M.+D.+Barnesauthor=V.+Kumarauthor=S.+Bajaksouzianauthor=S.+D.+Rudinauthor=P.+N.+Ratherauthor=S.+Bhavsarauthor=T.+Ravikumarauthor=P.+K.+Deshpandeauthor=V.+Patilauthor=R.+Yeoleauthor=S.+S.+Bhagwatauthor=M.+V.+Patelauthor=F.+van+den+Akkerauthor=R.+A.+Bonomo&title=Strategic+approaches+to+overcome+resistance+against+gram-negative+pathogens+using+%CE%B2-lactamase+inhibitors+and+%CE%B2-lactam+enhancers%3A+activity+of+three+novel+diazabicyclooctanes+WCK+5153%2C+zidebactam+%28WCK+5107%29%2C+and+WCK+4234&doi=10.1021%2Facs.jmedchem.8b00091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.; Nguyen, Nhu Q.; Jacobs, Michael R.; Bethel, Christopher R.; Barnes, Melissa D.; Kumar, Vijay; Bajaksouzian, Saralee; Rudin, Susan D.; Rather, Philip N.; Bhavsar, Satish; Ravikumar, Tadiparthi; Deshpande, Prasad K.; Patil, Vijay; Yeole, Ravindra; Bhagwat, Sachin S.; Patel, Mahesh V.; van den Akker, Focco; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4067-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Limited treatment options exist to combat infections caused by multidrug-resistant (MDR) Gram-neg. bacteria possessing broad-spectrum β-lactamases.  The design of novel β-lactamase inhibitors is of paramount importance.  Here, three novel diazabicyclooctanes (DBOs), WCK 5153, zidebactam (WCK 5107), and WCK 4234 (compds. 1-3, resp.), were synthesized and biochem. characterized against clin. important bacteria.  Compd. 3 inhibited class A, C, and D β-lactamases with unprecedented k2/K values against OXA carbapenemases.  Compds. 1 and 2 acylated class A and C β-lactamses rapidly but not the tested OXAs.  Compds. 1-3 formed highly stable acyl-complexes as demonstrated by mass spectrometry.  Crystallog. revealed that 1-3 complexed with KPC-2 adopted a "chair conformation" with the sulfate occupying the carboxylate binding region.  The cefepime-2 and meropenem-3 combinations were effective in murine peritonitis and neutropenic lung infection models caused by MDR Acinetobacter baumannii.  Compds. 1-3 are novel β-lactamase inhibitors that demonstate potent cross-class inhibition, and clin. studies targeting MDR infections are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKL3--mMKuLLVg90H21EOLACvtfcHk0lgwP9Q3Jff85Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntF2ntL4%253D&md5=3f4189d431cb020d003d5494f3d57e9b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00091%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DJacobs%26aufirst%3DM.%2BR.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DBarnes%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DBajaksouzian%26aufirst%3DS.%26aulast%3DRudin%26aufirst%3DS.%2BD.%26aulast%3DRather%26aufirst%3DP.%2BN.%26aulast%3DBhavsar%26aufirst%3DS.%26aulast%3DRavikumar%26aufirst%3DT.%26aulast%3DDeshpande%26aufirst%3DP.%2BK.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DYeole%26aufirst%3DR.%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26aulast%3DPatel%26aufirst%3DM.%2BV.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DStrategic%2520approaches%2520to%2520overcome%2520resistance%2520against%2520gram-negative%2520pathogens%2520using%2520%25CE%25B2-lactamase%2520inhibitors%2520and%2520%25CE%25B2-lactam%2520enhancers%253A%2520activity%2520of%2520three%2520novel%2520diazabicyclooctanes%2520WCK%25205153%252C%2520zidebactam%2520%2528WCK%25205107%2529%252C%2520and%2520WCK%25204234%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4067%26epage%3D4086%26doi%3D10.1021%2Facs.jmedchem.8b00091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismael, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopeit, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiros, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, A.</span></span> <span> </span><span class="NLM_article-title">A focused fragment library targeting the antibiotic resistance enzyme - oxacillinase-48: synthesis, structural evaluation and inhibitor design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.ejmech.2017.12.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29348071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVentLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=634-648&author=S.+Akhterauthor=B.+A.+Lundauthor=A.+Ismaelauthor=M.+Langerauthor=J.+Isakssonauthor=T.+Christopeitauthor=H.+S.+Leirosauthor=A.+Bayer&title=A+focused+fragment+library+targeting+the+antibiotic+resistance+enzyme+-+oxacillinase-48%3A+synthesis%2C+structural+evaluation+and+inhibitor+design&doi=10.1016%2Fj.ejmech.2017.12.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design</span></div><div class="casAuthors">Akhter, Sundus; Lund, Bjarte Aarmo; Ismael, Aya; Langer, Manuel; Isaksson, Johan; Christopeit, Tony; Leiros, Hanna-Kirsti S.; Bayer, Annette</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">634-648</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are of utmost importance when treating bacterial infections in the medical community.  However, currently their utility is threatened by the emergence and spread of β-lactam resistance.  The most prevalent resistance mechanism to β-lactam antibiotics is expression of β-lactamase enzymes.  One way to overcome resistance caused by β-lactamases, is the development of β-lactamase inhibitors and today several β-lactamase inhibitors e.g. avibactam, are approved in the clinic.  Our focus is the oxacillinase-48 (OXA-48), an enzyme reported to spread rapidly across the world and commonly identified in Escherichia coli and Klebsiella pneumoniae.  To guide inhibitor design, we used diversely substituted 3-aryl and 3-heteroaryl benzoic acids to probe the active site of OXA-48 for useful enzyme-inhibitor interactions.  In the presented study, a focused fragment library contg. 49 3-substituted benzoic acid derivs. were synthesized and biochem. characterized.  Based on crystallog. data from 33 fragment-enzyme complexes, the fragments could be classified into R1 or R2 binders by their overall binding conformation in relation to the binding of the R1 and R2 side groups of imipenem.  Moreover, binding interactions attractive for future inhibitor design were found and their usefulness explored by the rational design and evaluation of merged inhibitors from orthogonally binding fragments.  The best inhibitors among the resulting 3,5-disubstituted benzoic acids showed inhibitory potential in the low micromolar range (IC50 = 2.9 μM).  For these inhibitors, the complex X-ray structures revealed non-covalent binding to Arg250, Arg214 and Tyr211 in the active site and the interactions obsd. with the mono-substituted fragments were also identified in the merged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoADO0JKwowYrVg90H21EOLACvtfcHk0lgwP9Q3Jff85Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVentLk%253D&md5=fba0b4c7b8c0c1bec4928b895d68c48d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DAkhter%26aufirst%3DS.%26aulast%3DLund%26aufirst%3DB.%2BA.%26aulast%3DIsmael%26aufirst%3DA.%26aulast%3DLanger%26aufirst%3DM.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DChristopeit%26aufirst%3DT.%26aulast%3DLeiros%26aufirst%3DH.%2BS.%26aulast%3DBayer%26aufirst%3DA.%26atitle%3DA%2520focused%2520fragment%2520library%2520targeting%2520the%2520antibiotic%2520resistance%2520enzyme%2520-%2520oxacillinase-48%253A%2520synthesis%252C%2520structural%2520evaluation%2520and%2520inhibitor%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D634%26epage%3D648%26doi%3D10.1016%2Fj.ejmech.2017.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouza, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallar, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of <i>Acinetobacter</i>-derived cephalosporinase: exploring the carboxylate recognition site using novel β-lactamase inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00153</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00153" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWnt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=337-348&author=E.+Caselliauthor=C.+Romagnoliauthor=R.+A.+Powersauthor=M.+A.+Taracilaauthor=A.+A.+Bouzaauthor=H.+C.+Swansonauthor=K.+A.+Smolenauthor=F.+Finiauthor=B.+J.+Wallarauthor=R.+A.+Bonomoauthor=F.+Prati&title=Inhibition+of+Acinetobacter-derived+cephalosporinase%3A+exploring+the+carboxylate+recognition+site+using+novel+%CE%B2-lactamase+inhibitors&doi=10.1021%2Facsinfecdis.7b00153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors</span></div><div class="casAuthors">Caselli, Emilia; Romagnoli, Chiara; Powers, Rachel A.; Taracila, Magdalena A.; Bouza, Alexandra A.; Swanson, Hollister C.; Smolen, Kali A.; Fini, Francesco; Wallar, Bradley J.; Bonomo, Robert A.; Prati, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Boronic acids are attracting a lot of attention as β-lactamase inhibitors, and in particular compd. S02030 (Ki = 44 nM) proved to be a good lead compd. against ADC-7 (Acinetobacter Derived Cephalosporinase), one of the most significant resistance determinants in A. baumannii.  The at. structure of the ADC-7/S02030 complex highlighted the importance of crit. structural determinants for recognition of the boronic acids.  Herein, to elucidate the role in recognition of the R2-carboxylate, which mimics the C3/C4 found in β-lactams, we designed, synthesized, and characterized six derivs. of S02030 (3a).  Out of the six compds., the best inhibitors proved to be those with an explicit neg. charge (compds. 3a-c and 3h,j, Ki = 44-115 nM), which is in contrast to the derivs. where the neg. charge is omitted, such as the amide deriv. 3d (Ki = 224 nM) and the hydroxyamide deriv. 3e (Ki = 155 nM).  To develop a structural characterization of inhibitor binding in the active site, the X-ray crystal structures of ADC-7 in a complex with compds. 3c, SM23, and EC04 were detd.  All three compds. share the same structural features as in S02030, but only differ in the carboxy-R2 side chain, thereby providing the opportunity of exploring the distinct binding mode of the neg. charged R2 side chain.  This cephalosporinase demonstrates a high degree of versatility in recognition, employing different residues to directly interact with the carboxylate, thus suggesting the existence of a "carboxylate binding region" rather than binding site in ADC enzymes.  Furthermore, this class of compds. was tested against resistant clin. strains of A. baumannii and are effective at inhibiting bacterial growth in conjunction with a β-lactam antibiotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLiVb5ID7RX7Vg90H21EOLACvtfcHk0lhxplvlTfFpqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWnt7nE&md5=d3f02a44ba426f305b6c43ea8f4b78fc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00153%26sid%3Dliteratum%253Aachs%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBouza%26aufirst%3DA.%2BA.%26aulast%3DSwanson%26aufirst%3DH.%2BC.%26aulast%3DSmolen%26aufirst%3DK.%2BA.%26aulast%3DFini%26aufirst%3DF.%26aulast%3DWallar%26aufirst%3DB.%2BJ.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520Acinetobacter-derived%2520cephalosporinase%253A%2520exploring%2520the%2520carboxylate%2520recognition%2520site%2520using%2520novel%2520%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D337%26epage%3D348%26doi%3D10.1021%2Facsinfecdis.7b00153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouza, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDine, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallar, B. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based analysis of boronic acids as inhibitors of <i>Acinetobacter</i>-derived cephalosporinase-7, a unique class C β-lactamase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00152</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00152" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=325-336&author=A.+A.+Bouzaauthor=H.+C.+Swansonauthor=K.+A.+Smolenauthor=A.+L.+VanDineauthor=M.+A.+Taracilaauthor=C.+Romagnoliauthor=E.+Caselliauthor=F.+Pratiauthor=R.+A.+Bonomoauthor=R.+A.+Powersauthor=B.+J.+Wallar&title=Structure-based+analysis+of+boronic+acids+as+inhibitors+of+Acinetobacter-derived+cephalosporinase-7%2C+a+unique+class+C+%CE%B2-lactamase&doi=10.1021%2Facsinfecdis.7b00152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase</span></div><div class="casAuthors">Bouza, Alexandra A.; Swanson, Hollister C.; Smolen, Kali A.; VanDine, Alison L.; Taracila, Magdalena A.; Romagnoli, Chiara; Caselli, Emilia; Prati, Fabio; Bonomo, Robert A.; Powers, Rachel A.; Wallar, Bradley J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-336</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acinetobacter baumannii is a multidrug resistant pathogen that infects more than 12,000 patients each year in the US.  Much of the resistance to β-lactam antibiotics in Acinetobacter spp. is a result of class C β-lactamases known as Acinetobacter-derived cephalosporinases (ADCs).  ADCs are unaffected by clin. used β-lactam-based β-lactamase inhibitors.  In this study, five boronic acid transition state analog inhibitors (BATSIs) were evaluated for inhibition of the class C cephalosporinase ADC-7.  Our goal was to explore the properties of BATSIs designed to probe the R1 binding site.  Ki values ranged from low micromolar to sub-nanomolar, and CD (CD) demonstrated that each inhibitor stabilizes the β-lactamase-inhibitor complexes.  Addnl., X-ray crystal structures of ADC-7 in complex with five inhibitors were detd. (resolns. from 1.80-2.09 Å).  In the ADC-7/CR192 complex, the BATSI with the lowest Ki (0.45 nM) and greatest ΔTm (+9 °C), a trifluoromethyl substituent interacts with Arg340.  Arg340 is unique to ADCs and may play an important role in the inhibition of ADC-7.  The ADC-7/BATSI complexes detd. in this study shed light into the unique recognition sites in ADC enzymes, and also offer insight into further structure-based optimization of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw1UA39oODrVg90H21EOLACvtfcHk0ljbK7ZUYLr53g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWntrfF&md5=6453dfb5439845b40e5a9085470cf5ff</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00152%26sid%3Dliteratum%253Aachs%26aulast%3DBouza%26aufirst%3DA.%2BA.%26aulast%3DSwanson%26aufirst%3DH.%2BC.%26aulast%3DSmolen%26aufirst%3DK.%2BA.%26aulast%3DVanDine%26aufirst%3DA.%2BL.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26aulast%3DWallar%26aufirst%3DB.%2BJ.%26atitle%3DStructure-based%2520analysis%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520Acinetobacter-derived%2520cephalosporinase-7%252C%2520a%2520unique%2520class%2520C%2520%25CE%25B2-lactamase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D325%26epage%3D336%26doi%3D10.1021%2Facsinfecdis.7b00152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1002/pro.3100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fpro.3100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27997706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=515-526&author=J.+P.+Wernerauthor=J.+M.+Mitchellauthor=M.+A.+Taracilaauthor=R.+A.+Bonomoauthor=R.+A.+Powers&title=Exploring+the+potential+of+boronic+acids+as+inhibitors+of+OXA-24%2F40+%CE%B2-lactamase&doi=10.1002%2Fpro.3100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase</span></div><div class="casAuthors">Werner, Josephine P.; Mitchell, Joshua M.; Taracila, Magdalena A.; Bonomo, Robert A.; Powers, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Lactam antibiotics are crucial to the management of bacterial infections in the medical community.  Due to overuse and misuse, clin. significant bacteria are now resistant to many com. available antibiotics.  The most widespread resistance mechanism to β-lactams is the expression of β-lactamase enzymes.  To overcome β-lactamase mediated resistance, inhibitors were designed to inactivate these enzymes.  However, current inhibitors (clavulanic acid, tazobactam, and sulbactam) for β-lactamases also contain the characteristic β-lactam ring, making them susceptible to resistance mechanisms employed by bacteria.  This presents a crit. need for novel, non-β-lactam inhibitors that can circumvent these resistance mechanisms.  The carbapenem-hydrolyzing class D β-lactamases (CHDLs) are of particular concern, given that they efficiently hydrolyze potent carbapenem antibiotics.  Unfortunately, these enzymes are not inhibited by clin. available β-lactamase inhibitors, nor are they effectively inhibited by the newest, non-β-lactam inhibitor, avibactam.  Boronic acids are known transition state analog inhibitors of class A and C β-lactamases, and are not extensively characterized as inhibitors of class D β-lactamases.  Importantly, boronic acids provide a novel way to potentially inhibit class D β-lactamases.  Sixteen boronic acids were selected and tested for inhibition of the CHDL OXA-24/40.  Several compds. were identified as effective inhibitors of OXA-24/40, with Ki values as low as 5 μM.  The X-ray crystal structures of OXA-24/40 in complex with BA3, BA4, BA8, and BA16 were detd. and revealed the importance of interactions with hydrophobic residues Tyr112 and Trp115.  These boronic acids serve as progenitors in optimization efforts of a novel series of inhibitors for class D β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphGKFNJYCrO7Vg90H21EOLACvtfcHk0ljbK7ZUYLr53g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kisrg%253D&md5=73c4063f4a06e5cf8bd8262e17b6e611</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fpro.3100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3100%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DJ.%2BP.%26aulast%3DMitchell%26aufirst%3DJ.%2BM.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DPowers%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520potential%2520of%2520boronic%2520acids%2520as%2520inhibitors%2520of%2520OXA-24%252F40%2520%25CE%25B2-lactamase%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D515%26epage%3D526%26doi%3D10.1002%2Fpro.3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Akker, F.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1128/AAC.02643-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02643-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26729491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1760-1766&author=N.+Q.+Nguyenauthor=N.+P.+Krishnanauthor=L.+J.+Rojasauthor=F.+Pratiauthor=E.+Caselliauthor=C.+Romagnoliauthor=R.+A.+Bonomoauthor=F.+van+den+Akker&title=Crystal+structures+of+KPC-2+and+SHV-1+%CE%B2-lactamases+in+complex+with+the+boronic+acid+transition+state+analog+S02030&doi=10.1128%2FAAC.02643-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030</span></div><div class="casAuthors">Nguyen, Nhu Q.; Krishnan, Nikhil P.; Rojas, Laura J.; Prati, Fabio; Caselli, Emilia; Romagnoli, Chiara; Bonomo, Robert A.; van den Akker, Focco</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1760-1766</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Resistance to expanded-spectrum cephalosporins and carbapenems has rendered certain strains of Klebsiella pneumoniae the most problematic pathogens infecting patients in the hospital and community.  This broad-spectrum resistance to β-lactamases emerges in part via the expression of KPC-2 and SHV-1 β-lactamases and variants thereof.  KPC-2 carbapenemase is particularly worrisome, as the genetic determinant encoding this β-lactamase is rapidly spread via plasmids.  Moreover, KPC-2, a class A enzyme, is difficult to inhibit with mechanism-based inactivators (e.g., clavulanate).  In order to develop new β-lactamase inhibitors (BLIs) to add to the limited available armamentarium that can inhibit KPC-2, we have structurally probed the boronic acid transition state analog S02030 for its inhibition of KPC-2 and SHV-1.  S02030 contains a boronic acid, a thiophene, and a carboxyl triazole moiety.  We present here the 1.54- and 1.87-Å resoln. crystal structures of S02030 bound to SHV-1 and KPC-2 β-lactamases, resp., as well as a comparative anal. of the S02030 binding modes, including a previously detd. S02030 class C ADC-7 β-lactamase complex.  S02030 is able to inhibit vastly different serine β-lactamases by interacting with the conserved features of these active sites, which includes (i) forming the bond with catalytic serine via the boron atom, (ii) positioning one of the boronic acid oxygens in the oxyanion hole, and (iii) utilizing its amide moiety to make conserved interactions across the width of the active site.  In addn., S02030 is able to overcome more distantly located structural differences between the β-lactamases.  This unique feature is achieved by repositioning the more polar carboxyl-triazole moiety, generated by click chem., to create polar interactions as well as reorient the more hydrophobic thiophene moiety.  The former is aided by the unusual polar nature of the triazole ring, allowing it to potentially form a unique C-H...O 2.9-Å hydrogen bond with S130 in KPC-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodGweMm-OAFbVg90H21EOLACvtfcHk0lgRYXR0h0U3zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtLzK&md5=f4ccda8606d59dfff5826da032927471</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1128%2FAAC.02643-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02643-15%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DN.%2BQ.%26aulast%3DKrishnan%26aufirst%3DN.%2BP.%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bden%2BAkker%26aufirst%3DF.%26atitle%3DCrystal%2520structures%2520of%2520KPC-2%2520and%2520SHV-1%2520%25CE%25B2-lactamases%2520in%2520complex%2520with%2520the%2520boronic%2520acid%2520transition%2520state%2520analog%2520S02030%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1760%26epage%3D1766%26doi%3D10.1128%2FAAC.02643-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1128/AAC.02641-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02641-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=26729496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1751-1759&author=L.+J.+Rojasauthor=M.+A.+Taracilaauthor=K.+M.+Papp-Wallaceauthor=C.+R.+Bethelauthor=E.+Caselliauthor=C.+Romagnoliauthor=M.+L.+Winklerauthor=B.+Spellbergauthor=F.+Pratiauthor=R.+A.+Bonomo&title=Boronic+acid+transition+state+inhibitors+active+against+KPC+and+other+class+A+%CE%B2-lactamases%3A+structure-activity+relationships+as+a+guide+to+inhibitor+design&doi=10.1128%2FAAC.02641-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid transition state inhibitors active against KPC and other class A β-lactamases: structure-activity relationships as a guide to inhibitor design</span></div><div class="casAuthors">Rojas, Laura J.; Taracila, Magdalena A.; Papp-Wallace, Krisztina M.; Bethel, Christopher R.; Caselli, Emilia; Romagnoli, Chiara; Winkler, Marisa L.; Spellberg, Brad; Prati, Fabio; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1751-1759</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Boronic acid transition state inhibitors (BATSIs) are competitive, reversible β-lactamase inhibitors (BLIs).  In this study, a series of BATSIs with selectively modified regions (R1, R2, and amide group) were strategically designed and tested against representative class A β-lactamases of Klebsiella pneumoniae, KPC-2 and SHV-1.  Firstly, the R1 group of compds. 1a to 1c and 2a to 2e mimicked the side chain of cephalothin, whereas for compds. 3a to 3c, 4a, and 4b, the thiophene ring was replaced by a Ph, typical of benzylpenicillin.  Secondly, variations in the R2 groups which included substituted aryl side chains (compds. 1a, 1b, 1c, 3a, 3b, and 3c) and triazole groups (compds. 2a to 2e) were chosen to mimic the thiazolidine and dihydrothiazine ring of penicillins and cephalosporins, resp.  Thirdly, the amide backbone of the BATSI, which corresponds to the amide at C-6 or C-7 of β-lactams, was also changed to the following bioisosteric groups: urea (compd. 3b), thiourea (compd. 3c), and sulfonamide (compds. 4a and 4b).  Among the compds. that inhibited KPC-2 and SHV-1 β-lactamases, nine possessed 50% inhibitory concns. (IC50s) of ≤ 600 nM.  The most active compds. contained the thiopheneacetyl group at R1 and for the chiral BATSIs, a carboxy- or hydroxy-substituted aryl group at R2.  The most active sulfonamido deriv., compd. 4b, lacked an R2 group.  Compd. 2b (S02030) was the most active, with acylation rates (k2/K) of 1.2 ± 0.2 ± 104 M-1 s-1 for KPC-2 and 4.7 ± 0.6 × 103 M-1 s-1 for SHV-1, and demonstrated antimicrobial activity against Escherichia coli DH10B carrying blaSHV variants and blaKPC-2 or blaKPC-2 and against clin. strains of Klebsiella pneumoniae and E. coli producing different class A β-lactamase genes.  At most, MICs decreased from 16 to 0.5 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHumxGp1lHkrVg90H21EOLACvtfcHk0lgRYXR0h0U3zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtL3O&md5=490342c29e85e45e3bd1875eff15c583</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FAAC.02641-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02641-15%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DL.%2BJ.%26aulast%3DTaracila%26aufirst%3DM.%2BA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DCaselli%26aufirst%3DE.%26aulast%3DRomagnoli%26aufirst%3DC.%26aulast%3DWinkler%26aufirst%3DM.%2BL.%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DBoronic%2520acid%2520transition%2520state%2520inhibitors%2520active%2520against%2520KPC%2520and%2520other%2520class%2520A%2520%25CE%25B2-lactamases%253A%2520structure-activity%2520relationships%2520as%2520a%2520guide%2520to%2520inhibitor%2520design%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1751%26epage%3D1759%26doi%3D10.1128%2FAAC.02641-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celenza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span> <span> </span><span class="NLM_article-title">First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1007/s10822-018-0182-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1007%2Fs10822-018-0182-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=30603820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVWlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=295-305&author=F.+Spyrakisauthor=P.+Bellioauthor=A.+Quotadamoauthor=P.+Lincianoauthor=P.+Benedettiauthor=G.+D%E2%80%99Arrigoauthor=M.+Baroniauthor=L.+Cendronauthor=G.+Celenzaauthor=D.+Tondi&title=First+virtual+screening+and+experimental+validation+of+inhibitors+targeting+GES-5+carbapenemase&doi=10.1007%2Fs10822-018-0182-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase</span></div><div class="casAuthors">Spyrakis, Francesca; Bellio, Pierangelo; Quotadamo, Antonio; Linciano, Pasquale; Benedetti, Paolo; D'Arrigo, Giulia; Baroni, Massimo; Cendron, Laura; Celenza, Giuseppe; Tondi, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-305</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The worldwide spread of beta-lactamases with hydrolytic activity extended to last resort carbapenems is aggravating the antibiotic resistance problem and endangers the successful antimicrobial treatment of clin. relevant pathogens.  As recently highlighted by the World Health Organization, new strategies to contain antimicrobial resistance are urgently needed.  Class A carbapenemases include members of the KPC, GES and SFC families.  These enzymes have the ability to hydrolyze penicillins, cephalosporins and carbapenems, while also being less susceptible to available beta-lactam inhibitors, such as clavulanic acid.  The KPC family is the most prevalent.  It is mostly found on plasmids in Klebsiella pneumoniae, meaning that great amts. of attention, in terms of inhibitor design and structural biol., have been dedicated to it, whereas no efforts have yet been dedicated to GES-type enzymes, despite their ability to rapidly and horizontally disseminate.  We herein report the first in silico screening against GES-5, which is the most dangerous GES-type beta-lactamase, using a library of 800K com. available candidates that all share drug-like properties, such as their MW, logP, rotatable bonds and HBA/HBD atoms.  The best screening results were filtered to enrich the no. of different chemotypes, and then submitted to mol. docking.  The 34 most promising candidates were selected for in vitro validation in biochem. assays against recombinant GES-5.  Six hits acted as inhibitors, in the high micromolar range, towards GES-5 and led to the identification of the first, novel chemotypes with inhibitory activity against this clin. relevant carbapenemase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzOD4NfjpS9rVg90H21EOLACvtfcHk0lhj0Sz0gZqduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVWlurY%253D&md5=508eb4df044bbe7fbb7cb2afc9d6cada</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs10822-018-0182-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-018-0182-2%26sid%3Dliteratum%253Aachs%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DBellio%26aufirst%3DP.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DBenedetti%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DG.%26aulast%3DBaroni%26aufirst%3DM.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DCelenza%26aufirst%3DG.%26aulast%3DTondi%26aufirst%3DD.%26atitle%3DFirst%2520virtual%2520screening%2520and%2520experimental%2520validation%2520of%2520inhibitors%2520targeting%2520GES-5%2520carbapenemase%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2019%26volume%3D33%26spage%3D295%26epage%3D305%26doi%3D10.1007%2Fs10822-018-0182-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilvawala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammarata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adediran, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbelt, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">A new covalent inhibitor of class C β-lactamases reveals extended active site specificity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7375</span>– <span class="NLM_lpage">7384</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWitLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=7375-7384&author=R.+Tilvawalaauthor=M.+Cammarataauthor=S.+A.+Adediranauthor=J.+S.+Brodbeltauthor=R.+F.+Pratt&title=A+new+covalent+inhibitor+of+class+C+%CE%B2-lactamases+reveals+extended+active+site+specificity&doi=10.1021%2Facs.biochem.5b01149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A New Covalent Inhibitor of Class C β-Lactamases Reveals Extended Active Site Specificity</span></div><div class="casAuthors">Tilvawala, Ronak; Cammarata, Michael; Adediran, S. A.; Brodbelt, Jennifer S.; Pratt, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">7375-7384</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">O-Aryloxycarbonyl hydroxamates have previously been shown to efficiently inactivate class C β-lactamases by crosslinking serine and lysine residues in the active site.  A new analog of these inhibitors, D-(R)-O-(phenoxycarbonyl)-N-[(4-amino-4-carboxy-1-butyl)oxycarbonyl]hydroxylamine, designed to inactivate certain low-mol. mass DD-peptidases, has now been synthesized.  Although the new mol. was found to be only a poor inactivator of the latter enzymes, it proved, unexpectedly, to be a very effective inactivator (ki = 3.5 × 104 M-1s-1) of class C β-lactamases, more so than the original lead compd., O-phenoxycarbonyl-N-(benzyloxycarbonyl)hydroxylamine.  Furthermore, the mechanism of inactivation is different.  Mass spectrometry demonstrated that β-lactamase inactivation by the new mol. involved formation of an O-alkoxycarbonylhydroxamate with the nucleophilic active site serine residue.  This acyl-enzyme did not cyclize to crosslink the active site as did that from the lead compd.  Model building suggested that the rapid enzyme acylation by the new mol. may occur because of favorable interaction between the polar terminus of its side chain and elements of the Ω loop that abuts the active site, Arg 204 in particular.  This interaction should be considered in the design of new covalent β-lactamase inhibitors.  The initially formed acyl-enzyme partitions (ratio of ∼1) between hydrolysis, which regenerates the active enzyme, and formation of an inert second acyl-enzyme.  Structural modeling suggests that the latter intermediate arises from conformational movement of the acyl group away from the reaction center, probably enforced by the inflexibility of the acyl group.  The new mol. is thus a mechanism-based inhibitor in which an inert complex is formed by noncovalent rearrangement.  Phosphyl analogs of the new mol. were efficient inactivators of neither DD-peptidases nor β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94QaIWIJdXrVg90H21EOLACvtfcHk0lhj0Sz0gZqduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWitLfN&md5=7c003a3fdf68d5740b69110dfe4490d7</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01149%26sid%3Dliteratum%253Aachs%26aulast%3DTilvawala%26aufirst%3DR.%26aulast%3DCammarata%26aufirst%3DM.%26aulast%3DAdediran%26aufirst%3DS.%2BA.%26aulast%3DBrodbelt%26aufirst%3DJ.%2BS.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DA%2520new%2520covalent%2520inhibitor%2520of%2520class%2520C%2520%25CE%25B2-lactamases%2520reveals%2520extended%2520active%2520site%2520specificity%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D7375%26epage%3D7384%26doi%3D10.1021%2Facs.biochem.5b01149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyrouthy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2172</span>, <span class="refDoi"> DOI: 10.1021/jm2014138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ehtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2163-2172&author=D.+A.+Nicholsauthor=P.+Jaishankarauthor=W.+Larsonauthor=E.+Smithauthor=G.+Liuauthor=R.+Beyrouthyauthor=R.+Bonnetauthor=A.+R.+Rensloauthor=Y.+Chen&title=Structure-based+design+of+potent+and+ligand-efficient+inhibitors+of+CTX-M+class+A+%CE%B2-lactamase&doi=10.1021%2Fjm2014138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Ligand-Efficient Inhibitors of CTX-M Class A β-Lactamase</span></div><div class="casAuthors">Nichols, Derek A.; Jaishankar, Priyadarshini; Larson, Wayne; Smith, Emmanuel; Liu, Guoqing; Beyrouthy, Racha; Bonnet, Richard; Renslo, Adam R.; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of CTX-M class A extended-spectrum β-lactamases poses a serious health threat to the public.  We have applied structure-based design to improve the potency of a novel noncovalent tetrazole-contg. CTX-M inhibitor (Ki = 21 μM) more than 200-fold via structural modifications targeting two binding hot spots, a hydrophobic shelf formed by Pro167 and a polar site anchored by Asp240.  Functional groups contacting each binding hot spot independently in initial designs were later combined to produce analogs with submicromolar potencies, including 6-trifluoromethyl-3H-benzoimidazole-4-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide, which had a Ki value of 89 nM and reduced the MIC of cefotaxime by 64-fold in CTX-M-9 expressing Escherichia coli.  The in vitro potency gains were accompanied by improvements in ligand efficiency (from 0.30 to 0.39) and LipE (from 1.37 to 3.86).  These new analogs represent the first nM-affinity noncovalent inhibitors of a class A β-lactamase.  Their complex crystal structures provide valuable information about ligand binding for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG6waxyEIRbVg90H21EOLACvtfcHk0lh0FgjP55L0JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ehtL8%253D&md5=401edc1ac861781d1cd8f6fc33fd6a9b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm2014138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014138%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BA.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DLarson%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DBeyrouthy%26aufirst%3DR.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DStructure-based%2520design%2520of%2520potent%2520and%2520ligand-efficient%2520inhibitors%2520of%2520CTX-M%2520class%2520A%2520%25CE%25B2-lactamase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2163%26epage%3D2172%26doi%3D10.1021%2Fjm2014138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFrees, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Antibacterial spectrum of a tetrazole-based reversible inhibitor of serine β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>, <span class="NLM_elocation-id">e02563-17</span> <span class="refDoi"> DOI: 10.1128/AAC.02563-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02563-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29844038" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&author=O.+A.+Pembertonauthor=X.+Zhangauthor=D.+A.+Nicholsauthor=K.+DeFreesauthor=P.+Jaishankarauthor=R.+Bonnetauthor=J.+Adamsauthor=L.+N.+Shawauthor=A.+R.+Rensloauthor=Y.+Chen&title=Antibacterial+spectrum+of+a+tetrazole-based+reversible+inhibitor+of+serine+%CE%B2-lactamases&doi=10.1128%2FAAC.02563-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FAAC.02563-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02563-17%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DNichols%26aufirst%3DD.%2BA.%26aulast%3DDeFrees%26aufirst%3DK.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DAntibacterial%2520spectrum%2520of%2520a%2520tetrazole-based%2520reversible%2520inhibitor%2520of%2520serine%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26doi%3D10.1128%2FAAC.02563-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aik, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinati, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1038/nchem.2110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fnchem.2110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=25411887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1084-1090&author=J.+Bremauthor=S.+S.+van+Berkelauthor=W.+Aikauthor=A.+M.+Rydzikauthor=M.+B.+Avisonauthor=I.+Pettinatiauthor=K.+D.+Umlandauthor=A.+Kawamuraauthor=J.+Spencerauthor=T.+D.+Claridgeauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=Rhodanine+hydrolysis+leads+to+potent+thioenolate+mediated+metallo-%CE%B2-lactamase+inhibition&doi=10.1038%2Fnchem.2110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition</span></div><div class="casAuthors">Brem, Jurgen; van Berkel, Sander S.; Aik, WeiShen; Rydzik, Anna M.; Avison, Matthew B.; Pettinati, Ilaria; Umland, Klaus-Daniel; Kawamura, Akane; Spencer, James; Claridge, Timothy D. W.; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The use of β-lactam antibiotics is compromised by bacterial resistance, which is provided by β-lactamases belonging to both metallo (MBL)- and serine (SBL)-β-lactamase subfamilies.  The rhodanines are one of very few compd. classes that inhibit penicillin-binding proteins (PBPs), SBLs and, as recently reported, MBLs.  Here, we describe crystallog. analyses of the mechanism of inhibition of the clin. relevant VIM-2 MBL by a rhodanine, which reveal that the rhodanine ring undergoes hydrolysis to give a thioenolate.  The thioenolate is found to bind via di-zinc chelation, mimicking the binding of intermediates in β-lactam hydrolysis.  Crystn. of VIM-2 in the presence of the intact rhodanine led to observation of a ternary complex of MBL, a thioenolate fragment and rhodanine.  The crystallog. observations are supported by kinetic and biophys. studies, including 19F NMR analyses, which reveal the rhodanine-derived thioenolate to be a potent broad-spectrum MBL inhibitor and a lead structure for the development of new types of clin. useful MBL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNzcR63eD9MbVg90H21EOLACvtfcHk0lis0RXALKjHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlt7rK&md5=8a8dae4e6ccb450a06c56d7d80f896b6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2110%26sid%3Dliteratum%253Aachs%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3Dvan%2BBerkel%26aufirst%3DS.%2BS.%26aulast%3DAik%26aufirst%3DW.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DPettinati%26aufirst%3DI.%26aulast%3DUmland%26aufirst%3DK.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DRhodanine%2520hydrolysis%2520leads%2520to%2520potent%2520thioenolate%2520mediated%2520metallo-%25CE%25B2-lactamase%2520inhibition%26jtitle%3DNat.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1084%26epage%3D1090%26doi%3D10.1038%2Fnchem.2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundriyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6229</span>– <span class="NLM_lpage">6232</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2Fj.bmcl.2012.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22921080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GksL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6229-6232&author=P.+Chenauthor=L.+B.+Hortonauthor=R.+L.+Mikulskiauthor=L.+Dengauthor=S.+Sundriyalauthor=T.+Palzkillauthor=Y.+Song&title=2-Substituted+4%2C5-dihydrothiazole-4-carboxylic+acids+are+novel+inhibitors+of+metallo-%CE%B2-lactamases&doi=10.1016%2Fj.bmcl.2012.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases</span></div><div class="casAuthors">Chen, Pinhong; Horton, Lori B.; Mikulski, Rose L.; Deng, Lisheng; Sundriyal, Sandeep; Palzkill, Timothy; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6229-6232</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bacterial resistance to β-lactam antibiotics caused by class B metallo-β-lactamases (MBL), esp. for certain hospital-acquired, Gram-neg. pathogens, poses a significant threat to public health.  We report several 2-substituted 4,5-dihydrothiazole-4-carboxylic acids to be novel MBL inhibitors.  Structure activity relationship (SAR) and mol. modeling studies were performed and implications for further inhibitor design are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm8WBZDmczb7Vg90H21EOLACvtfcHk0lis0RXALKjHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GksL7O&md5=29b1ffedd227a81e8a05e99a186cb603</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHorton%26aufirst%3DL.%2BB.%26aulast%3DMikulski%26aufirst%3DR.%2BL.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSundriyal%26aufirst%3DS.%26aulast%3DPalzkill%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DY.%26atitle%3D2-Substituted%25204%252C5-dihydrothiazole-4-carboxylic%2520acids%2520are%2520novel%2520inhibitors%2520of%2520metallo-%25CE%25B2-lactamases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6229%26epage%3D6232%26doi%3D10.1016%2Fj.bmcl.2012.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span> <span> </span><span class="NLM_article-title">In silico fragment-based design identifies subfamily B1 metallo-β-lactamase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1255-1260&author=R.+Cainauthor=J.+Bremauthor=D.+Zollmanauthor=M.+A.+McDonoughauthor=R.+M.+Johnsonauthor=J.+Spencerauthor=A.+Makenaauthor=M.+I.+Abboudauthor=S.+Cahillauthor=S.+Y.+Leeauthor=P.+J.+McHughauthor=C.+J.+Schofieldauthor=C.+W.+G.+Fishwick&title=In+silico+fragment-based+design+identifies+subfamily+B1+metallo-%CE%B2-lactamase+inhibitors&doi=10.1021%2Facs.jmedchem.7b01728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors</span></div><div class="casAuthors">Cain, Ricky; Brem, Jurgen; Zollman, David; McDonough, Michael A.; Johnson, Rachel M.; Spencer, James; Makena, Anne; Abboud, Martine I.; Cahill, Samuel; Lee, Sook Y.; McHugh, Peter J.; Schofield, Christopher J.; Fishwick, Colin W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1255-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Zinc ion-dependent β-lactamases (MBLs) catalyze the hydrolysis of almost all β-lactam antibiotics and resist the action of clin. available β-lactamase inhibitors.  We report how application of in silico fragment-based mol. design employing thiol-mediated metal anchorage leads to potent MBL inhibitors.  The new inhibitors manifest potent inhibition of clin. important B1 subfamily MBLs, including the widespread NDM-1, IMP-1, and VIM-2 enzymes; with lower potency, some of them also inhibit clin. relevant Class A and D serine-β-lactamases.  The inhibitors show selectivity for bacterial MBL enzymes compared to that for human MBL fold nucleases.  Cocrystn. of one inhibitor, which shows potentiation of Meropenem activity against MBL-expressing Enterobacteriaceae, with VIM-2 reveals an unexpected binding mode, involving interactions with residues from conserved active site bordering loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGrruTiqpfGLVg90H21EOLACvtfcHk0lhD7gXmYAMcew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaks7jE&md5=1b7a800b3104ceb1217775417cb55aff</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01728%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DR.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DZollman%26aufirst%3DD.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BM.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DMakena%26aufirst%3DA.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DCahill%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DMcHugh%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26atitle%3DIn%2520silico%2520fragment-based%2520design%2520identifies%2520subfamily%2520B1%2520metallo-%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1255%26epage%3D1260%26doi%3D10.1021%2Facs.jmedchem.7b01728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Castellanos, J.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avison, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5806</span>– <span class="NLM_lpage">5809</span>, <span class="refDoi"> DOI: 10.1039/C7CC02394D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1039%2FC7CC02394D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=28470248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslWrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=5806-5809&author=G.+B.+Liauthor=J.+Bremauthor=R.+Lesniakauthor=M.+I.+Abboudauthor=C.+T.+Lohansauthor=I.+J.+Cliftonauthor=S.+Y.+Yangauthor=J.%0AC.+Jimenez-Castellanosauthor=M.+B.+Avisonauthor=J.+Spencerauthor=M.+A.+McDonoughauthor=C.+J.+Schofield&title=Crystallographic+analyses+of+isoquinoline+complexes+reveal+a+new+mode+of+metallo-%CE%B2-lactamase+inhibition&doi=10.1039%2FC7CC02394D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition</span></div><div class="casAuthors">Li, Guo-Bo; Brem, Jurgen; Lesniak, Robert; Abboud, Martine I.; Lohans, Christopher T.; Clifton, Ian J.; Yang, Sheng-Yong; Jimenez-Castellanos, Juan-Carlos; Avison, Matthew B.; Spencer, James; McDonough, Michael A.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">5806-5809</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Crystallog. analyses of VIM-5 metallo-β-lactamase (MBL) with isoquinoline inhibitors reveal non-Zn2+ ion binding modes.  Comparison with other MBL-inhibitor structures directed addn. of a Zn2+-binding thiol enabling identification of potent B1 MBL inhibitors.  The inhibitors potentiated meropenem activity against clin. isolates harboring MBLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-V5jcoISU0rVg90H21EOLACvtfcHk0lhliXOX9JqzVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslWrsbY%253D&md5=ee793982b9b0e10270e44de82b574d91</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2FC7CC02394D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02394D%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%2BB.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DLesniak%26aufirst%3DR.%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DJimenez-Castellanos%26aufirst%3DJ.%2BC.%26aulast%3DAvison%26aufirst%3DM.%2BB.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCrystallographic%2520analyses%2520of%2520isoquinoline%2520complexes%2520reveal%2520a%2520new%2520mode%2520of%2520metallo-%25CE%25B2-lactamase%2520inhibition%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D5806%26epage%3D5809%26doi%3D10.1039%2FC7CC02394D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linciano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianquinto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span> <span> </span><span class="NLM_article-title">Ten years with New Delhi Metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKnurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=9-34&author=P.+Lincianoauthor=L.+Cendronauthor=E.+Gianquintoauthor=F.+Spyrakisauthor=D.+Tondi&title=Ten+years+with+New+Delhi+Metallo-%CE%B2-lactamase-1+%28NDM-1%29%3A+from+structural+insights+to+inhibitor+design&doi=10.1021%2Facsinfecdis.8b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design</span></div><div class="casAuthors">Linciano, Pasquale; Cendron, Laura; Gianquinto, Eleonora; Spyrakis, Francesca; Tondi, Donatella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-34</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized the past decade, endangering efficacious antibacterial treatments.  No inhibitors for NDM-1 are available in therapy, nor are promising compds. in the pipeline for future NDM-1 inhibitors.  We report the studies dedicated to the design and development of effective NDM-1 inhibitors.  The discussion for each agent moves from the employed design strategy to the ability of the identified inhibitor to synergize β-lactam antibiotics.  A structural anal. of NDM-1 mechanism of action based on selected X-ray complexes is also reported: the intrinsic flexibility of the binding site and the comparison between penicillin/cephalosporin and carbapenem mechanisms of hydrolysis are evaluated.  Despite the valuable progress in terms of structural and mechanistic information, the design of a potent NDM-1 inhibitor to be introduced in therapy remains challenging.  Certainly, only the deep knowledge of NDM-1 architecture and of the variable mechanism of action that NDM-1 employs against different classes of substrates could orient a successful drug discovery campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokXul9Vl3087Vg90H21EOLACvtfcHk0lhliXOX9JqzVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKnurjK&md5=de0c4542ca7fd9755620caef244bf2aa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00247%26sid%3Dliteratum%253Aachs%26aulast%3DLinciano%26aufirst%3DP.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DGianquinto%26aufirst%3DE.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DTondi%26aufirst%3DD.%26atitle%3DTen%2520years%2520with%2520New%2520Delhi%2520Metallo-%25CE%25B2-lactamase-1%2520%2528NDM-1%2529%253A%2520from%2520structural%2520insights%2520to%2520inhibitor%2520design%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D9%26epage%3D34%26doi%3D10.1021%2Facsinfecdis.8b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyrakis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quotadamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibacache, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span> <span> </span><span class="NLM_article-title">Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17716</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-17399-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1038%2Fs41598-017-17399-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29255163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BC1MzivFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17716&author=M.+Santucciauthor=F.+Spyrakisauthor=S.+Crossauthor=A.+Quotadamoauthor=D.+Farinaauthor=D.+Tondiauthor=F.+De+Lucaauthor=J.+D.+Docquierauthor=A.+I.+Prietoauthor=C.+Ibacacheauthor=J.+Blazquezauthor=A.+Venturelliauthor=G.+Crucianiauthor=M.+P.+Costi&title=Computational+and+biological+profile+of+boronic+acids+for+the+detection+of+bacterial+serine-+and+metallo-%CE%B2-lactamases&doi=10.1038%2Fs41598-017-17399-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases</span></div><div class="casAuthors">Santucci Matteo; Spyrakis Francesca; Quotadamo Antonio; Farina Davide; Tondi Donatella; Venturelli Alberto; Costi Maria Paola; Spyrakis Francesca; Cross Simon; De Luca Filomena; Docquier Jean-Denis; Prieto Ana Isabel; Blazquez Jesus; Ibacache Claudia; Blazquez Jesus; Venturelli Alberto; Cruciani Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17716</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Lactamases (BLs) able to hydrolyze β-lactam antibiotics and more importantly the last resort carbapenems, represent a major mechanism of resistance in Gram-negative bacteria showing multi-drug or extensively drug resistant phenotypes.  The early detection of BLs responsible of resistant infections is challenging: approaches aiming at the identification of new BLs inhibitors (BLI) can thus serve as the basis for the development of highly needed diagnostic tools.  Starting from benzo-[b]-thiophene-2-boronic acid (BZB), a nanomolar inhibitor of AmpC β-lactamase (K i  = 27 nM), we have identified and characterized a set of BZB analogues able to inhibit clinically-relevant β-lactamases, including AmpC, Extended-Spectrum BLs (ESBL), KPC- and OXA-type carbapenemases and metallo-β-lactamases (MBL).  A multiligand set of boronic acid (BA) β-lactamase inhibitors was obtained using covalent molecular modeling, synthetic chemistry, enzyme kinetics and antibacterial susceptibility testing.  Data confirmed the possibility to discriminate between clinically-relevant β-lactamases on the basis of their inhibition profile.  Interestingly, this work also allowed the identification of potent KPC-2 and NDM-1 inhibitors able to potentiate the activity of cefotaxime (CTX) and ceftazidime (CAZ) against resistant clinical isolates (MIC reduction, 32-fold).  Our results open the way to the potential use of our set of compounds as a diagnostic tool for the sensitive detection of clinically-relevant β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH6MmIE8u3OvcsfMJQC1ZdfW6udTcc2eZ2DTKJ9fkBvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzivFaruw%253D%253D&md5=8801f8e77467d45ce1808121ce0fa5d1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-17399-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-17399-7%26sid%3Dliteratum%253Aachs%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DSpyrakis%26aufirst%3DF.%26aulast%3DCross%26aufirst%3DS.%26aulast%3DQuotadamo%26aufirst%3DA.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DTondi%26aufirst%3DD.%26aulast%3DDe%2BLuca%26aufirst%3DF.%26aulast%3DDocquier%26aufirst%3DJ.%2BD.%26aulast%3DPrieto%26aufirst%3DA.%2BI.%26aulast%3DIbacache%26aufirst%3DC.%26aulast%3DBlazquez%26aufirst%3DJ.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26atitle%3DComputational%2520and%2520biological%2520profile%2520of%2520boronic%2520acids%2520for%2520the%2520detection%2520of%2520bacterial%2520serine-%2520and%2520metallo-%25CE%25B2-lactamases%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D17716%26doi%3D10.1038%2Fs41598-017-17399-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gretes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrienko, G. I.</span></span> <span> </span><span class="NLM_article-title">Cyclobutanone analogues of β-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-β-lactamases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1021/ja9086374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9086374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=2558-2560&author=J.+W.+Johnsonauthor=M.+Gretesauthor=V.+J.+Goodfellowauthor=L.+Marroneauthor=M.+L.+Heynenauthor=N.+C.+Strynadkaauthor=G.+I.+Dmitrienko&title=Cyclobutanone+analogues+of+%CE%B2-lactams+revisited%3A+insights+into+conformational+requirements+for+inhibition+of+serine-+and+metallo-%CE%B2-lactamases&doi=10.1021%2Fja9086374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutanone analogues of β-lactams revisited: Insights into conformational requirements for inhibition of serine- and metallo-β-lactamases</span></div><div class="casAuthors">Johnson, Jarrod W.; Gretes, Michael; Goodfellow, Valerie J.; Marrone, Laura; Heynen, Miriam L.; Strynadka, Natalie C. J.; Dmitrienko, Gary I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2558-2560</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most important mode of bacterial resistance to β-lactam antibiotics is the expression of β-lactamases.  New cyclobutanone analogs of penams and penems have been prepd. and evaluated for inhibition of class A, B, C, and D β-lactamases.  Inhibitors which favor conformations in which the C4 carboxylate is equatorial were found to be more potent than those in which the carboxylate is axial, and mol. modeling studies with enzyme inhibitor complexes indicate that an equatorial orientation of the carboxylate is required for binding to β-lactamases.  An X-ray structure of OXA-10 complexed with a cyclobutanone confirms that a serine hemiketal is formed in the active site and that the inhibitor adopts the exo envelope.  An unsatd. penem analog was also found to enhance the potency of meropenem against carbapenem-resistant MBL-producing strains of Chryseobacterium meningosepticum and Stenotrophomonas maltophilia.  These cyclobutanones represent the first type of reversible inhibitors to show moderate (low micromolar) inhibition of both serine- and metallo-β-lactamases and should be considered for further development into practical inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqKuq7N7EiPbVg90H21EOLACvtfcHk0lgN64E9wJZR4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslSiurc%253D&md5=5247e08059abf08178fd0c522adabd93</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja9086374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9086374%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DGretes%26aufirst%3DM.%26aulast%3DGoodfellow%26aufirst%3DV.%2BJ.%26aulast%3DMarrone%26aufirst%3DL.%26aulast%3DHeynen%26aufirst%3DM.%2BL.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26aulast%3DDmitrienko%26aufirst%3DG.%2BI.%26atitle%3DCyclobutanone%2520analogues%2520of%2520%25CE%25B2-lactams%2520revisited%253A%2520insights%2520into%2520conformational%2520requirements%2520for%2520inhibition%2520of%2520serine-%2520and%2520metallo-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D2558%26epage%3D2560%26doi%3D10.1021%2Fja9086374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutledge, P. J.</span></span> <span> </span><span class="NLM_article-title">Cyclobutanone analogues of β-lactam antibiotics: β-lactamase inhibitors with untapped potential?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1002%2Fcbic.201600529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=27992105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFGms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=338-351&author=P.+Deviauthor=P.+J.+Rutledge&title=Cyclobutanone+analogues+of+%CE%B2-lactam+antibiotics%3A+%CE%B2-lactamase+inhibitors+with+untapped+potential%3F&doi=10.1002%2Fcbic.201600529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?</span></div><div class="casAuthors">Devi, Prarthana; Rutledge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-351</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">β-Lactam antibiotics have been used for many years to treat bacterial infections.  However the effective treatment of an increasing range of microbial infections is threatened by bacterial resistance to β-lactams: the prolonged, widespread (and at times reckless) use of these drugs has spawned widespread resistance, which renders them ineffective against many bacterial strains.  The cyclobutanone ring system is isosteric with β-lactam: in cyclobutanone analogs, the eponymous cyclic amide is replaced with an all-carbon ring, the amide N is substituted by a tertiary C-H α to a ketone.  Cyclobutanone analogs of various β-lactam antibiotics have been investigated over the last 35 years, initially as prospective antibiotics in their own right and inhibitors of the β-lactamase enzymes that impart resistance to β-lactams.  More recently they have been tested as inhibitors of other serine proteases and as mechanistic probes of β-lactam biosynthesis.  Cyclobutanone analogs of the penam ring system are the first reversible inhibitors with moderate activity against all classes of β-lactamase; other compds. from this family inhibit Streptomyces R61 DD-carboxypeptidase/transpeptidase, human neutrophil elastase and porcine pancreatic elastase.  But has their potential as enzyme inhibitors been fully exploited.  Challenges in synthesizing diversely functionalized cyclobutanone derivs. mean that only a limited no. have been made (with limited structural diversity) and evaluated.  This review surveys the different synthetic approaches that have been taken to these compds., the investigations made to evaluate their biol. activity and prospects for future developments in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9NfgXFAxC7Vg90H21EOLACvtfcHk0lgBDk4qwItOsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFGms7w%253D&md5=e8e299c02ced6c277771bc210bb6a0c0</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600529%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DP.%26aulast%3DRutledge%26aufirst%3DP.%2BJ.%26atitle%3DCyclobutanone%2520analogues%2520of%2520%25CE%25B2-lactam%2520antibiotics%253A%2520%25CE%25B2-lactamase%2520inhibitors%2520with%2520untapped%2520potential%253F%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D338%26epage%3D351%26doi%3D10.1002%2Fcbic.201600529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geibel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span> <span> </span><span class="NLM_article-title">1401. A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of single and repeat doses of VNRX-5133 in healthy subjects</span>. <i>Open Forum Infectious Diseases</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">S431</span>, <span class="refDoi"> DOI: 10.1093/ofid/ofy210.1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fofid%2Fofy210.1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=S431&author=B.+Geibelauthor=J.+Dowellauthor=D.+Dickersonauthor=T.+Henkel&title=1401.+A+randomized%2C+double-blind%2C+placebo-controlled+study+of+the+safety+and+pharmacokinetics+of+single+and+repeat+doses+of+VNRX-5133+in+healthy+subjects&doi=10.1093%2Fofid%2Fofy210.1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fofid%2Fofy210.1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fofid%252Fofy210.1232%26sid%3Dliteratum%253Aachs%26aulast%3DGeibel%26aufirst%3DB.%26aulast%3DDowell%26aufirst%3DJ.%26aulast%3DDickerson%26aufirst%3DD.%26aulast%3DHenkel%26aufirst%3DT.%26atitle%3D1401.%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520single%2520and%2520repeat%2520doses%2520of%2520VNRX-5133%2520in%2520healthy%2520subjects%26jtitle%3DOpen%2520Forum%2520Infectious%2520Diseases%26date%3D2018%26volume%3D5%26spage%3DS431%26doi%3D10.1093%2Fofid%2Fofy210.1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of substrate recognition and product release by the <i>Klebsiella pneumoniae</i> Carbapenemase (KPC-2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00158</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00158" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3525-3530&author=O.+A.+Pembertonauthor=X.+Zhangauthor=Y.+Chen&title=Molecular+basis+of+substrate+recognition+and+product+release+by+the+Klebsiella+pneumoniae+Carbapenemase+%28KPC-2%29&doi=10.1021%2Facs.jmedchem.7b00158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span></div><div class="casAuthors">Pemberton, Orville A.; Zhang, Xiujun; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3525-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the prodn. of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase.  Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics contg. hydrolyzed cefotaxime and faropenem.  They provide exptl. insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity.  These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRxiGIa-agP7Vg90H21EOLACvtfcHk0lixKY2w_bm90A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D&md5=4ec87803561ad874f178f1345e9a3dda</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00158%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMolecular%2520basis%2520of%2520substrate%2520recognition%2520and%2520product%2520release%2520by%2520the%2520Klebsiella%2520pneumoniae%2520Carbapenemase%2520%2528KPC-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3525%26epage%3D3530%26doi%3D10.1021%2Facs.jmedchem.7b00158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taracila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hujer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endimiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span> <span> </span><span class="NLM_article-title">Exploring the inhibition of CTX-M-9 by β-lactamase inhibitors and carbapenems</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3465</span>– <span class="NLM_lpage">3475</span>, <span class="refDoi"> DOI: 10.1128/AAC.00089-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.00089-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21555770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=3465-3475&author=C.+R.+Bethelauthor=M.+Taracilaauthor=T.+Shyrauthor=J.+M.+Thomsonauthor=A.+M.+Distlerauthor=K.+M.+Hujerauthor=A.+M.+Hujerauthor=A.+Endimianiauthor=K.+Papp-Wallaceauthor=R.+Bonnetauthor=R.+A.+Bonomo&title=Exploring+the+inhibition+of+CTX-M-9+by+%CE%B2-lactamase+inhibitors+and+carbapenems&doi=10.1128%2FAAC.00089-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the inhibition of CTX-M-9 by β-lactamase inhibitors and carbapenems</span></div><div class="casAuthors">Bethel, Christopher R.; Taracila, Magdalena; Shyr, Teresa; Thomson, Jodi M.; Distler, Anne M.; Hujer, Kristine M.; Hujer, Andrea M.; Endimiani, Andrea; Papp-Wallace, Krisztina; Bonnet, Richard; Bonomo, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3465-3475</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Currently, CTX-M β-lactamases are among the most prevalent and most heterogeneous extended-spectrum β-lactamases (ESBLs).  In general, CTX-M enzymes are susceptible to inhibition by β-lactamase inhibitors.  However, it is unknown if the pathway to inhibition by β-lactamase inhibitors for CTX-M ESBLs is similar to TEM and SHV β-lactamases and why bacteria possessing only CTX-M ESBLs are so susceptible to carbapenems.  Here, we have performed a kinetic anal. and timed electrospray ionization mass spectrometry (ESI-MS) studies to reveal the intermediates of inhibition of CTX-M-9, an ESBL representative of this family of enzymes.  CTX-M-9 β-lactamase was inactivated by sulbactam, tazobactam, clavulanate, meropenem, doripenem, ertapenem, and a 6-methylidene penem, penem 1.  Ki values ranged from 1.6 ± 0.3 μM (mean ± std. error) for tazobactam to 0.02 ± 0.01 μM for penem 1.  Before and after tryptic digestion of the CTX-M-9 β-lactamase apo-enzyme and CTX-M-9 inactivation by inhibitors (meropenem, clavulanate, sulbactam, tazobactam, and penem 1), ESI-MS and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) identified different adducts attached to the peptide contg. the active site Ser70 (+52, 70, 88, and 156 ± 3 amu).  This study shows that a multistep inhibition pathway results from modification or fragmentation with clavulanate, sulbactam, and tazobactam, while a single acyl enzyme intermediate is detected when meropenem and penem 1 inactivate CTX-M-9 β-lactamase.  More generally, we propose that Arg276 in CTX-M-9 plays an essential role in the recognition of the C3 carboxylate of inhibitors and that the localization of this pos. charge to a "region of the active site" rather than a specific residue represents an important evolutionary strategy used by β-lactamases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjoVQ_gJpbkrVg90H21EOLACvtfcHk0lixKY2w_bm90A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OrtLY%253D&md5=c58179b2f00181bd04e2b5fe202f8a3d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1128%2FAAC.00089-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00089-11%26sid%3Dliteratum%253Aachs%26aulast%3DBethel%26aufirst%3DC.%2BR.%26aulast%3DTaracila%26aufirst%3DM.%26aulast%3DShyr%26aufirst%3DT.%26aulast%3DThomson%26aufirst%3DJ.%2BM.%26aulast%3DDistler%26aufirst%3DA.%2BM.%26aulast%3DHujer%26aufirst%3DK.%2BM.%26aulast%3DHujer%26aufirst%3DA.%2BM.%26aulast%3DEndimiani%26aufirst%3DA.%26aulast%3DPapp-Wallace%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DR.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26atitle%3DExploring%2520the%2520inhibition%2520of%2520CTX-M-9%2520by%2520%25CE%25B2-lactamase%2520inhibitors%2520and%2520carbapenems%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D3465%26epage%3D3475%26doi%3D10.1128%2FAAC.00089-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomanicek, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrader, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, L.</span></span> <span> </span><span class="NLM_article-title">Neutron and X-ray crystal structures of a perdeuterated enzyme inhibitor complex reveal the catalytic proton network of the Toho-1 β-lactamase for the acylation reaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">4715</span>– <span class="NLM_lpage">4722</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.436238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1074%2Fjbc.M112.436238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23255594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=4715-4722&author=S.+J.+Tomanicekauthor=R.+F.+Standaertauthor=K.+L.+Weissauthor=A.+Ostermannauthor=T.+E.+Schraderauthor=J.+D.+Ngauthor=L.+Coates&title=Neutron+and+X-ray+crystal+structures+of+a+perdeuterated+enzyme+inhibitor+complex+reveal+the+catalytic+proton+network+of+the+Toho-1+%CE%B2-lactamase+for+the+acylation+reaction&doi=10.1074%2Fjbc.M112.436238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Neutron and X-ray Crystal Structures of a Perdeuterated Enzyme Inhibitor Complex Reveal the Catalytic Proton Network of the Toho-1 β-Lactamase for the Acylation Reaction</span></div><div class="casAuthors">Tomanicek, Stephen J.; Standaert, Robert F.; Weiss, Kevin L.; Ostermann, Andreas; Schrader, Tobias E.; Ng, Joseph D.; Coates, Leighton</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4715-4722</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism by which class A β-lactamases hydrolyze β-lactam antibiotics has been the subject of intensive investigation using many different exptl. techniques.  Here, we report on the novel use of both neutron and high resoln. x-ray diffraction to help elucidate the identity of the catalytic base in the acylation part of the catalytic cycle, wherein the β-lactam ring is opened and an acyl-enzyme intermediate forms.  To generate protein crystals optimized for neutron diffraction, we produced a perdeuterated form of the Toho-1 β-lactamase R274N/R276N mutant.  Protein perdeuteration, which involves replacing all of the hydrogen atoms in a protein with deuterium, gives a much stronger signal in neutron diffraction and enables the positions of individual deuterium atoms to be located.  We also synthesized a perdeuterated acylation transition state analog, benzothiophene-2-boronic acid, which was also isotopically enriched with 11B, as 10B is a known neutron absorber.  Using the neutron diffraction data from the perdeuterated enzyme-inhibitor complex, we were able to det. the positions of deuterium atoms in the active site directly rather than by inference.  The neutron diffraction results, along with supporting bond-length anal. from high resoln. x-ray diffraction, strongly suggest that Glu-166 acts as the general base during the acylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1N46HO6A-bVg90H21EOLACvtfcHk0ljOzpojDT5BNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLc%253D&md5=7788933f2cc2194f7aa701272df7c5f7</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.436238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.436238%26sid%3Dliteratum%253Aachs%26aulast%3DTomanicek%26aufirst%3DS.%2BJ.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DWeiss%26aufirst%3DK.%2BL.%26aulast%3DOstermann%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BE.%26aulast%3DNg%26aufirst%3DJ.%2BD.%26aulast%3DCoates%26aufirst%3DL.%26atitle%3DNeutron%2520and%2520X-ray%2520crystal%2520structures%2520of%2520a%2520perdeuterated%2520enzyme%2520inhibitor%2520complex%2520reveal%2520the%2520catalytic%2520proton%2520network%2520of%2520the%2520Toho-1%2520%25CE%25B2-lactamase%2520for%2520the%2520acylation%2520reaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D4715%26epage%3D4722%26doi%3D10.1074%2Fjbc.M112.436238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, J. D.</span></span> <span> </span><span class="NLM_article-title">Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and <i>Pseudomonas aeruginosa</i> AmpC β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2496</span>– <span class="NLM_lpage">2505</span>, <span class="refDoi"> DOI: 10.1128/AAC.02247-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1128%2FAAC.02247-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=23439634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2496-2505&author=S.+D.+Lahiriauthor=S.+Manganiauthor=T.+Durand-Revilleauthor=M.+Benvenutiauthor=F.+De+Lucaauthor=G.+Sanyalauthor=J.+D.+Docquier&title=Structural+insight+into+potent+broad-spectrum+inhibition+with+reversible+recyclization+mechanism%3A+avibactam+in+complex+with+CTX-M-15+and+Pseudomonas+aeruginosa+AmpC+%CE%B2-lactamases&doi=10.1128%2FAAC.02247-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases</span></div><div class="casAuthors">Lahiri, Sushmita D.; Mangani, Stefano; Durand-Reville, Thomas; Benvenuti, Manuela; De Luca, Filomena; Sanyal, Gautam; Docquier, Jean-Denis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2496-2505</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Although β-lactams have been the most effective class of antibacterial agents used in clin. practice for the past half century, their effectiveness on Gram-neg. bacteria has been eroded due to the emergence and spread of β-lactamase enzymes that are not affected by currently marketed β-lactam/β-lactamase inhibitor combinations.  Avibactam is a novel, covalent, non-β-lactam β-lactamase inhibitor presently in clin. development in combination with either ceftaroline or ceftazidime.  In vitro studies show that avibactam may restore the broad-spectrum activity of cephalosporins against class A, class C, and some class D β-lactamases.  Here we describe the structures of two clin. important β-lactamase enzymes bound to avibactam, the class A CTX-M-15 extended-spectrum β-lactamase and the class C Pseudomonas aeruginosa AmpC β-lactamase, which together provide insight into the binding modes for the resp. enzyme classes.  The structures reveal similar binding modes in both enzymes and thus provide a rationale for the broad-spectrum inhibitory activity of avibactam.  Identification of the key residues surrounding the binding pocket allows for a better understanding of the potency of this scaffold.  Finally, avibactam has recently been shown to be a reversible inhibitor, and the structures provide insights into the mechanism of avibactam recyclization.  Anal. of the ultra-high-resoln. CTX-M-15 structure suggests how the deacylation mechanism favors recyclization over hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBwwMi5MIpF7Vg90H21EOLACvtfcHk0ljSpRcMKqi63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslyrsrY%253D&md5=c8a5fa5871f2b5d9efc78b6c4c5d7742</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1128%2FAAC.02247-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02247-12%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DS.%2BD.%26aulast%3DMangani%26aufirst%3DS.%26aulast%3DDurand-Reville%26aufirst%3DT.%26aulast%3DBenvenuti%26aufirst%3DM.%26aulast%3DDe%2BLuca%26aufirst%3DF.%26aulast%3DSanyal%26aufirst%3DG.%26aulast%3DDocquier%26aufirst%3DJ.%2BD.%26atitle%3DStructural%2520insight%2520into%2520potent%2520broad-spectrum%2520inhibition%2520with%2520reversible%2520recyclization%2520mechanism%253A%2520avibactam%2520in%2520complex%2520with%2520CTX-M-15%2520and%2520Pseudomonas%2520aeruginosa%2520AmpC%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2496%26epage%3D2505%26doi%3D10.1128%2FAAC.02247-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub><i>I</i></sub>) and the concentration of inhibitor which causes 50 percent inhibition (<i>I</i><sub><i>50</i></sub>) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28KI%29+and+the+concentration+of+inhibitor+which+causes+50+percent+inhibition+%28I50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0ljSpRcMKqi63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528KI%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520percent%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mysinger, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colizzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wassam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span> <span> </span><span class="NLM_article-title">Automated docking screens: a feasibility study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5712</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1021/jm9006966</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006966" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5712-5720&author=J.+J.+Irwinauthor=B.+K.+Shoichetauthor=M.+M.+Mysingerauthor=N.+Huangauthor=F.+Colizziauthor=P.+Wassamauthor=Y.+Cao&title=Automated+docking+screens%3A+a+feasibility+study&doi=10.1021%2Fjm9006966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Docking Screens: A Feasibility Study</span></div><div class="casAuthors">Irwin, John J.; Shoichet, Brian K.; Mysinger, Michael M.; Huang, Niu; Colizzi, Francesco; Wassam, Pascal; Cao, Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5712-5720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. docking is the most practical approach to leverage protein structure for ligand discovery, but the technique retains important liabilities that make it challenging to deploy on a large scale.  We have therefore created an expert system, DOCK Blaster, to investigate the feasibility of full automation.  The method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full screen of large libraries.  A crit. feature is self-assessment, which ests. the anticipated reliability of the automated screening results using pose fidelity and enrichment.  Against common benchmarks, DOCK Blaster recapitulates the crystal ligand pose within 2 Å rmsd 50-60% of the time; inferior to an expert, but respectable.  Half the time the ligand also ranked among the top 5% of 100 phys. matched decoys chosen on the fly.  Further tests were undertaken culminating in a study of 7755 eligible PDB structures.  In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched decoys while also posing within 2 Å rmsd, suggesting that unsupervised prospective docking is viable.  DOCK Blaster is available at http://blaster.docking.org.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPZAd6CrHGp7Vg90H21EOLACvtfcHk0lhKUEl7CnQ6pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOjurjN&md5=f302db1f77b87f26d1fa2fece55bca96</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm9006966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006966%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DMysinger%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DWassam%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DY.%26atitle%3DAutomated%2520docking%2520screens%253A%2520a%2520feasibility%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5712%26epage%3D5720%26doi%3D10.1021%2Fjm9006966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorber, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Protein-protein docking with multiple residue conformations and residue substitutions</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1408</span>, <span class="refDoi"> DOI: 10.1110/ps.2830102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1110%2Fps.2830102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=12021438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1393-1408&author=D.+M.+Lorberauthor=M.+K.+Udoauthor=B.+K.+Shoichet&title=Protein-protein+docking+with+multiple+residue+conformations+and+residue+substitutions&doi=10.1110%2Fps.2830102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein docking with multiple residue conformations and residue substitutions</span></div><div class="casAuthors">Lorber, David M.; Udo, Maria K.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1393-1408</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The protein docking problem has two major aspects: sampling conformations and orientations, and scoring them for fit.  To investigate the extent to which the protein docking problem may be attributed to the sampling of ligand side-chain conformations, multiple conformations of multiple residues were calcd. for the uncomplexed (unbound) structures of protein ligands.  These ligand conformations were docked into both the complexed (bound) and unbound conformations of the cognate receptors, and their energies were evaluated using an atomistic potential function.  The following questions were considered: (1) does the ensemble of precalcd. ligand conformations contain a structure similar to the bound form of the ligand (2) Can the large no. of conformations that are calcd. be efficiently docked into the receptors (3) Can near-native complexes be distinguished from non-native complexes Results from seven test systems suggest that the precalcd. ensembles do include side-chain conformations similar to those adopted in the exptl. complexes.  By assuming additivity among the side chains, the ensemble can be docked in less than 12 h on a desktop computer.  These multiconformer dockings produce near-native complexes and also non-native complexes.  When docked against the bound conformations of the receptors, the near-native complexes of the unbound ligand were always distinguishable from the non-native complexes.  When docked against the unbound conformations of the receptors, the near-native dockings could usually, but not always, be distinguished from the non-native complexes.  In every case, docking the unbound ligands with flexible side chains led to better energies and a better distinction between near-native and non-native fits.  An extension of this algorithm allowed for docking multiple residue substitutions (mutants) in addn. to multiple conformations.  The rankings of the docked mutant proteins correlated with exptl. binding affinities.  These results suggest that sampling multiple residue conformations and residue substitutions of the unbound ligand contributes to, but does not fully provide, a soln. to the protein docking problem.  Conformational sampling allows a classical atomistic scoring function to be used; such a function may contribute to better selectivity between near-native and non-native complexes.  Allowing for receptor flexibility may further extend these results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBFjIchqgD47Vg90H21EOLACvtfcHk0lhKUEl7CnQ6pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFWgsr8%253D&md5=aacce8d982110403befeeb033d4557c2</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1110%2Fps.2830102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.2830102%26sid%3Dliteratum%253Aachs%26aulast%3DLorber%26aufirst%3DD.%2BM.%26aulast%3DUdo%26aufirst%3DM.%2BK.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DProtein-protein%2520docking%2520with%2520multiple%2520residue%2520conformations%2520and%2520residue%2520substitutions%26jtitle%3DProtein%2520Sci.%26date%3D2002%26volume%3D11%26spage%3D1393%26epage%3D1408%26doi%3D10.1110%2Fps.2830102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span> <span> </span><span class="NLM_article-title">iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&author=T.%0AG.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+Leslie&title=iMOSFLM%3A+a+new+graphical+interface+for+diffraction-image+processing+with+MOSFLM&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0lg_pevZWRt2Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26atitle%3DiMOSFLM%253A%2520a%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520MOSFLM%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lg_pevZWRt2Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span> <span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lig_Z7gBiAR9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lig_Z7gBiAR9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhfVBTZuuM4cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0lhV4qNXQRYekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhV4qNXQRYekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span> <span> </span><span class="NLM_article-title">Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1107/S0907444908004319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444908004319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=18453687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlagt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=515-524&author=T.+C.+Terwilligerauthor=R.+W.+Grosse-Kunstleveauthor=P.+V.+Afonineauthor=N.+W.+Moriartyauthor=P.+D.+Adamsauthor=R.+J.+Readauthor=P.+H.+Zwartauthor=L.+W.+Hung&title=Iterative-build+OMIT+maps%3A+map+improvement+by+iterative+model+building+and+refinement+without+model+bias&doi=10.1107%2FS0907444908004319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias</span></div><div class="casAuthors">Terwilliger, Thomas C.; Grosse-Kunstleve, Ralf W.; Afonine, Pavel V.; Moriarty, Nigel W.; Adams, Paul D.; Read, Randy J.; Zwart, Peter H.; Hung, Li Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">515-524</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A procedure for carrying out iterative model building, d. modification and refinement is presented in which the d. in an OMIT region is essentially unbiased by an at. model.  D. from a set of overlapping OMIT regions can be combined to create a composite 'iterative-build' OMIT map that is everywhere unbiased by an at. model but also everywhere benefiting from the model-based information present elsewhere in the unit cell.  The procedure may have applications in the validation of specific features in at. models as well as in overall model validation.  The procedure is demonstrated with a mol.-replacement structure and with an exptl. phased structure and a variation on the method is demonstrated by removing model bias from a structure from the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Xrehe6KWKLVg90H21EOLACvtfcHk0liOIvHcCtRKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlagt78%253D&md5=fdb2b503063ca565775d5d9c51aed5e5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1107%2FS0907444908004319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444908004319%26sid%3Dliteratum%253Aachs%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DHung%26aufirst%3DL.%2BW.%26atitle%3DIterative-build%2520OMIT%2520maps%253A%2520map%2520improvement%2520by%2520iterative%2520model%2520building%2520and%2520refinement%2520without%2520model%2520bias%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D515%26epage%3D524%26doi%3D10.1107%2FS0907444908004319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0liOIvHcCtRKoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eaZ6_k14ITLRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, M. J.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial susceptibility testing: a review of general principles and contemporary practices</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1086/647952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.1086%2F647952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=19857164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sjt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1749-1755&author=J.+H.+Jorgensenauthor=M.+J.+Ferraro&title=Antimicrobial+susceptibility+testing%3A+a+review+of+general+principles+and+contemporary+practices&doi=10.1086%2F647952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial susceptibility testing: a review of general principles and contemporary practices</span></div><div class="casAuthors">Jorgensen, James H.; Ferraro, Mary Jane</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1749-1755</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  An important task of the clin. microbiol. lab. is the performance of antimicrobial susceptibility testing of significant bacterial isolates.  The goals of testing are to detect possible drug resistance in common pathogens and to assure susceptibility to drugs of choice for particular infections.  The most widely used testing methods include broth microdilution or rapid automated instrument methods that use com. marketed materials and devices.  Manual methods that provide flexibility and possible cost savings include the disk diffusion and gradient diffusion methods.  Each method has strengths and weaknesses, including organisms that may be accurately tested by the method.  Some methods provide quant. results (eg, min. inhibitory concn.), and all provide qual. assessments using the categories susceptible, intermediate, or resistant.  In general, current testing methods provide accurate detection of common antimicrobial resistance mechanisms.  However, newer or emerging mechanisms of resistance require const. vigilance regarding the ability of each test method to accurately detect resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowA9YEcYMoYLVg90H21EOLACvtfcHk0ljKSqOeiX_eOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sjt7fI&md5=8a4a78feca6b9fe7140805044fd50ccf</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1086%2F647952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F647952%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BH.%26aulast%3DFerraro%26aufirst%3DM.%2BJ.%26atitle%3DAntimicrobial%2520susceptibility%2520testing%253A%2520a%2520review%2520of%2520general%2520principles%2520and%2520contemporary%2520practices%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D49%26spage%3D1749%26epage%3D1755%26doi%3D10.1086%2F647952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fleeman, R.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debevec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welmaker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghten, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giulianotti, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel polyamine scaffold with potent efflux pump inhibition activity toward multi-drug resistant bacterial pathogens</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1301</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.01301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=10.3389%2Ffmicb.2018.01301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=29963035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FjvVequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1301&author=R.%0AM.+Fleemanauthor=G.+Debevecauthor=K.+Antonenauthor=J.+L.+Adamsauthor=R.+G.+Santosauthor=G.+S.+Welmakerauthor=R.+A.+Houghtenauthor=M.+A.+Giulianottiauthor=L.+N.+Shaw&title=Identification+of+a+novel+polyamine+scaffold+with+potent+efflux+pump+inhibition+activity+toward+multi-drug+resistant+bacterial+pathogens&doi=10.3389%2Ffmicb.2018.01301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens</span></div><div class="casAuthors">Fleeman Renee M; Antonen Kirsten; Adams Jessie L; Shaw Lindsey N; Debevec Ginamarie; Santos Radleigh G; Welmaker Gregory S; Houghten Richard A; Giulianotti Marc A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1301</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">We have previously reported the use of combinatorial chemistry to identify broad-spectrum antibacterial agents.  Herein, we extend our analysis of this technology toward the discovery of anti-resistance molecules, focusing on efflux pump inhibitors.  Using high-throughput screening against multi-drug resistant Pseudomonas aeruginosa, we identified a polyamine scaffold that demonstrated strong efflux pump inhibition without possessing antibacterial effects.  We determined that these molecules were most effective with an amine functionality at R1 and benzene functionalities at R2 and R3.  From a library of 188 compounds, we studied the properties of 5 lead agents in detail, observing a fivefold to eightfold decrease in the 90% effective concentration of tetracycline, chloramphenicol, and aztreonam toward P. aeruginosa isolates.  Additionally, we determined that our molecules were not only active toward P. aeruginosa, but toward Acinetobacter baumannii and Staphylococcus aureus as well.  The specificity of our molecules to efflux pump inhibition was confirmed using ethidium bromide accumulation assays, and in studies with strains that displayed varying abilities in their efflux potential.  When assessing off target effects we observed no disruption of bacterial membrane polarity, no general toxicity toward mammalian cells, and no inhibition of calcium channel activity in human kidney cells.  Finally, combination treatment with our lead agents engendered a marked increase in the bactericidal capacity of tetracycline, and significantly decreased viability within P. aeruginosa biofilms.  As such, we report a unique polyamine scaffold that has strong potential for the future development of novel and broadly active efflux pump inhibitors targeting multi-drug resistant bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfwniovcBepP_I8Jvzw4xCfW6udTcc2eaarihlyiiNcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FjvVequg%253D%253D&md5=5ffeac572333ace791f89a430ceb27a4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.01301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.01301%26sid%3Dliteratum%253Aachs%26aulast%3DFleeman%26aufirst%3DR.%2BM.%26aulast%3DDebevec%26aufirst%3DG.%26aulast%3DAntonen%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DSantos%26aufirst%3DR.%2BG.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26atitle%3DIdentification%2520of%2520a%2520novel%2520polyamine%2520scaffold%2520with%2520potent%2520efflux%2520pump%2520inhibition%2520activity%2520toward%2520multi-drug%2520resistant%2520bacterial%2520pathogens%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1301%26doi%3D10.3389%2Ffmicb.2018.01301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15','PDB','6D15'); return false;">PDB: 6D15</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18','PDB','6D18'); return false;">PDB: 6D18</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8','PDB','5UL8'); return false;">PDB: 5UL8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A','PDB','6D1A'); return false;">PDB: 6D1A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D','PDB','6D1D'); return false;">PDB: 6D1D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F','PDB','6D1F'); return false;">PDB: 6D1F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0','PDB','6DD0'); return false;">PDB: 6DD0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7','PDB','6NY7'); return false;">PDB: 6NY7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E','PDB','6D1E'); return false;">PDB: 6D1E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G','PDB','6D1G'); return false;">PDB: 6D1G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T','PDB','6O5T'); return false;">PDB: 6O5T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19','PDB','6D19'); return false;">PDB: 6D19</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJ3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJ3','PDB','5UJ3'); return false;">PDB: 5UJ3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HL2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HL2','PDB','4HL2'); return false;">PDB: 4HL2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF','PDB','4TZF'); return false;">PDB: 4TZF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3','PDB','1KO3'); return false;">PDB: 1KO3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D16" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D16','PDB','6D16'); return false;">PDB: 6D16</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D17" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D17','PDB','6D17'); return false;">PDB: 6D17</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1B','PDB','6D1B'); return false;">PDB: 6D1B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1C','PDB','6D1C'); return false;">PDB: 6D1C</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1H','PDB','6D1H'); return false;">PDB: 6D1H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1I','PDB','6D1I'); return false;">PDB: 6D1I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1J','PDB','6D1J'); return false;">PDB: 6D1J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1K','PDB','6D1K'); return false;">PDB: 6D1K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD1','PDB','6DD1'); return false;">PDB: 6DD1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3R','PDB','6O3R'); return false;">PDB: 6O3R</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00728">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01546"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00728">10.1021/acs.jmedchem.9b00728</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional figures of IC<sub>50</sub> curves, complex structures of phosphonate compounds with KPC-2, NDM-1, and VIM-2, cytotoxicity testing, <sup>1</sup>H NMR spectra of synthetic analogs, and table of crystallographic data collection and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and the SBL/MBL <i>K</i><sub>i</sub> data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_001.pdf">jm9b00728_si_001.pdf (6.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00728/suppl_file/jm9b00728_si_002.csv">jm9b00728_si_002.csv (1.12 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D15">6D15</a> (KPC-2 with compound <b>1</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D16">6D16</a> (KPC-2 with compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D17">6D17</a> (KPC-2 with compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D18">6D18</a> (KPC-2 with compound <b>6</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D19">6D19</a> (KPC-2 with compound <b>9</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1A">6D1A</a> (NDM-1 with compound <b>1</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1B">6D1B</a> (NDM-1 with compound <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1C">6D1C</a> (NDM-1 with compound <b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1D">6D1D</a> (NDM-1 with compound <b>6</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1E">6D1E</a> (NDM-1 with compound <b>7</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1F">6D1F</a> (NDM-1 with compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1G">6D1G</a> (NDM-1 with compound <b>9</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1H">6D1H</a> (NDM-1 with compound <b>11</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1I">6D1I</a> (NDM-1 with compound <b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1J">6D1J</a> (NDM-1 with compound <b>13</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D1K">6D1K</a> (NDM-1 with compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD0">6DD0</a> (VIM-2 with compound <b>8</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DD1">6DD1</a> (VIM-2 with compound <b>14</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O3R">6O3R</a> (NDM-1 D199N with compound <b>7</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NY7">6NY7</a> (NDM-1 D199N with compound <b>16</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6O5T">6O5T</a> (VIM-2 with compound <b>16</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00728%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00728" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a6157ffb191d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
